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Abstract 
Ring distortion reactions directly alter the core ring systems of small molecules and can 
lead to striking changes in molecular structure. Strategic application of ring distortion reactions to 
complex molecules, such as natural products, is an effective method for the generation of 
compounds that exhibit significant molecular complexity, but possess vastly different molecular 
structures. The compounds produced by this complexity to diversity approach are advantageous 
starting points for the discovery of new biologically active compounds, as they possess a level of 
molecular complexity found in approved drugs but lacking in other screening collections used in 
drug discovery. 
The chapters herein emphasize the utility of ring distortion reactions for modifying 
complex molecules and assert the potential of ring distortion as strategy for the synthesis of 
complex and diverse small molecules. Chapter 1 defines the different methods of ring distortion 
and demonstrates how these reactions can be employed for the selective modification of complex 
molecules. Chapter 2 focuses on the application of ring distortion reactions to the cinchona 
alkaloid natural product quinine towards the creation of a collection of complex and diverse small 
molecules. Chapter 3 details the ring distortion of the terpene natural product abietic acid and 
details strategies for the synthesis of derivative libraries from the products of ring distortion. 
Chapter 4 describes on the ring distortion of the terpene natural product pleuromutilin and the 
discovery of a pleuromutilin-derived compound with anticancer activity. 
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Chapter 1: Chemical Modification of Complex Molecules via Ring Distortion 
1.1 Ring Distortion 
 Ring distortion reactions are reactions that directly alter the connectivity of rings in a 
molecule and modify the three-dimensional arrangement of functional groups (Scheme 1.1). These 
reactions include reactions that alter ring size (ring expansion and ring contraction), reactions that 
break rings (ring cleavage) and form new rings (ring fusion), reactions that alter multiple rings 
(ring rearrangement), and reactions that alter the aromaticity of rings (aromatization and 
dearomatization). The strategic application of ring distortion reactions to complex molecules is an 
effective method for dramatically altering compound structure and can also lead to significant 
changes in biological activity. 
The ability of ring distortion reactions to alter small molecule structure and function is 
demonstrated in the biosynthesis of secondary metabolites, as many natural products are produced 
via enzymatic ring distortion of a structurally complex biosynthetic intermediate.1 Furthermore, 
divergent evolution has led to different organisms utilizing the same complex biosynthetic 
intermediate to produce natural products with very different structures and biological activities.1 
 
Scheme 1.1: Ring distortion reactions. 
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For example, strictosidine is a common intermediate in the biosynthesis of a myriad of different 
terpene indole alkaloid natural products (Scheme 1.2).2 The natural products produced via 
enzymatic ring distortion of strictosidine possess diverse structural features and many exhibit 
medicinally important biological activities (e.g. anticancer, antimalaria, antiarrhythmia).2  
Synthetic chemists have also realized the utility of ring distortion for modulating small 
molecule structure and function. Thus, a multitude of synthetic methods have been developed to 
alter the ring systems of complex small molecules. Ring distortion reactions are routinely 
employed in the chemical synthesis of complex molecules and are particularly useful for the 
creation of ring systems that would be challenging to prepare from simple starting materials. 
Herein, an overview is presented of the different types of ring distortion reactions for altering 
complex molecules (ring expansion, contraction, cleavage, fusion, rearrangement, ring 
aromatization/dearomatization), synthetic methods to achieve these reactions, and relevant 
examples of their use in the synthesis of complex small molecules. 
 
Scheme 1.2: Ring distortion in the biosynthesis of terpene indole alkaloids from strictosidine. 
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1.2 Ring Expansion 
Ring expansion reactions are reactions that increase ring size by one or more atoms.3, 4 
These reactions are an advantageous method for incorporating heteroatoms and altering the three-
dimensional shape of complex ring systems.5 Ring expansion reactions are also particularly useful 
for accessing rings of uncommon size (e.g. 7-membered rings).4-6 There are four general strategies 
for achieving ring expansion (Scheme 1.3). The first involves incorporation of a pendant group Z, 
which possesses charge or carbene character, and ring expansion by migratory shift or insertion 
(Scheme 1.3A). Ring expansion can also be achieved by cleavage of a shared bond in polycyclic 
ring system (Scheme 1.3B). Electrocyclic reactions can also be used for ring expansion (Scheme 
1.3C). Additionally, ring expansion can be accomplished by a ring cleavage/ring fusion cascade, 
which involves cleavage of an existing ring followed by a ring fusion reaction to provide a new, 
larger ring (Scheme 1.3D).  
1.2.1 Ring Expansion by Migratory Shift  
1.2.1.1 Incorporation of an Oxygen Atom 
 Ring expansion reactions are excellent methods for the addition of heteroatoms into rings 
containing carbonyl groups. Ring expansion to incorporate an oxygen atom is typically 
accomplished by the Baeyer-Villiger reaction, which involves the addition of a peroxy acid into a 
carbonyl followed by migratory shift of a C-C bond to form a lactone.7 The predictable migratory 
aptitude of different carbon groups in the Baeyer-Villiger reaction and the relatively mild reaction 
conditions have enabled widespread use of the Baeyer-Villiger reaction on complex molecules 
(Scheme 1.4). A ketone derived from gibberellic acid (G19) was subjected to Baeyer-Villiger ring 
 
Scheme 1.3: Strategies for ring expansion. 
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expansion in the synthesis of G6 (Scheme 1.4A).8 Baeyer-Villiger ring expansion of AA4 to AA6 
was employed as an intermediate ring distortion step in synthesis of structurally diverse complex 
molecules from abietic acid (Scheme 1.4B, see Chapter 3).9 The Baeyer-Villiger reaction has also 
been used as a ring distortion strategy in total synthesis. For example, the Fuchs groups used a 
Baeyer-Villiger reaction to facilitate the synthesis of cephalostatin 1 analogues (Scheme 1.4C).10  
1.2.1.2 Incorporation of a Nitrogen Atom 
Ring expansion of rings containing carbonyl groups to incorporate a nitrogen atom can be 
accomplished by the Schmidt reaction or via the Beckmann reaction (Scheme 1.5). The Schmidt 
reaction of ketones often requires harsh, strongly acidic conditions and is complicated by the poor 
regioselectivity of C-C bond migration and competing ring cleavage pathways.11 For example, the 
Schmidt reaction of adrenosterone resulted in ring expansion of the A-ring and C-ring cleavage to 
form the constitutional isomers A6 and A7 (Scheme 1.5A).8 However, milder conditions can be 
employed in the intramolecular molecular variant of the Schmidt reaction. The Aube group 
recently used the intramolecular Schmidt reaction to create a collection of structurally diverse 
alkaloid-inspired scaffolds (Scheme 1.5B and 1.5C).12    
 
Scheme 1.4: Ring expansion via the Baeyer-Villiger reaction. 
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The Beckmann reaction is an alternative strategy for the incorporation of a nitrogen atom 
by ring expansion and involves the activation and rearrangement of an oxime.13 The 
regioselectivity of the Beckmann reaction is dependent on the configuration of the oxime starting 
material and single isomers of amide products can be obtained. Numerous methods have been 
developed for oxime activation and Beckmann reaction initiation.13 The milder conditions of the 
Beckmann reaction and the improved regioselectivity compared to the Schmidt reaction make the 
 
Scheme 1.5: Ring expansion via the Schmidt reaction. 
 
Scheme 1.6: Ring expansion via the Beckmann reaction. 
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Beckmann reaction a popular choice for the ring expansion of complex molecules (Scheme 1.6). 
The Beckmann reaction has been used in the ring distortion of several natural products. Beckmann 
reaction of adrenosterone provided the ring expansion product A18 (Scheme 1.6A).8 Ring 
expansion of pleuromutilin-derived oxime P21 was accomplished by a Beckmann reaction 
(Scheme 1.6B, also Chapter 4). The Georg group also applied the Beckmann ring expansion to 
isosteviol, a degradation product of stevioside (Scheme 1.6C).14  
1.2.1.3 Incorporation of a Carbon Atom 
 Ring expansion to incorporate a carbon atom is a useful strategy for the ring distortion of 
complex molecules and is a popular strategy for the creation of 7-membered rings.4, 15 Most ring 
expansion strategies to incorporate a carbon atom involve the creation of an exocyclic carbocation, 
radical, or carbene adjacent to an existing ring that can undergo a 1,2-alkyl migration.4 Due to the 
high reactivity of carbocations, radicals, and carbenes, achieving regioselective 1,2-migration can 
be challenging for unbiased substrates. However, these reactions are very useful for ring distortion 
of certain substrates. For instance, activation of a secondary alcohol derived from pleuromutilin 
results in carbocation formation and ring expansion of the 6-membered ring via Wagner-Meerwein 
rearrangement (Scheme 1.7A, see Chapter 4). In order to gain better control of ring expansion 
reactions, methods have been developed to modulate the reactivity of the carbocation, radical, or 
carbene adjacent to the ring. Ring expansion via the pinacol and related rearrangements typically 
occurs on substrates containing cyclic tertiary alcohols with vicinal exocyclic leaving groups that 
rearrange to form ring-expanded ketones.16 Numerous leaving groups have been developed for 
pinacol-type ring expansions and these reaction have widespread synthetic utility.4 For example, 
the Baran group used a vinylogous pinacol rearrangement in order to create the 7-membered ring 
of the diterpenoid natural product ingenol (Scheme 1.7B).17 
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1.2.2  Ring Expansion by Polycycle Cleavage 
Cleavage of a shared bond in a fused polycyclic ring system is another method for ring 
expansion (Scheme 1.3B).3 This method is particularly useful for ring expansion of polycycles 
containing a 3- or 4-membered rings due to the strain-release associated with the cleavage of these 
small rings. For example, ring expansion of a dibromocyclopropane derivative of abietic acid 
(AA8) was accomplished by carbocation formation and cyclopropane cleavage to form 
cycloheptene AA9 (Scheme 1.8A, see Chapter 3).9 Grob fragmentation reactions are another useful 
method for ring expansion of polycyclic molecules.18 Rigid polycyclic molecules containing an 
electrophile and a nucleophile separated by 5 bonds are excellent substrates for the Grob 
fragmentation. A good example of the synthetic utility of the Grob fragmentation for the chemical 
diversification of natural products was provided by the Wang group in their ring distortion of the 
diterpenoid alkaloid Deltaline (Scheme 1.8B).19 Another strategy for ring expansion of polycyclic 
 
Scheme 1.7: Ring expansion to incorporate a carbon atom. 
Scheme 1.8: Ring expansion by polycycle cleavage. 
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molecules is oxidative cleavage of an olefin shared between two rings. The Tan lab employed this 
oxidative ring expansion strategy to form a library of complex macrocycles from polycyclic 
dihydropyrans (Scheme 1.8C).20 
1.2.3 Ring Expansion via Pericyclic Reactions  
 Pericyclic reactions can also be employed to induce ring expansion (Scheme 1.3C). [3.3]-
Sigmatropic rearrangements, such as the Cope, Oxy-Cope and Claisen, are useful methods for the 
ring expansion of strained rings in complex molecules. For example, Fukuyama and coworkers 
employed a Cope rearrangement of a divinyl cyclopropane as the key cyclization step in their total 
synthesis of Gelsemoxine (Scheme 1.9A).21 Retro-Diels-Alder reactions can also be employed for 
ring expansion. These reactions are typically accomplished by Diels-Alder cycloaddition between 
an endocyclic diene with an alkyne followed retro-Diels-Alder to form a paracyclophane. This ring 
distortion strategy was recently employed by the Cossy group to create a collection of different 
macrocycles (Scheme 1.9B).22  
1.2.4 Ring Expansion by Ring Cleavage/Ring Fusion Cascade 
Certain substrates can undergo ring expansion by a two-step ring cleavage/ring fusion 
sequence, which involves breaking a ring to provide a substrate that can condense to form a new, 
larger ring (Scheme 1.3D). Ring cleavage/ring fusion cascades are often accomplished by 
oxidative cleavage of rigid polycyclic ring systems. Oxidative cleavage of a diol derived from 
gibberellic acid (G17) led to ring cleavage to form a dialdehyde, which undergoes a ring fusion to 
 
Scheme 1.9: Ring expansion by pericyclic reactions. 
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form acetal G4 (Scheme 1.10A).8 Ring expansion of the 5-membered ring of P10 was achieved 
by treatment with lead tetraacetate, which results in cleavage of the α-hydroxy ketone to form an 
intermediate ester-aldehyde that then undergoes a condensation reaction to form P1 (Scheme 
1.10B, see Chapter 4). The Wang group also employed a ring expansion via ring cleavage/ring 
fusion sequence in their studies on the ring distortion of deltaline (Scheme 1.10C).19   
1.3  Ring Contraction 
Ring contraction reactions are reactions that decrease ring size by one or more atoms and 
are commonly employed in the synthesis of 5- membered rings.23, 24 There are six general strategies 
for achieving ring contraction (Scheme 1.11). Carbocation formation adjacent to a suitable electron 
donating group (Z) facilitates bond migration and ring contraction (Scheme 1.11A). Anionic ring 
contraction can be performed via the Favorskii rearrangement of cyclic α-halo ketones (Scheme 
1.11B) or by the quasi-Favorskii rearrangement (Scheme 1.11C). Generation of a cyclic carbene 
vicinal to a ketone can lead to ring contraction via Wolff rearrangement (Scheme 1.11D). 
 
Scheme 1.10: Ring expansion by tandem ring cleavage/ring fusion. 
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Transannular cyclization reactions are another method for ring contraction (Scheme 1.11E).  
Additionally, ring cleavage/ring fusion cascades can be employed for ring contraction (Scheme 
1.11F).  
1.3.1 Ring Contraction by Carbocation Rearrangement 
 Ring contraction by cyclic carbocation formation and rearrangement is a useful strategy 
for ring distortion of complex molecules (Scheme 1.12).16, 23 Wagner-Meerwein rearrangements 
of rings containing a leaving group can be employed for ring contraction and are best-suited to 
rigid polycyclic molecules. For example, activation of the cyclic secondary alcohol of 
pleuromutilin leads to carbocation formation and ring contraction to form P7 (Scheme 1.12A). The 
regioselectivity of carbocation rearrangement can be biased to ring contraction by 
functionalization of the carbon that is expelled from the ring during ring contraction. Vicinal cyclic 
diols and cyclic epoxides are commonly used groups for ring contraction by carbocation 
rearrangement.16 Kita and coworkers utilized a ring contraction via carbocation rearrangement of 
a cyclic epoxide in their synthesis of fredricamycin A (Scheme 1.12B).25      
 
Scheme 1.11: Strategies for ring contraction. 
 
Scheme 1.12: Ring contraction by carbocation rearrangement. 
11 
 
1.3.2 Anionic Ring Contraction 
 The Favorskii reaction26 and the quasi-Favorskii rearrangement27 are the most common 
methods for anionic ring contraction (Scheme 1.11B and 1.11C, respectively). The Favorskii 
reaction involves α-deprotonation of a ketone bearing a leaving group on the α’-position and 
intramolecular cyclization to form a cyclopropanone that undergoes nucleophilic ring opening to 
form a ring-contracted product. However, the use of the Favorskii rearrangement on complex 
molecules is rare and the reaction is more frequently used on chiral-pool cyclohexanones to prepare 
optically active cyclopentanes.23 An example of the Favorskii rearrangement of a structurally 
complex molecule is the ring contraction of an α-halo ketone derived from epicandicandiol into a 
gibberellin A12 isomer by the Fraga group (Scheme 1.13A).
28 The quasi-Favorskii rearrangement 
is more often employed in complex molecules and is the anionic equivalent of the pinacol 
rearrangement.16 For example, the Wang group utilized a quasi-Favorskii rearrangement to 
perform a ring contraction of the yunaconitine scaffold (Scheme 1.13B).29    
1.3.3  Ring Contraction by Carbene Rearrangement 
 α-Diazo ketones can undergo ring contraction via carbene formation and Wolff 
rearrangement upon exposure to light, heat, or silver(I) salts (Scheme 1.11D).30 The Wolff 
rearrangement has been applied to numerous complex molecules in the context of total synthesis 
and natural product modification. The Koreeda group employed a Wolff rearrangement as a late-
stage ring contraction in the total synthesis of acanthordal (Scheme 1.14A).31 Ring contraction of 
 
Scheme 1.13: Examples of anionic ring contraction. 
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the pleuromutilin scaffold was accomplished by Berner and coworkers using a light-mediated 
Wolff rearrangement (Scheme 1.14B).32 
1.3.4 Ring Contraction by Transannular Cyclization 
 Transannular cyclization of a medium or large ring to form two or more smaller rings is 
another strategy for ring contraction (Scheme 1.11E). Several different types of reaction can be 
employed to achieve ring contraction by transannular cyclization, however, these reactions are 
highly dependent on the configuration and functionality of the ring system. Intramolecular 
cyclization of the 8-membered ring of the pleuromutilin scaffold was accomplished by enolate 
displacement of an acetate to form P17 (Scheme 1.15A, see Chapter 4).33 Tochtrop and coworkers 
utilized acid-catalyzed transannular cyclization reactions to induce ring contraction of a lanosterol-
derived diketone (Scheme 1.15B). 
1.3.5 Ring Contraction by Ring Cleavage/Ring Fusion Cascades 
 Ring cleavage/ring fusion cascades can also lead to ring contraction (Scheme 1.11F). 
Oxidative cleavage or a diol or olefin followed by aldol cyclization is a useful strategy for this type 
of ring expansion. For example, oxidative cleavage of diol AA19 followed by treatment with base 
 
Scheme 1.14: Examples of anionic ring contraction. 
Scheme 1.15: Ring contraction by transannular cyclization reactions. 
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enabled ring cleavage and aldol addition onto the B-ring of the abietic acid scaffold (Scheme 
1.16A, see Chapter 3).9 Ring contraction of the C-ring of the abietic acid scaffold was achieved in 
a similar fashion by oxidative cleavage and aldol condensation of diol AA1 (Scheme 1.16B, see 
Chapter 3).9 
1.4 Ring Cleavage 
Ring cleavage reactions are reactions that break a ring. Numerous ring cleavage reactions 
have been reported and an overview of the several types of ring cleavage reactions that are useful 
for ring distortion of complex molecules will be highlighted herein (Scheme 1.17). Oxidative 
cleavage of olefins, vicinal diols, and related functional groups is a common and useful method 
for ring cleavage (Scheme 1.17A). Nucleophilic addition to cyclic carbonyl derivatives can also 
lead to ring cleavage (Scheme 1.17B). Amine dealkylation via Hoffmann elimination can be 
employed to induce ring cleavage of cyclic amines (Scheme 1.17C). Ring cleavage can also be 
achieved by fragmentation reactions such as Grob fragmentation and retro-aldol/retro-Michael 
reactions (Scheme 1.17D).  
 
Scheme 1.16: Examples of ring contraction by ring cleavage/ring fusion cascades. 
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1.4.1 Oxidative Ring Cleavage 
 Oxidative cleavage reactions are popular methods for opening rings in complex molecules 
(Scheme 1.17A) but can be complicated by the tendency of ring cleavage products to undergo ring 
cleavage/ring fusion cascades.  Numerous reagents have been developed for oxidative cleavage of 
compounds containing C-C double bonds and compounds containing vicinal alcohols.34 Ring 
cleavage of adrenosterone was accomplished by treatment with sodium periodate and potassium 
permanganate to form keto-acid A8 (Scheme 1.18A).8 Oxidative ring cleavage of an epoxide 
derived from gibberellic acid (G14) enabled ring cleavage of the 5-membered ring to form G2 
(Scheme 1.18B).33 
1.4.2 Ring Cleavage by Nucleophilic Addition to Carbonyl Derivatives 
 Several different cyclic carbonyl derivatives can undergo ring cleavage (Scheme 1.17B). 
Lactones can be opened by nucleophilic addition of water, alcohols, amines, thiols, or hydrides. 
For example, treatment of gibberellic acid with base leads to lactone rearrangement and ring 
cleavage to from G9 (Scheme 1.19A).8 Cyclic ketals and aminals can also be cleaved by hydride 
addition. Ring cleavage of a hemiaminal ether derived from quinine was achieved by addition of 
sodium cyanoborohydride (Scheme 1.19B, see Chapter 2). Also, some cyclic ketones can be 
 
Scheme 1.17: Ring cleavage reactions 
Scheme 1.18: Oxidative ring cleavage reactions. 
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cleaved by the Schmidt or Beckmann reaction. Schmidt reaction of ketone derived from 
adrenosterone results in cleavage of 5-membered ring. (Scheme 1.19C).8 
1.4.3  Ring Cleavage by Amine Dealkylation 
 Cyclic amines are present in many complex molecules and can undergo ring distortion by 
amine activation and ring cleavage (Scheme 1.17C). Activation of cyclic tertiary amines via 
alkylation or exposure to acid results in C-N bond cleavage and elimination (Hoffmann 
elimination). Hudlicky and coworkers utilized exhaustive amine alkylation and Hoffmann 
elimination to achieve ring cleavage of the piperidine ring of hydrocodone (Scheme 1.20A).35 
Hoffmann elimination of quinine was also accomplished under acidic conditions to form Q6 
(Scheme 1.20B, see Chapter 2). Ring cleavage of cyclic amines can also be accomplished by 
acylation and nucleophilic displacement. The quinuclidine of quinine was cleaved by acylation 
and chloride addition to provide Q1 (Scheme 1.20C, see Chapter 2).  
 
Scheme 1.19: Ring cleavage reactions of carbonyl derivatives. 
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1.4.4 Ring Cleavage by Fragmentation Reactions 
 Fragmentation reactions are a useful strategy for ring cleavage of suitably functionalized 
complex molecules (Scheme 1.17D). Compounds bearing a 1,3-arrangement of a donor and 
acceptor group can undergo ring cleavage via Grob fragmentation or retro-aldol reaction. For 
example, the Nagase group employed a Grob fragmentation of a chloramine derived from 
naltrexone in their semisynthesis of (-)-homogalanthamine (Scheme 1.21A).36 Ring cleavage of 
cyclic compounds possessing a 1,5-diketone can be accomplished via a retro-Michael reaction. 
 
Scheme 1.20: Ring cleavage by amine dealkylation. 
 
Scheme 1.21: Ring cleavage by fragmentation reactions. 
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This strategy was successfully used to cleave the 8-membered ring of the pleuromutilin scaffold 
to form P20 (Scheme 1.21B, see Chapter 4).   
1.5 Ring Fusion 
 Ring fusion reactions are reactions that form new rings. Ring fusion reactions are numerous 
and readily employed on complex molecules (Scheme 1.22). Several types of ring fusion reactions 
are highlighted herein, but this review is not exhaustive. Molecules containing olefins or alkynes 
can undergo ring fusion by intermolecular cycloaddition reactions (Scheme 1.22A). Intramolecular 
cyclization reactions are another strategy for ring fusion (Scheme 1.22B). Ring fusion onto 
compounds containing two nucleophilic groups or two electrophilic groups can be accomplished 
by treatment with a suitable bifunctional electrophile or nucleophile (Scheme 1.22C). Additional 
examples of ring fusion reactions are shown in the sections describing ring expansion and 
contraction by ring cleavage/ring fusion cascades (Scheme 1.10 and Scheme 1.16, respectively). 
1.5.1 Ring Fusion by Intermolecular Cycloaddition Reactions 
 Intermolecular cycloaddition reactions are useful methods for ring fusion onto complex 
molecules containing olefins or alkynes (Scheme 1.22A). Ring fusion onto the abietic acid scaffold 
was accomplished by a [2+1] cycloaddition to form dibromocyclopropane AA8 (Scheme 1.23A, 
see Chapter 3). For molecules containing a conjugated diene, [4+2] cycloaddition reactions are an 
excellent method for achieving ring fusion. For example, ring fusion onto a diene derived from 
pleuromutilin (P10) was readily accomplished by reaction with a dienophile to provide P2 
(Scheme 1.23B, see Chapter 4). 
 
Scheme 1.22: Types of ring fusion reactions. 
18 
 
1.5.2 Ring Fusion by Intramolecular Cyclization 
 Intramolecular cyclization reactions are a strategy for ring fusion onto complex molecules 
that involves pairing two or more functional groups on a molecule (Scheme 1.22B). Compounds 
that can be modified so that they possess a nucleophile and an electrophile can undergo ring fusion 
by nucleophilic displacement. For example, treatment of a keto-acid derived from adrenosterone 
with an amine results in imine formation and cyclization to form enamide A13 (Scheme 1.24A).8 
Another valuable method for intramolecular cyclization is ring closing metathesis, as these 
reactions are typically highly robust and olefins can be readily incorporated into complex 
molecules. Ring closing metathesis was successfully employed in the intramolecular cyclization 
of a quinine-derived diene to form aza-decalin Q2 (Scheme 1.24B, see Chapter 2). Intramolecular 
cyclization can also be performed by C-H activation. Ring fusion onto the 8-membered ring of 
pleuromutilin was accomplished by C-H activation and cyclization to form cyclic carbamate P24 
(Scheme 1.24C, see Chapter 4). 
 
Scheme 1.23: Examples of ring fusion by intermolecular cycloaddition. 
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1.5.3 Ring Fusion of Bifunctional Molecules  
 Molecules that possess two nucleophilic or electrophilic groups in close proximity can 
undergo ring fusion by reaction with an electrophile or nucleophile that can react with both groups 
(Scheme 1.22C). For example, ring fusion onto the abietic acid scaffold was accomplished by 
reaction of vicinal diol AA13 with triphosgene to form AA5 (Scheme 1.25A, see Chapter 3). The 
Porco group achieved ring fusion onto fumagillol by nucleophilic addition of a primary aniline to 
the two epoxides (Scheme 1.25B).37  
 
Scheme 1.24: Examples of ring fusion by intramolecular cyclization. 
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1.6 Ring Rearrangement 
 Ring rearrangement reactions are reactions that induce both ring contraction and ring 
expansion on a polycyclic molecule in a single sequence. Ring rearrangement reactions typically 
occur by migration of a bond shared between two or more rings. While ring rearrangement 
reactions are highly substrate-dependent, they can be accomplished in several ways. Carbocation 
formation near a bond shared between two rings can lead to bond migration and ring rearrangement 
(Scheme 1.26A). Anionic ring rearrangement can be accomplished by deprotonation of bridgehead 
alcohols vicinal to leaving groups (Scheme 1.26B). Photochemical rearrangements can also be 
used for ring rearrangement (Scheme 1.26C). 
 
Scheme 1.25: Ring fusion reactions of bifunctional molecules. 
 
Scheme 1.26: Ring rearrangement reactions. 
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1.6.1 Ring Rearrangement by Carbocation Rearrangement 
 Ring rearrangement by carbocation rearrangement can be accomplished by Wagner-
Meerwein, transannular, and pinacol-type rearrangements (Scheme 1.27). The Appendino group 
utilized an acid-catalyzed Wagner-Meerwein rearrangement and transannular cyclization to 
achieve ring rearrangement of a Lathyrane diterpene (Scheme 1.27A).38 Ring rearrangement of the 
pleuromutilin scaffold was accomplished by alcohol activation of cyclopropyl derivative P18 of 
pleuromutilin and transannular bond migration to provide P4 (Scheme 1.27B, see Chapter 4). A 
ring rearrangement by a semi-pinacol reaction was employed by the Tanino group in their 
synthesis of ingenol (Scheme 1.27C).39 
1.6.2 Anionic and Photochemical Ring Rearrangement 
 Ring rearrangement can also be performed by anionic or photochemical rearrangements of 
polycyclic molecules (Scheme 1.26B and Scheme 1.26C, respectively). Anionic ring 
rearrangement is typically performed by the quasi-Favorskii reaction. For example, the Corey 
group employed a quasi-Favorskii rearrangement in their synthesis of β-araneosene (Scheme 
1.28A).40 Photochemical ring rearrangement is a useful strategy for the ring rearrangement of 
polycyclic molecules containing cross-conjugated cyclohexadienones and has been employed on 
numerous complex molecules.23 The classic example of a photochemical ring rearrangement is the 
 
Scheme 1.27: Ring rearrangement reactions. 
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rearrangement of α-santonin in the presence of light and acetic acid (Scheme 1.28B).41 
Additionally, the Carreira group employed a photochemical ring rearrangement in their synthetic 
studies towards (+)-resiniferatoxin (Scheme 1.28C).42 
1.7 Aromatization/Dearomatization 
 Aromatization (Scheme 1.29A) and dearomatization (Scheme 1.29B) reactions are 
reactions that induce ring distortion by affecting the planarity of polycyclic molecules.43, 44 
Aromatization reactions increase planarity by flattening the ring and orienting all substituents in 
the plane of the ring. For example, treatment of gibberellic acid with acid leads to aromatization 
 
Scheme 1.28: Ring rearrangement by anionic and photochemical rearrangement reactions. 
 
Scheme 1.29: Ring distortion by aromatization and dearomatization. 
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and loss of 4 stereogenic centers to form G10 (Scheme 1.29C).8 Dearomatization reactions have 
the opposite effect of aromatization, and decrease planarity by orienting the atoms of the ring and 
all substituents out of plane. Dearomatization of the quinoline ring of quinine was accomplished 
by treatment with phenyl magnesium chloride to form Q12 (Scheme 1.29D, see Chapter 2). 
1.8 Potential Ring Distortion Reactions 
 In addition to the reactions presented in Chapters 2-4, numerous other ring distortion 
reactions can be employed on complex molecules. Herein, several additional ring distortion 
reactions are proposed that employ the ring distortion strategies presented above in order to 
demonstrate how ring distortion can be used to alter complex molecules (Scheme 1.30). Compound 
P20 contains an olefin that is shared between two rings that could undergo oxidative cleavage and 
ring expansion (Scheme 1.30A, see Section 1.2.2). A ring contraction of diol A13 could be 
Scheme 1.30: Potential ring distortion reactions to alter the abietic acid and pleuromutilin 
scaffolds. 
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accomplished by a quasi-Favorskii rearrangement (Scheme 1.30B, see Section 1.3.2). The 
secondary alcohol of P12 could be subjected to elimination and oxidative cleavage to break the 8-
membered ring (Scheme 1.30C, see Section 1.4.1). Ring fusion onto abietic acid could occur by 
ester reduction, sulfamate ester formation and intramolecular cyclization (Scheme 1.30D, see 
Section 1.5.2). A semi-pinacol rearrangement could be used to induce a ring rearrangement of diol 
AA19 (Scheme 1.30E, see Section 1.6.1). These proposed reactions demonstrate how ring 
distortion can be used to systematically alter ring systems. 
1.9 Synthesis of Complex and Diverse Molecules by Ring Distortion 
 Ring distortion is an effective strategy for dramatically altering the molecular structure of 
complex molecules in few synthetic steps. Many complex molecules are readily available to 
synthetic chemists and possess several sites that can undergo ring distortion. The most abundant 
and structurally diverse source of complex molecules are natural products, which can be obtained 
from commercial vendors or by isolation. By performing multiple ring distortion reactions on these 
complex starting materials, molecules can be prepared that possess markedly different structures 
from each other and from the starting complex molecule (Scheme 1.31). Through this complexity 
to diversity approach, large collections of complex and structurally diverse small molecules can 
be prepared through short synthetic sequences.  
 
Scheme 1.31: Ring distortion to create collections of complex and diverse molecules. 
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 As exemplified in the enzymatic ring distortion of strictosidine to different terpene indole 
alkaloids (Scheme 1.2), alteration of the ring systems of complex molecules can lead to 
dramatically different biological activities. Thus, the compounds produced by synthetic ring 
distortion of complex molecules are highly advantageous compounds for the discovery of new 
bioactive leads and probes. In addition to the structural diversity of these compounds, they also 
possess considerable molecular complexity, a feature that is lacking in current compound 
collections and highly sought after in drug discovery.45 
1.10 Summary 
 Ring distortion reactions are reactions that modulate the size and shape of rings in a 
molecule. Exposure of small molecules to ring distortion reactions results in dramatic changes to 
the core ring systems of these molecules and can significantly alter biological activity.  Thus, a 
myriad of synthetic methods have been developed to induce ring distortion, and examples of their 
synthetic utility are numerous. Ring expansion and contraction reactions modulate ring size and 
are advantageous methods for altering the shape of a single ring. Ring cleavage reactions involve 
breaking of one or more rings and can introduce new functional groups for further diversification. 
Ring fusion reactions result in the formation of a new ring and add to the rigidity of the molecule. 
Ring rearrangement reactions alter multiple rings and can have an enormous impact on the 
connectivity and shape of a ring system. Aromatization and dearomatization reactions modulate 
the planarity of rings. The ability of ring distortion reactions to modulate complex molecules and 
the abundance of complex molecules available to synthetic chemists offers exciting opportunities 
for creating collections of structurally complex and diverse molecules through ring distortion. 
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Chapter 2: Ring Distortion of Quinine 
Portions are reprinted with permission from Huigens, R.W. III; Morrison, K.C.; Hicklin, R.W.; 
Flood, T.A. Jr.; Richter, M.F.; Hergenrother, P.J. “A Ring Distortion Strategy to Construct 
Stereochemically Complex and Structurally Diverse Compounds from Natural Products” Nature 
Chem. 2013, 5, 195-202. 
2.1 Introduction 
The cinchona alkaloid quinine (Figure 2.1) is a structurally complex natural product 
composed of quinoline and quinuclidine ring systems that contains four stereogenic centers. In 
addition to the quinoline heterocycle and the quinuclidine tertiary amine, quinine contains several 
other functional groups amenable to synthetic modification (i.e. secondary alcohol, terminal olefin, 
and methyl ether). Quinine is found in the bark of the trees of the genus cinchona, which are native 
to the forests of western South America.1 The bark of the cinchona tree was used by the indigenous 
people of the Tropical Andes as a muscle relaxant to treat shivering caused by exposure to cold air 
or water.2 In the early seventeenth century, cinchona bark was introduced to Europeans and its use 
was extended to the treatment of the cold and shivering caused by fevers.2 The bark was 
particularly effective in treating fevers caused by malaria and, eventually, was found to be a cure 
for the malady.2 Quinine was found to be the curative agent in cinchona bark in the early nineteenth 
century and quinine was the primary treatment for malaria until the middle of the twentieth 
century.3  
 
Figure 2.1: Quinine structure and important functional groups. 
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Interestingly, the antimalarial activity of quinine is unrelated to the muscle relaxing effects 
for which it was originally discovered. Quinine induces its antimalarial effect by altering heme 
metabolism in the parasite that causes malaria (plasmodium falciparum), leading to a buildup of 
toxic heme and death of the parasite.4 The exact mechanism of action for the muscle relaxant 
properties of quinine are unclear but it acts on skeletal muscles to decrease the excitability of the 
motor end plate to nerve stimulation.5 While quinine has been extensively prescribed as an 
antimalarial and muscle relaxant in the past, newer and more effective drugs are now the standard 
of care for these indications.5, 6 However, approximately 700 metric tons of cinchona alkaloids, 
including quinine, are extracted annually with nearly half of this material being used in the food 
and beverage industry as a bitter additive.7 
 Due to its widespread availability, critical biological activity, and interesting structural 
properties, quinine has been investigated by organic chemists for centuries.8 Pioneering work on 
the chemical reactivity of quinine was performed by Pasteur and resulted in the synthesis of 
quinotoxine (Scheme 2.1A), which he used to achieve the first chiral resolution of racemic tartaric 
acid.9 The structure of quinine was established by Rabe10 in 1907 and was followed by a 
semisynthesis of quinine from quinotoxine in 1918.11 The first total synthesis of quinine was 
accomplished by Woodward and Doering in 1944 and involved the total synthesis of quinotoxine 
followed by conversion to quinine via the method established by Rabe.12, 13 Several impressive 
stereoselective syntheses of quinine have since been reported.14-20 
The ability of quinine and its derivatives to differentially interact with chiral and prochiral 
molecules has led to the widespread use of these alkaloids as chiral resolution agents and catalysts 
for enantioselective reactions.21 As originally demonstrated by Pasteur with quinotoxine, structural 
modification of the quinine scaffold can modulate the ability of quinine to interact with chiral 
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molecules.9 Thus, a large number of synthetic derivatives of quinine have been reported in the 
context of identifying better chiral resolution agents or enantioselective catalysts.22 In addition to 
numerous functional group modifications of quinine, a number of reactions that alter the ring 
system of quinine have been developed (Scheme 2.1).8 Ring cleavage reactions of the quinine 
scaffold include the acid catalyzed degradation of quinine to quinotoxine (Scheme 2.1A),9 a Grob 
fragmentation of a brominated quinine derivative (Scheme 2.1B),23 and the degradation of quinine 
to quincorine (Scheme 2.1C).24 Reactions that alter ring size of quinine include a fluoroantimonic 
acid-induced rearrangement of the quinuclidine ring (Scheme 2.1D)25 and quinoline ring 
expansion of a p-tosyl derivative of quinine (Scheme 2.1E).26 Dearomatization and ring fusion of 
the quinoline ring can be achieved by the diastereoselective addition of organomagnesium reagents 
 
Scheme 2.1: Known ring distortion reactions of Quinine 
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to quinine (Scheme 2.1F).27 These known reactions demonstrated the innate reactivity of the 
quinine ring system and several were selected as synthetic starting points for the creation of 
structurally diverse compounds from quinine (Scheme 2.1A and F).  
2.2  Synthesis of Complex and Diverse Molecules from Quinine  
Our approach to create a library of complex and diverse small molecules from quinine 
focused on the application of ring distortion reactions to modify the quinuclidine and quinoline 
ring systems (Scheme 2.2).28 We hypothesized that cleavage of the tertiary amine would be the 
most expedient method for altering the quinuclidine ring system and would reveal several new 
functional groups for further ring distortion. Since there are three potential C-N bonds that could 
undergo cleavage, several different quinuclidine ring cleavage reactions were envisioned (Scheme 
2.2, Q1-Q3). Our strategy to distort the quinoline ring focused on the addition of organometallic 
 
Scheme 2.2: Ring distortion strategy for the chemical diversification of quinine via the 
modification of the quinuclidine (red) and quinoline (blue) rings. 
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reagents to quinine in order to dearomatize the quinoline ring and install an aminal that could be 
subjected to additional ring distortion reactions (Scheme 2.2, Q4-Q5).  
Through this complexity to diversity strategy, 5 complex and diverse scaffolds were 
synthesized in a total of 12 synthetic steps (Scheme 2.2, Q1-Q5). Furthermore, since all 
intermediate compounds produced in these synthetic endeavors (Figure 2.2, Q6-Q12) were 
stereochemically complex and structurally different than quinine and Q1-Q5; these compounds 
were also included in the collection. 
 
Figure 2.2: Target scaffolds and intermediates produced through ring distortion of quinine. 
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2.2.1 N1-C2 Quinuclidine Cleavage: Synthesis of Q1 
 A number of chloroformate and chlorothionoformate reagents have been developed to 
dealkylate tertiary amines.29, 30 Treatment of quinine with O-phenyl chlorothionoformate results in 
ring cleavage and ring fusion to form thiocarbamate Q1 as a single isomer (Scheme 2.3). 
The connectivity of the carbon framework of Q1 was determined by multidimensional 
NMR spectroscopy (Figure 2.3). The 1H-13C HMBC experiment showed strong signals between 
the carbonyl carbon and the protons on carbons C6, C8, and C9, indicating the presence and 
location of a 5-membered heterocycle and confirming that the N1-C6 and N1-C8 bond remain 
intact. The low 13C NMR chemical shift of C9 (47.5 ppm) is indicative of an S-alkyl 
thiocarbamate.31, 32 However, X-ray crystallography was used to confirm the heteroatom 
connectivity and determine the absolute configuration of Q1 (Figure 2.3). The crystal structure of 
Q1 shows a trans configuration of the 5-membered ring, confirms the presence of sulfur at C9, 
and indicates that quinuclidine cleavage occurs at N1-C2. 
 
Scheme 2.3: Quinuclidine cleavage of quinine and ring fusion to form Q1. 
Figure 2.3: Characterization of the Q1 scaffold by NMR spectroscopy and X-ray crystallography. 
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  The accepted mechanism for chlorothionoformate dealkylation of tertiary amines involves 
acylation of the tertiary amine followed by alkyl C-N bond cleavage and chlorination.30 The exact 
mechanism for the rearrangement that follows C-N bond cleavage in the formation of Q1 is unclear 
and there are several potential mechanisms that would result in the observed trans configuration 
of the five-membered ring (Scheme 2.4). The configuration at the benzylic position of Q1 could 
result from SN2
 displacement of an activated secondary alcohol (Pathway A), or an SN1 mechanism 
involving a benzylic carbocation that preferentially reacts from one face to minimize the steric 
interaction between the quinoline and the piperidine rings (Pathway B).  
2.2.2  N1-C8 Quinuclidine Cleavage: Synthesis of Q2 and Q3 
The Pasteur degradation of quinine to quinotoxine was employed as an alternative method 
of cleaving the quinuclidine ring (Scheme 2.5).9 The mechanism of this transformation has been 
suggested to involve protonation and tautomerization to an enol/enamine followed by cleavage of 
the C8-N1 bond to form an enol, which tautomerizes to the ketone found in the product.8  
Scheme 2.4: Potential mechanisms for the formation of Q1: Pathway A involves quinuclidine 
cleavage and SN2 displacement of an activated secondary alcohol to form an oxonium intermediate 
that hydrolyzes to Q1. Pathway B involves quinuclidine cleavage followed by nucleophilic attack 
of the secondary alcohol on the thiocarbamate to form a cyclic O-alkyl thiocarbamate that 
rearranges to the S-alkyl thiocarbamate Q1. 
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In order to simplify the purification of quinotoxine, and to mask the basic nitrogen to enable 
further diversification, the crude degradation product was acylated with benzyl chloroformate 
under Schotten-Baumann conditions to provide Q6 (Scheme 2.6).  
Compound Q6 contains several potential sites for further diversification. Synthetic routes 
were developed to selectively modify the piperidine and quinoline rings and induce ring distortion 
(Scheme 2.7). The ketone of Q6 was functionalized by Petasis olefination, which enabled a ring 
fusion onto the piperidine ring by ring closing metathesis with second generation Grubbs catalyst 
to create azadecalin Q2. Quinoline N-oxidation and chlorination of Q6 facilitates the incorporation 
of a new ring onto the quinoline ring system by nucleophilic aromatic substitution with a proline-
derived amine to provide Q3. 
 
 
Scheme 2.5: Mechanism of acid degradation of quinine to quinotoxine via protonation of the 
quinoline and quinuclidine nitrogen atoms, tautomerization to an enol/enamine, cleavage of the 
C8-N1 bond to form an enol, and tautomerization to a ketone.   
 
Scheme 2.6: Synthesis of Q6 from quinine by acid degradation and carbamate formation. 
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2.2.3  Quinoline Ring Fusion: Synthesis of Q4 and Q5 
Efforts to directly modify the quinoline ring of quinine focused on the addition of 
organomagenesium reagents to the quinine scaffold. Previous work by Hintermann and coworkers 
demonstrated that heating cinchona alkaloids in the presence of organomagnesium reagents results 
in diastereoselective addition to the 4’-position of the quinoline ring and cyclization of the 
resulting imine to form aminal products (Scheme 2.8).27 This reaction is highly advantageous for 
the preparation of complex compounds from quinine as it results in dearomatization of the 
quinoline ring and creates two new stereogenic centers.  
 
Scheme 2.7: Ring distortion of Q6 by ring closing metathesis (Q2) and quinoline amination (Q3).  
 
Scheme 2.8: Dearomatization of quinine by chelate-directed addition of organomagnesium 
reagents to the quinolone ring. 
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We found that addition of isoamylmagnesium bromide to quinine successfully results in 
the formation of aminal Q4 as a single diastereomer (Scheme 2.9). We also confirmed that addition 
of phenylmagnesium chloride results in Q12 and explored further diversification of this scaffold. 
Aminal reduction of Q12 with sodium cyanoborohydride results in ring cleavage to form amine 
Q7. Treatment of Q7 with O-phenyl chlorothionoformate was anticipated to lead to quinuclidine 
cleavage, however, bis-acylation to carbamate Q5 was the major product observed.      
2.2.4 Synthesis of Derivative Libraries of Q1 
 In order to demonstrate that the compounds created by our complexity to diversity strategy 
are readily amenable to traditional functional group diversification strategies, derivative libraries 
were created to systematically modify two sites on the Q1 scaffold. Arylation of the quinoline ring 
was accomplished by addition of an organolithium reagent to quinine to form PhOPhQ, which 
readily undergoes ring cleavage and ring fusion to provide Q1a (Scheme 2.10).  
Scheme 2.9: Ring distortion of quinine by aminal formation (Q4, Q12). Compound Q12 was 
subjected to further ring distortion by aminal ring cleavage (Q7) and carbamate formation (Q5).  
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Azide displacement of the chloride of Q1 and Q1a affords azides Q1b and Q1c, 
respectively (Scheme 2.11). Copper-catalyzed 1,3-dipolar cycloaddition of Q1b and Q1c with a 
variety of commercially available alkynes enabled the synthesis of 12 different triazole derivatives 
of Q1 (Q1f-Q1q). Azide reduction of Q1b and Q1c provides amines Q1d and Q1e, which are 
amenable to several diversification strategies (Schemes 2.12 and 2.13). Reaction of Q1d and Q1e 
with several commercially available acyl chlorides provides 11 different amides and ureas 
(Scheme 2.12, Q1r-Q1bb). Exposure of Q1d and Q1e to different commercially available sulfonyl 
chlorides affords 11 sulfonamide derivatives of Q1 (Scheme 2.13, Q1cc-Q1mm). In total, 40 
derivatives of Q1 and quinine were created through this diversification strategy, each containing 
multiple stereogenic centers and complex ring systems.  
 
Scheme 2.10: Preparation of a quinoline derivative of Q1 by arylation of quinine and 
rearrangement. 
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Scheme 2.11: Preparation of a Q1 azides (Q1b and Q1c) and triazoles (Q1f-Q1q). 
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Scheme 2.12: Synthesis of Q1 amines (Q1d and Q1e), amides (Q1r-Q1t, Q1v-Q1y, and Q1aa-
Q1bb), and ureas (Q1u and Q1z). 
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Scheme 2.13: Synthesis of Q1 sulfonamides (Q1cc-Q1mm). 
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2.3  Complexity and Diversity of the Quinine Collection  
 The goal of our synthetic efforts on natural products is to create a collection of structurally 
complex and diverse molecules for the enhancement of biological screening libraries. Upon visual 
inspection, the compounds created from quinine (Figure 2.2, Q1-Q12) appear to be quite complex, 
having multiple rings and stereogenic centers, and structurally diverse, possessing different ring 
systems and arrangements of functional groups. However, methods to quantify the complexity and 
diversity of the library are required in order to compare the complexity and diversity of the quinine 
library to other biological screening collections.  
2.3.1 Quantifying the Molecular Complexity of the Quinine Collection  
Complex molecules have widely varied structural features and it is challenging to 
adequately differentiate complex molecules from noncomplex molecules using a single metric. 
Two simple and intuitive metrics have been proposed to approximate molecular complexity: 
Fraction sp3 (Fsp3) and the number of stereogenic centers.28, 33, 34 Fsp3 is defined as the ratio of sp3 
hybridized carbon atoms to the sum of sp3 and sp2 hybridized carbons atoms.33 Compounds with 
higher Fsp3 have greater three-dimensionality than compounds with lower Fsp3 and can 
potentially interact with proteins in ways not accessible to flat compounds.33 The presence of 
stereogenic centers is a hallmark of complex molecules and has been correlated improved 
outcomes in drug development.33 Fsp3 and the number of stereogenic centers can be calculated 
manually or by a number of commercial cheminformatic software packages. Additionally, 
increased Fsp3 and the presence of stereogenic centers have been correlated with decreased 
promiscuity.34 
Since there are some obvious examples of simple noncomplex molecules with high Fsp3 
(e.g. cyclohexane Fsp3: 1) and complex molecules with low Fsp3 (e.g. doxorubicin Fsp3: 0.42), 
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we chose to plot both Fsp3 and the number of stereogenic centers for each molecule in a three-
dimensional histogram plot to further differentiate complex molecules from simple molecules (e.g. 
cyclohexane has 0 stereogenic centers and doxorubicin has 6 stereogenic centers). Compounds 
that lack molecular complexity will occupy the back left quadrant of the graph with low Fsp3 and 
few stereogenic centers, while compounds that are more complex will occupy the front right 
quadrant with high Fsp3 and multiple stereogenic centers. Compounds Q1-Q12 (Figure 2.2) show 
a good range of molecular complexity (Fsp3: range 0.30-0.68, average: 0.40, median: 0.37 and 
number stereogenic centers: range 2-6, average: 3.4, median: 2.5) and occupy the central area of 
the histogram plot, indicating an intermediate level of complexity (Figure 2.4). A similar 
complexity profile was seen for the entire quinine collection composed of Q1-Q12 and all 
derivatives (Q1a-Q1mm and PhOPhQ), although the inclusion of the functional group derivatives 
did result in a lower average and median Fsp3 (Fsp3: range 0.30-0.68, average: 0.33, median: 0.31 
and number stereogenic centers: range 2-6, average: 3.9, median: 4).  
In order to determine if the compounds derived from quinine are more complex than other 
screening libraries, and if that complexity is biologically relevant, the molecular complexity of the 
Chembridge Microformat Library,35 the NCI oncology collection and FDA approved antibacterial 
drugs were assessed (Figure 2.5). The Chembridge Microformat collection shows very low 
 
Figure 2.4: Three-dimensional histograms plotting fraction sp3 (Fsp3) and the number of 
stereogenic centers for Q1-Q12 and the full quinine set including derivatives.  
9+
6
3
0
0
5
10
15
20
25
0
0
.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.9 1
C
o
u
n
t
Full Quinine Set (52)
9+
6
3
0
0
1
2
3
4
5
0
0
.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.9 1
C
o
u
n
t
Q1-Q12 (12)
46 
 
molecular complexity (Fsp3: range: 0.0-1.0, average: 0.23, median: 0.20 and number of 
stereogenic centers: range: 0-11, average: 0.27, median: 0.0) and occupies the back left quadrant 
of the graph. The NCI oncology drug set and FDA approved antibacterial drugs show a broad 
range of complexity (anticancer: Fsp3: range: 0.0-1.0, average: 0.44, median: 0.44 and number of 
stereogenic centers: range: 0-25, average: 2.64, median: 0.5; antibacterials: Fsp3: range: 0.0-1.0, 
average: 0.41, median: 41 and number of stereogenic centers: range: 0-20, average: 3.49, median: 
2.0) and occupy most regions of the graph. Comparing the Chembrigde Microformat Library to 
anticancer and antibacterial drugs it is clear that the screening collection lacks compounds with 
the molecular complexity found in the drug collections. Gratifyingly, the compounds of the quinine 
collection occupy a region of the graph occupied by approved drugs, indicating that the molecular 
complexity of the quinine set is biologically relevant. 
2.3.2  Quantifying the Structural Diversity of the Quinine Collection  
 The structural diversity of the quinine collection was quantified by comparing extended 
connectivity fingerprints using Tanimoto similarity coefficients. Extended connectivity 
fingerprints (ECFP) are a method for representing molecular structures as a series of numerical 
fingerprints, such that each atom in a molecule has a unique fingerprint that contains information 
about that atom (atomic number, hybridization, etc) and the neighboring atoms up to a desired 
number of bonds away. The numerical fingerprints for two molecules can then be compared based 
 
Figure 2.5: Three-dimensional histogram graphs plotting fraction sp3 (Fsp3) and the number of 
stereogenic centers for the Chembridge Microformat library, NCI Oncology library, and FDA 
approved antibacterial drugs. 
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on the number of identical fingerprints between the two molecules in order to generate a Tanimoto 
similarity coefficient.36 Compounds that are identical to one another will have a Tanimoto score 
of 1 and compounds with no fingerprints in common will have a score of 0. In our analysis, 
fingerprints were generated in Canvas (Schrodinger, New York) using ECFP_6 three-bond radial 
fingerprints37 with Daylight invariant atom types and distinguishing bonds by bond order. 
Tanimoto similarity coefficients were then calculated for each pairwise combination of molecules 
in Canvas in order to create a matrix that shows the structural similarity for every molecule in the 
collection. In this analysis, high structural diversity is indicated by low similarity coefficients 
between all pairwise combinations of molecules (with the exception of the comparison between a 
molecule and itself, which will always be 1).  
Tanimoto similarity matrices were created to evaluate the diversity of the compounds 
created by ring distortion (Table 2.1, quinine (Q) and Q1-Q12) and also the entire collection 
including derivatives (Table 2.2, Q, Q1-Q12, Q1a-Q1mm, and PhOPhQ). The data in Table 2.1 
clearly demonstrates that the target molecules Q1-Q5 are highly structurally diverse and possess 
low similarity scores between each other and quinine (blue to green in color, range: 0.07-0.22, 
average: 0.12, median: 0.10). Including the intermediate compounds created in the synthesis of Q-
Q5 (compounds Q6-Q12) leads to higher similarity scores (yellow to orange in color), as several 
of the intermediates are structurally related (notably Q6 and Q8-Q11), however, the overall 
diversity of the set remains high, since most pairwise combinations of molecules lead to low 
similarity scores (range: 0.07-0.59, average: 0.19, median: 0.12).  The complete matrix containing 
all pairwise combinations of molecules created from quinine (Table 2.2) demonstrates the 
differences in structural diversity between compounds created via ring distortion and traditional 
functional group derivatives. The Q1 derivatives (bottom right, Q1a-Q1mm) have much higher 
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structural similarity to each other, with many pairwise combinations colored yellow and orange 
(range: 0.12-0.82, average: 0.39, median: 0.34). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1: Tanimoto similarity matrix (ECFP_6, Schrodinger) for quinine (Q) and the quinine 
set (Q1-Q12). Compounds with a high score have higher structural similarity than compounds 
with low scores. 
1.00
0.00
0.50
Q Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12
Q 1.00 0.15 0.13 0.12 0.08 0.13 0.15 0.09 0.17 0.15 0.11 0.13 0.08
Q1 0.15 1.00 0.16 0.13 0.10 0.08 0.16 0.09 0.18 0.15 0.12 0.15 0.10
Q2 0.13 0.16 1.00 0.22 0.07 0.08 0.30 0.08 0.22 0.29 0.21 0.24 0.07
Q3 0.12 0.13 0.22 1.00 0.08 0.10 0.51 0.09 0.24 0.44 0.46 0.56 0.08
Q4 0.08 0.10 0.07 0.08 1.00 0.10 0.08 0.13 0.08 0.07 0.07 0.07 0.41
Q5 0.13 0.08 0.08 0.10 0.10 1.00 0.10 0.13 0.09 0.10 0.10 0.10 0.11
Q6 0.15 0.16 0.30 0.51 0.08 0.10 1.00 0.09 0.50 0.59 0.57 0.59 0.08
Q7 0.09 0.09 0.08 0.09 0.13 0.13 0.09 1.00 0.10 0.09 0.09 0.09 0.16
Q8 0.17 0.18 0.22 0.24 0.08 0.09 0.50 0.10 1.00 0.30 0.25 0.27 0.08
Q9 0.15 0.15 0.29 0.44 0.07 0.10 0.59 0.09 0.30 1.00 0.46 0.50 0.08
Q10 0.11 0.12 0.21 0.46 0.07 0.10 0.57 0.09 0.25 0.46 1.00 0.53 0.08
Q11 0.13 0.15 0.24 0.56 0.07 0.10 0.59 0.09 0.27 0.50 0.53 1.00 0.08
Q12 0.08 0.10 0.07 0.08 0.41 0.11 0.08 0.16 0.08 0.08 0.08 0.08 1.00
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Table 2.2: Full Tanimoto similarity matrix for Q set including derivatives. 
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2.4 Conclusion 
 The chemical diversification of natural products by ring distortion offers an expedient and 
general method for the synthesis of collections of complex molecules. Our synthetic approach to 
the chemical diversification of quinine focused on the application of ring distortion reactions to 
modify the quinuclidine and quinoline rings. Two different ring cleavage methods were employed 
to cleave the quinuclidine ring and a dearomatization/ring fusion strategy was used to alter the 
quinoline ring. From these initial ring distortion reactions, and subsequent ring cleavage and ring 
fusion reactions, 5 structurally diverse molecular scaffolds were created. In the course our 
synthetic endeavors, an additional 7 intermediate compounds were synthesized along with 40 
functional group derivatives of Q1 and quinine to provide a collection of 52 complex molecules. 
The molecular complexity (Fsp3 and number of stereogenic centers) of the compounds derived 
from quinine indicate a level of complexity found in approved anticancer and antibacterial drugs, 
but lacking in a typical screening collection. Tanimoto similarity of ECFP_6 fingerprints was used 
to quantify the structural diversity of the compounds. The compounds created by ring distortion 
were found to be quite structurally diverse; these compounds were found to be significantly more 
diverse than compounds created by traditional functional group diversification. All of these 
compounds have been added to the complex molecule screening collection curated by the 
Hergenrother lab and have been made available to interested researchers. 
 
 
 
 
 
51 
 
2.5 Methods and Characterization 
Chemical reagents were purchased from commercial sources and used without further 
purification.  Quinine and was purchased from Sigma-Aldrich (at ≥98.0% purity). Anhydrous 
solvents used during these studies were dried after being passed through columns with activated 
alumina.   
1H NMR and 13C NMR experiments were recorded on Varian Unity spectrometers at 400 
MHz and 500 MHz and 125 MHz, respectively.  Spectra were obtained in the following solvents 
(reference peaks also included for 1H and 13C NMRs): CDCl3 (
1H NMR: 7.26 ppm; 13C NMR: 
77.23 ppm), d6-DMSO (
1H NMR: 2.50 ppm; 13C NMR: 39.52 ppm), d6-benzene (
1H NMR: 7.16 
ppm; 13C NMR: 128.06 ppm).  NMR experiments were performed at room temperature unless 
otherwise indicated.  Chemical shift values are reported in parts per million (ppm) for all 1H NMR 
and 13C NMR spectra.  1H NMR multiplicities are reported as: s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet, br = broad.  All melting points were uncorrected and obtained using a 
Digimelt MPA 160. 
2.5.1 Ring Distortion of Quinine: Synthesis and Characterization 
 
 
Procedure: O-phenyl chlorothionoformate (448.8 mg, 2.60 mmol) was added to a stirring solution 
of quinine (324.4 mg, 1.00 mmol) in anhydrous dichloromethane (10 mL) at room temperature.  
The resulting reaction was allowed to stir for 2.5 hours before the reaction was diluted with 
dichloromethane and quenched with a saturated solution of sodium bicarbonate.  The contents of 
the quenched reaction were then transferred to a separatory funnel. The biphasic mixture was 
52 
 
separated and the organic layer washed with brine, dried with magnesium sulfate, and concentrated 
under reduced pressure. The crude product was purified by column chromatography 3:2 
chloroform/ethyl acetate to provide 133.3 mg (33% yield) of S-thiocarbamate Q1 as a tan foam. 
Co-crystallization with benzene provided colorless crystals of suitable quality for x-ray diffraction 
analysis.  
Note: Spectral data for Q1 is reported in both CDCl3 and d6-benzene.  This was required to attain 
optimal spectra to fully characterize Q1 in 1-D and 2-D NMR experiments. 
 
 
1H NMR (CDCl3, 500 MHz): δ 8.81 (d, J = 4.6 Hz, 1H), 8.16 (d, J = 9.2 Hz, 1H), 7.64 (d, J = 4.7 
Hz, 1H), 7.47 (dd, J = 9.3, 2.6 Hz, 1H), 7.25 (d, J = 3.1 Hz, 1H), 5.69 (ddd, J = 17.0, 10.1, 9.0 Hz, 
1H), 5.21 (dd, J = 10.2, 1.4 Hz, 1H), 5.18 - 5.10 (m, 2H), 4.05 - 3.96 (m, 2H), 3.98 (s, 3H), 3.53 
(dd, J = 11.2, 3.4 Hz, 1H), 3.42 (dd, J = 11.2, 4.8 Hz, 1H), 2.97 (ddd, J = 13.3, 13.3, 3.4 Hz, 1H), 
2.61 (ddd, J = 14.3, 9.1, 4.1 Hz, 1H), 2.20 - 2.13 (m, 1H), 2.07 - 2.00 (m, 1H), 1.88 (ddd, J = 13.8, 
11.8, 4.7 Hz, 1H), 1.85 - 1.79 (m, 1H), 1.68 (dddd, J = 13.9, 13.9, 4.9, 4.9 Hz, 1H). 
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13C NMR (CDCl3, 125 MHz): δ 170.4, 158.7, 147.8, 144.8, 141.8, 137.5, 132.4, 127.8, 122.4, 
119.6, 118.6, 100.7, 60.4, 55.9, 47.7, 47.6, 44.0, 39.2, 32.7, 32.0, 26.0.  
1H NMR (d6-benzene, 500 MHz): δ 8.71 (d, J = 4.5 Hz, 1H), 8.25 (d, J = 9.2 Hz, 1H), 7.25 (d, J 
= 4.5 Hz, 1H), 7.21 (dd, J = 9.2, 2.7 Hz, 1H), 7.08 (d, J = 2.7 Hz, 1H), 5.33 (ddd, J = 17.1, 10.2, 
9.1 Hz, 1H), 4.89 (dd, J = 10.2, 1.7 Hz, 1H), 4.70 (dd, 17.1, 1.0 Hz, 1H), 4.66 (d, J = 7.2 Hz, 1H), 
3.89 (ddd, J = 13.6, 5.1, 2.6 Hz, 1H), 3.45 (s, 3H), 3.37 (dd, J = 14.4, 5.1 Hz, 1H), 2.97 (dd, J = 
11.2, 3.1 Hz, 1H), 2.90 (dd, J = 11.2, 4.8 Hz, 1H), 2.44 (td, J = 13.2, 3.5 Hz, 1H), 1.83 (ddd, J = 
9.6, 9.0, 4.6 Hz, 1H), 1.59 - 1.48 (m, 2H), 1.29 - 1.08 (m, 3H). 
13C NMR (d6-benzene, 125 MHz): δ 169.6, 158.8, 148.2, 145.8, 141.5, 137.9, 133.3, 128.4, 121.8, 
119.4, 117.9, 101.4, 59.6, 55.3, 47.5, 47.4, 43.2, 39.1, 32.1, 31.9, 25.7.  
HRMS(ESI): m/z calc. for C21H24ClN2O2S [M+H]
+: 403.1247, found: 403.1244. 
Melting Point: 158-160 °C. 
X-ray Crystallographic Data for Q1: 
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Table 2.3 Crystal data and structure refinement for bm28ras.  
 
Identification code    bm28ras 
Empirical formula    C21 H23 Cl N2 O2 S 
Formula weight   559.14 
Temperature     193(2)K  
Wavelength     0.71073 Å  
Crystal system   Monoclinic  
Space group    P2(1) 
Unit cell dimensions    a = 10.774(2)Å α= 90°  
     b = 9.935(2)Å  β= 103.813(2) 
     c = 14.000(3)Å  γ= 90°  
Volume     1455.1(5) Å3   
Z     2  
Density (calculated)    1.276 g/cm3  
Absorption coefficient  0.236 mm-1  
F(000)     592 
Crystal size    0.436 x 0.20 x 0.165 mm3  
Theta range for data collection  1.95 to 25.36°  
Index ranges    -12<=h<=12, -11<=k<=11, -16<=l<=16  
Reflections collected   15549  
Independent reflections  5290 [R(int) = 0.0377]  
Completeness to theta = 25.36°  99.5 %  
Absorption correction   Integration 
Max. and min. transmission   0.8628 and 0.8386 
Refinement method    Full-matrix least-squares on F2  
Data / restraints / parameters   5290 / 295 / 415 
Goodness-of-fit on F2   1.039  
Final R indices [I>2sigma(I)]  R1 = 0.0336, wR2 = 0.0727  
R indices (all data)   R1 = 0.0402, wR2 = 0.0764 
Absolute structure (Flack) parameter -0.01(4)   
Largest diff. peak and hole  0.162 and -0.159 e. Å-3  
 
Crystallographic data have been deposited at the Cambridge Crystallographic Centre, 12 Union 
Road, Cambridge CB2 1EZ, UK, and copies can be obtained on request, free of charge, by quoting 
the publication citation and the deposition number CCDC 872159. 
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Procedure: Quinine (10 g, 30.8 mmol) was dissolved in a 1.2 M solution of acetic acid (140 mL) 
and stirred at 102 C for 72 hours before cooling to room temperature. The reaction mixture was 
diluted with ethyl acetate followed by addition of 1 M sodium hydroxide until basic. The solution 
was transferred to a separatory funnel and extracted with ethyl acetate (3x). The combined organic 
layers were concentrated under reduced pressure to provide crude quinotoxine Q8 which was 
directly carried on to the next step. Quinotoxine Q8 was dissolved in a 1:1 mixture of ethyl acetate 
and a saturated solution sodium bicarbonate (460 mL) along with 4-(dimethylamino)-pyridine (40 
mg, 0.329 mmol) and cooled to 0 C with stirring. Benzyl chloroformate (4.43 g, 37.0 mmol) was 
added to the stirring reaction dropwise and the reaction mixture was warmed to room temperature 
and allowed to stir overnight. The reaction mixture was then transferred to a separatory funnel and 
the carbamate product extracted with ethyl acetate (3x). The combined organic layers were washed 
with brine, dried with magnesium sulfate and concentrated in vacuo to afford a tan residue. 
Purification by column chromatography using 49:1 ethyl acetate/triethylamine provided 6.70 g 
(47% yield over two steps) of carbamate Q6 as a tan oil. 
Note: Best yields for this reaction sequence were obtained when quinotoxine Q8 was carried on 
without chromatographic purification; however, flash column chromatography using 3:2:0.1 ethyl 
acetate/methanol/aqueous ammonium hydroxide afforded Q8 in 66% yield.  Spectral data obtained 
for Q8 were identical to that previously reported and are not reported here.38 Reaction of pure Q8 
with benzyl chloroformate provided Q6 in 60% yield.  
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1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 8.87 (d, J = 4.4 Hz, 1H), 8.01 (d, J = 9.2 Hz, 1H), 7.82 
(d, J = 4.4 Hz, 1H), 7.70 (d, J = 2.9 Hz, 1H), 7.47 (dd, J = 9.2, 2.9 Hz, 1H), 7.40 - 7.26 (m, 5H), 
5.80 (ddd, J = 17.4, 10.5, 8.6 Hz, 1H), 5.16 (ddd, J = 17.4, 2.2, 1.1 Hz, 1H), 5.13 - 5.02 (m, 1H), 
5.08 (d, J = 6.5 Hz, 2H), 4.01 - 3.95 (m, 1H), 3.95 - 3.84 (m, 1H), 3.89 (s, 3H), 3.15 - 3.06 (m, 
3H), 2.92 (ddd, J = 12.5, 11.3, 3.30 Hz, 1H), 2.41 (dddd, J = 7.6, 3.6, 3.5, 3.5 Hz, 1H), 1.74 (dddd, 
J = 10.8, 7.2, 3.7, 3.7 Hz, 1H), 1.69 - 1.57 (m, 2H), 1.54 (dddd, J = 13.4, 3.4, 3.4, 3.4 Hz, 1H), 
1.38 (dddd, J = 13.5, 11.2, 11.2, 4.5 Hz, 1H).  
13C NMR (CDCl3, 125 MHz): δ 203.8, 159.6, 155.7, 147.1, 145.9, 140.5, 137.0, 135.4, 131.6, 
128.6, 128.1, 128.0, 125.3, 123.0, 120.2, 117.6, 103.2, 67.2, 55.8, 49.2, 44.1, 42.8, 39.3, 38.5, 27.9, 
27.6. 
 HRMS(ESI): m/z calc. for C28H31N2O4 [M+H]
+: 459.2284, found: 459.2286. 
 
Procedure: Carbamate Q6 (610 mg, 1.33 mmol) was added to a solution of 12% w/w dimethyl 
titanocene in toluene (5 mL, 2.5 mmol) containing titanocene dichloride (44 mg, 0.18 mmol).39 
The reaction mixture was heated at 80 C for 6 hours before cooling to room temperature. Sodium 
57 
 
bicarbonate (600 mg), methanol (6 mL), and water (1 mL) were added to the reaction mixture 
followed by heating at 40 C for 18 hours to decompose and precipitate the remaining 
organotitanium residues. The reaction was cooled, filtered, washed with water (3x) and brine, dried 
with MgSO4, and concentrated under reduced pressure. The crude material was purified by column 
chromatography using 1:1 hexane/ethyl acetate to yield 135 mg (22% yield) of the desired olefin 
Q9 as a tan oil.  
 
1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 8.68 (d, J = 4.3 Hz, 1H), 7.95 (d, J = 9.1 Hz, 1H), 7.42 
(dd, J = 9.1, 2.9 Hz, 1H), 7.37 - 7.29 (m, 5H), 7.28 (d, J = 2.9 Hz, 1H), 7.22 (d, J = 4.3 Hz, 1H), 
5.68 (ddd, J = 17.3, 11.3, 9.1 Hz, 1H), 5.50 (d, J = 1.6 Hz, 1H), 5.14 (m, 1H), 5.11 - 4.92 (m, 2H), 
5.05 (d, J = 6.9 Hz, 2H), 3.93 (ddd, J = 13.3, 3.8, 3.8 Hz, 1H), 3.90 - 3.78 (m, 1H), 3.88 (s, 3H), 
3.03 (dd, J = 13.0, 3.1 Hz, 1H), 2.87 (dd, J = 12.4, 12.4 Hz, 1H), 2.58 - 2.51 (m, 2H), 2.31 (ddd, J 
= 7.5, 3.6, 3.6 Hz, 1H), 1.66 (dddd, J = 10.1, 3.4, 3.4, 3.2 Hz, 1H), 1.43 (dd, J = 13.3, 3.1 Hz, 1H), 
1.39 - 1.23 (m, 2H). 
13C NMR (CDCl3, 125 MHz): δ 157.8, 155.6, 148.4, 147.5, 146.7, 144.8, 137.0, 135.5, 131.5, 
128.5, 128.0, 127.9, 127.5, 121.8, 120.0, 117.2, 116.4, 103.6, 67.1, 55.6, 49.1, 44.2, 42.5, 38.5, 
34.9, 31.6, 27.6. 
HRMS(ESI): m/z calc. for C29H33N2O3 [M+H]
+: 457.2491, found: 457.2482. 
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Procedure: To a solution of Q9 (70 mg, 0.15 mmol) in anhydrous dichloromethane (38 mL) was 
added Grubbs second-generation catalyst (19.5mg, 0.023 mmol). The reaction mixture was heated 
to 40 C and allowed to stir 24 hours. The reaction was then cooled to room temperature and the 
solvent was removed in vacuo and the crude mixture purified by column chromatography using 
9:1 ethyl acetate/hexane to provide 28.4 mg (43% yield) of the desired [4.4.0]-bicycle Q2 as a tan 
oil. 
 
1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 8.67 (d, J = 4.4 Hz, 1H), 7.95 (d, J = 9.1 Hz, 1H), 7.40 
(dd, J = 9.1, 2.8 Hz, 1H), 7.23 (d, J = 2.8 Hz, 1H), 7.23 - 7.17 (m, 5H), 7.16 (d, J = 4.4 Hz, 1H), 
5.69 - 5.61 (m, 1H), 5.06 (d, J = 12.7 Hz, 1H), 4.99 (d, J = 12.7 Hz, 1H), 3.84 (s, 3H), 3.80 - 3.65 
(m, 2H), 3.46 (dd, J = 13.3, 4.2 Hz, 1H), 3.25 (ddd, J = 10.6, 9.7, 5.1 Hz, 1H), 2.58 (ddddd, J = 
7.8, 5.4, 5.4, 3.0, 3.0 Hz, 1H), 2.40 - 2.34 (m, 2H), 2.11 (dddd, J = 11.1, 8.5, 4.6, 4.6 Hz, 1H), 1.94 
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(dddd, J = 12.4, 6.0, 5.9, 5.9 Hz, 1H), 1.83 (dddd, J = 13.6, 7.2, 7.1, 3.5 Hz, 1H), 1.77 - 1.58 (m, 
2H). 
13C NMR (d6-DMSO, 125 MHz, 80 °C): δ 156.9, 154.3, 147.9, 147.1, 143.9, 136.6, 136.3, 130.6, 
129.1, 127.7, 127.1, 126.8, 126.4, 120.8, 119.3, 103.2, 65.6, 54.9, 46.8, 41.9, 35.0, 30.2, 26.8, 26.4, 
24.8.  
HRMS(ESI): m/z calc. for C27H29N2O3 [M+H]
+: 429.2178, found: 429.2178. 
 
Procedure: Carbamate Q6 (1.00 g, 2.18 mmol) was dissolved in dichloromethane (50 mL) at 
room temperature. Sodium bicarbonate (1.48 g, 14.0 mmol) was added and the solution was cooled 
to 0 C. m-Chloroperoxybenzoic acid (600 mg, 2.68 mmol calculated at 77% purity) was added 
and the reaction was stirred overnight. Upon warming to room temperature, the reaction was 
diluted with dichloromethane (50 mL) and quenched with a saturated solution of sodium 
bicarbonate (50 mL). The reaction mixture was transferred to a separatory funnel and extracted 
with dichloromethane (3x). The combined organic layers were washed with brine, dried with 
magnesium sulfate, and concentrated under reduced pressure. The crude material was purified by 
column chromatography using 9:1 chloroform/acetone to provide 555 mg (54%) of N-oxide Q10 
as a yellow oil. 
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1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 8.52 (d, J = 9.5 Hz, 1H), 8.46 (d, J = 6.5 Hz, 1H), 8.23 
(d, J = 2.8 Hz, 1H), 8.03 (d, J = 6.5 Hz, 1H), 7.47 (dd, J = 9.6, 2.8 Hz, 1H), 7.40 - 7.27 (m, 5H), 
5.81 (ddd, J = 17.3, 10.5, 8.5 Hz, 1H), 5.17 (ddd, J = 17.3, 2.1, 1.0 Hz, 1H), 5.13 - 5.03 (m, 3H), 
4.01 - 3.95 (m, 1H), 3.95 - 3.87 (m, 1H), 3.92 (s, 3H), 3.15 - 3.07 (m, 3H), 2.94 (ddd, J = 13.8, 
11.5, 3.5 Hz, 1H), 2.42 (ddd, J = 7.9, 4.0, 4.0 Hz, 1H), 1.74 (dddd, J = 11.1, 7.4, 3.8, 3.8 Hz, 1H), 
1.70 - 1.51 (m, 3H), 1.39 (dddd, J = 13.6, 11.4, 11.3, 4.5 Hz, 1H). 
13C NMR (CDCl3, 125 MHz): δ 200.3, 161.3, 155.6, 138.3, 137.0, 135.5, 132.3, 129.5, 128.5, 
128.1, 128.0, 127.9, 123.6, 123.0, 121.3, 117.6, 105.1, 67.1, 55.9, 49.1, 44.1, 42.8, 38.5, 38.2, 27.8, 
27.6. 
HRMS(ESI): m/z calc. for C28H31N2O5 [M+H]
+: 475.2233, found: 475.2234. 
 
Procedure: To a solution of N-oxide Q10 (50.0 mg, 0.105 mmol) in dichloromethane (0.525 mL) 
at 0 C was added 2,6-lutidine (28.1 mg, 0.263 mmol) followed by dropwise addition of oxalyl 
chloride (19.9 mg, 0.157 mmol). The reaction warmed to room temperature and stirred 2 hours. 
Upon completion, the reaction was quenched by cooling to 0 C followed by careful addition of a 
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cold saturated solution of sodium bicarbonate. The reaction mixture was then transferred to a 
separatory funnel, washed with additional saturated solution of sodium bicarbonate, and extracted 
with dichloromethane (3x).  The combined organic extracts were washed with brine, dried with 
magnesium sulfate, and evaporated. The crude product was purified by column chromatography 
using 9:1 ethyl acetate/hexane to provide 50.8 mg (98% yield) of chloride Q11 as a bright yellow 
oil. 
 
1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 7.94 (d, J = 9.1 Hz, 1H), 7.91 (s, 1H), 7.59 (d, J = 2.8 
Hz, 1H), 7.53 (dd, J = 9.1, 2.8 Hz, 1H), 7.40 - 7.27 (m, 5H), 5.80 (ddd, J = 17.3, 10.5, 8.6 Hz, 1H), 
5.17 (ddd, J = 17.3, 2.1, 1.0 Hz, 1H), 5.13 - 5.03 (m, 3H), 4.03 - 3.94 (m, 1H), 3.94 - 3.90 (m, 1H), 
3.90 (s, 3H), 3.14 (m, 2H), 3.11 (dd, J = 13.2, 3.3 Hz, 1H), 2.94 (ddd, J = 13.7, 12.6, 3.4 Hz, 1H), 
2.43 (dddd, J = 7.4, 3.5, 3.5, 3.5 Hz, 1H), 1.74 (ddddd, J = 11.0, 7.4, 3.9, 3.7, 3.7 Hz, 1H), 1.69 - 
1.51 (m, 3H), 1.38 (dddd, J = 13.4, 11.2, 11.2, 4.5 Hz, 1H). 
13C NMR (CDCl3, 125 MHz): δ 202.5, 159.7, 155.7, 147.4, 145.4, 143.7, 137.0, 135.4, 130.6, 
128.6, 128.1, 128.0, 124.3, 123.9, 121.5, 117.8, 103.6, 67.2, 55.9, 49.3, 44.1, 42.8, 39.5, 38.5, 27.6, 
27.5.  
HRMS (ESI): m/z calc. for C28H30ClN2O4 [M+H]
+: 493.1894, found: 493.1901. 
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Procedure: A solution of chloride Q11 (100 mg, 0.203 mmol), (S)-2-(methoxymethyl)pyrrolidine 
(47 mg, 0.408 mmol), and N,N-disoproylethylamine (130 mg, 1.01 mmol) in N-methyl-2-
pyrrolidone (0.910 mL) was heated at 140 C in a sealed tube with stirring for 24 hours. The 
reaction contents were directly purified by column chromatography using 96:3:1 
chloroform/acetone/triethylamine to provide 113 mg (98% yield) of the desired amine Q3 as a 
yellow oil.  
 
1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 7.56 (d, J = 9.1 Hz, 1H), 7.37 (d, J = 2.9 Hz, 1H), 7.36 
- 7.29 (m, 5H), 7.24 (dd, J = 9.1, 2.9 Hz, 1H), 7.17 (s, 1H), 5.80 (ddd, J = 17.3, 10.5, 8.6 Hz, 1H), 
5.15 (ddd, J = 17.3, 2.1, 1.1 Hz, 1H), 5.13 - 5.02 (m, 3H), 4.40 (ddddd, J = 9.2, 3.2, 3.2, 2.4, 2.4 
Hz, 1H), 4.02 - 3.94 (m, 1H), 3.91 (ddd, J = 13.0, 3.6, 1.7 Hz, 1H), 3.80 (s, 3H), 3.68 - 3.57 (m, 
2H), 3.51 (ddd, J = 10.2, 8.8, 6.6 Hz, 1H), 3.42 (dd, J = 9.6, 6.9 Hz, 1H), 3.32 (s, 3H), 3.14 - 3.02 
(m, 2H), 2.98 - 2.89 (m, 1H), 2.41 (dddd, J = 7.7, 3.7, 3.7, 3.7 Hz, 1H), 2.12 - 1.93 (m, 5H), 1.73 
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(dddd, J = 11.1, 7.4, 3.8, 3.8 Hz, 1H), 1.67 - 1.57 (m, 2H), 1.57 - 1.50 (m, 1H), 1.38 (dddd, J = 
13.5, 11.3, 11.3, 4.4 Hz, 1H).  
13C NMR (CDCl3, 125 MHz): δ 204.7, 155.7, 155.6, 154.1, 145.3, 143.6, 137.1, 135.5, 128.6, 
128.1, 128.0, 121.8, 118.8, 117.9, 117.6, 109.7, 104.0, 74.0, 67.2, 59.4, 57.5, 55.7, 49.3, 48.0, 44.1, 
42.8, 39.6, 38.5, 28.9, 28.0, 27.6, 23.9. 
HRMS(ESI): m/z calc. for C34H42N3O5 [M+H]
+: 572.3124, found: 572.3117. 
 
Procedure: A flame dried three necked flask was charged with magnesium (2.43 g, 100 mmol) 
and heated to 130 °C under vacuum for 30 minutes. The flask was then cooled and flushed with 
argon. Anhydrous THF (10 mL) and diisobutylaluminum hydride (0.6 mL, 1.0 M in 
tetrahydrofuran) were then added. Isoamyl bromide (2.40 mL, 20 mmol) was then added dropwise 
until an exotherm was observed then slow addition maintained a gentle reflux. After complete 
addition, the reaction mixture was refluxed 2h and cooled to provide a 0.9 M solution of 
isoamylmagnesium bromide in tetrahydrofuran (titrated with menthol/2,2’-bipyridine). To a flame 
dried round bottom flask charged with dry toluene (20 mL) was added isoamylmagnesium bromide 
(5.0 mL, 0.9 M in tetrahydrofuran, 4.5 mmol) followed by addition of quinine (292 mg, 0.9 mmol) 
as a single portion with vigorous stirring. The mixture was stirred at 70 C for 3 hours at which 
point a second portion of isoamylmagnesium bromide (1.5 mL, 0.9 M in tetrahydrofuran, 1.2 
mmol) was added.  The reaction was refluxed an additional 12 hours and then cooled to 0C, 
diluted with methyl tert-butyl ether, and quenched by careful addition of a saturated solution of 
ammonium chloride. The biphasic mixture was separated and the organic layer was washed with 
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additional ammonium chloride followed by water.  The organic layer was then collected from a 
separatory funnel, dried with magnesium sulfate and concentrated under reduced pressure. 
Purification by column chromatography using 49:1 ethyl acetate/triethylamine provided 83.1 mg 
(23% yield) of aminal Q4 as a tan oil. 
 
1H NMR (500 MHz, CDCl3): δ 6.61 (m, 2H), 6.44 (d, J = 9.1 Hz, 1H), 5.67 (ddd, J = 17.7, 9.8, 
7.9 Hz, 1H), 5.11 (dd, J = 5.1, 3.2 Hz, 1H), 4.91 - 4.82 (m, 2H), 4.49 - 4.43 (m, 1H), 3.89 (d, J = 
5.1 Hz, 1H), 3.73 (s, 3H), 2.96 (dd, J = 13.7, 10.0 Hz, 1H), 2.92 - 2.83 (m, 1H), 2.63 - 2.52 (m, 
1H), 2.41 (ddd, J = 13.7, 4.6, 2.4 Hz, 1H), 2.38 - 2.32 (m, 1H), 2.28 (d, J = 10.9 Hz, 1H), 2.19 
(ddd, J = 13.2, 13.1, 3.6 Hz, 1H), 2.15 - 1.99 (m, 2H), 1.65 - 1.46 (m, 4H), 1.40 - 1.30 (m, 2H), 
1.23 - 1.07 (m, 2H), 1.00 (ddd, J = 13.7, 8.5, 3.4 Hz, 1H), 0.92 (d, J = 6.5 Hz, 3H), 0.90 (d, J = 6.6 
Hz, 3H).         
13C NMR (CDCl3, 125 MHz): δ 153.2, 142.5, 136.8, 129.1, 116.2, 113.8, 113.1, 112.7, 96.9, 83.8, 
57.2, 56.1, 55.9, 47.9, 42.6, 40.5, 37.8, 34.6, 29.8, 28.9, 27.9, 27.6, 23.5, 22.8, 22.8. 
HRMS(ESI): m/z calc. for C25H37N2O2 [M+H]
+: 397.2855, found: 397.2853. 
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Procedure: To a flame dried round bottom flask charged with anhydrous toluene (20 mL) was 
added phenyl magnesium chloride (4.65 mL, 2.0 M in tetrahydrofuran, 9.29 mmol) followed by 
addition of quinine (600 mg, 1.85 mmol) as a single portion with vigorous stirring. The mixture 
was stirred at 70 C for 3 hours and an additional portion of phenyl magnesium chloride (4.65 mL, 
2.0 M in tetrahydrofuran, 9.29 mmol) was added.  The reaction was refluxed an additional 1.5 
hours and then cooled to 0 C, diluted with methyl tert-butyl ether, and quenched by careful 
addition of a saturated solution of ammonium chloride. The biphasic mixture was separated and 
the organic layer was washed with ammonium chloride and then water.  The organic layer was 
then dried with magnesium sulfate and concentrated under reduced pressure. Purification by 
column chromatography using 47:2:1 ethyl acetate/methanol/triethylamine afforded 434 mg (58% 
yield) of aminal Q12 as a tan crystalline powder that had identical spectra to those that were 
previously published (1H NMR and 13C NMR) for this compound.27  
 
Procedure: Aminal Q11 (400 mg, 1.00 mmol) was dissolved in a solution of glacial acetic acid 
(0.25 mL) and methanol (2 mL) at 0 C. Sodium cyanoborohydride (126 mg, 2.00 mmol) was 
added and the reaction was stirred 2.5 hours before concentrated hydrochloric acid (0.60 mL) was 
added and stirred for an additional 12 hours. The reaction was quenched by the addition of 2 M 
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sodium hydroxide until pH >9 and transferred to a separatory funnel. The crude mixture was 
extracted with ethyl acetate (3x), washed with brine, dried with magnesium sulfate, and 
concentrated under reduced pressure. Purification by column chromatography using 49:1 ethyl 
acetate/triethylamine yielded 352 mg (88% yield) of tetrahydroquinoline Q12 as a white foam. 
 
1H NMR (CDCl3, 500 MHz): δ 7.33 - 7.27 (m, 4H), 7.21 - 7.17 (m, 1H), 6.98 (d, J = 2.8 Hz, 1H), 
6.69 (dd, J = 8.6, 2.8 Hz, 1H), 6.43 (d, J = 8.6 Hz, 1H), 5.79 (ddd, J = 17.1, 10.4, 7.9 Hz, 1H), 4.97 
- 4.88 (m, 2H), 4.39 (d, J = 4.5 Hz, 1H), 3.75 (s, 3H), 3.59 - 3.48 (m, 1H), 3.30 (dddd, J = 11.4, 
5.7, 3.0, 3.0 Hz, 1H), 3.22 - 3.09 (m, 2H), 3.09 - 3.01 (m, 2H), 2.68 - 2.55 (m, 2H), 2.49 (ddd, J = 
13.7, 5.4, 2.4 Hz, 1H), 2.20 (ddd, J = 8.0, 8.0, 7.8 Hz, 1H), 1.93 - 1.82 (m, 2H), 1.80 (d, J = 4.6 
Hz, 1H), 1.72 - 1.60 (m, 2H), 1.50 (dddd, J = 13.4, 10.4, 3.2, 3.2 Hz, 1H), 1.38 (dddd, J = 15.5, 
10.7, 5.3, 2.9 Hz, 1H). 
13C NMR (CDCl3, 125 MHz): δ 151.4, 145.0, 142.6, 139.1, 128.6, 128.5, 126.6, 125.6, 115.7, 
114.8, 114.4, 114.0, 79.7, 57.0, 56.4, 56.3, 50.5, 42.8, 40.7, 39.0, 28.6, 27.7, 26.8, 22.2. 
HRMS(ESI): m/z calc. for C26H33N2O2 [M+H]
+: 405.2542, found: 405.2542. 
Melting point: 143-146 °C. 
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Procedure: Tetrahydroquinoline Q7 (202 mg, 0.50 mmol) was dissolved in anhydrous 
dichloromethane (7 mL) and cooled to 0 °C. O-phenyl chlorothionoformate (190 mg, 2.20 mmol) 
was added and the reaction was warmed to room temperature and stirred for 7.5 hours. The reaction 
mixture was then diluted with dichloromethane, quenched with a saturated solution of sodium 
bicarbonate and transferred to a separatory funnel. The biphasic mixture was separated and the 
organic layer washed with brine, dried with magnesium sulfate, and concentrated under reduced 
pressure. The crude product was purified by column chromatography using 100:0 to 90:10 
chloroform/ethyl acetate to provide 119 mg (35% yield) of O-thiocarbonate Q5 as a white solid. 
 
1H NMR (CDCl3, 500 MHz): δ 7.44 (d, J = 9.1 Hz, 1H), 7.39 - 7.32 (m, 3H), 7.31 - 7.22 (m, 8H), 
7.15 (dd, J = 8.4, 6.3 Hz, 1H), 6.88 (d, J = 8.9 Hz, 1H), 6.88 - 6.81 (m, 2H), 6.64 (d, J = 7.8 Hz, 
2H), 6.29 (d, J = 2.6 Hz, 1H), 5.85 (ddd, J = 17.4, 10.0, 7.4 Hz, 1H), 5.07 - 4.96 (m, 2H), 4.74 - 
4.66 (m, 1H), 3.90 - 3.82 (m, 1H), 3.86 (s, 3H), 3.38 (dd, J = 8.7, 8.7 Hz, 1H), 3.32 - 3.22 (m, 1H), 
3.12 (dd, J = 11.9, 11.9 Hz, 1H), 3.05 - 2.94 (m, 1H), 2.75 - 2.64 (m, 1H), 2.63 - 2.54 (m, 1H), 
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2.34 - 2.25 (m, 1H), 2.08 (ddd, J = 12.0, 10.9, 6.1 Hz, 1H), 1.93 - 1.85 (m, 1H) 1.85 - 1.74 (m, 
2H), 1.62 - 1.47 (m, 2H). 
13C NMR (CDCl3, 125 MHz): δ 187.0, 157.6, 155.9, 154.0, 153.4, 141.9, 139.6, 130.1, 129.8, 
129.6, 129.2, 128.2, 127.3, 126.7, 125.9, 122.6, 122.0, 120.7, 115.6, 114.6, 113.2, 112.0, 88.3, 
57.6, 56.3, 55.8, 51.4, 47.8, 42.8, 40.0, 29.3, 28.0, 27.7, 23.3. 
HRMS(ESI): m/z calc. for C40H41N2O4S2 [M+H]
+: 677.2508, found: 677.2514. 
Melting point: 169-171 °C. 
2.5.2 Derivative Libraries of Q1: Synthesis and Characterization 
 
 
Procedure: To a flame dried round bottom flask under argon containing a suspension of quinine 
(3.153 g, 9.7 mmol) in methyl t-butyl ether (58 mL) at -10 C was added (4-phenoxyphenyl)lithium 
(5.142 g, 29.2 mmol). The reaction mixture was stirred for 20 min at -10 C, warmed to room 
temperature for 1 h, and quenched by dropwise addition of acetic acid at 0 C. Upon dilution with 
water and ethyl acetate, solid iodine (~700 mg) was added with vigorous stirring until a dark brown 
color persisted. A saturated aqueous solution of sodium metabisulfite was then added to quench 
excess iodine. The reaction mixture was basified with 25% aqueous ammonia and extracted with 
dichloromethane (3x). The organic layer was washed with brine, dried with magnesium sulfate, 
and evaporated. Purification by column chromatography using 1:9 methanol/toluene with 2% 
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triethylamine provided 1.406 g (29%) of PhOPh-Q as a white solid. Spectral data for PhOPh-Q 
(1H NMR, 13C NMR, and HRMS) matched previously reported spectra.40  
 
Procedure: To a solution of PhOPh-Q (700 mg, 1.42 mmol) in dry dichloromethane (28.4 mL) 
at 0 C under argon was added O-Phenyl chlorothionoformate (295.2 mg, 1.71 mmol). The 
reaction was warmed to room temperature and stirred overnight. Upon cooling to 0 C, the reaction 
was quenched by slow addition of aqueous sodium bicarbonate and transferred to a separatory 
funnel. The crude mixture was washed 3 times with 1 M NaOH to remove phenol then washed 
with brine, dried with magnesium sulfate, and evaporated. Purification by column chromatography 
using 1:12 to 0:1 hexanes/chloroform provided Q1a (368 mg, 45%) as a yellow powder.  
1H NMR (CDCl3, 500 MHz): δ 8.16 - 8.10 (m, 3H), 8.07 (s, 1H), 7.44 (dd, J = 9.2, 2.6 Hz, 1H), 
7.39 - 7.35 (m, 2H), 7.25 (d, J = 2.7 Hz, 1H), 7.18 - 7.12 (m, 3H), 7.10 - 7.06 (m, 2H), 5.68 (dt, J 
= 17.1, 9.7 Hz, 1H), 5.21 (dd, J = 10.1, 1.5 Hz, 1H), 5.18 (d, J = 7.3 Hz, 1H), 5.13 (dd, J = 17.0, 
1.4 Hz, 1H), 4.06 - 3.99 (m, 2H), 3.99 (s, 3H), 3.52 (dd, J = 11.2, 3.4 Hz, 1H), 3.40 (dd, J = 11.1, 
5.1 Hz, 1H), 2.97 (td, J = 13.3, 3.4 Hz, 1H), 2.61 (dq, J = 14.4, 4.5 Hz, 1H), 2.19 - 2.12 (m, 1H), 
2.09 (dd, J = 14.1, 2.5 Hz, 1H), 1.95 - 1.87 (m, 1H), 1.86 - 1.80 (m, 1H), 1.73 - 1.64 (m, 1H). 
HRMS(ESI): m/z calc. for C33H32N2O3SCl [M+H]
+: 571.1822, found: 571.1811. 
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General procedure for the preparation of of Q1 azides: To a solution of chloride Q1 of Q1a 
(0.26 mmol) in N,N-dimethylformamide (2.6 mL) was added sodium azide (51.4 mg, 0.79 mmol). 
The reaction mixture was heated to 50 C and stirred 24 h. Upon cooling, the reaction was poured 
into brine and extracted with ethyl acetate. Washing the organic layer with brine (4x), drying with 
magnesium sulfate, and evaporation of solvent provided pure azide. (Note: This procedure was 
performed at several scales 0.22 - 1.66 mmol.) 
Q1b: Prepared from Q1. 
Yield: 451.7 mg, 89% yield. 
1H NMR (CDCl3, 500 MHz): δ 8.79 (d, J = 4.6 Hz, 1H), 8.08 (d, J = 9.2 
Hz, 1H), 7.60 (d, J = 4.6 Hz, 1H), 7.43 (dd, J = 9.2, 2.6 Hz, 1H), 7.25 (d, J = 2.7 Hz, 1H), 5.59 
(ddd, J = 16.9, 10.2, 9.4 Hz, 1H), 5.20 (dd, J = 10.2, 1.5 Hz, 1H), 5.16 (dd, J = 17.1, 1.5 Hz, 1H), 
5.12 (d, J = 7.8 Hz, 1H), 4.03 - 3.96 (m, 2H), 3.96 (s, 3H), 3.26 (dd, J = 12.3, 4.7 Hz, 1H), 3.20 
(dd, J = 12.3, 5.8 Hz, 1H), 2.95 (td, J = 13.2, 3.3 Hz, 1H), 2.48 (tt, J = 10.5, 5.3 Hz, 1H), 2.02 - 
1.94 (m, 2H), 1.85 - 1.77 (m, 2H), 1.62 (tt, J = 13.7, 4.8 Hz, 1H).   
HRMS(ESI): m/z calc. for C21H24N5O2S [M+H]
+: 410.1651, found: 410.1655. 
Q1c: Prepared from Q1a. 
Yield: 143 mg, 95%. 
1H NMR (CDCl3, 500 MHz): δ 8.17 - 8.10 (m, 3H), 8.09 (s, 1H), 7.45 
(dd, J = 9.2, 2.6 Hz, 1H), 7.40 - 7.34 (m, 2H), 7.26 (d, J = 2.3 Hz, 1H), 
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7.18 - 7.12 (m, 3H), 7.10 - 7.05 (m, 2H), 5.59 (dt, J = 17.1, 9.8 Hz, 1H), 5.23 - 5.13 (m, 3H), 4.07 
- 4.00 (m, 2H), 3.98 (s, 3H), 3.27 (dd, J = 12.3, 4.7 Hz, 1H), 3.19 (dd, J = 12.3, 5.9 Hz, 1H), 2.96 
(td, J = 13.3, 3.3 Hz, 1H), 2.48 (tt, J = 10.4, 5.3 Hz, 1H), 2.08 - 2.01 (m, 1H), 2.02 - 1.95 (m, 1H), 
1.90 - 1.79 (m, 2H), 1.64 (tt, J = 13.7, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C33H32N5O3S [M+H]
+: 578.2226, found: 578.2220. 
 
Procedure: A solution of azide Q1b (481.8 mg, 1.18 mmol) and triphenylphosphine (926 mg, 
3.53 mmol) in tetrahydrofuran (30 mL) and water (2 mL) was stirred at 50 C for 6 hours. The 
reaction was then cooled to room temperature, washed with brine, dried with magnesium sulfate, 
and evaporated. Purification by column chromatography using a gradient of 1:49 to 3:22 
methanol/ethyl acetate with 2% triethylamine provided amine Q1d (377.3 mg, 83%) as a white 
solid. 
1H NMR (CDCl3, 500 MHz): δ 8.74 (d, J = 4.6 Hz, 1H), 8.02 (d, J = 9.2 Hz, 1H), 7.55 (d, J = 4.6 
Hz, 1H), 7.38 (dd, J = 9.2, 2.6 Hz, 1H), 7.21 (d, J = 2.7 Hz, 1H), 5.39 (dt, J = 17.0, 9.7 Hz, 1H), 
5.18 (dd, J = 10.2, 1.8 Hz, 1H), 5.13 - 5.06 (m, 2H), 4.01 (ddd, J = 11.5, 8.0, 3.0 Hz, 1H), 3.96 - 
3.92 (m, 1H), 3.92 (s, 3H), 2.95 (td, J = 13.2, 3.1 Hz, 1H), 2.63 (dd, J = 12.1, 3.5 Hz, 1H), 2.33 
(dd, J = 12.0, 9.2 Hz, 1H), 2.29 - 2.20 (m, 1H), 1.96 - 1.90 (m, 1H), 1.85 - 1.69 (m, 3H), 1.56 (tt, 
J = 13.5, 4.5 Hz, 1H). 
HRMS(ESI): m/z calc. for C21H26N3O2S [M+H]
+: 384.1746, found: 384.1750. 
72 
 
 
Procedure: A solution of azide Q1c (135 mg, 0.234 mmol) and triphenylphosphine (67 mg, 0.257 
mmol) in tetrahydrofuran (1.17 mL) and water (5 μL) was stirred at room temperature for 36 hours. 
The reaction was then evaporated and purified by column chromatography using a gradient of 1:49 
to 2:23 methanol/ethyl acetate with 2% triethylamine provided amine Q1e (96 mg, 74%) as a white 
solid.  
1H NMR (CDCl3, 500 MHz): δ 8.15 - 8.09 (m, 3H), 8.07 (s, 1H), 7.43 (dd, J = 9.2, 2.8 Hz, 1H), 
7.39 - 7.34 (m, 2H), 7.25 (d, J = 2.9 Hz, 1H), 7.18 - 7.11 (m, 3H), 7.10 - 7.04 (m, 2H), 5.44 (dt, J 
= 17.0, 9.8 Hz, 1H), 5.21 (dd, J = 10.2, 1.8 Hz, 1H), 5.16 (d, J = 7.9 Hz, 1H), 5.13 (dd, J = 17.1, 
1.8 Hz, 1H), 4.12 - 4.05 (m, 1H), 4.03 - 3.98 (m, 1H), 3.97 (s, 3H), 3.00 (td, J = 13.1, 3.1 Hz, 1H), 
2.67 (dd, J = 12.1, 3.5 Hz, 1H), 2.38 (dd, J = 12.0, 9.2 Hz, 1H), 2.28 (qd, J = 9.5, 3.3 Hz, 1H), 2.07 
- 2.00 (m, 1H), 1.91 - 1.77 (m, 3H), 1.63 (td, J = 8.8, 4.3 Hz, 1H). 
HRMS(ESI): m/z calc. for C33H34N3O3S [M+H]
+: 552.2321, found: 552.2311. 
 
General procedure for the preparation of Q1 triazoles: To a vial containing azide Q1b or Q1c 
(0.017 mmol) was added a solution of copper sulfate pentahydrate (2 mg, 0.0080 mmol) and 
sodium ascorbate (5 mg, 0.025 mmol)  in 2:1 water/t-butanol (600 μL) followed by alkyne (0.051 
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mmol). Dichloromethane (200 μL) was then added to vials containing Q1c to help dissolve the 
azide. The reaction was stirred at room temperature for 24 hours then diluted with water and 
extracted with chloroform. The organic layer was washed, dried with magnesium sulfate, 
evaporated, and purified by preparative TLC (hexanes/ethyl acetate) to provide the triazole. (Note: 
This procedure was performed at scales from 0.017-0.147 mmol azide) 
Q1f: Prepared from phenylacetylene. 
Yield: 32.3 mg, 90%.  
1H NMR (CDCl3, 500 MHz): δ 8.86 - 8.76 (m, 1H), 8.18 (d, J = 8.8 
Hz, 1H), 7.83 - 7.71 (m, 3H), 7.68 (s, 1H), 7.49 - 7.26 (m, 5H), 5.53 (dt, J = 16.5, 9.8 Hz, 1H), 
5.24 - 5.10 (m, 2H), 5.01 (d, J = 16.5 Hz, 1H), 4.47 (dd, J = 13.7, 3.4 Hz, 1H), 4.32 - 4.24 (m, 1H), 
4.20 (dd, J = 13.7, 7.8 Hz, 1H), 4.03 - 3.92 (m, 1H), 3.98(s, 3H), 3.07 - 2.97 (m, 1H), 2.99 - 2.89 
(m, 1H), 2.24 (d, J = 13.5 Hz, 1H), 2.10 - 1.88 (m, 2H), 1.89 - 1.76 (m, 1H), 1.76 - 1.60 (m, 1H).  
HRMS(ESI): m/z calc. for C29H30N5O2S [M+H]
+: 512.2120, found: 512.2119. 
Q1g: Prepared from 1-ethynyl-4-phenoxybenzene.  
Yield: 71.6 mg, 81%. 
1H NMR (CDCl3, 500 MHz): δ 8.80 (d, J = 4.6 Hz, 1H), 8.05 
(d, J = 9.2 Hz, 1H), 7.75 - 7.69 (m, 2H), 7.64 (d, J = 4.6 Hz, 1H), 7.59 (s, 1H), 7.41 (dd, J = 9.2, 
2.6 Hz, 1H), 7.36 - 7.30 (m, 2H), 7.25 (d, J = 2.7 Hz, 1H), 7.15 - 7.07 (m, 1H), 7.05 - 6.99 (m, 
4H), 5.50 (dt, J = 17.0, 9.9 Hz, 1H), 5.19 - 5.09 (m, 2H), 4.98 (dd, J = 17.0, 1.2 Hz, 1H), 4.41 (dd, 
J = 13.9, 3.8 Hz, 1H), 4.23 (ddd, J = 11.3, 7.9, 3.0 Hz, 1H), 4.15 (dd, J = 13.8, 8.2 Hz, 1H), 3.97 - 
3.89 (m, 1H), 3.95 (s, 3H), 2.99 (td, J = 13.5, 3.3 Hz, 1H), 2.95 - 2.86 (m, 1H), 2.26 - 2.17 (m, 
1H), 2.00 - 1.93 (m, 1H), 1.89 (ddd, J = 13.9, 11.9, 4.6 Hz, 1H), 1.85 - 1.77 (m, 1H), 1.65 (tt, J = 
13.6, 4.8 Hz, 1H). 
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HRMS(ESI): m/z calc. for C35H34N5O3S [M+H]
+: 604.2382, found: 604.2382. 
Q1h: Prepared from 1-ethynylcyclopentanol.  
Yield: 58.5 mg, 77%. 
1H NMR (d6-DMSO, 500 MHz, 80 °C): δ 8.79 (d, J = 4.6 Hz, 1H), 
7.99 (d, J = 9.1 Hz, 1H), 7.81 (s, 1H), 7.78 (d, J = 4.6 Hz, 1H), 7.49 (d, J = 2.7 Hz, 1H), 7.46 (dd, 
J = 9.1, 2.7 Hz, 1H), 5.59 (d, J = 6.5 Hz, 1H), 5.49 (dt, J = 16.7, 10.1 Hz, 1H), 4.96 - 4.94 (m, 1H), 
4.94 - 4.90 (m, 1H), 4.61 - 4.49 (m, 1H), 4.34 (dd, J = 13.7, 4.1 Hz, 1H), 4.23 (dd, J = 13.7, 9.5 
Hz, 1H), 3.94 (s, 3H), 3.79 - 3.70 (m, 1H), 3.20 - 3.06 (m, 2H), 2.09 - 2.02 (m, 1H), 1.97 - 1.83 
(m, 4H), 1.82 - 1.72 (m, 4H), 1.73 - 1.66 (m, 1H), 1.66 - 1.58 (m, 2H), 1.58 - 1.49 (m, 1H).    
HRMS(ESI): m/z calc. for C28H34N5O3S [M+H]
+: 520.2382, found 520.2390. 
Q1i: Prepared from N-(propargyloxy)phthalimide. 
Yield: 66.6 mg, 74%. 
1H NMR (CDCl3, 500 MHz): δ 8.77 (d, J = 5.0 Hz, 1H), 8.05 
(d, J = 9.2 Hz, 1H), 7.77 - 7.66 (m, 5H), 7.62 (d, J = 4.6 Hz, 
1H), 7.39 (dd, J = 9.2, 2.6 Hz, 1H), 7.23 (d, J = 2.7 Hz, 1H), 5.50 (dt, J = 16.9, 9.8 Hz, 1H), 5.28 
(s, 2H), 5.18 - 5.08 (m, 2H), 4.97 (dd, J = 17.1, 1.5 Hz, 1H), 4.39 (dd, J = 13.9, 3.7 Hz, 1H), 4.23 
- 4.13 (m, 2H), 3.98 - 3.92 (m, 1H), 3.93 (s, 3H), 2.98 (td, J = 13.3, 3.4 Hz, 1H), 2.88 - 2.78 (m, 
1H), 2.21 - 2.13 (m, 1H), 1.93 - 1.84 (m, 2H), 1.83 - 1.77 (m, 1H), 1.66 (ddq, J = 13.4, 9.3, 4.4 Hz, 
1H). 
HRMS(ESI): m/z calc. for C32H31N6O5S [M+H]
+: 611.2077, found: 611.2071. 
Q1j: Prepared from 4-pentyn-1-ol. 
Yield: 47.0 mg, 65%. 
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1H NMR (CDCl3, 500 MHz): δ 8.78 (d, J = 4.7 Hz, 1H), 8.04 (d, J = 9.2 Hz, 1H), 7.64 (d, J = 4.6 
Hz, 1H), 7.40 (dd, J = 9.2, 2.6 Hz, 1H), 7.23 (d, J = 2.7 Hz, 1H), 7.16 (s, 1H), 5.44 (dt, J = 17.0, 
9.9 Hz, 1H), 5.13 (d, J = 8.0 Hz, 1H), 5.08 (dd, J = 10.1, 1.4 Hz, 1H), 4.92 (dd, J = 17.0, 1.4 Hz, 
1H), 4.32 (dd, J = 13.9, 3.9 Hz, 1H), 4.21 (ddd, J = 11.2, 7.9, 3.1 Hz, 1H), 4.06 (dd, J = 13.8, 8.2 
Hz, 1H), 3.94 (s, 3H), 3.93 - 3.87 (m, 1H), 3.63 (t, J = 6.1 Hz, 2H), 2.96 (td, J = 13.3, 3.4 Hz, 1H), 
2.84 (tt, J = 12.8, 3.8 Hz, 1H), 2.73 (t, J = 7.3 Hz, 2H), 2.18 - 2.09 (m, 1H), 1.91 (dd, J = 12.3, 4.2 
Hz, 2H), 1.88 - 1.83 (m, 2H), 1.83 - 1.75 (m, 1H), 1.63 (tt, J = 13.6, 4.9 Hz, 1H).  
HRMS(ESI): m/z calc. for C26H32N5O3S [M+H]
+: 494.2226, found: 494.2230. 
Q1k: Prepared from 1-bromo-4-ethynylbenzene. 
Yield: 60.0 mg, 69%. 
1H NMR (CDCl3, 500 MHz): δ 8.87 - 8.62 (m, 1H), 8.14 - 7.96 
(m, 1H), 7.72 - 7.57 (m, 1H), 7.39 (d, J = 7.7 Hz, 1H), 7.36 - 7.18 (m, 5H), 7.14 - 6.94 (m, 1H), 
5.40 (dt, J = 16.4, 9.7 Hz, 1H), 5.12 (d, J = 7.9 Hz, 1H), 5.06 (d, J = 10.1 Hz, 1H), 4.88 (d, J = 
16.9 Hz, 1H), 4.40 - 4.29 (m, 1H), 4.26 - 4.16 (m, 1H), 4.04 - 3.85 (m, 2H), 3.92 (s, 3H), 3.02 - 
2.89 (m, 1H), 2.89 - 2.76 (m, 1H), 2.19 - 2.04 (m, 1H), 2.00 - 1.81 (m, 2H), 1.81 - 1.74 (m, 1H), 
1.64 (tt, J = 13.2, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C29H29N5O2SBr [M+H]
+: 590.1225, found: 590.1223. 
Q1l: Prepared from 1,1-diphenyl-2-propyn-1-ol. 
Yield: 80.2 mg, 88%. 
1H NMR (CDCl3, 500 MHz): δ 1H NMR (500 MHz, CDCl3) δ 8.79 
(d, J = 4.6 Hz, 1H), 8.05 (d, J = 9.2 Hz, 1H), 7.66 - 7.58 (m, 8H), 
7.51 - 7.46 (m, 4H), 7.41 (dd, J = 9.2, 2.6 Hz, 1H), 7.24 (d, J = 2.7 Hz, 1H), 5.49 (dt, J = 17.0, 9.8 
Hz, 1H), 5.16 - 5.10 (m, 2H), 4.97 (dd, J = 17.1, 1.5 Hz, 1H), 4.41 (dd, J = 13.9, 3.8 Hz, 1H), 4.21 
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(ddd, J = 11.4, 8.0, 3.0 Hz, 1H), 4.14 (dd, J = 13.9, 8.3 Hz, 1H), 3.94 (s, 3H), 3.94 - 3.90 (m, 1H), 
2.98 (td, J = 13.3, 3.3 Hz, 1H), 2.94 - 2.85 (m, 1H), 2.18 (dd, J = 13.9, 2.4 Hz, 1H), 1.99 - 1.93 
(m, 1H), 1.89 (ddd, J = 13.9, 11.8, 4.6 Hz, 1H), 1.80 (dt, J = 14.0, 2.7 Hz, 1H), 1.65 (tt, J = 13.9, 
4.9 Hz, 1H). 
HRMS(ESI): m/z calc. for C36H36N5O3S [M+H]
+: 618.2539, found: 618.2543. 
Q1m: Prepared from phenylacetylene. 
Yield: 7.6 mg, 65%. 
1H NMR (CDCl3, 500 MHz): δ 8.20 (d, J = 8.7 Hz, 2H), 8.18 - 8.09 
(m, 2H), 7.75 - 7.70 (m, 2H), 7.57 (s, 1H), 7.44 (dd, J = 9.2, 2.6 Hz, 
1H), 7.42 - 7.37 (m, 2H), 7.37 - 7.31 (m, 3H), 7.28 (d, J = 2.6 Hz, 1H), 7.19 - 7.14 (m, 2H), 7.14 - 
7.10 (m, 1H), 7.06 (dd, J = 8.6, 1.1 Hz, 2H), 5.51 (dt, J = 17.1, 9.8 Hz, 1H), 5.23 (d, J = 7.7 Hz, 
1H), 5.13 (dd, J = 10.0, 1.2 Hz, 1H), 4.97 (d, J = 17.1 Hz, 1H), 4.44 (dd, J = 13.7, 3.7 Hz, 1H), 
4.30 (td, J = 7.9, 4.0 Hz, 1H), 4.16 (dd, J = 13.8, 8.3 Hz, 1H), 4.05 - 3.99 (m, 1H), 3.98 (s, 3H), 
3.00 (td, J = 13.3, 3.3 Hz, 1H), 2.98 - 2.87 (m, 1H), 2.36 - 2.29 (m, 1H), 2.03 - 1.94 (m, 2H), 1.84 
(d, J = 14.2 Hz, 1H), 1.76 - 1.66 (m, 1H). 
HRMS(ESI): m/z calc. for C41H38N5O3S [M+H]
+: 680.2695, found: 680.2709. 
Q1n: Prepared from 1-ethynylcyclopentanol. 
Yield: 9.0 mg, 77%. 
1H NMR (CDCl3, 500 MHz): δ 8.18 (d, J = 8.4 Hz, 2H), 8.14 - 8.11 
(m, 2H), 7.47 - 7.41 (m, 1H), 7.40 - 7.33 (m, 2H), 7.30 - 7.22 (m, 
2H), 7.17 - 7.09 (m, 3H), 7.09 - 7.04 (m, 2H), 5.47 (dt, J = 16.9, 9.8 Hz, 1H), 5.21 (d, J = 7.9 Hz, 
1H), 5.11 (d, J = 10.2 Hz, 1H), 4.93 (d, J = 16.8 Hz, 1H), 4.36 (dd, J = 13.7, 3.7 Hz, 1H), 4.28 
(ddd, J = 11.1, 7.9, 3.2 Hz, 1H), 4.08 (dd, J = 13.8, 8.4 Hz, 1H), 4.03 - 3.97 (m, 1H), 3.98 (s, 3H), 
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3.00 (td, J = 13.2, 3.5 Hz, 1H), 2.92 - 2.83 (m, 1H), 2.32 - 2.23 (m, 1H), 2.14 - 1.86 (m, 8H), 1.86 
- 1.59 (m, 4H). 
HRMS(ESI): m/z calc. for C40H42N5O4S [M+H]
+: 688.2958, found: 688.2944. 
Q1o: Prepared from 1,1-diphenyl-2-propyn-1-ol.  
Yield: 6.1 mg, 46%. 
1H NMR (CDCl3, 500 MHz): δ 8.18 (d, J = 8.7 Hz, 2H), 8.14 - 
8.05 (m, 2H), 7.42 (dd, J = 9.2, 2.6 Hz, 1H), 7.34 (dd, J = 8.6, 7.3 
Hz, 2H), 7.26 (q, J = 2.5, 1.7 Hz, 11H), 7.17 - 7.11 (m, 3H), 7.06 (dd, J = 8.4, 1.1 Hz, 2H), 6.92 
(s, 1H), 5.42 (dt, J = 17.0, 9.9 Hz, 1H), 5.21 (d, J = 8.1 Hz, 1H), 5.08 (dd, J = 10.1, 1.4 Hz, 1H), 
4.89 (dd, J = 17.2, 1.3 Hz, 1H), 4.40 (dd, J = 13.7, 3.8 Hz, 1H), 4.33 - 4.26 (m, 1H), 4.05 - 3.95 
(m, 2H), 3.96 (s, 3H), 2.99 (td, J = 13.1, 3.4 Hz, 1H), 2.95 - 2.83 (m, 1H), 2.24 (d, J = 14.5 Hz, 
1H), 2.01 (dd, J = 34.3, 8.1 Hz, 2H), 1.84 (d, J = 13.9 Hz, 1H), 1.69 (d, J = 16.9 Hz, 1H). 
HRMS(ESI): m/z calc. for C48H44N5O4S [M+H]
+: 786.3114, found: 786.3118. 
Q1p: Prepared from N-(propargyloxy)phthalimide. 
Yield: 7.8 mg, 59%. 
1H NMR (CDCl3, 500 MHz): δ 8.20 - 8.02 (m, 4H), 7.73 
(dddd, J = 18.5, 5.1, 3.3, 2.0 Hz, 4H), 7.68 (d, J = 1.7 Hz, 1H), 
7.43 (dt, J = 9.2, 2.3 Hz, 1H), 7.39 - 7.32 (m, 2H), 7.27 (d, J = 
2.3 Hz, 1H), 7.13 (ddd, J = 6.6, 4.1, 1.5 Hz, 3H), 7.06 (ddd, J = 8.3, 2.0, 1.0 Hz, 2H), 5.51 (dtd, J 
= 17.1, 9.9, 1.9 Hz, 1H), 5.27 (s, 2H), 5.21 (d, J = 7.5 Hz, 1H), 5.12 (d, J = 10.0 Hz, 1H), 4.97 (d, 
J = 17.1 Hz, 1H), 4.43 - 4.34 (m, 1H), 4.28 - 4.13 (m, 2H), 4.05 - 3.97 (m, 1H), 3.97 (s, 3H), 3.05 
- 2.94 (m, 1H), 2.90 - 2.78 (m, 1H), 2.27 - 2.21 (m, 1H), 2.01 - 1.88 (m, 2H), 1.86 - 1.78 (m, 1H), 
1.71 (d, J = 13.9 Hz, 1H). 
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HRMS(ESI): m/z calc. for C44H39N6O6S [M+H]
+: 779.2652, found: 779.2640. 
Q1q: Prepared from 4-ethynyl-N,N-dimethylaniline. 
Yield: 6.1 mg, 50%. 
 1H NMR (CDCl3, 500 MHz): δ 8.21 - 8.17 (m, 2H), 8.15 (s, 
1H), 8.13 (d, J = 9.5 Hz, 1H), 7.62 - 7.57 (m, 2H), 7.45 - 7.42 
(m, 1H), 7.42 (s, 1H), 7.34 (t, J = 7.5 Hz, 2H), 7.28 (d, J = 3.3 Hz, 1H), 7.16 (dd, J = 8.6, 1.3 Hz, 
2H), 7.14 - 7.10 (m, 1H), 7.06 (d, J = 7.9 Hz, 2H), 6.73 (d, J = 8.2 Hz, 2H), 5.51 (dt, J = 16.8, 9.8 
Hz, 1H), 5.21 (d, J = 7.6 Hz, 1H), 5.12 (d, J = 10.1 Hz, 1H), 4.97 (d, J = 17.0 Hz, 1H), 4.38 (dd, J 
= 13.9, 3.7 Hz, 1H), 4.31 - 4.22 (m, 1H), 4.16 (dd, J = 13.8, 7.9 Hz, 1H), 4.02 (t, J = 3.8 Hz, 1H), 
3.98 (s, 3H), 3.09 (q, J = 7.2 Hz, 1H), 2.98 (d, J = 1.3 Hz, 6H), 2.88 (d, J = 9.3 Hz, 1H), 2.36 - 
2.26 (m, 1H), 1.97 (t, J = 11.6 Hz, 2H), 1.83 (d, J = 15.7 Hz, 1H), 1.75 - 1.65 (m, 1H). 
HRMS(ESI): m/z calc. for C43H43N6O3S [M+H]
+: 723.3117, found: 723.3124. 
 
General procedure for the preparation of Q1 amides/ureas: To a solution of amine Q1d or 
Q1e, N,N-dimethylaminopyridine (1 mg, 0.008 mmol), and triethylamine (7.5 μL, 0.054 mmol) in 
dichloromethane (2 mL) was added acyl chloride (0.036 mmol). The reaction was stirred at room 
temperature 24 hours, quenched with methanol, evaporated, and purified by preparative TLC 
(hexanes/ethyl acetate) to provide the amide/urea. (Note: This procedure was performed at several 
scales: 0.018 - 0.104 mmol amine) 
 
79 
 
Q1r: prepared from acetyl chloride. 
Yield: 38.6 mg, 87%.  
1H NMR (CDCl3, 500 MHz): δ 8.82 (d, J = 4.6 Hz, 1H), 8.03 (d, J = 9.2 
Hz, 1H), 7.80 (d, J = 4.7 Hz, 1H), 7.38 (dd, J = 9.2, 2.7 Hz, 1H), 7.21 (d, J = 2.7 Hz, 1H), 5.86 - 
5.69 (m, 1H), 5.45 (dt, J = 16.9, 9.8 Hz, 1H), 5.21 (dd, J = 10.1, 1.7 Hz, 1H), 5.14 - 5.07 (m, 2H), 
4.34 (ddd, J = 12.0, 9.0, 3.1 Hz, 1H), 3.95 (s, 3H), 3.96 - 3.88 (m, 1H), 3.67 (ddd, J = 13.0, 7.3, 
3.1 Hz, 1H), 2.97 (td, J = 13.2, 3.1 Hz, 1H), 2.60 (ddd, J = 12.8, 10.1, 4.6 Hz, 1H), 2.56 - 2.47 (m, 
1H), 2.19 (dd, J = 13.8, 2.6 Hz, 1H), 1.95 (s, 3H), 1.88 - 1.77 (m, 2H), 1.74 - 1.64 (m, 1H), 1.66 - 
1.56 (m, 1H). 
HRMS(ESI): m/z calc. for C23H28N3O3S [M+H]
+: 426.1851, found: 426.1854. 
Q1s: Prepared from benzoyl chloride. 
Yield: 33.6 mg, 66%. 
1H NMR (CDCl3, 500 MHz): δ 8.86 (d, J = 4.6 Hz, 1H), 8.05 (d, J = 
9.2 Hz, 1H), 7.89 (d, J = 4.7 Hz, 1H), 7.76 - 7.67 (m, 2H), 7.53 - 7.46 (m, 1H), 7.45 - 7.37 (m, 
3H), 7.24 (d, J = 2.7 Hz, 1H), 6.44 - 6.37 (m, 1H), 5.54 (dt, J = 17.0, 9.9 Hz, 1H), 5.25 (dd, J = 
10.1, 1.7 Hz, 1H), 5.18 - 5.09 (m, 2H), 4.42 (ddd, J = 11.9, 8.8, 3.0 Hz, 1H), 3.96 (s, 3H), 3.99 - 
3.93 (m, 1H), 3.89 (ddd, J = 13.2, 7.3, 3.4 Hz, 1H), 2.99 (td, J = 13.3, 3.2 Hz, 1H), 2.82 (ddd, J = 
13.1, 10.1, 4.7 Hz, 1H), 2.73 - 2.63 (m, 1H), 2.28 (dd, J = 13.8, 2.6 Hz, 1H), 1.93 - 1.82 (m, 2H), 
1.75 (ddd, J = 13.7, 11.8, 4.3 Hz, 1H), 1.65 (ddt, J = 13.3, 8.7, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C28H30N3O3S [M+H]
+: 488.2008, found: 488.2005. 
Q1t: Prepared from acetoxyacetyl chloride. 
Yield: 29.1 mg, 77%. 
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1H NMR (CDCl3, 500 MHz): δ 8.83 (dd, J = 4.6, 0.9 Hz, 1H), 8.06 (dd, J = 9.2, 0.8 Hz, 1H), 7.77 
(d, J = 4.6 Hz, 1H), 7.41 (ddd, J = 9.2, 2.7, 0.9 Hz, 1H), 7.22 (d, J = 2.6 Hz, 1H), 6.32 - 6.21 (m, 
1H), 5.49 (dt, J = 17.3, 9.8 Hz, 1H), 5.28 - 5.22 (m, 1H), 5.18 - 5.08 (m, 2H), 4.55 (d, J = 3.9 Hz, 
2H), 4.31 (ddd, J = 11.8, 8.7, 3.0 Hz, 1H), 4.00 - 3.94 (m, 1H), 3.96 (s, 3H), 3.73 (ddd, J = 13.1, 
7.4, 3.3 Hz, 1H), 2.98 (td, J = 13.3, 3.1 Hz, 1H), 2.68 (ddd, J = 13.2, 10.3, 4.5 Hz, 1H), 2.54 (qd, 
J = 10.2, 9.6, 3.1 Hz, 1H), 2.18 (dd, J = 13.8, 2.6 Hz, 1H), 2.13 (s, 3H), 1.91 - 1.79 (m, 2H), 1.74 
(ddd, J = 13.7, 11.8, 4.2 Hz, 1H), 1.65 (tt, J = 13.5, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C25H30N3O5S [M+H]
+: 484.1906, found: 484.1897. 
Q1u: Prepared from 4-morpholinecarbonyl chloride.  
Yield: 31.5 mg, 81%. 
1H NMR (CDCl3, 500 MHz): δ 8.83 (d, J = 4.6 Hz, 1H), 8.06 (d, J = 
9.2 Hz, 1H), 7.86 (d, J = 4.4 Hz, 1H), 7.40 (dd, J = 9.3, 2.5 Hz, 1H), 7.22 (d, J = 2.6 Hz, 1H), 5.48 
(dt, J = 17.1, 9.7 Hz, 1H), 5.23 (dt, J = 10.1, 1.7 Hz, 1H), 5.18 - 5.01 (m, 2H), 4.60 (dd, J = 8.0, 
3.9 Hz, 1H), 4.40 (ddd, J = 11.9, 8.9, 3.0 Hz, 1H), 3.97 (s, 3H), 4.00 - 3.94 (m, 1H), 3.74 - 3.65 
(m, 1H), 3.68 (td, J = 4.9, 1.5 Hz, 4H), 3.31 (td, J = 4.5, 1.5 Hz, 4H), 2.99 (td, J = 13.4, 3.1 Hz, 
1H), 2.65 - 2.49 (m, 2H), 2.24 (dt, J = 13.7, 2.5 Hz, 1H), 1.90 - 1.79 (m, 2H), 1.71 (ddd, J = 13.6, 
11.9, 4.2 Hz, 1H), 1.67 - 1.59 (m, 1H). 
HRMS(ESI): m/z calc. for C26H33N4O4S [M+H]
+: 497.2223, found: 497.2230. 
Q1v: Prepared from benzyloxyacetyl chloride. 
Yield: 32.4 mg, 78%. 
1H NMR (CDCl3, 500 MHz): δ 8.83 (d, J = 4.6 Hz, 1H), 8.06 (d, 
J = 9.2 Hz, 1H), 7.78 (d, J = 4.7 Hz, 1H), 7.40 (dd, J = 9.2, 2.7 
Hz, 1H), 7.38 - 7.27 (m, 5H), 7.22 (d, J = 2.7 Hz, 1H), 6.75 (s, 1H), 5.47 (dt, J = 17.0, 9.9 Hz, 1H), 
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5.22 (dd, J = 10.2, 1.7 Hz, 1H), 5.17 - 5.05 (m, 2H), 4.55 (s, 2H), 4.31 (ddd, J = 11.7, 8.6, 3.0 Hz, 
1H), 3.97 (d, J = 3.2 Hz, 2H), 4.02 - 3.93 (m, 1H), 3.96 (s, 3H), 3.69 (ddd, J = 13.2, 7.4, 3.4 Hz, 
1H), 2.98 (td, J = 13.4, 3.1 Hz, 1H), 2.71 (ddd, J = 13.1, 10.1, 4.8 Hz, 1H), 2.53 (qd, J = 10.2, 3.3 
Hz, 1H), 2.19 (dd, J = 13.8, 2.6 Hz, 1H), 1.90 - 1.80 (m, 2H), 1.73 (ddd, J = 13.8, 11.8, 4.2 Hz, 
1H), 1.68 - 1.58 (m, 1H). 
HRMS(ESI): m/z calc. for C30H34N3O4S [M+H]
+: 532.2270, found: 532.2280. 
Q1w: Prepared from 6-chloronicotinoyl chloride. 
Yield: 28.8 mg, 71%. 
1H NMR (CDCl3, 500 MHz): δ 8.83 (s, 1H), 8.69 (d, J = 2.5 Hz, 
1H), 8.10 - 8.01 (m, 2H), 7.84 (d, J = 4.7 Hz, 1H), 7.48 - 7.34 (m, 2H), 7.24 (d, J = 2.7 Hz, 1H), 
6.63 (s, 1H), 5.53 (dt, J = 17.1, 9.8 Hz, 1H), 5.24 (dd, J = 10.1, 1.7 Hz, 1H), 5.18 - 5.09 (m, 2H), 
4.38 (ddd, J = 12.0, 9.0, 3.1 Hz, 1H), 3.96 (s, 3H), 3.97 - 3.91 (m, 1H), 3.85 (ddd, J = 13.2, 7.0, 
3.3 Hz, 1H), 2.99 (td, J = 13.3, 3.2 Hz, 1H), 2.84 (ddd, J = 13.4, 10.3, 4.9 Hz, 1H), 2.67 (ddd, J = 
20.4, 10.2, 3.1 Hz, 1H), 2.23 (dd, J = 13.7, 2.6 Hz, 1H), 1.94 - 1.81 (m, 2H), 1.80 - 1.70 (m, 1H), 
1.65 (ddt, J = 22.7, 9.4, 4.5 Hz, 1H). 
HRMS(ESI): m/z calc. for C27H28N4O3SCl [M+H]
+: 523.1571, found: 523.1581. 
Q1x: Prepared from acetyl chloride. 
Yield: 7.5 mg, 70%. 
1H NMR (CDCl3, 500 MHz): δ 8.25 - 8.14 (m, 3H), 8.11 (dd, J = 9.3, 
0.8 Hz, 1H), 7.42 (dd, J = 9.3, 2.7 Hz, 1H), 7.39 - 7.33 (m, 2H), 7.25 (d, 
J = 2.6 Hz, 1H), 7.17 - 7.10 (m, 3H), 7.10 - 7.05 (m, 2H), 5.54 - 5.41 (m, 2H), 5.21 (dd, J = 10.2, 
1.7 Hz, 1H), 5.17 (d, J = 8.2 Hz, 1H), 5.10 (dd, J = 17.0, 1.7 Hz, 1H), 4.39 (ddd, J = 11.3, 8.2, 3.1 
Hz, 1H), 4.02 - 3.97 (m, 1H), 3.99 (s, 3H), 3.53 (ddd, J = 12.9, 6.4, 3.4 Hz, 1H), 3.01 (td, J = 13.3, 
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3.1 Hz, 1H), 2.69 (ddd, J = 13.0, 10.0, 5.0 Hz, 1H), 2.58 (qd, J = 10.1, 3.2 Hz, 1H), 2.21 (dd, J = 
13.5, 2.7 Hz, 1H), 1.88 (s, 3H), 1.87 - 1.76 (m, 3H), 1.65 (ddt, J = 18.4, 9.6, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C35H36N3O4S [M+H]
+: 594.2427, found: 594.2434.  
Q1y: Prepared from 6-chloronicotinoyl chloride. 
Yield: 7.1 mg, 57%. 
1H NMR (CDCl3, 500 MHz): δ 8.60 - 8.56 (m, 1H), 8.26 - 8.18 (m, 
3H), 8.11 (d, J = 9.3 Hz, 1H), 7.86 (dd, J = 8.3, 2.5 Hz, 1H), 7.42 
(dd, J = 9.2, 2.7 Hz, 1H), 7.37 - 7.32 (m, 2H), 7.31 (dd, J = 8.3, 0.9 Hz, 1H), 7.27 (d, J = 2.8 Hz, 
1H), 7.18 - 7.11 (m, 1H), 7.08 - 7.00 (m, 4H), 6.29 - 6.20 (m, 1H), 5.52 (dt, J = 16.8, 9.8 Hz, 1H), 
5.25 - 5.20 (m, 2H), 5.11 (dd, J = 17.0, 1.7 Hz, 1H), 4.45 (ddd, J = 11.8, 8.8, 3.0 Hz, 1H), 4.04 - 
4.00 (m, 1H), 3.99 (s, 3H), 3.75 (ddt, J = 9.8, 6.7, 2.9 Hz, 1H), 3.03 (td, J = 13.5, 3.2 Hz, 1H), 2.84 
- 2.75 (m, 1H), 2.70 (qd, J = 10.3, 3.0 Hz, 1H), 2.29 - 2.19 (m, 1H), 1.95 - 1.84 (m, 2H), 1.85 - 
1.74 (m, 1H), 1.74 - 1.52 (m, 1H). 
HRMS(ESI): m/z calc. for C39H36N4O4SCl [M+H]
+: 691.2146, found: 619.2155. 
Q1z: Prepared from 4-morpholinecarbonyl chloride. 
Yield: 8.4 mg, 70%. 
1H NMR (CDCl3, 500 MHz): δ 8.31 - 8.15 (m, 3H), 8.10 (d, J = 9.1 
Hz, 1H), 7.41 (dd, J = 9.3, 2.5 Hz, 1H), 7.37 (t, J = 7.7 Hz, 2H), 7.27 
- 7.23 (m, 1H), 7.14 (t, J = 7.5 Hz, 1H), 7.08 (dd, J = 10.5, 8.0 Hz, 4H), 5.45 (dt, J = 16.8, 9.6 Hz, 
1H), 5.25 - 5.15 (m, 2H), 5.09 (dd, J = 17.3, 1.8 Hz, 1H), 4.53 - 4.42 (m, 2H), 4.03 - 3.97 (m, 1H), 
3.98 (s, 3H), 3.63 - 3.52 (m, 5H), 3.25 - 3.14 (m, 4H), 3.11 - 2.98 (m, 1H), 2.68 - 2.51 (m, 2H), 
2.29 - 2.17 (m, 1H), 1.84 (dd, J = 9.9, 5.2 Hz, 2H), 1.79 - 1.68 (m, 1H), 1.70 - 1.59 (m, 1H). 
HRMS(ESI): m/z calc. for C38H41N4O5S [M+H]
+: 665.2798, found: 665.2802. 
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Q1aa: Prepared from acetoxyacetyl chloride. 
Yield: 7.8 mg, 66%. 
1H NMR (CDCl3, 500 MHz): δ 8.21 - 8.14 (m, 3H), 8.11 (d, J = 9.2 
Hz, 1H), 7.42 (dd, J = 9.1, 2.7 Hz, 1H), 7.39 - 7.33 (m, 2H), 7.24 
(d, J = 2.7 Hz, 1H), 7.17 - 7.10 (m, 3H), 7.10 - 7.04 (m, 2H), 6.13 (t, J = 5.7 Hz, 1H), 5.48 (dt, J = 
16.8, 10.0 Hz, 1H), 5.23 (dd, J = 10.1, 1.7 Hz, 1H), 5.17 (d, J = 8.0 Hz, 1H), 5.15 - 5.08 (m, 1H), 
4.52 - 4.38 (m, 2H), 4.37 - 4.27 (m, 1H), 4.04 - 4.00 (m, 1H), 3.99 (s, 3H), 3.56 (ddd, J = 13.1, 
6.7, 3.5 Hz, 1H), 3.12 - 2.93 (m, 1H), 2.76 (ddd, J = 13.1, 10.1, 5.0 Hz, 1H), 2.56 (ddt, J = 13.6, 
10.2, 6.2 Hz, 1H), 2.25 - 2.15 (m, 1H), 2.10 (s, 3H), 1.94 - 1.74 (m, 3H), 1.75 - 1.57 (m, 1H). 
HRMS(ESI): m/z calc. for C37H38N3O6S [M+H]
+: 652.2481, found: 652.2490. 
Q1bb: Prepared from benzyloxyacetyl chloride. 
Yield: 7.7 mg, 61%. 
1H NMR (CDCl3, 500 MHz): δ 8.20 - 8.14 (m, 3H), 8.11 (d, J = 
9.3 Hz, 1H), 7.42 (dd, J = 9.2, 2.7 Hz, 1H), 7.39 - 7.29 (m, 5H), 
7.28 - 7.22 (m, 3H), 7.16 - 7.09 (m, 3H), 7.09 - 7.03 (m, 2H), 6.67 - 6.60 (m, 1H), 5.47 (dt, J = 
17.1, 9.8 Hz, 1H), 5.26 - 5.13 (m, 2H), 5.09 (d, J = 17.1 Hz, 1H), 4.49 (s, 2H), 4.33 (td, J = 8.3, 
4.1 Hz, 1H), 4.03 - 3.99 (m, 1H), 3.98 (s, 3H), 3.88 (d, J = 2.4 Hz, 2H), 3.52 (ddd, J = 13.1, 6.9, 
3.7 Hz, 1H), 3.00 (td, J = 13.2, 3.3 Hz, 1H), 2.82 (ddd, J = 13.5, 10.2, 5.5 Hz, 1H), 2.57 (qd, J = 
9.8, 3.4 Hz, 1H), 2.25 - 2.15 (m, 1H), 1.93 - 1.77 (m, 3H), 1.71 - 1.61 (m, 1H). 
HRMS(ESI): m/z calc. for C42H42N3O5S [M+H]
+: 700.2845, found: 700.2849.  
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General procedure for the preparation of Q1 sulfonamides: To a solution of amine Q1d or 
Q1e and triethylamine (7.5 μL, 0.054 mmol) in dichloromethane (2 mL) was added sulfonyl 
chloride (0.036 mmol). The reaction was stirred at room temperature 24 hours, quenched with 
methanol, evaporated, and purified by preparative TLC (hexanes/ethyl acetate) to provide the 
sulfonamide. (note: This procedure was performed at several scales: 0.018-0.078 mmol amine) 
Q1cc: Prepared from p-toluenesulfonyl chloride. 
Yield: 39.3 mg, 94%. 
1H NMR (CDCl3, 500 MHz): δ 8.85 (d, J = 4.8 Hz, 1H), 8.19 (d, J 
= 9.2 Hz, 1H), 7.82 (d, J = 4.7 Hz, 1H), 7.52 - 7.48 (m, 2H), 7.45 (dd, J = 9.3, 2.6 Hz, 1H), 7.28 
(d, J = 2.6 Hz, 1H), 7.16 (d, J = 7.9 Hz, 2H), 5.44 - 5.30 (m, 1H), 5.23 (dd, J = 10.2, 1.6 Hz, 1H), 
5.20 - 5.12 (m, 2H), 5.13 - 5.02 (m, 1H), 4.25 (t, J = 9.4 Hz, 1H), 3.99 (s, 3H), 3.98 - 3.93 (m, 1H), 
3.11 - 3.03 (m, 1H), 2.95 (td, J = 13.4, 3.1 Hz, 1H), 2.61 - 2.47 (m, 2H), 2.36 (s, 3H), 2.13 (d, J = 
13.4 Hz, 1H), 1.87 - 1.70 (m, 3H), 1.60 (tt, J = 13.5, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C28H32N3O4S2 [M+H]
+: 538.1834, found: 538.1840. 
Q1dd: Prepared from 1-naphthalenesulfonyl chloride. 
Yield: 32.6 mg, 73%. 
1H NMR (CDCl3, 500 MHz): δ 8.82 (d, J = 4.6 Hz, 1H), 8.54 - 8.48 
(m, 1H), 8.13 (d, J = 9.2 Hz, 1H), 7.95 - 7.90 (m, 1H), 7.90 - 7.86 (m, 1H), 7.78 (dd, J = 7.3, 1.3 
Hz, 1H), 7.67 (d, J = 4.7 Hz, 1H), 7.62 - 7.54 (m, 2H), 7.45 (dd, J = 9.2, 2.6 Hz, 1H), 7.25 - 7.18 
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(m, 2H), 5.24 (dt, J = 16.9, 9.8 Hz, 1H), 5.14 (dd, J = 10.2, 1.6 Hz, 1H), 5.07 (d, J = 8.6 Hz, 1H), 
4.95 - 4.86 (m, 2H), 4.04 (ddd, J = 11.7, 8.6, 3.0 Hz, 1H), 3.97 (s, 3H), 3.92 - 3.85 (m, 1H), 3.12 - 
3.04 (m, 1H), 2.77 (td, J = 13.3, 3.1 Hz, 1H), 2.45 (ddd, J = 13.3, 9.7, 3.5 Hz, 1H), 2.36 - 2.26 (m, 
1H), 1.86 (dd, J = 13.7, 2.6 Hz, 1H), 1.73 - 1.66 (m, 2H), 1.61 (ddd, J = 13.6, 11.8, 4.2 Hz, 1H), 
1.58 - 1.46 (m, 1H). 
HRMS(ESI): m/z calc. for C31H32N3O4S2 [M+H]
+: 574.1834, found: 574.1838. 
Q1ee: Prepared from N-acetylsulfanilyl chloride. 
Yield: 44.6 mg, 98%. 
1H NMR (CDCl3, 500 MHz): δ 8.78 (d, J = 4.6 Hz, 1H), 8.44 (s, 
1H), 8.04 (d, J = 9.2 Hz, 1H), 7.68 (d, J = 4.6 Hz, 1H), 7.50 (d, J = 8.6 Hz, 2H), 7.45 - 7.42 (m, 
2H), 7.41 (dd, J = 9.2, 2.6 Hz, 2H), 5.34 (dt, J = 16.9, 9.4 Hz, 1H), 5.22 (dd, J = 10.1, 1.7 Hz, 1H), 
5.18 - 5.10 (m, 2H), 5.10 - 5.01 (m, 1H), 4.17 - 4.08 (m, 1H), 3.96 (s, 3H), 3.96 - 3.90 (m, 1H), 
3.00 (t, J = 9.4 Hz, 1H), 2.90 (td, J = 13.4, 3.1 Hz, 1H), 2.47 (dtd, J = 18.9, 12.1, 11.4, 8.5 Hz, 
2H), 2.19 (s, 3H), 2.01 - 1.92 (m, 1H), 1.83 - 1.74 (m, 2H), 1.74 - 1.63 (m, 1H), 1.63 - 1.53 (m, 
1H). 
HRMS(ESI): m/z calc. for C29H33N4O5S2 [M+H]
+: 581.1892, found: 581.1895. 
Q1ff: Prepared from 6-phenoxypyridine-3-sulphonyl chloride  
Yield: 39.6 mg, 82%. 
1H NMR (CDCl3, 500 MHz): δ 8.78 (d, J = 4.5 Hz, 1H), 8.42 - 
8.37 (m, 1H), 8.04 (d, J = 9.2 Hz, 1H), 7.77 (dd, J = 8.7, 2.4 Hz, 1H), 7.64 (d, J = 4.6 Hz, 1H), 
7.48 - 7.41 (m, 2H), 7.39 (dd, J = 9.3, 2.6 Hz, 1H), 7.30 - 7.25 (m, 1H), 7.23 (d, J = 2.7 Hz, 1H), 
7.15 - 7.10 (m, 2H), 6.87 (d, J = 8.7 Hz, 1H), 5.40 - 5.31 (m, 1H), 5.24 (dd, J = 10.1, 1.7 Hz, 1H), 
5.21 - 5.15 (m, 1H), 5.13 (d, J = 8.5 Hz, 1H), 5.00 (dd, J = 9.0, 3.1 Hz, 1H), 4.12 (ddd, J = 11.7, 
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8.6, 3.0 Hz, 1H), 3.99 - 3.93 (m, 1H), 3.95 (s, 3H), 3.07 (t, J = 9.2 Hz, 1H), 2.93 (td, J = 13.3, 3.1 
Hz, 1H), 2.58 - 2.44 (m, 2H), 1.97 (dd, J = 13.7, 2.6 Hz, 1H), 1.87 - 1.68 (m, 3H), 1.60 (ddq, J = 
16.9, 9.2, 4.5 Hz, 1H). 
HRMS(ESI): m/z calc. for C29H33N4O5S2 [M+H]
+: 617.1892, found: 617.1896. 
Q1gg: Prepared from 5-[1-methyl-5-(trifluoromethyl)-1H-
pyrazol-3-yl]thiophene-2-sulfonyl chloride.  
Yield: 58.5 mg, 74%. 
1H NMR (CDCl3, 500 MHz): δ 8.87 (s, 1H), 8.12 (d, J = 9.2 Hz, 1H), 7.71 (s, 1H), 7.44 (dd, J = 
9.1, 2.6 Hz, 1H), 7.26 - 7.25 (m, 2H), 7.09 (d, J = 3.9 Hz, 1H), 6.81 (s, 1H), 5.39 (dt, J = 16.8, 9.7 
Hz, 1H), 5.29 (dd, J = 10.1, 1.7 Hz, 1H), 5.19 (dd, J = 16.9, 1.7 Hz, 1H), 5.13 (d, J = 8.7 Hz, 1H), 
4.78 (d, J = 7.4 Hz, 1H), 4.20 (ddd, J = 11.9, 8.7, 2.9 Hz, 1H), 4.01 (s, 3H), 3.98 (s, 3H), 3.97 - 
3.93 (m, 1H), 3.24 (ddd, J = 12.7, 9.0, 3.4 Hz, 1H), 2.94 (td, J = 13.4, 3.1 Hz, 1H), 2.64 (ddd, J = 
13.0, 9.6, 3.5 Hz, 1H), 2.55 (qd, J = 9.5, 3.3 Hz, 1H), 2.09 - 2.01 (m, 1H), 1.89 - 1.78 (m, 2H), 
1.74 (ddd, J = 13.9, 11.9, 4.3 Hz, 1H), 1.64 (ddt, J = 13.4, 8.8, 4.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C30H31N5O4F3S3 [M+H]
+: 678.1490, found: 678.1483. 
Q1hh: Prepared from benzofuran-2-sulfonyl chloride. 
Yield: 30.8 mg, 70%. 
1H NMR (CDCl3, 500 MHz): δ 8.87 (d, J = 4.6 Hz, 1H), 8.14 (d, J 
= 9.2 Hz, 1H), 7.73 (d, J = 4.7 Hz, 1H), 7.59 - 7.53 (m, 1H), 7.50 - 7.41 (m, 2H), 7.36 - 7.27 (m, 
2H), 7.25 (d, J = 3.0 Hz, 1H), 7.03 (s, 1H), 5.37 (dt, J = 16.9, 9.8 Hz, 1H), 5.27 (dd, J = 10.0, 1.8 
Hz, 1H), 5.17 - 5.08 (m, 2H), 5.03 - 4.96 (m, 1H), 4.15 (ddd, J = 11.8, 8.6, 3.0 Hz, 1H), 3.98 (s, 
3H), 3.94 - 3.86 (m, 1H), 3.34 (ddd, J = 13.2, 9.1, 3.5 Hz, 1H), 2.77 (td, J = 13.4, 3.4 Hz, 1H), 
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2.69 (ddd, J = 13.6, 10.0, 3.6 Hz, 1H), 2.49 - 2.38 (m, 1H), 2.05 (dt, J = 14.3, 2.8 Hz, 1H), 1.85 - 
1.67 (m, 3H), 1.61 (ddd, J = 13.4, 8.4, 4.6 Hz, 1H). 
HRMS(ESI): m/z calc. for C29H30N3O5S2 [M+H]
+: 564.1627, found: 564.1617. 
Q1ii: Prepared from p-toluenesulfonyl chloride.  
Yield: 8.3 mg, 65%. 
1H NMR (CDCl3, 500 MHz): δ 8.23 - 8.09 (m, 4H), 7.47 (dd, J = 
9.2, 2.0 Hz, 1H), 7.38 - 7.31 (m, 2H), 7.28 (s, 1H), 7.24 (d, J = 8.1 
Hz, 2H), 7.16 - 7.08 (m, 3H), 7.04 (dd, J = 7.5, 1.0 Hz, 2H), 7.00 (d, J = 7.9 Hz, 2H), 5.33 (dt, J = 
17.4, 9.8 Hz, 1H), 5.26 - 5.15 (m, 2H), 5.11 (dd, J = 16.9, 2.1 Hz, 1H), 4.38 (dd, J = 8.9, 4.2 Hz, 
1H), 4.10 - 4.02 (m, 1H), 4.00 (s, 3H), 3.97 - 3.92 (m, 1H), 2.99 - 2.82 (m, 2H), 2.47 (ddd, J = 
13.1, 9.1, 4.0 Hz, 1H), 2.43 - 2.33 (m, 1H), 2.30 (s, 3H), 2.02 - 1.92 (m, 1H), 1.87 - 1.70 (m, 3H), 
1.67 - 1.58 (m, 1H). 
HRMS(ESI): m/z calc. for C40H40N3O5S2 [M+H]
+: 706.2409, found: 706.2415. 
Q1jj: Prepared from N-acetylsulfanilyl chloride. 
Yield: 5.7 mg, 42%. 
1H NMR (CDCl3, 500 MHz): δ 8.23 - 8.07 (m, 4H), 7.48 (dd, J 
= 9.3, 2.6 Hz, 1H), 7.39 (s, 1H), 7.38 - 7.33 (m, 2H), 7.33 - 7.20 
(m, 5H), 7.17 - 7.08 (m, 3H), 7.07 - 7.00 (m, 2H), 5.34 (dt, J = 16.7, 9.7 Hz, 1H), 5.28 - 5.16 (m, 
2H), 5.11 (dd, J = 17.0, 1.8 Hz, 1H), 4.45 (dd, J = 8.8, 4.0 Hz, 1H), 4.06 - 3.99 (m, 1H), 3.99 (s, 
3H), 3.98 - 3.92 (m, 1H), 2.89 (qd, J = 12.6, 3.1 Hz, 2H), 2.48 (ddd, J = 13.2, 9.3, 3.9 Hz, 1H), 
2.35 (qd, J = 9.8, 3.5 Hz, 1H), 2.15 (s, 3H), 2.01 - 1.90 (m, 1H), 1.85 - 1.67 (m, 3H), 1.62 (ddt, J 
= 15.6, 11.5, 3.6 Hz, 1H). 
HRMS(ESI): m/z calc. for C41H41N4O6S2 [M+H]
+: 749.2468, found: 749.2476. 
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Q1kk: 6-phenoxypyridine-3-sulphonyl chloride. 
Yield: 8.2 mg, 58%. 
1H NMR (CDCl3, 500 MHz): δ 8.26 (d, J = 2.6 Hz, 1H), 8.18 
(s, 1H), 8.13 (d, J = 8.8 Hz, 2H), 8.11 (d, J = 9.4 Hz, 1H), 7.48 
(dt, J = 8.9, 1.8 Hz, 1H), 7.46 - 7.40 (m, 3H), 7.38 - 7.32 (m, 2H), 7.30 - 7.26 (m, 2H), 7.16 - 7.07 
(m, 5H), 7.04 (dd, J = 8.6, 1.2 Hz, 2H), 6.75 (d, J = 8.7 Hz, 1H), 5.40 - 5.30 (m, 1H), 5.29 - 5.14 
(m, 3H), 4.50 (dd, J = 8.9, 3.0 Hz, 1H), 4.14 - 4.05 (m, 1H), 4.01 (dd, J = 5.1, 2.6 Hz, 1H), 3.97 
(s, 3H), 2.94 (td, J = 11.6, 10.1, 4.0 Hz, 2H), 2.54 - 2.40 (m, 2H), 1.96 (d, J = 13.6 Hz, 1H), 1.87 
- 1.73 (m, 3H), 1.70 - 1.58 (m, 1H). 
HRMS(ESI): m/z calc. for C44H41N4O6S2 [M+H]
+: 785.2468, found: 785.2478. 
Q1ll: Prepared from benzofuran-2-sulfonyl chloride. 
Yield: 9.7 mg, 74%. 
1H NMR (CDCl3, 500 MHz): δ 8.24 - 8.11 (m, 4H), 7.50 (dd, J = 
9.2, 2.6 Hz, 1H), 7.46 - 7.40 (m, 2H), 7.39 (dd, J = 2.4, 1.2 Hz, 1H), 
7.36 (dd, J = 8.6, 7.1 Hz, 2H), 7.29 (d, J = 3.1 Hz, 1H), 7.27 - 7.23 (m, 1H), 7.17 - 7.11 (m, 3H), 
7.07 - 7.02 (m, 2H), 6.64 (s, 1H), 5.38 (dt, J = 16.8, 9.7 Hz, 1H), 5.27 (dd, J = 10.1, 1.6 Hz, 1H), 
5.22 (d, J = 7.5 Hz, 1H), 5.17 (dd, J = 16.8, 1.7 Hz, 1H), 4.80 (dd, J = 8.6, 3.9 Hz, 1H), 4.09 - 4.03 
(m, 1H), 4.02 (s, 3H), 3.99 - 3.90 (m, 1H), 3.18 (ddd, J = 12.9, 8.7, 3.3 Hz, 1H), 2.78 (td, J = 13.3, 
3.3 Hz, 1H), 2.66 (ddd, J = 13.6, 9.7, 4.0 Hz, 1H), 2.43 - 2.32 (m, 1H), 2.04 (d, J = 13.6 Hz, 1H), 
1.91 - 1.80 (m, 2H), 1.77 (d, J = 13.4 Hz, 1H), 1.65 (dt, J = 18.1, 6.5 Hz, 1H). 
HRMS(ESI): m/z calc. for C41H38N3O6S2 [M+H]
+: 732.2202, found: 732.2191. 
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Q1mm: Prepared from 1-naphthalenesulfonyl chloride. 
Yield: 12.1 mg, 91%. 
1H NMR (CDCl3, 500 MHz): δ 8.45 - 8.39 (m, 1H), 8.25 - 8.15 (m, 
4H), 7.83 - 7.74 (m, 2H), 7.59 - 7.49 (m, 2H), 7.49 (dd, J = 9.2, 2.5 
Hz, 1H), 7.43 (dd, J = 7.3, 1.2 Hz, 1H), 7.32 (dd, J = 8.6, 7.3 Hz, 2H), 7.28 - 7.26 (m, 1H), 7.16 - 
7.09 (m, 3H), 7.05 - 6.98 (m, 3H), 5.24 (dt, J = 16.9, 9.8 Hz, 1H), 5.18 - 5.08 (m, 2H), 4.90 (dd, J 
= 17.0, 1.7 Hz, 1H), 4.65 (dd, J = 9.0, 3.6 Hz, 1H), 3.99 (s, 3H), 3.98 - 3.95 (m, 1H), 3.92 (ddd, J 
= 13.6, 5.0, 2.4 Hz, 1H), 2.92 (ddd, J = 12.8, 8.9, 3.3 Hz, 1H), 2.78 (td, J = 13.2, 3.2 Hz, 1H), 2.39 
(ddd, J = 13.3, 9.5, 3.6 Hz, 1H), 2.24 (qd, J = 9.7, 3.0 Hz, 1H), 1.84 (dd, J = 12.7, 2.8 Hz, 1H), 
1.77 - 1.62 (m, 3H), 1.57 - 1.48 (m, 1H). 
HRMS(ESI): m/z calc. for C43H40N3O5S2 [M+H]
+: 742.2409, found: 742.2419. 
2.5.3 Computational Analysis 
Molecular Property Distribution Histograms 
Library data for the MicroFormat Library was obtained via the ChemBridge website. 
Library data for approved cancer drugs was obtained from NCI as the Approve Oncology Drugs 
Set VI (https://wiki.nci.nih.gov/display/NCIDTPdata/Compound+Sets). Library data for approved 
antibacterials was obtained from O’Shea and Moser.41  
The number of stereogenic centers were calculated in Canvas 2.2 (Schrodinger, New York) 
using the Ligfilter Descriptor “Num_chiral_centers” in the Molecular Properties application. The 
following Python program (ctd_score.py) calculates several relevant molecular descriptors given 
a properly formatted sdf file. The ctd_score.py requires RDKit, an open-source collection of 
cheminformatics software. 
The program is run from the command line with the following syntax: 
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  > python ctd_score.py FILENAME.sdf 
where FILENAME.sdf is a collection of molecules to be calculated. A new file is written with 
“descr.sdf” appended to the end of the filename. 
 
#   
# calculation of molecular descriptors and complexity index   
#   
# Implements RDKit   
#   
# Bryon Drown, May 2015   
# Updated Oct. 9, 2015   
# University of Illinois, Urbana-Champaign   
#   
#   
   
import sys   
from rdkit import Chem   
from rdkit.Chem import Descriptors   
from rdkit.ML.Descriptors import MoleculeDescriptors   
from collections import defaultdict   
from collections import OrderedDict   
   
def calcRingDescriptors(m):   
  nBonds = m.GetNumBonds()   
  nAtoms = m.GetNumAtoms()   
  cyclomatic = nBonds - nAtoms + 1   
  if(cyclomatic < 1): return   
     
  ri = m.GetRingInfo()   
  if(ri.NumRings() < 1): return   
  # get total ring path and nBondRings   
  totalRing = 0   
  Bonds = []   
  Bridges = []   
  for ring in ri.BondRings():   
    for id in ring:   
      if (ri.NumBondRings(id) > 1):   
        Bridges.append(id)   
      totalRing+=1   
      Bonds.append(id)   
         
  # remove duplicates, then get length     
  nBondRings = len(OrderedDict.fromkeys(Bonds).keys())   
  nBridgeEdges = len(OrderedDict.fromkeys(Bridges).keys())   
     
  # get nAtomRings   
  Atoms=[]   
  for ring in ri.AtomRings():   
    for id in ring:   
      Atoms.append(id)       
  nAtomRings=len(OrderedDict.fromkeys(Atoms).keys())   
     
  # descriptors   
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  ringFusionDensity = 2 * float(nBridgeEdges) / float(nAtomRings)   
  ringComplexityIndex = float(totalRing) / float(nAtomRings)   
  molecularCyclizedDegree = float(nAtomRings) / float(nAtoms)   
  nRingSystems = (nBonds - nBondRings) - (nAtoms - nAtomRings) + 1   
  if(nRingSystems < 1):    
    ringFusionDegree = 0   
  else:   
    ringFusionDegree = float(cyclomatic) / float(nRingSystems)   
     
  # set props   
  m.SetProp('TotalRing',str(totalRing))   
  m.SetProp('NumBridges',str(nBridgeEdges))   
  m.SetProp('nBondRings',str(nBondRings))   
  m.SetProp('nAtomRings',str(nAtomRings))   
  m.SetProp('ringFusionDensity',str(ringFusionDensity))   
  m.SetProp('ringFusionDegree',str(ringFusionDegree))   
  m.SetProp('ringComplexityIndex',str(ringComplexityIndex))   
  m.SetProp('molecularCyclizedDegree',str(molecularCyclizedDegree))   
  m.SetProp('NumRingSystems',str(nRingSystems))   
     
  return    
   
if __name__=='__main__':   
    file_in  = sys.argv[1]   
    file_out = file_in+".descr.sdf"   
    ms = [x for x in Chem.SDMolSupplier(file_in) if x is not None]   
    ms_wr = Chem.SDWriter(file_out)   
   
    nms= ('BalabanJ','BertzCT','FractionCSP3','MolWt','RingCount')   
    calc = MoleculeDescriptors.MolecularDescriptorCalculator(nms)   
   
    for i in range(len(ms)):   
      descrs = calc.CalcDescriptors(ms[i])   
      calcRingDescriptors(ms[i])   
      for x in range(len(descrs)):   
        ms[i].SetProp(str(nms[x]),str(descrs[x]))   
      ms_wr.write(ms[i])   
 
Three-dimensional histograms plotting Fsp3 and the number of stereogenic centers were 
prepared in OriginPro 2015 (OriginLab, Northampton, MA) using the 2D Frequency 
Count/Binning feature. The number of stereogenic centers was set to X and bin range was set to 
“Bin Centers”. The minimum bin center was set to 0, the max bin center was set to 8, and the bin 
size was set to 1. Outliers greater than or equal to the maximum were included and the output 
binning order was set to descending. Fsp3 was set to Y and the bin range was set to “Bin Centers”. 
The minimum bin center was set to 0, the max bin center was set to 1, and the bin size was set to 
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0.1. Outliers greater than or equal to the maximum were included and the output binning order was 
set to ascending. The quantity to compute was set to “Count”. The resulting data set was then 
exported to Excel (Microsoft, Redmond WA) and plotted in a 3D column plot (number stereogenic 
centers = series, Fsp3 = category).      
Tanimoto Similarity Analysis 
 
Extended connectivity fingerprints (32-bit) were calculated with Canvas 2.2 (Schrodinger, 
New York) using hashed radial (ECFP) fingerprints with 3 radial iterations, daylight invariant 
atom types, and bonds distinguished by bond order. Similarity matrices were created in Canvas 
using the “Similarity/Distance From Fingerprints” task. Heatmaps were generated in Excel 
(Microsoft, Redmond WA) using a three-color scale set to 0.04 (R=104, G=148, B=190), 0.38 
(R=216, G=227, B=125), and 1.0 (R=248, G=105, B=107).  
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      Chapter 3: Ring Distortion of Abietic Acid 
Portions are reprinted with permission from Rafferty, R. J.; Hicklin, R. W.; Maloof, K. A.; 
Hergenrother, P. J. Synthesis of Complex and Diverse Compounds through Ring Distortion of 
Abietic Acid Angew. Chem. Int. Ed. 2014, 53, 220-224. Compounds are named according to the 
nomenclature defined therein.  
3.1 Introduction 
Abietic acid is a tricyclic rosin acid terpene containing 3 stereogenic centers that are 
functionalized by a carboxylic acid on the A-ring and trisubstituted olefins on the B- and C-rings 
(Figure 3.1). Abietic acid is the major component of rosin, which is obtained from the resin exuded 
from pine trees.1 Rosin, also known as colophony, was traded in Asia Minor as early as the 1st 
century.2 The major historical application of rosin was as a caulk for the bottom of wooden sailing 
vessels.2 Rosin has a wide variety of modern industrial applications and is used in paper sizing, 
printing inks, glazing agents, and synthetic rubber production.1 Rosin is also widely used by 
musicians and athletes to increase friction.1 Due to the numerous applications of rosin and its 
abundant supply, global production of rosin was about 1.2 x 106 tons per year in 1995.2  
  Abietic acid is readily crystallized from rosin upon alcohol digestion or treatment with 
mineral acid3 and was first isolated by Baup in 1826 and named “acide abiétique.”4 Significant 
efforts throughout the 19th and early 20th century were made to identify the structure of abietic acid 
by extensive chemical degradation,3, 5 and the structure of abietic acid was conclusively determined 
 
Figure 3.1: Structure and key functional groups of abietic acid. 
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by Ruzicka in 1941.6 More recent studies have employed abietic acid as a complex starting material 
for the semisynthesis of natural products7-10 and other fine chemicals.11-14 Thus, a wide variety of 
ring distortion reactions of abietic acid have been reported (Scheme 3.1). The C-ring of abietic 
acid can be modified by Diels-Alder ring fusion with maleic anhydride after thermal isomerization 
of the diene (Scheme 3.1A).5, 11, 15 C-ring aromatization and B-ring benzylic oxidation of abietic 
acid methyl ester can be accomplished by exposure to selenium dioxide (Scheme 3.1B).16 Ring 
cleavage of the C-ring occurs upon dihydroxylation, methylation of the acid and treatment with 
lead tetraacetate (Scheme 3.1C).12 Sulfuric acid degradation of abietic acid results in C-ring 
contraction (Scheme 3.1.D).13 Ozonolysis of abietic acid leads to C-ring oxidative cleavage and 
epoxidation of the B-ring (Scheme 3.1E).17 A ring fusion between the A- and B-rings occurs upon 
Scheme 3.1: Examples of known ring distortion reactions of the abietic acid scaffold. 
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lithium/ammonia reduction of abietic acid,  p-tosic acid isomerization, and treatment with 
hydrogen bromide in glacial acetic acid (Scheme 3.1F).18  
3.2 Synthesis of Complex and Diverse Molecules from Abietic Acid 
Due to its high molecular complexity, low cost, and established reactivity profile, abietic 
acid is an excellent substrate for chemical diversification by ring distortion. Both the B- and C-
rings of abietic acid contain a trisubstituted olefin, making differential functionalization of the B- 
and C-rings a critical first step for ring distortion. Based on the known reactivity of abietic acid 
(Scheme 3.1), the C-ring of abietic acid is the most readily modified. Thus, synthetic routes were 
 
Scheme 3.2: Ring distortion of abietic acid (AA) 
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developed that involved distortion of the C-ring as the initial step in order to enable late-stage 
diversification of the B-ring (Scheme 3.2, AA2, AA3, AA7, AA9, AA10, and AA11).  
Through this ring distortion approach, 6 complex and diverse scaffolds were readily 
prepared (Scheme 3.2). During the course of these synthetic efforts, an additional 14 intermediates 
and related compounds were prepared during the course of these studies and were included in 
further analyses. The full set of target scaffolds and intermediates prepared by ring distortion of 
abietic acid are shown in Figure 3.2. The work described herein was performed in collaboration 
with Dr. Ryan Rafferty. Dr. Rafferty designed all synthetic routes and synthesized target scaffolds 
AA2, AA3, AA7, AA10, and AA11. My main contribution to this project focused on the synthesis 
of AA9 and the creation of a library of AA9 derivatives. I also aided in the characterization of 
scaffolds by multidimensional NMR and obtained single crystals of AA8 for X-ray 
crystallography.  
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Figure 3.2: Compounds created by ring distortion of abietic acid (AA). 
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3.2.1 C-Ring Dihydroxylation and Cleavage: Synthesis of AA2 and AA3 
 Regioselective and diastereoselective dihydroxylation of the C-ring olefin of abietic acid 
was performed using known procedures to provide diol AA12 as a single diastereomer (Scheme 
3.3).10 Esterification of the carboxylic acid with methyl iodide afforded AA13. Treatment of diol 
AA13 with lead tetraacetate resulted in ring cleavage of the C-ring to provide keto-aldehyde 
AA1.12 Compound AA1 possesses several sites for further modification (ketone and α,β-
unsaturated aldehyde) and several ring distortion strategies were explored.  
 Wittig olefination of the ketone and aldehyde of AA1 provided AA14. Ring fusion onto 
the B-ring of AA14 was readily accomplished by Diels-Alder cycloaddition to afford compound 
AA2 as a single diastereomer (Scheme 3.4).The cycloaddition reaction to form AA2 results in the 
introduction of a new stereogenic center (red) that could either be axial “down” or equatorial “up” 
(as depicted in Figure 3.3). The configuration of the new stereogenic center was assigned using 
 
Scheme 3.3: C-ring dihydroxylation of abietic acid (AA12) and oxidative cleavage to form AA1. 
 
Scheme 3.4: Reactions of AA1: Olefination and Diels-Alder ring fusion to create AA2. 
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1D 1H-1H NOESY NMR spectroscopy (Figure 3.3). The configurations of the blue axial “down” 
proton and green axial “up” methyl group of AA2 were assigned based on the configuration of 
abietic acid and were used to determine the configurations of the protons colored red, orange, and 
pink. Irradiation of the blue axial “down” proton resulted in a strong Nuclear Overhauser Effect 
(NOE) signal with the proton colored pink, indicating that the pink proton is equatorial “down” 
and the geminal orange proton is axial “up”. No NOE signal was observed between the blue proton 
and the red proton. Irradiation of the orange axial “up” proton showed NOE signals for the geminal 
 
Figure 3.3: Assignment of the configuration of AA2 by 1D 1H-1H NOESY NMR spectroscopy. 
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pink proton, the axial “up” methyl protons (green), and the red proton, indicating that the 
configuration of the red proton is likely equatorial “up”. This hypothesis was confirmed by 
irradiation of the green axial “up” methyl proton, which shows a strong NOE signal for the red 
proton, and irradiation of the red proton itself, which shows NOE signals for the orange axial “up” 
proton and the green axial “up” methyl protons. These data were consistent with the structure in 
Figure 3.3.  
As discussed in Chapter 1, a formal ring contraction of rings functionalized by a vicinal 
diol can be accomplished by oxidative cleavage and aldol condensation. Thus, exposure of diol 
cleavage product AA1 to base resulted in ring fusion via aldol condensation to form AA3, which 
contains a 5-membered C-ring (Scheme 3.5). Compound AA1 was also functionalized by 
amidation (AA15) and reductive amination to form amine AA16.   
 
Scheme 3.5: Reactions of AA1: Aldol condensation to form AA3 and reductive amination to 
form AA16. 
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3.2.2  C-Ring Dihydroxylation and Ring Fusion: Synthesis of AA9-AA11  
In addition to oxidative cleavage, vicinal diols, such as AA13, are good substrates for ring 
fusion by cyclic carbonate formation. Reaction of AA13 with triphosgene resulted in ring fusion 
to form cyclic carbonate AA5 and enabled modification of the B-ring olefin (Scheme 3.6). Ring 
fusion onto the B-ring was accomplished by diastereoselective dibromocyclopropanation to form 
AA8 as a single isomer, whose configuration was assigned by X-ray crystallography. Treatment 
of AA8 with silver tetrafluoroborate resulted in ring expansion of the B-ring via electrocyclic 
cyclopropane opening and elimination to form diene AA9.    
The B-ring olefin of AA5 was also subjected to dihydroxylation to form AA19 as a single 
diastereomer (Scheme 3.7). The dihydroxylation of AA5 to form AA19 introduces two new 
stereogenic centers to the scaffold. However, only the configuration of the proton geminal to the 
secondary alcohol (red) needed to be determined by 1D 1H-1H NOESY NMR spectroscopy since 
osmium tetroxide dihydroxylation is syn specific; both alcohols must be on the same face of the 
scaffold (Figure 3. 4).  
 
Scheme 3.6: Reactions of AA13: Cyclic carbonate formation and B-ring expansion. 
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Scheme 3.7: B-ring dihydroxylation of AA5. 
 
Figure 3.4: Assignment of the configuration of AA19 by 1D 1H-1H NOESY NMR spectroscopy. 
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The configurations of the pink axial “down” proton, green axial “up” methyl group, and 
blue equatorial “down” proton of AA19 were assigned based on the configuration of AA5 and 
were used to determine the configuration of the red proton geminal to the secondary alcohol. 
Irradiation of the pink axial “down” proton showed no NOE signal for the red proton. Irradiation 
of the blue equatorial “down” proton shows an NOE signal for the red proton, indicating that the 
red proton is likely equatorial “up.” Irradiation of the green axial “up” methyl protons also showed 
an NOE signal for the red proton, providing further evidence that the red proton has an equatorial 
“up” configuration. Irradiation of the red proton showed NOE signals for both the blue equatorial 
“down” proton and the green axial “up” methyl protons, confirming the observed correlations 
between the red, blue, and green protons. The observed NOE correlations found for compound 
AA19 are consistent with the structure in Figure 3.4.  
In a similar manner to the synthesis of AA3, diol AA19 was subjected to oxidative cleavage 
by reaction with lead tetraacetate to form AA20 (Scheme 3.8). Treatment of AA20 with piperidine 
and acetic acid resulted in aldol addition to provide the formal ring contraction product AA10 as 
a single isomer. Additionally, the AA20 scaffold was functionalized by sodium borohydride 
reduction of the aldehyde to form alcohol AA11.  
 
Scheme 3.8: B-ring oxidative cleavage of AA19. 
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The aldol addition to form AA10 results in the formation of two new stereogenic centers, 
both of which were assigned by 1D 1H-1H NOESY NMR spectroscopy (Figure 3.5). The red proton 
alpha to the aldehyde was assigned as “up” based on its strong NOE signal to the green axial “up” 
methyl protons. Assignment of the tertiary alcohol was more challenging as there were no geminal 
protons. However, NOE signals were observed between the blue proton geminal to the oxygen in 
the cyclic carbonate and both the orange aldehyde proton and the red proton. Only the 
 
Figure 3.5: Assignment of the configuration of AA10 by 1D 1H-1H NOESY NMR spectroscopy. 
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configuration with a trans-fusion of the C-ring and the alcohol in the axial “up” configuration 
positions the blue proton and the B-ring protons (red and orange) on the same face of the C-ring 
and close enough to enable spin transfer.  
3.2.3 C-ring Aromatization and B-ring Cleavage: Synthesis of AA7 
 Aromatization of the C-ring of abietic acid and related terpenes is an established and useful 
strategy for differentiating the B- and C- ring olefins and incorporating new functionality into the 
abietic acid scaffold.5, 14 Aromatization of the C-ring of the methyl ester of abietic acid (AA17) 
using selenium dioxide also results in benzylic oxidation to provide AA18 as a mixture of isomers 
(Scheme 3.9).16 Alcohol oxidation of AA18 provides a ketone that is amenable to ring distortion 
by oxidative ring expansion and ring cleavage. Baeyer-Villiger ring expansion of AA18 with m-
chloroperbenzoic acid provided ester AA6. Ring cleavage of the B-ring of AA6 was accomplished 
by global reduction with lithium aluminum hydride to form triol AA7.   
 
Scheme 3.9: C-ring aromatization and B-ring cleavage of abietic acid. 
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3.3 Functional Group Diversification of Abietic Acid-Derived Scaffolds 
 Many of the compounds created from abietic acid (AA1-AA20) are well suited to 
functional group diversification and are useful starting points for the creation of derivative 
libraries. Several strategies for functional group diversification of the abietic acid-derived 
compounds were explored to demonstrate utility of such complex molecules for the rapid and 
efficient synthesis of large libraries of functional group derivatives. In addition to traditional 
single-point libraries, methods for accessing multiple single-point libraries along a single route 
and a method for iterative creation of a three-point-derivative library were developed. 
3.3.1 Single-Point-Derivative Libraries 
 Compound AA9 contains a vinyl bromide group, which is a useful functional group handle 
for sp2-sp2 cross coupling (Scheme 3.10). Reaction of AA9 with a series of six commercially 
available alkenyl, aryl, and heteroaryl boronic acid pinacol esters under palladium catalysis 
enabled the creation of 6 AA9 derivatives (AA21-AA26).  
 
Scheme 3.10: Single-point derivatives of AA9 by Suzuki cross coupling. 
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 The aldehyde of compound AA10 is another useful functional group for chemical 
diversification and library generation via reductive amination (Scheme 3.11). Treatment of AA10 
with 5 different commercially available secondary heterocyclic and primary benzylic amines in 
presence of sodium cyanoborohydride resulted in the synthesis of 5 amine derivatives of AA10 
(AA27-AA30).   
 The carboxylic acid of AA12 is readily amidated under PyBOP conditions to provide a 
library of AA12 amides (Scheme 3.12, AA31a-AA31g). Furthermore, each of these amides can 
be subjected to the oxidative cleavage and ring fusion sequence performed in the synthesis of AA3. 
Thus, libraries of aldehydes (AA32a-AA32g) and dienes (AA33a-AA33g) can be readily 
prepared. Though this strategy, 21 new derivatives (7 diols, 7 aldehydes, and 7 dienes) were 
expediently prepared using the same reagents.  
 
 
Scheme 3.11: Single-point derivatives of AA10 by reductive amination. 
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3.3.2 Multi-Point-Derivative Libraries 
 By varying the reagents in a multistep diversification sequence, large multi-point derivative 
libraries can be created (scheme 3.13). The synthesis of the AA2 scaffold from AA1 can readily 
accommodate the incorporation of new functionality by varying the substituents on the Wittig 
reagent and the dienophile used to prepare the AA14 and AA2 scaffolds, respectively. As several 
derivatives of the AA1 scaffold were prepared in the creation of other libraries, 3 aldehydes were 
chosen for the creation of the multipoint derivative library (AA1, AA15, and AA32g). By reacting 
3 different Wittig reagents with aldehydes AA1, AA15, and AA32g, a collection of 9 different 
dienes was prepared (AA14, AA34a-AA36c). Treatment of each of the 9 dienes with 3 different 
dienophiles resulted in the synthesis of 27 different ring fusion products (AA2, AA37a-AA45c). 
In total, 34 new derivatives were created by this approach (AA2 and AA14 were previously 
synthesized).  
 
Scheme 3.12: Synthesis of amide and ester libraries of AA9, AA1, and AA3. 
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3.4  Assessing the Complexity and Diversity of the Abietic Acid Collection 
 The ring distortion of abietic acid detailed above resulted in the synthesis of numerous 
stereochemically complex multi-ring scaffolds. Visual inspection of these compounds reveals that 
they appear to have high molecular complexity and considerable structural diversity. The 
complexity and diversity of the compounds derived from abietic acid were quantified using the 
metrics introduced in Chapter 2 (Fsp3 vs. number stereogenic centers and Tanimoto similarity).   
3.4.1 Quantifying the Molecular Complexity of the Abietic Acid Collection 
The Fsp3 and number of chiral centers in a molecule are simple and intuitive metrics that 
provide a good approximation of molecular complexity (See Chapter 2). Compounds with 
increased Fsp3 are more likely to contain complex ring systems and three-dimensional 
arrangements of functional groups than molecules with low Fsp3. The presence of stereogenic 
 
Scheme 3.13: Synthesis of a three-point-derivative library based on AA2. 
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centers in a molecule indicates increased rigidity and a defined three-dimensional shape. By 
quantifying both the Fsp3 and the number of stereogenic centers for each molecule in a compound 
collection, a good approximation of the molecular complexity of the overall collection can be 
obtained using a three-dimensional histogram plot. The compounds produced by the ring distortion 
of abietic acid (Figure 3.2, AA1-AA20) occupy the front right quadrant of the plot in Figure 3.6 
and exhibit high Fsp3 (range: 0.54-0.91, average: 0.74, median: 0.75) and all possess multiple 
stereogenic centers (range 3-8, average: 5.1, median: 4.5). Analysis of all of the compounds 
produced from abietic acid (AA1-AA45c) shows that all of the compounds possess a good 
molecular complexity profile, but the inclusion of the functional group derivatives results in a 
decrease in the average and median Fsp3 for the collection (range: 0.49-0.92, average: 0.69, 
median: 0.68). 
 Comparison of the molecular complexity of the abietic acid to the Chembridge 
Microformat library shows a stark difference in complexity of the two sets (Figure 3.7). The abietic 
acid compounds have a substantially higher average Fsp3 and number of stereogenic centers than 
the Chembridge set (Fsp3: range: 0.0-1.0, average: 0.23, median: 0.20 and number of stereogenic 
 
Figure 3.6: Three-dimensional histogram graphs plotting Fsp3 and the number of stereogenic 
centers for the AA1-AA20 and the full abietic acid set including derivatives.  
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centers: range: 0-11, average: 0.27, median: 0.0) and the two collections occupy different 
quadrants of the graph. The NCI oncology drug set and FDA approved antibacterial drugs occupy 
most regions of the graph (anticancer: Fsp3: range: 0.0-1.0, average: 0.44, median: 0.44 and 
number of stereogenic centers: range: 0-25, average: 2.64, median: 0.5; antibacterials: Fsp3: range: 
0.0-1.0, average: 0.41, median: 41 and number of stereogenic centers: range: 0-20, average: 3.49, 
median: 2.0), however, the abietic acid compounds occupy a region of the graph that is populated 
by anticancer and antibacterial drugs but is severely underrepresented in the Chembridge 
collection. 
3.4.2 Quantifying the Diversity of the Abietic Acid Collection 
The structural diversity of the abietic acid collection was assessed by creating a matrix of Tanimoto 
similarity coefficients (See Chapter 2) generated from ECFP_6 three-bond radial fingerprints with 
Daylight invariant atom types and distinguishing bonds by bond order in Canvas (Schrodinger, 
New York). Table 3.1 depicts the Tanimoto similarity matrix for the compounds created by ring 
distortion of abietic acid (AA1-AA20). The structural similarity between abietic acid (AA) and the 
pairwise combinations of the target scaffolds (AA2, AA3, AA7, AA9-AA10) is quite low (blue to 
green in color, range: 0.03-0.32, average: 0.12, median: 0.12), indicating significant structural 
diversity between these molecules. The structural diversity of all the compounds created by ring 
 
Figure 3.7: Three-dimensional histogram graphs plotting Fsp3 and the number of stereogenic 
centers for the Chembridge Microformat library, NCI oncology drugs, and FDA approved 
antibacterial drugs.  
9+
6
3
0
0
10000
20000
30000
40000
0
0
.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.9 1
C
o
u
n
t
Microformat (150K)
9+
6
3
0
0
2
4
6
8
10
12
0
0
.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.9 1
C
o
u
n
t
NCI Oncology (117)
9+
6
3
0
0
2
4
6
8
10
0
0
.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.9 1
C
o
u
n
t
Antibacterial Drugs (128)
115 
 
distortion of abietic acid (AA1-AA20) is also high as the Tanimoto similarity between these 
molecules is generally low (blue to orange in color, range: 0.03-0.58, average: 0.13, median: 0.11).  
The entire abietic acid collection including the functional group derivatives (AA1-AA45c) 
also shows good overall diversity (Table 3.2). The single-point libraries (AA21-AA33g) tend to 
have high similarity to compounds with the same scaffold, but the use of several different scaffolds 
increases the overall diversity of the single-point library collection (blue to dark orange in color, 
range: 0.06-0.77, average: 0.18, median: 0.12). The three-point-derivative library (AA34a-AA45c) 
showed lower Tanimoto similarity scores within the library due to the presence of multiple sites 
of diversification (blue to orange in color, range: 0.05-0.64, average: 0.15, median: 0.11). 
 
Table 3.1: Tanimoto similarity matrix (ECFP_6, Schrodinger) for abietic acid (AA) and the abietic 
set (AA2, AA3, AA7, AA9-AA10). Compounds with a high score have higher structural similarity 
than compounds with low scores. 
1.00
0.00
0.50
AA AA2 AA3 AA7 AA9 AA10 AA11 AA1 AA4 AA5 AA6 AA8 AA12 AA13 AA14 AA15 AA16 AA17 AA18 AA19 AA20
AA 1.00 0.12 0.32 0.03 0.13 0.11 0.09 0.16 0.09 0.10 0.06 0.09 0.26 0.19 0.15 0.12 0.07 0.54 0.08 0.11 0.10
AA2 0.12 1.00 0.14 0.06 0.16 0.13 0.08 0.10 0.16 0.09 0.10 0.08 0.10 0.12 0.12 0.09 0.09 0.14 0.15 0.17 0.09
AA3 0.32 0.14 1.00 0.03 0.16 0.14 0.12 0.19 0.13 0.13 0.08 0.13 0.19 0.27 0.18 0.12 0.09 0.44 0.11 0.14 0.13
AA7 0.03 0.06 0.03 1.00 0.03 0.04 0.05 0.05 0.12 0.03 0.14 0.03 0.04 0.04 0.05 0.06 0.06 0.03 0.09 0.04 0.03
AA9 0.13 0.16 0.16 0.03 1.00 0.21 0.16 0.11 0.16 0.17 0.09 0.15 0.12 0.14 0.10 0.07 0.07 0.15 0.13 0.23 0.17
AA10 0.11 0.13 0.14 0.04 0.21 1.00 0.15 0.11 0.15 0.15 0.10 0.15 0.12 0.14 0.10 0.06 0.06 0.14 0.13 0.24 0.15
AA11 0.09 0.08 0.12 0.05 0.16 0.15 1.00 0.11 0.11 0.40 0.08 0.16 0.09 0.11 0.10 0.07 0.07 0.12 0.10 0.15 0.56
AA1 0.16 0.10 0.19 0.05 0.11 0.11 0.11 1.00 0.11 0.12 0.11 0.19 0.12 0.15 0.48 0.24 0.11 0.19 0.10 0.11 0.13
AA4 0.09 0.16 0.13 0.12 0.16 0.15 0.11 0.11 1.00 0.11 0.22 0.09 0.08 0.10 0.10 0.09 0.09 0.12 0.26 0.16 0.11
AA5 0.10 0.09 0.13 0.03 0.17 0.15 0.40 0.12 0.11 1.00 0.08 0.16 0.10 0.12 0.11 0.07 0.08 0.13 0.10 0.15 0.44
AA6 0.06 0.10 0.08 0.14 0.09 0.10 0.08 0.11 0.22 0.08 1.00 0.10 0.07 0.09 0.10 0.09 0.10 0.08 0.16 0.10 0.08
AA8 0.09 0.08 0.13 0.03 0.15 0.15 0.16 0.19 0.09 0.16 0.10 1.00 0.11 0.14 0.18 0.09 0.07 0.13 0.09 0.17 0.16
AA12 0.26 0.10 0.19 0.04 0.12 0.12 0.09 0.12 0.08 0.10 0.07 0.11 1.00 0.58 0.12 0.09 0.07 0.19 0.09 0.12 0.10
AA13 0.19 0.12 0.27 0.04 0.14 0.14 0.11 0.15 0.10 0.12 0.09 0.14 0.58 1.00 0.15 0.09 0.08 0.27 0.11 0.14 0.12
AA14 0.15 0.12 0.18 0.05 0.10 0.10 0.10 0.48 0.10 0.11 0.10 0.18 0.12 0.15 1.00 0.16 0.09 0.19 0.10 0.10 0.11
AA15 0.12 0.09 0.12 0.06 0.07 0.06 0.07 0.24 0.09 0.07 0.09 0.09 0.09 0.09 0.16 1.00 0.26 0.12 0.08 0.06 0.08
AA16 0.07 0.09 0.09 0.06 0.07 0.06 0.07 0.11 0.09 0.08 0.10 0.07 0.07 0.08 0.09 0.26 1.00 0.08 0.07 0.06 0.08
AA17 0.54 0.14 0.44 0.03 0.15 0.14 0.12 0.19 0.12 0.13 0.08 0.13 0.19 0.27 0.19 0.12 0.08 1.00 0.11 0.14 0.13
AA18 0.08 0.15 0.11 0.09 0.13 0.13 0.10 0.10 0.26 0.10 0.16 0.09 0.09 0.11 0.10 0.08 0.07 0.11 1.00 0.14 0.10
AA19 0.11 0.17 0.14 0.04 0.23 0.24 0.15 0.11 0.16 0.15 0.10 0.17 0.12 0.14 0.10 0.06 0.06 0.14 0.14 1.00 0.15
AA20 0.10 0.09 0.13 0.03 0.17 0.15 0.56 0.13 0.11 0.44 0.08 0.16 0.10 0.12 0.11 0.08 0.08 0.13 0.10 0.15 1.00
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Table 3.2: Full Tanimoto similarity matrix for the abietic acid set including derivatives. 
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3.5 Conclusion    
 The ring distortion of abietic acid was predicated on the use of reactions to differentiate 
and functionalize the B- and C- ring olefins in order to facilitate selective ring distortion. C-ring 
dihydroxylation of abietic acid was tremendously useful for differentiating the B- and C-ring 
olefins and enabled C-ring cleavage, C-ring fusion, and numerous ring distortion reactions on the 
B-ring. Aromatization of the C-ring of abietic acid enabled oxidative ring expansion and ring 
cleavage of the B-ring. The result of these chemical diversification efforts was the synthesis of a 
collection of 6 highly complex and diverse molecular scaffolds as well as 14 additional 
intermediate scaffolds. The potential to rapidly create large functional group libraries of complex 
molecules from these compounds was demonstrated via the synthesis of single- and multi-point-
derivative libraries of 7 different scaffolds derived from abietic acid. In total, 84 complex and 
diverse small molecules were created from abietic acid. The molecular complexity of the 
compounds created from abietic acid was assessed by comparing the Fsp3 and number of 
stereogenic centers of the abietic acid compounds to a typical HTS screening collection from 
Chembridge and approved anticancer and antibacterial drugs. The abietic acid compounds were 
vastly more complex than the Chembridge collection and had a complexity profile that overlapped 
with approved anticancer and antibacterial drugs. The structural diversity of the abietic acid 
compounds was measured by Tanimoto similarity of extended connectivity molecular fingerprints 
and showed that the abietic acid-derived scaffolds were considerably structurally different from 
each other and the starting natural product. 
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3.6  Methods and Characterization 
Chemical reagents were purchased from commercial sources and used without further 
purification.  Abietic acid was purchased from Sigma-Aldrich (at ≥98.0% purity). All chemicals 
were purchased commercially and used without further purification.  Flash chromatography was 
performed using silica (230-400 mesh). Anhydrous solvents used during these studies were dried 
after being passed through columns with activated alumina.   
1H NMR and 13C NMR experiments were recorded on Varian Unity spectrometers at 500 
MHz and 125 MHz, respectively.  Spectra were obtained in the following solvents (reference peaks 
include 1H & 13C NMR):  CDCl3 (
1H NMR: 7.26 ppm; 13C NMR: 77.23 ppm) and d6-DMSO (
1H 
NMR: 2.50 ppm; 13C NMR: 39.52 ppm).  NMR experiments were performed at room temperature 
unless otherwise indicated.  Chemical shift values are reported in parts per million (ppm) for all 
1H NMR and 13C NMR spectra.  1H NMR multiplicities are reported as: s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet, br = broad.   
3.6.1 Ring Distortion of Abietic Acid: Synthesis and Characterization 
 
 
Procedure: Abietic acid (4.0 g, 13.2 mmol, 1.0 eq.) was added to a 50 mL sealed tube that 
contained t-butanol (20 mL) followed by the addition of pyridine (1.5 mL) and H2O (2 mL) at rt.  
The mixture was allowed to stir until all of the solid dissolved, at which time trimethylamine oxide 
(1.8 g, 15.9 mmol, 1.2 eq) was added followed by solid osmium tetraoxide (100 mg, 0.397 mmol, 
0.03 eq.).  The container was sealed and brought to 100 °C.  After 4 days, the reaction was cooled 
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to rt, at which point a saturated solution of sodium sulfite (2 mL) was added and allowed to stir 
for 30 min.  The crude reaction material was transferred to a round bottom flask (RBF) and 
concentrated under reduced pressure to give a crude greenish solid, which was taken up in EtOAc 
(250 mL) and washed with 1 N HCl (75 mL) twice.  The organic layer was washed with saturated 
sodium carbonate twice, and once with brine.  The crude acidic aqueous layer was extracted once 
with EtOAc and the organic layer was washed with saturated sodium carbonate and brine.  The 
organic layer was dried over sodium sulfate and concentrated under reduce pressure.  The crude 
material was taken up in CH2Cl2 to which silica gel was added, the mixture was concentrated under 
reduce pressure to give the crude material adsorbed onto silica for subsequent purification.  The 
pre-loaded crude material was purified by flash silica gel chromatography (1:1 EtOAc:Hexane) to 
give 3.59 g (81% yield) of AA12 as an off-white solid. 
 
 
1H-NMR (d6-DMSO, 500 MHz): δ 5.80 – 5.63 (m, 1H), 4.28 (d, J = 8.4 Hz, 1H), 3.82 – 3.68 (m, 
1H), 3.21 (s, 1H), 2.04 (hept, J = 6.8 Hz, 1H), 1.95 – 1.85 (m, 1H), 1.84 – 1.73 (m, 2H), 1.72 – 
1.55 (m, 3H), 1.55 – 1.39 (m, 5H), 1.40 – 1.31 (m, 1H), 1.20 – 1.12 (m, 1H), 1.15 (s, 3H), 1.09 – 
0.99 (m, 1H), 0.83 (d, J = 7.0 Hz, 3H), 0.81 (d, J = 6.9 Hz, 3H), 0.79 (s, 3H). 
13C-NMR (d6-DMSO, 125 MHz): δ 179.6, 139.6, 117.1, 75.1, 72.5, 51.1, 45.3, 44.3, 38.8, 36.6, 
34.6, 33.1, 26.0, 24.4, 18.9, 18.0, 17.7, 17.3, 16.6, 15.2. 
HRMS(ESI): m/z calc. for C20H32O4Na [M+Na]+: 359.2913, found: 359.2196. 
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Melting Point: 156-157 °C. 
 
 
Procedure: Compound AA12 (5.92 g, 17.6 mmol, 1.0 eq) was added to acetone (80 mL) followed 
by K2CO3 (6.1 g, 44.0 mmol, 2.5 eq.) and iodomethane (3.3 mL, 52.8 mmol, 3.0 eq) and then 
brought to reflux.  After 14 h the reaction was allowed to cool to rt, at which point H2O (40 mL) 
was added, and then the crude material was extracted with Et2O (2x).  The organic layers were 
combined, washed with brine, dried over sodium sulfate and concentrated under reduce pressure.  
The crude material was purified by flash silica gel chromatography (3:7 EtOAc:Hexane) to give 
5.6 g (91% yield) of AA13 as colorless solid.  
 
 
1H-NMR (CDCl3, 500 MHz): δ 5.86 (dd, J = 6.0, 1.9 Hz, 1H), 3.94 (d, J = 2.5 Hz, 1H), 3.63 (s, 
3H), 2.14 (hept, J = 6.9 Hz, 1H), 2.04 – 1.94 (m, 1H), 1.91 – 1.83 (m, 2H), 1.80 – 1.49 (m, 10H), 
1.40 (qd, J = 12.9, 3.6 Hz, 1H), 1.34 – 1.28 (m, 1H), 1.25 (s, 3H), 1.11 (ddd, J = 12.8, 9.2, 6.6 Hz, 
1H), 0.93 (dd, J = 6.9, 1.0 Hz, 3H), 0.90 (dd, J = 6.9, 1.0 Hz, 3H), 0.86 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 179.4, 138.1, 120.0, 76.4, 73.4, 52.1, 51.4, 46.7, 44.9, 39.3, 37.1, 
35.4, 33.3, 26.6, 25.2, 19.4, 18.2, 18.0, 17.7, 16.6, 15.7.  
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HRMS(ESI): m/z calc. for C21H35O4 [M+H]
+: 323.2541, found: 323.2573. 
 
Melting Point: 106-107 °C. 
 
 
Procedure: Compound AA13 (1.0 g, 2.9 mmol, 1.0 eq) was dissolved into dry benzene (15 mL) 
to which lead tetraacetate (1.9 g, 4.3 mmol, 1.5 eq) was added.  The reaction was left to stir at rt 
for 1 h, at which time ethylene glycol (3 mL) was added and allowed to stir for an additional 45 
min.  A solution of saturated sodium bicarbonate (10 mL) was added slowly to the reaction and 
then extracted with CH2Cl2 (20 mL x 3).  The organic layers were combined, washed with brine, 
dried over sodium sulfate and concentrated under reduced pressure.  The crude material was 
purified by flash silica gel chromatography (1:4 EtOAc:Hexane) to afford 854 mg (86% yield) of 
compound AA1 as a tan oil.  
 
 
1H-NMR (CDCl3, 500 MHz): δ 9.35 (s, 1H), 6.75 (dd, J = 5.4, 2.2 Hz, 1H), 3.65 (s, 3H), 3.11 
(ddd, J = 17.1, 10.8, 1H), 2.62 (sep, 1H), 2.43 (ddd, J = 16.8, 10.7, 5.6 Hz, 1H), 2.29 (dddd, J = 
19.0, 11.1, 4.1, 2.2 Hz, 1H), 2.10 – 1.93 (m, 4H), 1.87 (dddd, J = 14.0, 10.7, 5.7, 2.8 Hz, 1H), 1.76 
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– 1.61 (m, 2H), 1.61 – 1.47 (m, 4H), 1.26 (s, 3H), 1.10 (s, 3H), 1.09 (d, J = 0.8 Hz, 3H), 0.82 (s, 
3H). 
13C-NMR (CDCl3, 125 MHz): δ 215.6, 195.0, 178.8, 152.5, 144.5, 52.3, 50.1, 46.4, 44.3, 42.7, 
40.9, 37.9, 37.2, 36.6, 27.0, 21.0, 18.6, 18.5, 17.9, 17.3, 14.4. 
HRMS(ESI): m/z calc. for C21H33O4 [M+H]
+: 349.2334, found: 349.2383. 
 
 
 
Procedure: Methyltriphenylphosphonium bromide (507 mg, 1.4 mmol, 3.0 eq) was added to THF 
(3 mL), cooled to -78°C, once at temperature, n-BuLi (1.6 M in hexane, 0.8 mL, 1.28 mmol, 2.7 
eq.) was added slowly.  After 15 min the reaction was allowed to warm to 0 °C, kept at the same 
temperature for 25 min, and then returned to -78 °C at which time a solution of compound AA1 
(165 mg, 0.5 mmol, 1.0 eq) in THF (0.5 mL) was added.  After 1 h the reaction was allowed to 
warm to room temperature gradually.  The reaction was filtered to remove the solid precipitate, 
the solid was washed with Et2O (5 mL x 3), dried over sodium sulfate and concentrated under 
reduce pressure to afford the crude material as an off-white foam.  The crude material was purified 
by flash silica gel chromatography (1:9 EtOAc:Hexane) to afford 146 mg (85% yield) of 
compound AA14 as an off-white  sticky foam. 
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1H-NMR (CDCl3, 500 MHz): δ 6.27 (dd, J = 17.1, 10.8, Hz, 1H), 5.71 – 5.68 (t, J = 1.9 Hz, 1H), 
5.20 (dd, J = 17.0, 2.2 Hz 1H), 4.90 (dd, J = 10.7, 2.2 Hz, 1H), 4.74 (d, J = 1.3 Hz, 1H), 4.68 (d, J 
= 1.5 Hz, 1H), 3.65 (s, 3H), 2.28 – 2.16 (m, 2H), 2.10 – 1.92 (m, 3H), 1.92 – 1.85 (m, 2H), 1.81 – 
1.66 (m, 2H), 1.66 – 1.58 (m, 2H), 1.56 (s, 2H), 1.45 – 1.32 (m, 1H), 1.23 (s, 3H), 1.16 – 1.05 (m, 
1H), 1.03 (s, 3H), 1.02 (s, 3H), 0.82 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 179.2, 156.6, 140.1, 139.1, 123.3, 113.2, 106.6, 53.4, 52.2, 46.8, 
45.1, 38.3, 37.3, 36.5, 36.4, 33.9, 26.0, 25.9, 22.2, 22.0, 18.2, 17.1, 14.3. 
HRMS(ESI): m/z calc. for C23H37O2 [M+H]
+: 345.2749, found: 345.2732. 
 
 
 
Procedure: Compound AA14 (20 mg, 0.06 mmol, 1.0 eq.) and 4-phenyl-1,2,4-triazoline-3,5-
dione (12 mg, 0.064 mmol, 1.1 eq.) were added to PhCH3 (1 mL) and heated to reflux.  After 18 h 
the reaction was concentrated under reduce pressure to afford crude foam material.  The crude 
material was purified by flash silica gel chromatography (1:4 EtOAc:Hexane) to give 26 mg (84%) 
of compound AA2 as an off-white solid. 
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1H-NMR (CDCl3, 500 MHz): δ 7.56 (d, 1H), 7.49 (dd, J = 8.7, 7.1 Hz, 2H), 7.41 – 7.36 (m, 2H), 
5.61 – 5.53 (m, 1H), 4.82 (s, 1H), 4.72 (s, 1H), 4.70 (t, J = 1.5 Hz, 1H), 4.33 (d, J = 1.1 Hz, 1H), 
4.01 (d, J = 1.3 Hz, 1H), 3.66 (s, 3H), 2.37 (td, J = 12.6, 9.1 Hz, 1H), 2.28 – 2.16 (m, 2H), 2.15 – 
2.08 (m, 1H), 2.05 (dd, J = 12.2, 7.0 Hz, 1H), 2.00 – 1.85 (m, 2H), 1.73 – 1.49 (m, 6H), 1.43 – 
1.33 (m, 2H), 1.31 (s, 3H), 1.09 (s, 3H), 1.05 (s, 3H), 1.04 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 178.6, 155.6, 153.1, 151.7, 137.4, 131.5, 129.3, 128.2, 125.6, 
114.9, 107.1, 55.5, 52.4, 49.4, 46.3, 43.7, 43.2, 42.1, 37.7, 37.6, 33.9, 33.2, 30.0, 29.0, 27.3, 22.2, 
22.0, 17.9, 17.8, 17.6. 
HRMS(ESI): m/z calc. for C31H42N3O4 [M+H]
+: 520.3131, found: 520.3177. 
Melting Point: 153-154 °C. 
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Procedure: KOtBu (2.2 eq.) was added to THF (0.05M) and left to stir at rt for 1 h at which time 
was added compound AA1 (375 mg, 1.1 mmol, 1.0 eq.) in THF (1.0 M).  The reaction was 
quenched 2 h later with 1 M HCl, taken up in CH2Cl2 and washed with saturated sodium hydrogen 
carbonate.  The organic layers were combined, dried over sodium sulfate and concentrated under 
reduce pressure.  The crude material was purified via flash silica gel chromatography (1:1 
EtOAc:Hexane) to give 257 mg (72% yield) of compound AA3 as a white foam. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.84 (s, 1H), 5.84 – 5.79 (m, 1H), 3.61 (s, 3H), 3.19 (hept, J = 6.8 
Hz, 1H), 2.69 – 2.61 (m, 1H), 2.58 – 2.50 (m, 1H), 2.39 (dt, J = 17.1, 4.3 Hz, 1H), 2.26 (dd, J = 
10.8, 6.4 Hz, 1H), 2.11 – 1.97 (m, 2H), 1.95 – 1.85 (m, 1H), 1.68 (dq, J = 13.0, 2.7 Hz, 1H), 1.64 
– 1.55 (m, 4H), 1.26 (s, 3H), 1.12 (d, J = 5.7 Hz, 3H), 1.10 (d, J = 5.3 Hz, 3H), 0.77 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): 204.1, 179.0, 146.2, 145.4, 140.1, 124.0, 54.0, 52.2, 46.5, 45.6, 
38.6, 37.6, 36.3, 34.4, 30.0, 26.9, 19.9, 19.4, 18.1, 16.5, 14.1. 
HRMS(ESI): m/z calc. for C21H31O3 [M+H]
+: 331.2228, found: 331.2273. 
Melting Point: 181-183 °C. 
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Procedure:  Compound AA1 (450 mg, 1.3 mmol, 1.0 eq.) was added to a pre-mixed solution of 
LiOH (155 mg, 6.5 mmol, 5 eq.) in THF (10 mL) and left to stir.  After 8 h the reaction was 
quenched with saturated NH4Cl, extracted with CH2Cl2 (x2), and washed with brine. The organic 
layers were combined and concentrated under reduced pressure.  The crude material was dissolved 
in CH2Cl2 (10 mL) followed by the addition of PyBOP (744 mg, 1.4 mmol, 1.1 eq.) and iPr2EtN 
(0.23 mL, 1.3 mmol, 1.0 eq) and left to stir for 2 h.  A pre-mixed solution of benzylamine (0.98 
mL, 1.7 mmol, 1.3 eq.) and iPr2EtN (0.74 mL, 1.7 mmol, 1.3 eq) was added and the reaction left 
to stir at rt for 12 h.  The reaction was concentrated, and the crude material purified via flash silica 
gel chromatography (1:1 EtOAc:Hexane) to afford 160 mg (29%, 2 steps) of compound AA15 as 
an oil. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 9.33 (s, 1H), 7.36 – 7.31 (m, 2H), 7.29 (d, J = 7.0 Hz, 1H), 7.26 – 
7.23 (m, 2H), 6.71 (t, J = 4.7, 2.3 Hz, 1H), 6.07 (t, J = 5.5 Hz, 1H), 4.47 – 4.36 (m, 2H), 3.13 (ddd, 
J = 17.1, 10.9, 4.6 Hz, 1H), 2.63 (hept, J = 6.9 Hz, 1H), 2.43 (ddd, J = 16.9, 10.7, 5.6 Hz, 1H), 
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2.23 (dddd, J = 19.7, 13.1, 5.2, 2.6 Hz, 1H), 2.13 – 2.00 (m, 3H), 1.97 (dq, J = 12.9, 2.6 Hz, 1H), 
1.90 – 1.77 (m, 2H), 1.71 (s, 1H), 1.64 – 1.48 (m, 4H), 1.27 (s, 3H), 1.10 (d, 3H), 1.09 – 1.08 (m, 
3H), 0.83 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 215.7, 195.0, 177.9, 152.5, 144.5, 138.6, 129.0, 127.9, 127.8, 
50.2, 46.2, 44.5, 44.2, 42.8, 40.9, 37.8, 37.8, 36.6, 26.7, 21.0, 18.6, 18.5, 18.1, 17.4, 14.5. 
HRMS(ESI): m/z calc. for C27H38NO3 [M+H]
+: 424.2807, found: 424.2789. 
 
 
Procedure: To a solution of compound AA15 (32 mg, 0.075 mmol, 1.0 eq.) in MeOH (0.5 mL) 
was added sodium cyanoborohydride (14 mg, 0.23 mmol, 3.0 eq.) at rt and left to stir for 14 h at 
rt. The reaction was quenched with a saturated sodium bicarbonate solution and extracted with 
Et2O (3x).  The organic layers were combined, washed with brine, dried over sodium sulfate and 
concentrated under reduced pressure.  The crude material was purified via flash silica gel 
chromatography (1:1, EtOAc:Hexane) to give 14 mg (35% yield) of compound AA16 as an oil. 
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1H-NMR (CDCl3, 500 MHz): δ 7.61 – 7.43 (m, 5H), 7.24 (d, J = 7.2 Hz, 2H), 7.01 (d, J = 6.9 Hz, 
2H), 6.23 (s, 1H), 5.72 (s, 1H), 4.48 – 4.41 (m, 2H), 4.24 – 4.19 (m, 2H), 3.76 (s, 3H), 3.58 (d, J 
= 3.2 Hz, 1H), 3.34 (d, J = 3.1 Hz, 1H), 2.92 (t, J = 1.9 Hz, 1H), 2.62 (hept, J = 6.1 Hz, 1H), 2.51 
– 2.42 (m, 2H), 2.26 – 2.19 (m, 1H), 2.16 – 1.91 (m, 3H), 1.87 – 1.76 (m, 2H), 1.74 – 1.53 (m, 
6H), 1.26 (s, 3H), 1.11 (d, J = 4.7 Hz, 6H), 0.81 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 204.1, 178.2, 146.2, 145.3, 140.2, 138.8, 128.9, 128.5, 127.9, 
127.7, 124.0, 114.1, 55.5, 54.0, 46.3, 46.1, 45.9, 44.1, 38.4, 38.1, 36.3, 34.4, 30.1, 26.6, 19.9, 19.4, 
18.3, 16.6, 14.2. 
HRMS(ESI): m/z calc. for C35H49N2O3 [M+H]
+: 545.3698, found: 545.3743. 
 
 
 
Procedure: To a solution of abietic acid (3.0 g, 9.9 mmol, 1.0 eq.) in acetone (45 mL) was added 
iodomethane (1.9 mL, 29.8 mmol, 3.0 eq.) and K2CO3 (3.4 g, 24.8 mmol, 2.5 eq.) and brought to 
reflux.  After 12 h the reaction was taken up in H2O and extracted with Et2O (3x).  The organic 
layers were combined, washed with brine, dried over sodium sulfate and concentrated under reduce 
pressure to afford crude product.  The crude material was purified via flash silica gel 
chromatography (1:9 EtOAc:Hexane) to give 2.91 g (93 % yield) of compound AA17 as a white 
solid that had identical spectra to those that were previously published (1H & 13C NMR) for this 
compound.19    
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Procedure: To a suspension of SeO2 (1.8 g, 16.6 mmol, 4.5 eq.) in CH2Cl2 (25 mL) was added 
tBuOOH (5.5 M in octane, 6.7 mL, 36.9 mmol, 10 eq.) and stirred.  After 30 min, compound AA17 
(1.2 g, 3.7 mmol, 1.0 eq.) in CH2Cl2 (10 mL) was added and left to stir.  The reaction was quenched 
12 h later with brine and extracted with EtOAc (2x).  The organic layers were combined, washed 
with brine, dried over sodium sulfate and concentrated under reduce pressure.  The crude material 
was purified via flash silica gel chromatography (1:4, EtOAc:Hexane) to give 1.0 g (83% yield) 
of compound AA18 that had identical spectra to those that were previously published (1H & 13C 
NMR) for this compound.20 
 
 
Procedure: DMSO (0.06 mL, 0.84 mmol, 2.4 eq.) was added slowly to a pre-cooled solution of 
oxalyl chloride (0.04 mL, 0.42 mmol, 0.42 eq.) in CH2Cl2 (2 mL) at -78 °C.  After 45 min 
compound AA18 (115 g, 0.35 mmol, 1.0 eq.) in CH2Cl2 (0.2 mL) was added and left to stir at the 
same temperature.  Triethylamine (0.24 mL, 1.7 mmol, 5.0 eq.) was added 1 h later to the reaction 
and upon addition was allowed to warm to rt.  The reaction was quenched with H2O and extracted 
with CH2Cl2.  The organic layers were combined, washed with brine, dried over sodium sulfate 
and concentrated under reduced pressure.  The crude material was purified via flash silica gel 
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chromatography (1:4, EtOAc:Hexane) to give 60 mg (52% yield) of compound AA4 as an oil that 
had identical spectra to those that were previously published (1H & 13C NMR) for this compound.16 
 
 
Procedure: Compound AA13 (364 mg, 1.0 mmol, 1.0 eq.) was added to DCM (20 mL) followed 
by pyridine (0.8 mL) and cooled to 0 °C.  Once cooled to 0 °C, triphosgene (432 mg, 1.5 mmol, 
1.4 eq.) was added to the reaction and allowed to warm to rt.  After 14 h the reaction was quenched 
with NH4Cl and extracted with CH2Cl2 (10 mL x 3).  The organic layers were combined, washed 
with brine, dried over sodium sulfate, and concentrated under reduced pressure to give a crude 
foam.  The crude material was purified via flash silica gel chromatography (3:7 EtOAc:Hexane) 
to afford 360 mg (92% yield) of compound AA5 as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 5.98 – 5.93 (m, 1H), 4.74 (s, 1H), 3.65 (s, 3H), 2.11 (dd, J = 12.0, 
4.9 Hz, 1H), 2.08 – 1.94 (m, 3H), 1.94 – 1.83 (m, 2H), 1.80 – 1.69 (m, 3H), 1.67 – 1.57 (m, 4H), 
1.49 (ddd, J = 14.8, 13.5, 3.2 Hz, 1H), 1.29 (s, 3H), 1.14 – 1.06 (m, 1H), 1.00 (d, J = 6.8 Hz, 3H), 
0.92 (d, J = 6.9 Hz, 3H), 0.79 (s, 3H) 
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13C-NMR (CDCl3, 125 MHz): δ 179.0, 154.8, 133.1, 130.6, 87.5, 82.0, 52.2, 52.1, 46.6, 45.4, 37.7, 
37.4, 36.7, 34.9, 29.8, 26.5, 18.3, 16.8, 16.6, 16.5, 16.4, 14.2. 
HRMS(ESI): m/z calc. for C22H33O5 [M+H]
+: 377.2283, found: 377.2328. 
Melting Point: 134-135 °C. 
 
 
Procedure: Compound AA4 (92 mg, 0.28 mmol, 1.0 eq.) was dissolved in CH2Cl2 (3 mL) 
followed by sodium carbonate (116 mg, 1.57 mmol, 5.6 eq.) and cooled to 0 °C.  After 30 min at 
this temp, mCPBA (3.2 g, 14.1 mmol, 9 eq.) was added to the reaction mixture.  The reaction was 
allowed to warm to rt, and then stirred under an inert atmosphere for 4 days.  The reaction was 
quenched with H2O and extracted with CH2Cl2.  The organic layers were combined, washed with 
brine, dried over sodium sulfate and concentrated under reduced pressure.  The crude material was 
purified via flash silica gel chromatography (1:4, EtOAc:Hexane) to give 12 mg (13% yield) of 
compound AA6 as an oil that had identical spectra to those that were previously published (1H & 
13C NMR) for this compound.21 
 
 
Procedure: To a stirring solution of compound AA6 (32 mg, 0.09 mmol, 1.0 eq.) in THF (0.5 mL) 
at 0 °C was added portion-wise lithium aluminum hydride (17 mg, 0.45 mmol, 5 eq.).  The reaction 
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was allowed to warm to rt and left to stir for 12 hours.  The reaction was concentrated under 
reduced pressure and purified via flash silica gel chromatography (1:2, EtOAc,Hexane) to give 11 
mg (38% yield) of compound AA7 as an oil. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 7.13 (d, J = 8.1 Hz, 1H), 6.68 (dd, J = 8.1, 1.9 Hz, 1H), 6.58 (d, J 
= 1.9 Hz, 1H), 3.56 (d, J = 11.8 Hz, 1H), 3.31 (ddd, J = 10.0, 4.5, 3.1 Hz, 1H), 3.23 (bs, 1H), 2.98 
(d, J = 11.8 Hz, 1H), 2.85 (t, J = 12.7 Hz, 1H), 2.78 (h, J = 6.8 Hz, 1H), 2.53 (td, J = 10.7, 10.2, 
2.9 Hz, 1H), 1.99 (td, J = 13.4, 4.0 Hz, 1H), 1.78 (qt, J = 13.7, 3.6 Hz, 1H), 1.60 – 1.44 (m, 3H), 
1.37 (s, 3H), 1.30 (s, 1H), 1.28 – 1.24 (m, 2H), 1.21 (d, J = 1.3 Hz, 3H), 1.19 (d, J = 1.3 Hz, 3H), 
1.18 – 1.15 (m, 2H), 0.80 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 155.0, 148.4, 133.1, 128.5, 118.0, 115.4, 71.7, 63.8, 42.5, 39.0, 
35.6, 35.1, 33.4, 28.5, 24.2, 24.0, 21.3, 19.2, 18.8. 
HRMS(ESI): m/z calc. for C20H33O3 [M+H]
+: 321.2385, found: 321.2430. 
 
 
Procedure: Compound AA5 (118 mg, 0.3 mmol, 1.0 eq.) and tetrabutylammonium bromide (14 
mg, 0.04 mmol, 0.14 eq.) were added to CHBr3 (5 mL) followed by a 50% NaOH solution in water 
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(1.6 mL).  The reaction was stirred vigorously for 14 h, after which time it was taken up in H2O 
and extracted with Et2O (10 mL x 2).  The organic layers were combined, washed with brine, dried 
over sodium sulfate and concentrated under reduced pressure to give a crude oil.  The crude 
material was purified by flash silica gel chromatography (1:4 EtOAc:Hexane) to afford 120 mg 
(73% yield) of compound AA8 as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 4.63 (s, 1H), 3.66 (s, 3H), 2.22 – 2.18 (m, 1H), 2.14 (hept, J = 6.8 
Hz, 1H), 2.07 – 2.04 (m, 1H), 2.00 (d, J = 7.5 Hz, 1H), 1.89 – 1.76 (m, 3H), 1.68 – 1.57 (m, 3H), 
1.57 – 1.49 (m, 4H), 1.46 – 1.40 (m, 1H), 1.40 – 1.33 (m, 1H), 1.19 (s, 3H), 1.08 (d, J = 6.9 Hz, 
3H), 1.04 (d, J = 6.7 Hz, 3H), 0.86 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 178.6, 154.2, 87.4, 84.5, 52.2, 47.3, 46.5, 45.8, 42.5, 37.5, 37.1, 
34.2, 34.2, 32.4, 31.0, 28.2, 19.7, 18.1, 16.8, 16.6, 16.2, 16.0, 14.7. 
HRMS(ESI): m/z calc. for C23H33Br2O5 [M+H]
+: 547.0650, found: 547.0695. 
Melting Point: 147-148 °C. 
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X-ray Crystallographic Data for AA8: 
 
Table 3.3 Crystal data and structure refinement for bm40uasic. 
 
Identification code     bm40uas 
Empirical formula     C23 H32 Br2 O5  
Formula weight    548.31 
Temperature      178(2)K  
Wavelength      0.71073 Å  
Crystal system    Monoclinic  
Space group     P2(1) 
Unit cell dimensions     a = 10.7505(18)Å α= 90°  
      b = 7.6094(13)Å β= 92.232(2) 
      c = 14.256(2)Å  γ= 90°  
Volume      1165.3(3) Å3   
Z      2  
Density (calculated)     1.563 g/cm3  
Absorption coefficient   3.509 mm-1  
F(000)      560 
Crystal size     0.386 x 0.203 x 0.108 mm3  
Theta range for data collection   1.43 to 25.40°  
Index ranges     -12<=h<=12, -9<=k<=9, -17<=l<=17  
Reflections collected    12778  
Independent reflections   4263 [R(int) = 0.0293]  
Completeness to theta = 25.40°   99.7 %  
Absorption correction    Integration 
Max. and min. transmission    0.7428 and 0.4182 
Refinement method     Full-matrix least-squares on F2  
Data / restraints / parameters    4263 / 1 / 277 
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(Cont. Table 3.3:)  
Goodness-of-fit on F2    1.052  
Final R indices [I>2sigma(I)]   R1 = 0.0200, wR2 = 0.0493  
R indices (all data)    R1 = 0.0212, wR2 = 0.0497 
Absolute structure (Flack) parameter  0.004(5)   
Largest diff. peak and hole   0.298 and -0.234 e. Å-3  
 
 
 
Procedure: A suspension of AA8 (450 mg, 0.821 mmol) and silver tetrafluoroborate (498 mg, 
2.56 mmol) in methanol (1.71 mL) was heated in a sealed tube at 80 C for 72 h. Upon cooling, 
the reaction mixture was dissolved in methanol and quenched with water. Extraction with ethyl 
acetate, washing with brine, drying with magnesium sulfate, and evaporation gave crude product. 
Purification by column chromatography (5:1 hexanes:ethyl acetate) afforded pure AA9 (188 mg, 
49%) as a tan oil. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.22 (dd, J = 13.2, 3.4 Hz, 1H), 5.56 (s, 1H), 5.30 (dd, J = 13.2, 
2.6 Hz, 1H), 3.71 (s, 3H), 3.07 (t, J = 3.1 Hz, 1H), 2.53 (dd, J = 13.1, 6.0 Hz, 1H), 2.03 (sp, J = 6.8 
Hz, 1H), 1.92 (ddd, J = 14.8, 4.5, 1.9 Hz, 1H), 1.89 – 1.83 (m, 1H), 1.80 – 1.60 (m, 5H), 1.54 – 
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1.39 (m, 1H), 1.36 – 1.24 (m, 2H), 1.19 (s, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H), 
0.90 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 178.8, 154.5, 138.8, 131.2, 131.0, 126.6, 88.2, 83.5, 56.7, 52.9, 
52.6, 49.7, 36.8, 36.6, 36.5, 34.5, 28.7, 19.1, 18.1, 17.4, 17.3, 16.7, 16.3. 
HRMS(ESI): m/z calc. for C23H32BrO5 [M+H]
+: 467.1433, found: 467.1434. 
Melting Point: 191-192 °C. 
 
 
Procedure: Compound AA5 (244 mg, 0.65 mmol, 1.0 eq.) was added to a 15 mL sealed tube that 
contained t-butanol (5 mL) followed by the addition of pyridine (0.1 mL) and H2O (0.1 mL) at rt.  
The mixture was allowed to stirred until all of the solid dissolved, at which time trimethylamine 
oxide (87 mg, 0.78 mmol, 1.2 eq) was added followed by solid osmium tetraoxide (5 mg, 0.02 
mmol, 0.03 eq.).  The container was sealed and brought to 100 °C.  After 4 days, the reaction was 
cooled to rt, at which point a saturated solution of sodium sulfite (2 mL) was added and allowed 
to stir for 30 min.  The crude reaction material was transferred to a RBF and concentrated under 
reduce pressure to give a crude greenish solid, which was taken up in EtOAc and washed with 1 
N HCl (2x).  The organic layer was washed with saturated sodium carbonate twice, and once with 
brine.  The crude acidic aqueous layer was extracted once with EtOAc, the organic layer washed 
with saturated sodium carbonate and brine.  The organic layer was dried over sodium sulfate and 
concentrated under reduce pressure.  The crude material was taken up in CH2Cl2 to which silica 
gel was added, the mixture was concentrated under reduce pressure to give the crude material 
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adsorbed onto silica for subsequent purification.  The pre-loaded crude material was purified by 
flash silica gel chromatography (1:1 EtOAc:Hexane) to give 245 mg (92% yield) of AA19 as an 
off-white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 4.39 (s, 1H), 4.27 (t, J = 8.4 Hz, 1H), 3.66 (s, 3H), 3.18 (bs, 1H), 
2.91 (bs, 1H), 2.21 (t, J = 9.5 Hz, 1H), 2.06 – 1.97 (m, 1H), 1.93 (p, J = 6.8 Hz, 1H), 1.88 – 1.77 
(m, 2H), 1.77 – 1.59 (m, 7H), 1.60 – 1.47 (m, 2H), 1.30 (t, J = 2.4 Hz, 1H), 1.26 (s, 3H), 1.04 (s, 
3H), 1.03 (s, 3H), 0.90 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 178.7, 154.6, 88.8, 79.4, 72.2, 66.6, 57.4, 52.3, 46.7, 44.5, 40.4, 
36.8, 36.4, 35.6, 29.2, 27.9, 18.0, 17.1, 16.6, 16.6, 16.5, 15.7. 
HRMS(ESI): m/z calc. for C22H35O7 [M+H]
+: 411.2338, found: 411.2383. 
Melting Point: 162-163 °C. 
 
 
Procedure: Compound AA19 (46 mg, 0.11 mmol, 1.0 eq) was dissolved into dry benzene (2 mL) 
to which lead tetraacetate (75 mg, 0.17 mmol, 1.5 eq) was added.  The reaction was left to stir at 
rt for 1 h, at which time ethylene glycol (0.15 mL) was added and allowed to stir for an additional 
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45 min.  A solution of saturated sodium bicarbonate (1 mL) was added slowly to the reaction and 
then extracted with CH2Cl2 (3 mL x 3).  The organic layers were combined, washed with brine, 
dried over sodium sulfate and concentrated under reduced pressure.  The crude material was 
purified by flash silica gel chromatography (1:1 EtOAc:Hexane) to afford 33 mg (74% yield) of 
compound AA20 as an oil.  
 
 
1H-NMR (CDCl3, 500 MHz): δ 9.68 (s, 1H), 4.44 (s, 1H), 3.62 (s, 3H), 2.80 (d, J = 5.1 Hz, 1H), 
2.49 – 2.37 (m, 2H), 2.21 (dt, J = 12.4, 3.8 Hz, 1H), 2.15 – 2.00 (m, 3H), 1.88 – 1.76 (m, 3H), 1.72 
– 1.53 (m, 4H), 1.45 (dt, J = 14.1, 7.1 Hz, 1H), 1.26 (s, 3H), 1.12 (s, 3H), 1.03 (d, J = 6.8 Hz, 3H), 
1.01 (d, J = 7.0 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 204.5, 202.2, 178.6, 153.6, 92.1, 82.1, 77.5, 55.9, 52.5, 47.7, 43.1, 
40.1, 38.7, 35.8, 35.4, 33.5, 27.9, 20.8, 20.3, 17.8, 16.8, 16.4. 
HRMS(ESI): m/z calc. for C22H33O7 [M+H]
+: 409.2182, found: 409.2226. 
 
 
Procedure: Compound AA20 (30 mg, 0.07 mmol, 1.0 eq.) was dissolved in benzene (0.5 mL) to 
which piperidine (0.5 μL, 0.005 mmol, 0.05 eq) and acetic acid (0.2 μL, 0.004 mmol, 0.05 eq) was 
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added.  The reaction was refluxed under an inert atmosphere for 3 h, cooled to rt, extracted with 1 
N HCl (0.5 mL), washed with saturated sodium bicarbonate and brine, dried over sodium sulfate 
and concentrated under reduce pressure.  The crude material was purified via flash silica gel 
chromatography (1:1 EtOAc:Hexane) to give 29 mg (51% yield) of compound AA10 as a sticky 
white foam. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 9.53 (d, J = 1.3 Hz, 1H), 4.44 (s, 1H), 4.42 (s, 1H), 3.64 (d, J = 
1.2 Hz, 3H), 2.91 (dd, J = 12.7, 1.3 Hz, 1H), 2.64 (d, J = 12.8 Hz, 1H), 1.99 (ddd, J = 14.6, 4.4, 
2.4 Hz, 1H), 1.97 – 1.90 (m, 1H), 1.85 – 1.75 (m, 2H), 1.75 – 1.56 (m, 6H), 1.43 (d, J = 3.3 Hz, 
3H), 1.31 – 1.19 (m, 2H), 1.05 (d, J = 1.4 Hz, 3H), 1.04 (d, J = 1.5 Hz, 3H), 0.93 (d, J = 3.1 Hz, 
3H). 
13C-NMR (CDCl3, 125 MHz): δ 205.5, 178.9, 153.9, 88.9, 79.4, 77.8, 59.6, 54.0, 52.5, 51.0, 44.7, 
41.5, 39.0, 37.2, 36.5, 28.7, 18.9, 17.4, 16.7, 16.7, 16.6, 15.6. 
HRMS(ESI): m/z calc. for C22H33O7 [M+H]
+: 409.2182, found: 409.2226. 
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Procedure: To a stirring solution of compound AA20 (13 mg, 0.03 mmol, 1.0 eq.) in THF (0.6 
mL) at 0 °C was added sodium borohydride (3 mg, 0.06 mmol, 2 eq.).  The reaction was allowed 
to warm to rt and left to stir.  After 4 h it was extracted with CH2Cl2 (x3), the organic layers 
combined, dried over sodium sulfate and concentrated under reduced pressure.  The crude material 
was purified via flash silica gel chromatography (1:4, EtOAc:hexanes) to afford 7 mg (54% yield) 
of AA11 as an oil. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 5.78 (s, 1H), 4.52 (d, J = 0.9 Hz, 1H), 4.02 – 3.87 (m, 2H), 3.74 
(s, 3H), 3.72 – 3.64 (m, 2H), 3.53 – 3.46 (m, 1H), 2.34 (d, J = 13.5 Hz, 1H), 2.03 – 1.93 (m, 2H), 
1.87 – 1.65 (m, 4H), 1.65 – 1.51 (m, 4H), 1.29 (s, 3H), 1.28 – 1.20 (m, 1H), 1.06 (dd, J = 6.8, 4.3 
Hz, 6H), 0.88 (s, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 211.5, 182.3, 154.4, 89.1, 79.2, 78.7, 60.6, 59.6, 53.2, 47.0, 45.2, 
42.8, 41.0, 39.1, 38.8, 36.4, 28.9, 19.1, 16.8, 16.7, 16.6, 15.7. 
HRMS(ESI): m/z calc. for C22H35O7 [M+H]
+: 411.2338, found: 411.2383. 
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3.6.2 Single-Point Libraries based on AA9: Synthesis and Characterization 
 
 
General Procedure: Compound AA9 (1.0 eq.), the appropriate boronic acid pinacol ester (2.0 
eq.), and K2CO3 (3 eq.) were added to a vial containing a mixture of THF and water (5:1, 0.133 
M) under argon. Pd(PPh3)4 (0.04 eq.) was added, the vial was sealed with electrical tape, and the 
reaction was stirred at 75 C 12-48 hours. Upon cooling, the reaction mixture was diluted with 
water, extracted with ethyl acetate (x2), dried with magnesium sulfate, and concentrated under 
reduced pressure. Purification was achieved by flash silica gel chromatography. 
Compound AA21. 
Flash Silica Gel Chromatography: 1:5 EtOAc:Hexane 
Yield: 18 mg, 61% 
1H-NMR (CDCl3, 500 MHz): δ 6.24 (d, J = 15.5 Hz, 1H), 5.95 (dd, J = 
13.1, 3.3 Hz, 1H), 5.37 (s, 1H), 5.36 – 5.29 (m, 2H), 3.70 (s, 3H), 3.00 (s, 1H), 2.49 (dd, J = 13.1, 
5.9 Hz, 1H), 1.96 (q, J = 6.8 Hz, 1H), 1.90 (ddd, J = 14.6, 4.4, 1.8 Hz, 1H), 1.87 – 1.78 (m, 1H), 
1.78 – 1.55 (m, 5H), 1.53 – 1.44 (m, 1H), 1.42 (dd, J = 13.6, 1.8 Hz, 1H), 1.39 – 1.19 (m, 2H), 
1.15 (s, 3H), 0.96 (d, J = 6.7 Hz, 3H), 0.88 – 0.76 (m, 8H), 0.50 – 0.43 (m, 2H).   
HRMS(ESI): m/z calc. for C28H39O5 [M+H]
+: 455.2797, found: 455.2798. 
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Compound AA22. 
Flash Silica Gel Chromatography: 1:3 EtOAc:Hexane  
Yield:  14 mg, 47% 
1H-NMR (CDCl3, 500 MHz): δ δ 5.71 (td, J = 13.2, 3.4 Hz, 0H), 5.40 (ddd, 
J = 13.0, 6.0, 2.5 Hz, 1H), 4.78 (d, J = 7.0 Hz, 1H), 3.73 (d, J = 1.7 Hz, 3H), 3.17 (h, J = 1.7 Hz, 
1H), 2.73 – 2.68 (m, 1H), 2.40 (s, 3H), 2.29 – 2.22 (m, 3H), 2.13 (d, J = 8.9 Hz, 3H), 2.00 – 1.89 
(m, 2H), 1.87 – 1.66 (m, 4H), 1.50 (dddd, J = 19.3, 15.5, 12.8, 3.7 Hz, 1H), 1.43 – 1.33 (m, 1H), 
1.32 – 1.25 (m, 1H), 1.21 (d, J = 4.2 Hz, 3H), 1.05 (d, J = 3.5 Hz, 3H), 0.90 (dd, J = 6.7, 2.0 Hz, 
3H), 0.75 (dd, J = 10.9, 6.9 Hz, 3H).   
HRMS(ESI): m/z calc. for C28H38NO6 [M+H]
+: 484.2699, found: 484.2696. 
Compound AA23. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 20 mg, 68% 
1H-NMR (CDCl3, 500 MHz): δ 7.37 (td, J = 7.4, 1.1 Hz, 2H), 7.34 – 7.27 
(m, 2H), 7.23 (dd, J = 8.5, 7.4 Hz, 1H), 6.01 (dd, J = 13.0, 3.4 Hz, 1H), 5.32 (dd, J = 13.0, 2.6 Hz, 
1H), 4.68 (s, 1H), 3.71 (s, 3H), 3.14 (s, 1H), 2.65 (dd, J = 13.3, 5.3 Hz, 1H), 1.96 – 1.84 (m, 2H), 
1.83 – 1.58 (m, 6H), 1.55 – 1.40 (m, 1H), 1.42 – 1.22 (m, 2H), 1.18 (s, 3H), 1.04 (s, 3H), 0.78 (d, 
J = 6.8 Hz, 3H), 0.64 (d, J = 6.9 Hz, 3H). 
HRMS(ESI): m/z calc. for C29H37O5 [M+H]
+: 465.2641, found: 465.2640. 
Compound AA24. 
Flash Silica Gel Chromatography: 1:6 EtOAc:Hexane 
Yield: 23 mg, 66% 
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1H-NMR (CDCl3, 500 MHz): δ 7.26 – 7.18 (m, 4H), 5.96 (dd, J = 13.0, 3.4 Hz, 1H), 5.35 (dd, J 
= 12.9, 2.5 Hz, 1H), 4.61 (s, 1H), 3.71 (s, 3H), 3.14 (s, 1H), 2.65 (dd, J = 13.2, 5.4 Hz, 1H), 1.97 
– 1.86 (m, 2H), 1.83 – 1.62 (m, 6H), 1.48 (q, J = 13.1 Hz, 1H), 1.42 – 1.23 (m, 2H), 1.18 (s, 3H), 
1.03 (s, 3H), 0.80 (d, J = 6.7 Hz, 3H), 0.65 (d, J = 6.8 Hz, 3H).   
HRMS(ESI): m/z calc. for C30H36O6F3 [M+H]
+: 549.2464, found: 549.2469. 
Compound AA25. 
Flash Silica Gel Chromatography: 1:4 to 1:1 EtOAc:Hexane 
Yield: 14 mg, 48% 
1H-NMR (CDCl3, 500 MHz): δ 7.46 (s, 1H), 7.40 (s, 1H), 6.03 (dd, J = 
13.2, 3.5 Hz, 1H), 5.31 (dd, J = 13.0, 2.5 Hz, 1H), 4.96 (s, 1H), 3.94 (d, J = 1.4 Hz, 3H), 3.71 (s, 
3H), 3.10 (s, 1H), 2.61 (dd, J = 13.1, 5.5 Hz, 1H), 1.95 – 1.84 (m, 2H), 1.84 – 1.59 (m, 6H), 1.44 
(dd, J = 13.6, 2.0 Hz, 1H), 1.41 – 1.32 (m, 1H), 1.31 – 1.21 (m, 1H), 1.15 (s, 3H), 0.92 (s, 3H), 
0.87 (dd, J = 7.0, 3.5 Hz, 3H), 0.68 (d, J = 6.8 Hz, 3H).  
HRMS(ESI): m/z calc. for C27H37N2O5 [M+H]
+: 469.2702, found: 469.2705. 
Compound AA26. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 28 mg, 78% 
1H-NMR (CDCl3, 500 MHz): δ 7.26 – 7.14 (m, 4H), 5.96 (dd, J = 
13.0, 3.4 Hz, 1H), 5.33 (dd, J = 12.9, 2.5 Hz, 1H), 4.65 (s, 1H), 3.71 (s, 3H), 3.14 (d, J = 3.2 Hz, 
1H), 3.05 (s, 3H), 3.01 (s, 1H), 2.64 (dd, J = 13.2, 5.4 Hz, 1H), 1.96 – 1.85 (m, 2H), 1.81 – 1.62 
(m, 6H), 1.47 (q, J = 13.2 Hz, 1H), 1.41 – 1.22 (m, 2H), 1.17 (s, 3H), 1.02 (s, 3H), 0.80 (d, J = 6.8 
Hz, 3H), 0.64 (d, J = 6.8 Hz, 3H).  
HRMS(ESI): m/z calc. for C30H40NO7S [M+H]
+: 558.2525, found: 558.2526. 
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3.6.3 Single-Point Libraries Based on AA10: Synthesis and Characterization 
 
General procedure accessing AA27-30:  To a solution of compound AA10 (1.0 eq.) in MeOH 
(0.15 M) was added the corresponding amine (1.5 eq.) and left to stir for 1 h, after which time 
sodium cyanoborohydride (3.0 eq.) was added and left to stir at rt for 14 h. The reaction was 
quenched with a saturated sodium bicarbonate solution and extracted with Et2O (3x).  The organic 
layers were combined, washed with brine, dried over sodium sulfate and concentrated under 
reduced pressure.  The crude material was purified via flash silica gel chromatography. 
Compound AA27. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 16 mg, 35% 
1H-NMR (CDCl3, 500 MHz): δ 4.47 (d, J = 7.8 Hz, 1H), 3.62 (s, 3H), 3.41 – 3.19 (m, 8H), 2.95 
(dt, J = 4.8, 2.4 Hz, 1H), 2.76 (dt, J = 5.1, 2.6 Hz, 1H), 2.48 (d, J = 6.5 Hz, 1H), 2.22 – 1.98 (m, 
7H), 1.81 – 1.61 (m, 5H), 1.42 (s, 3H), 1.31 – 1.19 (m, 2H), 1.08 (s, J = 5.1 Hz, 6H), 0.95 (s, 3H). 
HRMS(ESI): m/z calc. for C26H42NO7 [M+H]
+: 480.2917, found: 480.2961. 
Compound AA28. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 10 mg, 14% 
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1H-NMR (CDCl3, 500 MHz): δ 7.41 – 7.31 (m, 5H), 4.41 (s, 1H), 3.86 (dd, J = 6.2, 7.5 Hz, 2H), 
3.64 (s, 3H), 2.99 (ddd, J = 12.5, 8.6, 2.9 Hz, 2H), 2.27 (d, J = 11.2 Hz, 1H), 2.13 (h, J = 6.4 Hz, 
1H), 2.01 (t, J = 6.2 Hz, 2H), 1.91 (dt, J = 12.0, 5.8 Hz, 2H), 1.85 – 1.69 (m, 3H), 1.62 – 1.56 (m, 
2H), 1.54 – 1.44 (m, 3H), 1.35 (t, J = 6.2 Hz, 1H), 1.09 (s, 3H), 1.01 (t, J = 8.1 Hz, 1H), 0.98 (d, J 
= 6.5 Hz, 6H), 0.86 (s, 3H). 
HRMS(ESI): m/z calc. for C29H42NO6 [M+H]
+: 500.2967, found: 500.3012. 
Compound AA29. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 7 mg, 11% 
1H-NMR (CDCl3, 500 MHz): δ 6.81 – 6.72 (m, 2H), 6.66 – 6.54 (m, 
2H), 4.43 (s, 1H), 3.98 (dd, J = 6.9, 8.2 Hz, 2H), 3.80 (s, 3H), 3.64 (s, 3H), 3.05 (dd, J = 11.3, 2.5 
Hz, 2H), 2.59 (d, J = 10.2 Hz, 1H), 2.11 (h, J = 6.5 Hz, 1H), 2.05 (t, J = 5.9 Hz, 2H), 1.91 – 1.55 
(m, 7H), 1.51 – 1.40 (m, 3H), 1.31 (t, J = 7.5 Hz, 1H), 1.15 (s, 3H), 1.06 (t, J = 7.5 Hz, 1H), 1.02 
(d, J = 6.3 Hz, 6H), 0.95 (s, 3H). 
HRMS(ESI): m/z calc. for C30H44NO7 [M+H]
+: 530.3073, found: 530.3118. 
Compound AA30. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 27 mg, 52% 
1H-NMR (CDCl3, 500 MHz): δ 7.49 (d, J = 7.5 Hz, 1H), 6.25 (d, J = 7.4 
Hz, 1H), 6.15 – 6.08 (m, 1H), 5.58 (d, J = 3.6 Hz, 1H), 4.49 – 4.32 (m, 2H), 3.92 (s, 1H), 3.74 (s, 
3H), 2.25 – 2.15 (m, 3H), 1.92 – 1.57 (m, 7H), 1.52 – 1.34 (, 5H), 1.25 (s, 3H), 1.19 – 1.07 (m, 
2H), 0.92 (d, J = 4.8 Hz, 3H), 0.87 (d, J = 4.9 Hz, 3H), 0.84 (s, 3H). 
HRMS(ESI): m/z calc. for C27H40NO7 [M+H]
+: 490.2795, found: 490.2805. 
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3.6.4 Libraries Based on AA12, AA1, and AA3: Synthesis and Characterization 
 
Functionalization of Carboxylic Acid Accessing AA31a-g:  
General Procedure:  Compound AA12 (1.0 eq), PyBOP (1.1 eq.), and iPr2EtN (1.1 eq) was added 
to CH2Cl2 (0.1 M to AA17) at rt and left to stir.  After 2 h, a solution of the appropriate amine or 
alcohol (2.0 eq.), iPr2EtN (2.0 eq.) in CH2Cl2 (1.0 M) was added and left to stir for 24 h at rt.  
Amines A, F and G were stirred for 24 h at reflux rather than rt.  The reaction was quenched with 
brine, extracted with CH2Cl2 (x2), the organic layers were combined, dried over sodium sulfate 
and concentrated under reduce pressure.  The crude material was purified via flash silica gel 
chromatography. 
Compound AA31a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 189 mg, 77% 
1H-NMR (CDCl3, 500 MHz): δ 7.33 (dd, J = 1.9, 0.9 Hz, 1H), 6.30 (dd, 
J = 3.2, 1.9 Hz, 1H), 6.19 (dd, J = 3.2, 0.9 Hz, 1H), 6.10 (t, J = 5.4 Hz, 1H), 5.81 (dq, J = 6.0, 1.9 
Hz, 1H), 4.48 – 4.31 (m, 2H), 3.94 – 3.89 (m, 1H), 2.31 – 2.19 (m, 1H), 2.15 (h, J = 7.0 Hz, 1H), 
1.97 – 1.61 (m, 9H), 1.58 – 1.46 (m, 5H), 1.40 (qd, J = 13.1, 3.7 Hz, 1H), 1.25 (s, 3H), 0.92 (d, J 
= 6.9 Hz, 3H), 0.89 (d, J = 6.9 Hz, 3H), 0.85 (s, 3H). 
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HRMS(ESI): m/z calc. for C25H38NO4 [M+H]
+: 416.2756, found: 416.2793. 
Compound AA31b. 
Flash Silica Gel Chromatography:  3:2 EtOAc:Hexane 
Yield: 162 mg, 82% 
1H-NMR (CDCl3, 500 MHz): δ 8.78 (s, 1H), 7.54 (d, J = 7.8 Hz, 
1H), 7.40 – 7.34 (m, 1H), 7.18 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H), 7.11 (dd, J = 8.0, 6.9 Hz, 1H), 6.99 
– 6.94 (m, 1H), 6.28 (d, J = 7.6 Hz, 1H), 5.65 – 5.62 (m, 1H), 4.89 (q, J = 6.3 Hz, 1H), 3.86 (d, J 
= 2.6 Hz, 1H), 3.69 (s, 3H), 3.35 – 3.24 (m, 2H), 2.16 (hept, J = 7.0 Hz, 1H), 1.83 – 1.75 (m, 1H), 
1.75 – 1.58 (m, 5H), 1.52 – 1.30 (m, 7H), 1.29 – 1.19 (m, 2H), 1.13 (s, 3H), 1.04 (td, J = 12.7, 4.6 
Hz, 1H), 0.94 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.78 (s, 3H). 
HRMS(ESI): m/z calc. for C32H45N2O5 [M+H]
+: 537.3286, found: 537.3301. 
Compound AA31c. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 296 mg, 85% 
1H-NMR (CDCl3, 500 MHz): δ 5.82 – 5.80 (m, 1H), 5.80 (d, J = 2.1 
Hz, 1H), 3.90 (d, J = 3.3 Hz, 1H), 3.26 – 3.09 (m, 2H), 2.79 (bs, 1H), 2.13 (hept, J = 6.9 Hz, 1H), 
1.95 – 1.86 (m, 1H), 1.85 – 1.71 (m, 5H), 1.71 – 1.60 (m, 3H), 1.53 – 1.38 (m, 7H), 1.29 (dt, J = 
14.9, 7.3 Hz, 2H), 1.21 (s, 3H), 1.10 (td, J = 12.3, 6.0 Hz, 1H), 0.91 – 0.85 (m, 9H), 0.83 (s, 3H). 
HRMS(ESI): m/z calc. for C24H42NO3 [M+H]
+: 392.3120, found: 392.3160. 
Compound AA31d. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 326 mg, 77% 
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1H-NMR (CDCl3, 500 MHz): 7.36 – 7.23 (m, 5H), 6.05 – 5.98 (m, 1H), 5.89 – 5.83 (m, 1H), 4.50 
– 4.36 (m, 2H), 3.98 – 3.91 (m, 1H), 2.16 (p, J = 6.9 Hz, 1H), 1.99 – 1.92 (m, 2H), 1.92 – 1.83 (m, 
3H), 1.83 – 1.69 (m, 3H), 1.65 – 1.48 (m, 6H), 1.46 – 1.35 (m, 1H), 1.32 (dd, J = 13.5, 3.7 Hz, 
1H), 1.28 (s, 3H), 0.95 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.88 (s, 3H). 
HRMS(ESI): m/z calc. for C27H40NO3 [M+H]
+: 426.2963, found: 426.3000. 
Compound AA31e. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 143 mg, 87% 
1H-NMR (CDCl3, 500 MHz):  δ 5.91 – 5.86 (m, 1H), 4.69 – 4.58 (m, 2H), 
3.96 (s, 1H), 2.44 (t, J = 2.4 Hz, 1H), 2.16 (hept, J = 6.9 Hz, 1H), 2.07 – 1.97 (m, 1H), 1.89 (ddd, 
J = 18.3, 12.5, 2.8 Hz, 2H), 1.83 – 1.59 (m, 7H), 1.59 – 1.51 (m, 3H), 1.47 – 1.31 (m, 2H), 1.29 
(s, 3H), 1.17 – 1.09 (m, 1H), 0.95 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.87 (s, 3H). 
HRMS(ESI): m/z calc. for C23H35O5 [M+H]
+: 375.2491, found: 375.2504. 
Compound AA31f. 
Flash Silica Gel Chromatography: 3:2 EtOAc:Hexane 
Yield: 127 mg, 92% 
1H-NMR (CDCl3, 500 MHz): δ 7.18 (d, J = 8.5 Hz, 2H), 6.86 (d, 
J = 8.6 Hz, 2H), 5.97 (t, J = 5.4 Hz, 1H), 5.87 – 5.81 (m, 1H), 4.35 (dd, J = 30.9, 5.3 Hz, 2H), 3.96 
– 3.91 (m, 1H), 3.79 (s, 3H), 2.16 (p, J = 6.9 Hz, 1H), 1.99 – 1.75 (m, 7H), 1.76 – 1.66 (m, 2H), 
1.60 – 1.48 (m, 4H), 1.41 (qd, J = 12.9, 3.5 Hz, 1H), 1.30 (dd, J = 13.6, 3.8 Hz, 1H), 1.25 (s, 3H), 
1.14 (ddd, J = 28.4, 13.5, 6.3 Hz, 1H), 0.94 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 6.9 Hz, 3H), 0.87 (s, 
3H). 
HRMS(ESI): m/z calc. for C28H42NO4 [M+H]
+: 456.3069, found: 456.3085. 
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Compound AA31g. 
Flash Silica Gel Chromatography: 3:2 EtOAc:Hexane 
Yield: 135 mg, 56% 
1H-NMR (CDCl3, 500 MHz): δ 5.91 – 5.85 (m, 1H), 3.94 (s, 1H), 3.71 – 
3.57 (m, 8H), 2.15 (hept, J = 7.0 Hz, 1H), 2.05 – 1.93 (m, 3H), 1.89 – 1.63 (m, 6H), 1.61 – 1.48 
(m, 4H), 1.42 (qd, J = 13.0, 3.6 Hz, 1H), 1.32 (s, 3H), 1.31 – 1.22 (m, 2H), 0.92 (d, J = 6.9 Hz, 
3H), 0.90 (d, J = 6.9 Hz, 3H), 0.88 (s, 3H). 
HRMS(ESI): m/z calc. for C24H40NO4 [M+H]
+: 406.2914, found: 406.2949. 
Oxidative Cleavage of Diol Accessing AA32a-g:  
General Procedure:  Compound AA31 (1.0 eq) was dissolved into dry benzene (0.2 M mL) to 
which lead tetraacetate (1.5 eq) was added.  The reaction was left to stir at rt for 1 h, at which time 
ethylene glycol (1/3 volume of PhH) was added and allowed to stir for an additional 45 min.  The 
reaction was quenched with the slow addition of a saturated sodium bicarbonate which was then 
extracted with CH2Cl2 (x2), the organic layers were combined, dried over sodium sulfate and 
concentrated under reduce pressure.  The crude material was purified via flash silica gel 
chromatography. 
Compound AA32a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 542 mg, 82% 
1H-NMR (CDCl3, 500 MHz): δ 9.31 (s, 1H), 7.34 (dd, J = 1.9, 0.9 Hz, 
1H), 6.70 (dt, J = 4.8, 2.4 Hz, 1H), 6.31 (dd, J = 3.2, 1.9 Hz, 1H), 6.20 
(dd, J = 3.2, 0.9 Hz, 1H), 6.10 (t, J = 5.4 Hz, 1H), 4.50 – 4.33 (m, 2H), 3.12 (ddd, J = 17.2, 10.9, 
4.6 Hz, 1H), 2.63 (h, J = 6.9 Hz, 1H), 2.42 (ddd, J = 16.9, 10.7, 5.6 Hz, 1H), 2.26 – 2.15 (m, 1H), 
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2.03 (ddd, J = 15.1, 6.5, 3.9 Hz, 4H), 1.98 – 1.92 (m, 1H), 1.91 – 1.74 (m, 2H), 1.63 – 1.47 (m, 
3H), 1.26 (s, 3H), 1.10 (d, J = 1.3 Hz, 3H), 1.08 (d, J = 1.4 Hz, 4H), 0.81 (s, 3H). 
HRMS(ESI): m/z calc. for C25H36NO4 [M+H]
+: 414.2600, found: 414.2615. 
Compound AA32b. 
Flash Silica Gel Chromatography: 3:2 EtOAc:Hexane 
Yield:  469 mg, 92% 
1H-NMR (CDCl3, 500 MHz): δ 9.24 (s, 1H), 8.61 – 8.56 (m, 1H), 
7.55 (d, J = 10.0 Hz, 1H), 7.35 (d, J = 10.0 Hz, 1H), 7.19 (t, J = 
8.1, 7.0 Hz, 1H), 7.12 (t, J = 8.0, 7.0 Hz, 1H), 6.98 (d, J = 2.4 Hz, 1H), 6.44 (dd, J = 4.9, 2.7 Hz, 
1H), 6.20 (d, J = 7.5 Hz, 1H), 4.86 (td, J = 7.2, 5.4 Hz, 1H), 3.70 (s, 3H), 3.36 – 3.21 (m, 2H), 3.08 
(ddd, J = 17.2, 10.9, 4.6 Hz, 1H), 2.61 (hept, J = 6.9 Hz, 1H), 2.42 – 2.31 (m, 1H), 1.92 – 1.74 (m, 
6H), 1.68 – 1.56 (m, 2H), 1.54 – 1.39 (m, 4H), 1.09 (s, 4H), 1.09 (d, J = 0.9 Hz, 2H), 1.07 (d, J = 
1.0 Hz, 3H), 0.71 (s, 3H). 
HRMS(ESI): m/z calc. for C32H43N2O5 [M+H]
+: 535.3127, found: 535.3207. 
Compound AA32c. 
Flash Silica Gel Chromatography:  1:1 EtOAc:Hexane 
Yield:  219 mg, 93% 
1H-NMR (CDCl3, 500 MHz): δ 9.29 (s, 1H), 6.69 (dt, J = 4.9, 2.2 Hz, 
1H), 5.84 (t, J = 5.2 Hz, 1H), 3.18 (tdd, J = 13.2, 9.5, 5.8 Hz, 2H), 
3.08 (ddd, J = 17.3, 11.0, 4.6 Hz, 1H), 2.64 – 2.54 (m, 1H), 2.39 (ddd, J = 16.8, 10.7, 5.6 Hz, 1H), 
2.23 – 2.10 (m, 1H), 2.08 – 1.97 (m, 3H), 1.95 – 1.88 (m, 1H), 1.88 – 1.70 (m, 2H), 1.58 – 1.39 
(m, 5H), 1.32 – 1.24 (m, 3H), 1.21 (s, 3H), 1.06 (d, J = 1.4 Hz, 3H), 1.05 (d, J = 1.5 Hz, 3H), 0.88 
(td, J = 7.3, 0.8 Hz, 4H), 0.79 (s, 3H). 
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HRMS(ESI): m/z calc. for C24H40NO3 [M+H]
+: 390.2963, found: 390.3010. 
Compound AA32e. 
Flash Silica Gel Chromatography:  1:2 EtOAc:Hexane  
Yield: 273 mg, 87% 
1H-NMR (CDCl3, 500 MHz): δ 7.26 (dd, J = 1.9, 0.9 Hz, 1H), 6.72 (dt, 
J = 4.9, 2.3 Hz, 1H), 4.42 – 4.25 (m, 2H), 3.08 (ddd, J = 16.3, 9.9, 5.1 
Hz, 1H), 2.68 (s, 1H), 2.63 (h, J = 6.9 Hz, 1H), 2.42 (ddd, J = 16.9, 10.7, 5.6 Hz, 1H), 2.26 – 2.15 
(m, 1H), 2.03 (ddd, J = 15.1, 6.5, 3.9 Hz, 4H), 1.98 – 1.92 (m, 1H), 1.91 – 1.74 (m, 2H), 1.63 – 
1.47 (m, 3H), 1.26 (s, 3H), 1.10 (d, J = 1.3 Hz, 3H), 1.08 (d, J = 1.4 Hz, 4H), 0.81 (s, 3H). 
HRMS(ESI): m/z calc. for C23H33O4 [M+H]
+: 373.2334, found: 373.2402. 
Compound AA32f. 
Flash Silica Gel Chromatography:  3:2 EtOAc:Hexane 
Yield: 28 mg, 56%   
1H-NMR (CDCl3, 500 MHz): δ 9.31 (s, 1H), 7.16 (d, J = 8.6 Hz, 
2H), 6.85 (d, J = 8.6 Hz, 4H), 6.72 – 6.68 (m, 1H), 6.06 – 6.00 
(m, 1H), 4.39 – 4.28 (m, 2H), 3.78 (s, 3H), 3.11 (ddd, J = 17.3, 10.9, 4.6 Hz, 1H), 2.62 (hept, J = 
6.9 Hz, 1H), 2.42 (ddd, J = 16.8, 10.7, 5.6 Hz, 1H), 2.20 (dddd, J = 20.3, 13.7, 4.1, 2.5 Hz, 1H), 
2.11 – 1.99 (m, 3H), 1.98 – 1.91 (m, 1H), 1.89 – 1.74 (m, 2H), 1.62 – 1.46 (m, 2H), 1.24 (s, 3H), 
1.09 (d, J = 1.4 Hz, 3H), 1.08 (d, J = 1.4 Hz, 3H), 0.81 (s, 3H). 
HRMS(ESI): m/z calc. for C28H39NO4 [M+H]
+: 454.2913, found: 454.2953. 
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Compound AA32g. 
Flash Silica Gel Chromatography: 3:2 EtOAc:Hexane  
Yield:  122 mg, 84% 
1H-NMR (CDCl3, 500 MHz): δ 9.35 (s, 1H), 6.83 – 6.77 (m, 1H), 3.73 – 
3.54 (m, 8H), 3.10 (ddd, J = 17.2, 10.7, 4.6 Hz, 1H), 2.62 (hept, J = 6.9 Hz, 1H), 2.43 (ddd, J = 
16.9, 10.5, 5.8 Hz, 1H), 2.32 (ddd, J = 15.8, 5.6, 2.8 Hz, 1H), 2.25 (ddd, J = 11.2, 4.0, 2.7 Hz, 1H), 
2.20 (d, J = 2.4 Hz, 1H), 2.02 (dt, J = 5.6, 3.0 Hz, 1H), 1.96 (dd, J = 13.6, 3.4 Hz, 1H), 1.88 (dddd, 
J = 13.9, 10.6, 5.7, 2.8 Hz, 1H), 1.84 – 1.77 (m, 1H), 1.70 – 1.49 (m, 5H), 1.34 (s, 3H), 1.10 (d, J 
= 1.7 Hz, 3H), 1.08 (d, J = 1.7 Hz, 3H), 0.85 (s, 3H). 
HRMS(ESI): m/z calc. for C24H38NO4 [M+H]
+: 404.2756, found: 404.2798. 
Intra-Molecular Aldol Accessing AA33a-g:  
General Procedure:  KOtBu (2.2 eq.) was added to THF (0.05M) and left to stir at rt for 1 h at 
which time was added compound AA32 (1.0 eq.) in THF (1.0 M).  The reaction was quenched 2 
h later with 1 M HCl, taken up in CH2Cl2 and washed with saturated sodium hydrogen carbonate.  
The organic layers were combined, dried over sodium sulfate and concentrated under reduce 
pressure.  The crude material was purified via flash silica gel chromatography. 
Compound AA33a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 8 mg, 93% 
1H-NMR (CDCl3, 500 MHz): δ 7.36 (dd, J = 1.9, 0.9 Hz, 1H), 6.83 (s, 
1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 6.22 (dd, J = 3.1, 0.9 Hz, 1H), 6.02 (t, J = 5.3 Hz, 1H), 5.80 
(q, J = 3.7 Hz, 1H), 4.51 – 4.35 (m, 2H), 3.18 (h, J = 6.9 Hz, 1H), 2.63 (td, J = 7.6, 6.5, 3.5 Hz, 
1H), 2.58 – 2.49 (m, 1H), 2.42 – 2.34 (m, 1H), 2.21 (dd, J = 11.4, 5.8 Hz, 1H), 2.09 – 1.83 (m, 
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3H), 1.71 – 1.52 (m, 5H), 1.26 (s, 3H), 1.11 (d, J = 5.3 Hz, 3H), 1.10 (d, J = 5.2 Hz, 3H), 0.76 (s, 
3H). 
HRMS(ESI): m/z calc. for C25H34NO3 [M+H]
+: 396.2494, found: 396.2521. 
Compound AA33b. 
Flash Silica Gel Chromatography: 3:2 EtOAc:Hexane 
Yield:  14 mg, 75% 
1H-NMR (CDCl3, 500 MHz): δ 8.71 (s, 1H), 7.60 (dd, J = 7.5, 1.6 
Hz, 1H), 7.31 (dd, J = 7.5, 1.5 Hz, 1H), 7.19 – 7.12 (m, 2H), 6.98 
(td, J = 7.4, 1.6 Hz, 1H), 6.26 (d, J = 1.1 Hz, 1H), 5.58 (s, 1H), 4.92 – 4.85 (m, 1H), 3.82 (s, 1H), 
3.62 (s, 3H), 3.38 – 3.26 (m, 2H), 2.16 (h, J = 6.4 Hz, 1H), 2.02 (s, 1H), 1.86 – 1.52 (m, 8H), 1.50 
– 1.18 (m, 3H), 1.15 (s, 3H), 0.97 (d, J = 6.4 Hz, 6H), 0.84 (s, 3H). 
HRMS(ESI): m/z calc. for C32H41N2O4 [M+H]
+: 517.3022, found: 517.3105. 
Compound AA33c. 
Flash Silica Gel Chromatography:  1:1 EtOAc:Hexane 
Yield:  28 mg, 79% 
1H-NMR (CDCl3, 500 MHz): δ 6.82 (s, 1H), 5.80 (q, J = 3.7 Hz, 2H), 
5.75 (t, J = 5.4 Hz, 1H), 3.31 – 3.13 (m, 3H), 2.66 – 2.59 (m, 1H), 2.56 
– 2.48 (m, 1H), 2.41 – 2.33 (m, 1H), 2.20 (dd, J = 11.2, 6.1 Hz, 1H), 2.09 – 1.81 (m, 3H), 1.69 – 
1.41 (m, 6H), 1.38 – 1.28 (m, 2H), 1.23 (s, 3H), 1.10 (d, J = 5.1 Hz, 3H), 1.09 (d, J = 5.0 Hz, 3H), 
0.92 (t, J = 7.3 Hz, 3H), 0.75 (s, 3H) 
HRMS(ESI): m/z calc. for C24H38NO2 [M+H]
+: 372.2858, found: 372.2913. 
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Compound AA33d. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 32 mg, 87% 
1H-NMR (CDCl3, 500 MHz): δ 7.37 – 7.21 (m, 5H), 6.83 (s, 1H), 6.02 
(t, J = 5.7 Hz, 1H), 5.81 (q, J = 3.7 Hz, 1H), 4.44 (h, J = 9.0 Hz, 2H), 
3.18 (hept, J = 6.1, 5.3 Hz, 1H), 2.64 (dp, J = 9.8, 3.4 Hz, 1H), 2.53 (dd, J = 16.9, 8.7 Hz, 1H), 
2.38 (dd, J = 16.7, 6.9 Hz, 1H), 2.26 (dd, J = 10.8, 6.4 Hz, 1H), 2.12 – 1.80 (m, 3H), 1.72 – 1.51 
(m, 5H), 1.26 (s, 3H), 1.10 (dd, J = 6.8, 5.4 Hz, 6H), 0.77 (s, 3H). 
HRMS(ESI): m/z calc. for C27H36NO2 [M+H]
+: 406.2701, found: 406.2743. 
Compound AA33e. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 12 mg, 65% 
1H-NMR (CDCl3, 500 MHz): δ 6.71 (d, J = 1.0 Hz, 1H), 5.74 (td, J = 6.2, 
0.9 Hz, 1H), 4.71 – 4.59 (d, J = 2.9 Hz, 2H), 3.21 (hept, J = 6.4 Hz, 1H), 
2.91 (s, 1H), 2.61 (t, J = 8.5 Hz, 1H), 2.51 (td, J = 9.2, 1.0 Hz, 1H), 2.41 – 2.38 (m, 1H), 2.21 – 
1.89 (m, 6H), 1.75 – 1.52 (m, 3H), 1.25 (s, 3H), 1.07 (d, J = 6.4 Hz, 6H), 0.75 (s, 3H). 
HRMS(ESI): m/z calc. for C23H31O3 [M+H]
+: 355.2228, found: 355.2234. 
Compound AA33f. 
Flash Silica Gel Chromatography:  3:2 EtOAc:Hexane 
Yield: 17 mg, 84%   
1H-NMR (CDCl3, 500 MHz): δ 6.98 (d, J = 8.3 Hz, 2H), 6.68 (d, 
J = 8.5 Hz, 2H), 6.50 (s, 1H), 6.02 (t, J = 5.6 Hz, 1H), 5.81 (s, 1H), 
4.59 – 4.51 (m, 2H), 4.01 (s, 3H), 3.21 (hept, J = 6.0, 5.4 Hz, 1H), 2.63 (dp, J = 9.8, 3.4 Hz, 1H), 
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2.54 (dd, J = 16.9, 8.7 Hz, 1H), 2.47 – 2.2.26 (m, 2H), 2.07 – 1.82 (m, 3H), 1.72 – 1.50 (m, 5H), 
1.26 (s, 3H), 1.08 (dd, J = 6.8, 5.4 Hz, 6H), 0.75 (s, 3H). 
HRMS(ESI): m/z calc. for C28H38NO3 [M+H]
+: 436.2807, found: 436.2821. 
Compound AA33g. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane  
Yield: 19 mg, 81%  
1H-NMR (CDCl3, 500 MHz): δ 6.86 (s, 1H), 5.87 (q, J = 3.7 Hz, 1H), 3.75 
– 3.57 (m, 8H), 3.19 (hept, J = 6.9 Hz, 1H), 2.61 (dp, J = 9.2, 3.5 Hz, 1H), 2.57 – 2.48 (m, 1H), 
2.42 – 2.35 (m, 2H), 2.28 – 2.19 (m, 1H), 2.13 – 2.03 (m, 1H), 1.80 – 1.74 (m, 2H), 1.70 – 1.55 
(m, 4H), 1.33 (s, 3H), 1.12 (d, J = 4.9 Hz, 3H), 1.10 (d, J = 4.8 Hz, 3H), 0.80 (s, 3H). 
HRMS(ESI): m/z calc. for C24H36NO3 [M+H]
+: 386.2650, found: 386.2686. 
3.6.5 Three-Point Library Based on AA2: Synthesis and Characterization 
 
Wittig Olefination of AA32g, AA15, and AA1 accessing AA34a,b,c-AA36a,b,c:  
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General Procedure for accessing AA34a-c and AA36a-c:  To a solution of either 
methyltriphenylphosphonium bromide (3.0 eq), isopropyltriphenylphosphonium iodide (3.0 eq.) 
or hexyltriphenylphosphonium bromide in THF (0.5 M) at -78 °C was added n-BuLi (1.6 M in 
hexanes, 0.91 eq. to the phosphonium) slowly.  After 30 min the reaction was warmed to 0 °C and 
left to stir at this temperature for 1.5 h, after which it is returned to -78 °C.  To compound AA32g, 
AA15, or AA1 (1.0 eq.) was added THF (1.0 M) and then added to the active ylide species via 
syringe.  After 15 min the reaction was allowed to warm to rt and left to stir for 1 h.  The reaction 
material was filter to remove the insoluble phosphine species, the solid wash washed with EtOAc 
(x2).  The organic layers were combined, dried over sodium sulfate and concentrated under reduce 
pressure.  The crude material was purified via flash silica gel chromatography. 
Compound AA34a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 288 mg, 72% 
1H-NMR (CDCl3, 500 MHz): δ 6.27 (dd, J = 17.0, 10.6 Hz, 1H), 5.76 – 
5.71 (m, 1H), 5.20 (dd, J = 17.0, 2.2 Hz, 1H), 4.90 (dd, J = 10.7, 2.2 Hz, 1H), 4.71 (dt, J = 30.4, 
1.4 Hz, 2H), 3.75 – 3.60 (m, 8H), 2.28 – 2.13 (m, 3H), 2.11 – 2.00 (m, 1H), 1.96 (td, J = 10.8, 
10.3, 6.0 Hz, 1H), 1.93 – 1.84 (m, 3H), 1.79 (td, J = 12.7, 5.9 Hz, 1H), 1.72 – 1.66 (m, 1H), 1.66 
– 1.56 (m, 4H), 1.39 (dddd, J = 14.1, 11.5, 7.1, 4.5 Hz, 1H), 1.31 (s, 3H), 1.03 (s, 3H), 1.02 (s, 
3H), 0.86 (s, 3H). 
 HRMS(ESI): m/z calc. for C26H42NO2 [M+H]
+: 400.3171, found: 400.3228. 
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Compound AA34b. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 302 mg, 51% 
1H-NMR (CDCl3, 500 MHz): δ 7.34 (tt, J = 6.7, 1.1 Hz, 2H), 7.30 – 
7.27 (m, 1H), 7.27 – 7.24 (m, 2H), 6.21 (dd, J = 17.1, 10.6 Hz, 1H), 
6.00 (t, J = 5.6 Hz, 1H), 5.68 – 5.65 (m, 1H), 5.15 (dd, J = 17.0, 2.2 Hz, 1H), 4.89 (dd, J = 10.7, 
2.2 Hz, 1H), 4.44 (qd, J = 14.7, 5.6 Hz, 2H), 2.64 – 2.52 (m, 2H), 2.47 (ddd, J = 17.6, 9.5, 6.2 Hz, 
1H), 2.05 (dd, J = 12.2, 4.1 Hz, 1H), 2.02 – 1.80 (m, 6H), 1.80 – 1.73 (m, 1H), 1.57 – 1.46 (m, 
4H), 1.24 (s, 3H), 1.17 – 1.10 (m, 2H), 1.08 (s, 3H), 1.07 (s, 3H), 0.82 (s, 3H). 
HRMS(ESI): m/z calc. for C29H42NO [M+H]
+: 420.3222, found: 420.3282. 
Compound AA35a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 127 mg, 79% 
1H-NMR (CDCl3, 500 MHz): δ 5.61 – 5.56 (m, 1H), 5.32 (dt, J = 4.6, 
2.2 Hz, 1H), 3.73 – 3.57 (m, 8H), 2.67 (ddd, J = 17.3, 9.9, 4.7 Hz, 1H), 2.54 (hept, J = 6.9 Hz, 
1H), 2.37 (ddd, J = 17.3, 9.4, 6.5 Hz, 1H), 2.17 (dd, J = 11.8, 4.5 Hz, 1H), 2.07 – 1.97 (m, 2H), 
1.98 – 1.83 (m, 3H), 1.82 – 1.74 (m, 3H), 1.72 (d, J = 1.4 Hz, 3H), 1.66 (d, J = 1.4 Hz, 3H), 1.64 
– 1.56 (m, 3H), 1.31 (s, 3H), 1.07 (d, J = 1.6 Hz, 3H), 1.06 (d, J = 1.5 Hz, 3H), 0.87 (s, 3H). 
HRMS(ESI): m/z calc. for C27H44NO3 [M+H]
+: 430.3276, found: 430.3378. 
Compound AA35b. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 293 mg, 67% 
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1H-NMR (CDCl3, 500 MHz): δ 7.32 (td, J = 7.0, 1.2 Hz, 2H), 7.30 – 7.21 (m, 3H), 6.03 (t, J = 5.5 
Hz, 1H), 5.56 (s, 1H), 5.29 – 5.22 (m, 1H), 4.43 (d, J = 5.5 Hz, 2H), 2.65 (ddd, J = 17.3, 10.2, 4.7 
Hz, 1H), 2.54 (hept, J = 6.9 Hz, 1H), 2.07 (dd, J = 12.2, 4.5 Hz, 1H), 2.03 – 1.89 (m, 2H), 1.85 
(td, J = 12.8, 6.0 Hz, 1H), 1.82 – 1.71 (m, 4H), 1.71 (s, 3H), 1.65 (s, 3H), 1.63 – 1.49 (m, 4H), 
1.30 (dp, J = 14.2, 4.7 Hz, 1H), 1.24 (s, 3H), 1.07 (s, 3H), 1.05 (s, 3H), 0.83 (s, 3H). 
HRMS(ESI): m/z calc. for C30H44NO2 [M+H]
+: 450.3327, found: 450.3401. 
Compound AA35c. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 351 mg, 77% 
1H-NMR (CDCl3, 500 MHz): δ 5.57 (s, 1H), 5.29 (tt, J = 4.0, 1.8 Hz, 1H), 
3.65 (s, 3H), 2.66 (ddd, J = 17.2, 10.2, 4.7 Hz, 1H), 2.55 (hept, J = 6.9 Hz, 1H), 2.36 (ddd, J = 
17.2, 9.8, 6.4 Hz, 1H), 2.09 – 1.99 (m, 2H), 1.96 – 1.90 (m, 1H), 1.80 – 1.73 (m, 3H), 1.72 (d, J = 
1.4 Hz, 3H), 1.66 (d, J = 1.4 Hz, 3H), 1.62 – 1.53 (m, 4H), 1.37 – 1.25 (m, 2H), 1.23 (s, 3H), 1.07 
(d, J = 6.9 Hz, 6H), 0.84 (s, 3H). 
HRMS(ESI): m/z calc. for C24H39O3 [M+H]
+: 375.2854, found: 375.2899. 
Compound AA36a. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 157 mg, 60% 
1H-NMR (CDCl3, 500 MHz): δ 5.54 (s, 1H), 5.27 (dt, J = 6.5, 2.9 Hz, 
1H), 3.65 (s, 3H), 2.71 (ddd, J = 17.3, 10.1, 4.7 Hz, 1H), 2.66 – 2.51 (m, 
2H), 2.39 (ddd, J = 17.4, 9.6, 6.4 Hz, 1H), 2.19 (td, J = 6.2, 2.9 Hz, 2H), 2.08 (q, J = 6.1 Hz, 2H), 
2.05 – 1.98 (m, 3H), 1.97 – 1.89 (m, 2H), 1.82 – 1.62 (m, 4H), 1.62 – 1.43 (m, 9H), 1.26 (d, J = 
5.4 Hz, 4H), 1.23 (s, 3H), 1.08 (d, J = 6.9 Hz, 6H), 0.84 (s, 3H). 
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HRMS(ESI): m/z calc. for C30H48NO3 [M+H]
+: 470.3589, found: 470.3612. 
Compound AA36b. 
Flash Silica Gel Chromatography: 2:9 EtOAc:Hexane 
Yield: 76 mg, 47% 
1H-NMR (CDCl3, 500 MHz): δ 7.35  – 7.18 (m, 5H), 6.21 (m, 1H), 
5.57 (s, 1H), 5.53 (dd, J = 4.6, 2.4 Hz, 1H), 4.51 – 4.43 (m, 2H), 2.75 
(hept, J = 6.4 Hz, 1H), 2.56 (t, J = 7.1 Hz, 1H), 2.41 (ddd, J = 17.3, 8.9, 6.1 Hz, 1H), 2.31 – 2.17 
(m, 2H), 2.11 (t, J = 5.8 Hz, 2H), 2.09 – 1.98 (m, 4H), 1.78 – 1.51 (m, 5H), 1.49 – 1.38 (m, 4H), 
1.27 – 1.22 (m, 5H), 1.23 (s, 3H), 1.09 (d, J = 0.6 Hz, 3H), 1.06 (d, J = 0.6 Hz, 3H), 0.81 (s, 3H). 
HRMS(ESI): m/z calc. for C33H48NO2 [M+H]
+: 490.3640, found: 490.3672. 
Compound AA36c. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 102 mg, 52% 
1H-NMR (CDCl3, 500 MHz): δ 5.54 (s, 1H), 5.27 (dd, J = 4.8, 2.3 Hz, 1H), 
3.65 (s, 3H), 2.71 (ddd, J = 17.2, 10.2, 4.8 Hz, 1H), 2.56 (dq, J = 13.8, 7.0 Hz, 1H), 2.39 (ddd, J = 
17.2, 9.6, 6.4 Hz, 1H), 2.25 – 2.15 (m, 2H), 2.09 (t, J = 5.8 Hz, 2H), 2.07 – 1.91 (m, 4H), 1.80 – 
1.57 (m, 5H), 1.55 – 1.45 (m, 4H), 1.26 – 1.23 (m, 5H), 1.23 (s, 3H), 1.08 (d, J = 0.7 Hz, 3H), 1.07 
(d, J = 0.7 Hz, 3H), 0.83 (s, 3H). 
HRMS(ESI): m/z calc. for C27H43O3 [M+H]
+: 415.3168, found: 415.3208. 
Diels-Alder upon AA34a,b,c-AA36a,b,c accessing AA37a,b,c –AA45a,b,c:  
 General Procedure:  To a vial containing diene AA34a,b,c-AA36a,b,c (1.0 eq.) was added dry 
PhCH3 (0.05 M) and the dienophile (4-phenyl-1,2,4-triazoline-3,5-dione, or tetracyanoethene, 1.2 
eq.) or (2.3-dihydrophthalazine-1,4-dione, 1.0 eq. and lead tetraacetate, 2 eq.).  The vial was sealed 
160 
 
tightly with a Teflon cap and wrapped with electrical tape and brought to 110 °C for 16 h. The 
reaction was concentrated, taken up in a minimum of CH2Cl2 and purified via flash silica gel 
chromatography.  
Compound AA37a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 5 mg, 63% 
1H-NMR (CDCl3, 500 MHz): δ 7.54 (d, J = 8.1 Hz, 2H), 7.46 (t, J = 
7.9 Hz, 2H), 7.36 (t, 1H), 5.58 – 5.52 (m, 1H), 4.79 (s, 1H), 4.72 – 
4.66 (m, 2H), 4.33 (dd, J = 16.0, 4.6 Hz, 1H), 4.01 (dt, J = 15.9, 2.7 Hz, 1H), 3.67 – 3.59 (m, 8H), 
2.34 – 2.14 (m, 4H), 2.13 – 2.03 (m, 1H), 1.98 – 1.73 (m, 6H), 1.58 – 1.50 (m, 3H), 1.38 (s, 3H), 
1.27 – 1.24 (m, 1H), 1.13 – 1.10 (m, 3H), 1.04 (d, J = 6.8 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H). 
HRMS(ESI): m/z calc. for C34H47N4O4 [M+H]
+: 575.3553, found: 575.3603. 
Compound AA37b. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 8 mg, 71% 
1H-NMR (CDCl3, 500 MHz): δ 7.53 – 7.45 (m, 5H), 7.39 – 7.35 
(m, 1H), 7.24 (d, J = 0.8 Hz, 1H), 7.23 – 7.17 (m, 3H), 5.97 (t, J = 
5.6 Hz, 1H), 5.55 – 5.52 (m, 1H), 4.80 (s, 1H), 4.70 (s, 1H), 4.65 (t, J = 8.5 Hz, 1H), 2.23 (dqd, J 
= 28.7, 15.0, 13.7, 6.8 Hz, 7H), 2.11 (dd, J = 12.3, 6.6 Hz, 3H), 1.97 – 1.84 (m, 6H), 1.39 – 1.32 
(m, 1H), 1.29 (s, 3H), 1.27 – 1.24 (m, 2H), 1.07 (s, 3H), 1.05 (d, J = 6.8 Hz, 3H), 1.03 (d, J = 6.8 
Hz, 3H). 
HRMS(ESI): m/z calc. for C37H47N4O3 [M+H]
+: 595.3603, found: 595.3671. 
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Compound AA38a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 4 mg, 68% 
1H-NMR (CDCl3, 500 MHz): δ 5.52 (d, J = 3.8 Hz, 1H), 4.79 (s, 1H), 
4.67 (d, J = 1.4 Hz, 1H), 3.70 – 3.59 (m, 8H), 3.35 (t, J = 8.3 Hz, 1H), 
3.27 (d, J = 18.4 Hz, 1H), 3.06 (dd, J = 18.1, 5.4 Hz, 1H), 2.24 – 2.08 (m, 5H), 1.95 – 1.85 (m, 
2H), 1.81 (d, J = 13.5 Hz, 1H), 1.76 – 1.60 (m, 1H), 1.62 – 1.53 (m, 4H), 1.39 (s, 3H), 1.37 – 1.22 
(m, 2H), 1.05 (s, 3H), 1.02 (d, J = 5.3 Hz, 3H), 1.01 (d, J = 5.5 Hz, 3H). 
HRMS(ESI): m/z calc. for C32H42N5O2 [M+H]
+: 528.3294, found: 528.3341. 
Compound AA38b. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 7 mg, 51% 
1H-NMR (CDCl3, 500 MHz): δ 7.35 (td, J = 7.4, 3.3 Hz, 2H), 7.31 – 
7.25 (m, 3H), 5.92 (t, J = 5.3 Hz, 1H), 5.50 (s, 1H), 4.51 (dd, J = 14.6, 
5.6 Hz, 1H), 4.34 (dd, J = 14.6, 4.6 Hz, 1H), 3.30 (d, J = 8.3 Hz, 1H), 3.26 – 3.20 (m, 1H), 3.06 
(dd, J = 17.8, 5.0 Hz, 1H), 2.61 – 2.48 (m, 2H), 2.43 – 2.31 (m, 1H), 2.17 (dd, J = 10.4, 4.0 Hz, 
1H), 2.15 – 2.08 (m, 1H), 2.08 – 2.02 (m, 1H), 1.99 – 1.84 (m, 4H), 1.56 (ddd, J = 21.2, 16.9, 13.2 
Hz, 4H), 1.40 (dtd, J = 14.5, 9.1, 5.4 Hz, 1H), 1.30 (s, 3H), 1.22 (d, J = 12.7 Hz, 2H), 1.09 (d, J = 
3.5 Hz, 3H), 1.08 (d, J = 3.5 Hz, 3H), 1.03 (s, 3H). 
HRMS(ESI): m/z calc. for C35H42N5O [M+H]
+: 548.3345, found: 548.3405. 
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Compound AA38c. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 6 mg, 72% 
1H-NMR (CDCl3, 500 MHz): δ 5.52 (qd, J = 3.0, 1.2 Hz, 1H), 4.79 (s, 1H), 
4.67 (t, J = 1.3 Hz, 1H), 3.66 (s, 3H), 3.35 – 3.29 (m, 1H), 3.23 (dtd, J = 
18.2, 3.0, 1.2 Hz, 1H), 3.06 (dddd, J = 18.4, 5.1, 2.4, 1.3 Hz, 1H), 2.24 – 2.08 (m, 4H), 1.98 – 1.82 
(m, 4H), 1.82 – 1.73 (m, 1H), 1.71 – 1.62 (m, 2H), 1.57 – 1.51 (m, 2H), 1.30 (s, 3H), 1.27 (d, J = 
12.4 Hz, 1H), 1.06 (dd, J = 6.9, 4.5 Hz, 1H), 1.03 – 0.99 (m, 9H). 
HRMS(ESI): m/z calc. for C29H37N4O2 [M+H]
+: 473.2872, found: 473.2893. 
Compound AA39a. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 4 mg, 48% 
1H-NMR (CDCl3, 500 MHz): δ 7.75 (d, J = 8.1 Hz, 2H), 7.52 (d, J = 
7.5 Hz, 2H), 5.52 (s, 1H), 4.81 – 4.79 (m, 1H), 4.61 (d, J = 1.9 Hz, 1H), 
4.58 (d, J = 1.8 Hz, 1H), 4.41 – 4.36 (m, 2H), 3.72 – 3.64 (m, 8H), 2.36 – 2.12 (m, 4H), 2.11 – 
2.04 (m, 1H), 1.94 – 1.73 (m, 6H), 1.61 – 1.53 (m, 3H), 1.41 (s, 3H), 1.31 – 1.28 (m, 1H), 1.09 (d, 
J = 6.7 Hz, 3H), 1.07 (d, J = 6.8 Hz, 3H), 0.99 (s, 3H). 
HRMS(ESI): m/z calc. for C34H46N3O4 [M+H]
+: 560.3440, found: 560.3500. 
Compound AA39b. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 5 mg, 51% 
1H-NMR (CDCl3, 500 MHz): δ 7.81-7.72 (m, 2H), 7.47 – 7.30 (m, 
2H), 7.39 – 7.35 (m, 1H), 7.24 (d, J = 0.8 Hz, 1H), 7.23 – 7.17 (m, 
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4H), 6.02 (t, J = 6.1 Hz, 1H), 5.56 – 5.53 (m, 1H), 4.62 – 4.60 (m, 1H), 4.58 – 4.54 (m, 2H), 4.45 
– 4.31 (m, 2H), 4.42 (t, J = 4.5 Hz, 2H), 2.42 (t, J = 5.2 Hz, 1H), 2.22 – 1.98 (m, 5H), 1.97 – 1.84 
(m, 5H), 1.39 – 1.32 (m, 3H), 1.21 (s, 3H), 1.11 (d, J = 6.6 Hz, 3H), 1.09 (d, J = 6.7 Hz, 3H), 1.00 
(s, 3H). 
HRMS(ESI): m/z calc. for C37H46N3O3 [M+H]
+: 580.3494, found: 580.3551. 
Compound AA39c. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 6 mg, 50% 
1H-NMR (CDCl3, 500 MHz): δ 8.15 (dd, J = 6.1, 1.9 Hz, 1H), 7.99 (dd, J 
= 7.0, 1.8 Hz, 1H), 7.83 – 7.77 (m, 2H), 5.52 (s, 1H), 4.81 – 4.79 (m, 1H), 
4.61 (d, J = 1.9 Hz, 1H), 4.58 (d, J = 1.8 Hz, 1H), 4.41 – 4.36 (m, 2H), 3.64 (s, 3H), 2.36 – 2.12 
(m, 4H), 2.11 – 2.04 (m, 1H), 1.94 – 1.73 (m, 6H), 1.61 – 1.53 (m, 3H), 1.41 (s, 3H), 1.31 – 1.28 
(m, 1H), 1.09 (d, J = 6.7 Hz, 3H), 1.07 (d, J = 6.8 Hz, 3H), 0.99 (s, 3H). 
HRMS(ESI): m/z calc. for C31H41N2O4 [M+H]
+: 505.3022, found: 505.3042. 
Compound AA40a. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 2 mg, 77% 
1H-NMR (CDCl3, 500 MHz): δ 7.55 – 7.52 (m, 2H), 7.48 – 7.43 (m, 
2H), 7.37 – 7.32 (m, 1H), 5.18 (s, 1H), 4.64 (t, J = 8.5 Hz, 1H), 3.68 
– 3.61 (m, 7H), 3.58 – 3.52 (m, 2H), 2.64 – 2.51 (m, 2H), 2.45 – 2.37 (m, 1H), 2.32 – 2.15 (m, 
3H), 2.10 – 2.03 (m, 1H), 1.96 (d, J = 9.2 Hz, 1H), 1.89 (d, J = 12.9 Hz, 1H), 1.79 (s, 3H), 1.75 – 
1.67 (m, 2H), 1.47 (s, 3H), 1.36 (s, 3H), 1.27 – 1.24 (m, 9H), 0.88 (td, J = 6.4, 2.8 Hz, 3H). 
HRMS(ESI): m/z calc. for C35H49N4O5 [M+H]
+: 605.3658, found: 605.3701. 
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Compound AA40b. 
Flash Silica Gel Chromatography: 1:6 EtOAc:Hexane 
Yield: 12 mg, 53% 
1H-NMR (CDCl3, 500 MHz): δ 7.49 – 7.36 (m, 5H), 7.29 – 7.20 
(m, 5H), 6.04 (t, J = 5.8 Hz, 1H), 5.56 (s, 1H), 5.10 – 4.99 (m, 1H), 
4.51 – 4.47 (m, 2H), 2.62 (hept, J = 6.7 Hz, 1H), 2.58 (dt, J = 12.2, 6.3 Hz, 2H), 2.27 (t, J – 7.6 
Hz, 1H), 2.11 – 1.95 (m, 5H), 1.92 – 1.71 (m, 6H), 1.31 (s, 3H), 1.29 (s, 3H), 1.12 (s, 3H), 1.09 
(d, J = 6.8 Hz, 3H), 1.07 (d, J = 6.8 Hz, 3H), 0.92 (s, 3H). 
HRMS(ESI): m/z calc. for C38H49N4O4 [M+H]
+: 625.3709, found: 625.3762. 
Compound AA40c. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 11 mg, 82% 
1H-NMR (CDCl3, 500 MHz): δ 7.54 – 7.50 (m, 2H), 7.48 – 7.43 (m, 
2H), 7.37 – 7.32 (m, 1H), 5.19 – 5.17 (m, 1H), 4.62 (t, J = 8.4 Hz, 1H), 
3.63 (s, 3H), 2.64 – 2.48 (m, 2H), 2.40 (ddd, J = 17.1, 8.3, 7.1 Hz, 1H), 2.26 (td, J = 12.6, 9.2 Hz, 
1H), 2.06 (dd, J = 12.4, 6.7 Hz, 1H), 1.98 (dd, J = 12.0, 3.2 Hz, 1H), 1.91 (dd, J = 13.4, 3.2 Hz, 
1H), 1.84 – 1.75 (m, 1H), 1.74 (s, 3H), 1.65 (h, J = 4.8 Hz, 2H), 1.60 – 1.49 (m, 3H), 1.45 (s, 3H), 
1.30 (dd, J = 13.0, 7.1 Hz, 1H), 1.27 (s, 3H), 1.25 – 1.22 (m, 1H), 1.12 (d, J = 1.2 Hz, 3H), 1.10 
(d, J = 6.4 Hz, 3H), 1.06 (s, 3H). 
HRMS(ESI): m/z calc. for C33H44N3O7 [M+H]
+: 594.3135, found: 594.3185. 
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Compound AA41a. 
Flash Silica Gel Chromatography: 1:1 EtOAc:Hexane 
Yield: 8 mg, 65% 
1H-NMR (CDCl3, 500 MHz): δ 5.37 (s, 1H), 3.71 – 3.55 (m, 8H), 3.32 
(t, J = 8.9 Hz, 1H), 2.62 – 2.54 (m, 2H), 2.38 (ddd, J = 17.1, 8.3, 6.5 Hz, 2H), 2.23 – 2.08 (m, 4H), 
1.91 (dq, J = 15.6, 6.2, 5.0 Hz, 3H), 1.84 – 1.69 (m, 4H), 1.67 (s, 3H), 1.38 (s, 3H), 1.25 (s, 3H), 
1.09 (t, J = 2.3 Hz, 6H), 1.04 (s, 3H). 
HRMS(ESI): m/z calc. for C33H44N5O3 [M+H]
+: 558.3399, found: 558.3422.  
Compound AA41b. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 9 mg, 47% 
1H-NMR (CDCl3, 500 MHz): δ 7.37 – 7.27 (m, 5H), 5.91 (t, J = 5.3 
Hz, 1H), 5.36 (dd, J = 2.2, 1.2 Hz, 1H), 4.41 (ddd, J = 59.1, 14.6, 5.2 
Hz, 2H), 3.29 (t, J = 8.1 Hz, 1H), 2.62 – 2.50 (m, 2H), 2.37 (ddd, J = 17.2, 8.8, 6.4 Hz, 1H), 2.13 
(ddd, J = 12.3, 8.2, 3.1 Hz, 2H), 2.10 – 2.06 (m, 1H), 1.99 (ddd, J = 11.1, 7.1, 4.4 Hz, 1H), 1.96 – 
1.85 (m, 4H), 1.65 (s, 3H), 1.57 (s, 3H), 1.43 (dtd, J = 14.4, 9.0, 5.4 Hz, 1H), 1.30 (s, 3H), 1.27 – 
1.18 (m, 3H), 1.10 (d, J = 4.0 Hz, 3H), 1.08 (d, J = 3.9 Hz, 3H), 1.02 (s, 3H). 
HRMS(ESI): m/z calc. for C36H44N5O2 [M+H]
+: 578.3450, found: 578.3487. 
Compound AA41c. 
Flash Silica Gel Chromatography: 3:7 EtOAc:Hexane 
Yield: 5 mg, 63% 
1H-NMR (CDCl3, 500 MHz): δ 5.37 (dd, J = 2.3, 1.2 Hz, 1H), 3.65 (s, 3H), 
3.33 – 3.28 (m, 1H), 2.62 – 2.51 (m, 2H), 2.36 (ddd, J = 17.3, 8.5, 6.7 Hz, 
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1H), 2.24 – 2.14 (m, 2H), 1.97 – 1.86 (m, 4H), 1.81 – 1.73 (m, 1H), 1.68 (dd, J = 3.1, 1.5 Hz, 1H), 
1.65 (s, 3H), 1.57 (s, 3H), 1.54 (s, 3H), 1.44 (dtd, J = 14.4, 8.8, 5.6 Hz, 1H), 1.30 (s, 3H), 1.10 (d, 
J = 3.9 Hz, 3H), 1.09 (d, J = 3.9 Hz, 3H), 1.02 (s, 3H). 
HRMS(ESI): m/z calc. for C30H39N4O3 [M+H]
+: 503.2977, found: 503.3019. 
Compound AA42a. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 3 mg, 58% 
1H-NMR (CDCl3, 500 MHz): δ 8.31 (dd, J = 6.5, 1.5 Hz, 1H), 8.24 (dd, 
J = 7.5, 1.6 Hz, 1H), 7.81 – 7.79 (m, 2H), 5.18 (s, 1H), 4.62 (d, J = 7.6 
Hz, 1H), 3.71 – 3.56 (m, 8H), 2.64 – 2.49 (m, 3H), 2.40 (ddd, J = 17.1, 8.3, 7.1 Hz, 1H), 2.26 (td, 
J = 12.6, 9.2 Hz, 1H), 2.06 (dd, J = 12.4, 6.7 Hz, 1H), 1.98 (dd, J = 12.0, 3.2 Hz, 1H), 1.91 (dd, J 
= 13.4, 3.2 Hz, 1H), 1.74 (s, 3H), 1.68 – 1.49 (m, 7H), 1.45 (s, 3H), 1.27 (s, 3H), 1.12 – 1.09 (m, 
6H), 1.06 (s, 3H). 
HRMS(ESI): m/z calc. for C35H48N3O5 [M+H]
+: 590.3549, found: 590.3592. 
Compound AA42b. 
Flash Silica Gel Chromatography: 1:2 EtOAc:Hexane 
Yield: 3 mg, 60% 
1H-NMR (CDCl3, 500 MHz): δ 8.33 (dd, J = 6.5, 1.5 Hz, 1H), 8.22 
(dd, J = 7.5, 1.6 Hz, 1H), 7.84 – 7.76 (m, 2H), 7.12 – 7.05 (m, 5H), 
5.88 (t, J = 5.6 Hz, 1H), 5.63 (t, J = 8.6 Hz, 1H), 5.11 (s, 1H), 4.42 (dd, J = 14.6, 6.0 Hz, 1H), 4.19 
(dd, J = 14.6, 5.2 Hz, 1H), 2.64 – 2.49 (m, 2H), 2.43 (dtd, J = 15.1, 8.2, 7.5, 4.3 Hz, 1H), 2.17 – 
2.02 (m, 3H), 1.97 (s, 3H), 1.96 – 1.90 (m, 2H), 1.88 – 1.75 (m, 3H), 1.58 – 1.53 (m, 4H), 1.52 (s, 
3H), 1.24 (s, 3H), 1.13 (s, 3H), 1.09 (dd, J = 8.1, 6.9 Hz, 6H). 
Me
Me
Me
Me
H
H
O
N
N
H
O
N
Me
Me
O
O
AA42a
O
Me
Me
Me
Me
H
H
O
N
N
H
O
HN
Me
Me
O
O
AA42b
167 
 
HRMS(ESI): m/z calc. for C38H48N3O4 [M+H]
+: 610.3600, found: 610.3635. 
Compound AA42c. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 2 mg, 75% 
1H-NMR (CDCl3, 500 MHz): δ 8.31 (dd, J = 6.4, 1.6 Hz, 1H), 8.21 (dd, J 
= 7.1, 1.5 Hz, 1H), 7.85 – 7.77 (m, 2H), 5.52 (t, J = 5.7 Hz, 1H), 5.27 (t, J 
= 8.9 Hz, 1H), 3.63 (s, 3H), 2.65 – 2.47 (m, 2H), 2.42 (dtd, J = 15.0, 8.1, 7.3, 4.0 Hz, 1H), 2.19 – 
2.02 (m, 3H), 1.98 (s, 3H), 1.96 – 1.90 (m, 2H), 1.88 – 1.75 (m, 3H), 1.58 – 1.53 (m, 4H), 1.50 (s, 
3H), 1.27 (s, 3H), 1.19 (s, 3H), 1.05 (dd, J = 7.8, 6.7 Hz, 6H). 
HRMS(ESI): m/z calc. for C32H43N2O5 [M+H]
+: 535.3127, found: 535.3168. 
Compound AA43a. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 4 mg, 47% 
1H-NMR (CDCl3, 500 MHz): δ 7.53 – 7.48 (m, 2H), 7.46 – 7.40 (m, 
2H), 7.32 – 7.28 (m, 1H), 5.76 (s, 1H), 4.92 (t, J = 7.9 Hz, 1H), 3.76 
– 3.28 (m, 8H), 2.95 (td, J = 13.3, 4.3 Hz, 1H), 2.63 – 2.51 (m, 2H), 2.48 – 2.33 (m, 1H), 2.22 (td, 
J = 11.8, 8.6 Hz, 1H), 2.17 (t, J = 4.2 Hz, 1H), 2.10 – 2.06 (m, 1H), 2.02 – 1.91 (m, 3H), 1.85 – 
1.74 (m, 5H), 1.70 – 1.51 (m, 6H), 1.46 – 1.31 (m, 2H), 1.25 (s, 3H), 1.23 – 1.19 (m, 2H), 1.14 (d, 
J = 5.6 Hz, 3H), 1.11 (d, J = 5.6 Hz, 3H), 1.01 (s, 3H). 
HRMS(ESI): m/z calc. for C38H53N4O5 [M+H]
+: 645.3971, found: 645.4012. 
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Compound AA43b. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 5 mg, 41% 
1H-NMR (CDCl3, 500 MHz): δ 7.56 – 7.47 (m, 2H), 7.42 – 7.31 
(m, 3H), 7.25 – 7.19 (m, 5H), 6.28 (s, 1H), 6.02 (s, 1H), 4.50 (t, J 
= 7.2 Hz, 1H), 4.33 – 4.26 (m, 2H), 2.73 (td, J = 13.1, 4.3 Hz, 2H), 2.62 – 2.50 (m, 2H), 2.38 (td, 
J = 9.8, 3.4 Hz, 2H), 2.21 – 1.98 (m, 6H), 1.81 – 1.42 (m, 11H), 1.49 (s, 3H), 1.08 (d, 4.9 Hz, 6H), 
0.92 – 0.88 (m, 1H), 0.84 (s, 3H), 0.81- 0.76 (m, 1H). 
HRMS(ESI): m/z calc. for C41H53N4O4 [M+H]
+: 665.4022, found: 665.4053. 
Compound AA43c. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 2 mg, 62% 
1H-NMR (CDCl3, 500 MHz): δ 7.54 – 7.50 (m, 2H), 7.48 – 7.42 (m, 
2H), 7.37 – 7.33 (m, 1H), 5.85 (s, 1H), 4.64 (t, J = 8.1 Hz, 1H), 3.63 (s, 
3H), 2.95 (td, J = 13.3, 4.3 Hz, 1H), 2.65 – 2.52 (m, 2H), 2.47 – 2.38 (m, 1H), 2.26 (td, J = 12.5, 
9.1 Hz, 1H), 2.16 (td, J = 12.9, 12.2, 4.2 Hz, 1H), 2.09 – 2.02 (m, 1H), 2.00 – 1.89 (m, 3H), 1.87 
– 1.72 (m, 5H), 1.69 – 1.49 (m, 6H), 1.46 – 1.31 (m, 2H), 1.27 (s, 3H), 1.27 – 1.23 (m, 2H), 1.12 
(d, J = 5.9 Hz, 3H), 1.10 (d, J = 5.9 Hz, 3H), 1.08 (s, 3H). 
HRMS(ESI): m/z calc. for C35H48N3O5 [M+H]
+: 590.3549, found: 590.3572. 
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Compound AA44a. 
Flash Silica Gel Chromatography: 1:8 EtOAc:Hexane 
Yield: 2 mg, 55% 
1H-NMR (CDCl3, 500 MHz): δ 6.01 (s, 1H), 3.82 – 3.26 (m, 8H), 3.35 
(t, J = 4.9 Hz, 1H), 2.66 – 2.53 (m, 4H), 2.42 – 2.28 (m, 3H), 2.23 – 
2.16 (m, 3H), 2.15 – 2.08 (m, 2H), 2.07 – 2.02 (m, 3H), 1.96 – 1.89 (m, 4H), 1.85 (d, J = 3.7 Hz, 
1H), 1.84 – 1.78 (m, 3H), 1.68 – 1.61 (m, 1H), 1.40 (t, J = 8.7, 1H), 1.29 (s, 3H), 1.11 (dd, J = 6.9, 
4.4 Hz, 6H), 0.99 (s, 3H). 
HRMS(ESI): m/z calc. for C36H48N5O3 [M+H]
+: 598.3712, found: 598.3782. 
Compound AA44b. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 3 mg, 72% 
1H-NMR (CDCl3, 500 MHz): δ 7.22 – 7.17 (m, 5H), 6.73 (t, J = 5.1 
Hz, 1H), 6.23 (s, 1H), 4.45 – 4.39 (m, 2H), 3.41 (t, J = 4.3 Hz, 1H), 
2.71-2.43 (m 7), 2.32 (td, J = 9.8, 6.7 Hz, 2H), 2.20 – 2.17 (m, 3), 2.01 – 1.82 (8H), 1.77 – 1.58 
(m, 4H), 1.49 (t, J = 7.6 Hz, 1H), 1.31 (s, 3H), 1.08 (d, J = 5.4 Hz, 6H), 0.93 (s, 3H). 
HRMS(ESI): m/z calc. for C39H48N5O2 [M+H]
+: 618.3763, found: 618.3802. 
Compound AA44c. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 5 mg, 65% 
1H-NMR (CDCl3, 500 MHz): δ 5.92 (s, 1H), 3.64 (s, 3H), 3.31 (t, J = 5.0 
Hz, 1H), 2.62 – 2.52 (m, 3H), 2.40 – 2.29 (m, 3H), 2.24 – 2.15 (m, 1H), 
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2.17 – 2.10 (m, 2H), 2.10 – 2.02 (m, 2H), 2.00 – 1.59 (m, 13H), 1.40 (dtd, J = 14.5, 8.7, 5.4 Hz, 
1H), 1.30 (s, 3H), 1.09 (dd, J = 6.9, 4.4 Hz, 6H), 1.03 (s, 3H). 
HRMS(ESI): m/z calc. for C33H43N4O3 [M+H]
+: 543.3290, found: 543.3320. 
Compound AA45a. 
Flash Silica Gel Chromatography: 1:4 EtOAc:Hexane 
Yield: 2 mg, 49% 
1H-NMR (CDCl3, 500 MHz): δ 7.76 – 7.52 (m, 2H), 7.39 – 7.31 (m, 
2H), 5.89 (s, 1H), 5.05 (t, J = 7.5 Hz, 1H), 3.82 – 3.26 (m, 7H), 2.86  – 
2.55 (m, 3H), 2.45 – 2.39 (m, 1H), 2.23 – 2.05 (m, 3H), 1.99 – 1.74 (m, 9H), 1.68 – 1.47 (m, 6H), 
1.43 – 1.30 (m, 2H), 1.24 (s, 3H), 1.22 – 1.17 (m, 2H), 1.13 (d, J = 5.5 Hz, 3H), 1.10 (d, J = 5.5 
Hz, 3H), 1.01 (s, 3H). 
HRMS(ESI): m/z calc. for C38H52N3O5 [M+H]
+: 630.3862, found: 630.3908. 
Compound AA45b. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 2 mg, 32% 
1H-NMR (CDCl3, 500 MHz): δ 7.72 – 7.56 (m, 2H), 7.42 – 7.38 (m, 
2H), 7.31 – 7.27 (m, 3H), 7.23 (dt, J = 7.2, 1.4 Hz, 2H), 5.97 (s, 1H), 
5.49 (d, J = 1.1 Hz, 1H), 5.01 (td, J = 8.1, 1.0 Hz, 1H), 4.47 – 4.41 (m, 2H), 2.73 – 2.61 (m, 3H), 
2.38 (dt, J = 12.5, 6.2 Hz, 2H), 2.14 – 2.00 (m, 3H), 1.97 – 1.92 (m, 2H), 1.78 – 1.54 (m, 8H), 1.49 
– 1.39 (m, 5H), 1.34 (p, J = 5.9 Hz, 1H), 1.29 (s, 3H), 1.15 (d, J = 4.9 Hz, 6H), 1.12 (s, 3H), 1.07 
(t, J = 5.8 Hz, 1H). 
HRMS(ESI): m/z calc. for C41H52N3O4 [M+H]
+: 650.3913, found: 650.3952. 
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Compound AA45c. 
Flash Silica Gel Chromatography: 1:9 EtOAc:Hexane 
Yield: 4 mg, 81% 
1H-NMR (CDCl3, 500 MHz): δ 7.82 – 7.65 (m, 2H), 7.48 – 7.39 (m, 2H),  
5.51 (d, J = 1.0 Hz, 1H), 4.89 (td, J = 8.1, 1.0 Hz, 1H), 3.60 (s, 3H), 2.70 
(t, J = 8.0 Hz, 2H), 2.65 (hept, J = 6.4 Hz, 1H), 2.48 – 2.37 (m, 3H), 2.03 – 1.95 (m, 2H), 1.89 – 
1.82 (m, 3H), 1.80 – 1.56 (m, 10H), 1.45 (ttd, J = 7.1, 5.5, 3.4 Hz, 2H), 1.37 (p, J = 5.8 Hz, 1H), 
1.30 (t, J = 5.9 Hz, 1H), 1.17 (s, 3H), 1.15 (d, J = 6.4 Hz, 6H), 1.12 (s, 3H). 
HRMS(ESI): m/z calc. for C35H47N2O5 [M+H]
+: 575.3440, found: 575.3465. 
3.6.6 Computational Analysis 
Molecular Property Distribution Histograms 
 
Library data for the MicroFormat Library was obtained via the ChemBridge website. 
Library data for approved cancer drugs was obtained from NCI as the Approve Oncology Drugs 
Set VI (https://wiki.nci.nih.gov/display/NCIDTPdata/Compound+Sets). Library data for approved 
antibacterials was obtained from O’Shea and Moser.22 
The number of stereogenic centers were calculated in Canvas 2.2 (Schrodinger, New York) 
using the Ligfilter Descriptor “Num_chiral_centers” in the Molecular Properties application. The 
following Python program (ctd_score.py) calculates several relevant molecular descriptors given 
a properly formatted sdf file. The ctd_score.py requires RDKit, an open-source collection of 
cheminformatics software. 
The program is run from the command line with the following syntax: 
  > python ctd_score.py FILENAME.sdf 
where FILENAME.sdf is a collection of molecules to be calculated. A new file is written with 
“descr.sdf” appended to the end of the filename. 
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#   
# calculation of molecular descriptors and complexity index   
#   
# Implements RDKit   
#   
# Bryon Drown, May 2015   
# Updated Oct. 9, 2015   
# University of Illinois, Urbana-Champaign   
#   
#   
   
import sys   
from rdkit import Chem   
from rdkit.Chem import Descriptors   
from rdkit.ML.Descriptors import MoleculeDescriptors   
from collections import defaultdict   
from collections import OrderedDict   
   
def calcRingDescriptors(m):   
  nBonds = m.GetNumBonds()   
  nAtoms = m.GetNumAtoms()   
  cyclomatic = nBonds - nAtoms + 1   
  if(cyclomatic < 1): return   
     
  ri = m.GetRingInfo()   
  if(ri.NumRings() < 1): return   
  # get total ring path and nBondRings   
  totalRing = 0   
  Bonds = []   
  Bridges = []   
  for ring in ri.BondRings():   
    for id in ring:   
      if (ri.NumBondRings(id) > 1):   
        Bridges.append(id)   
      totalRing+=1   
      Bonds.append(id)   
         
  # remove duplicates, then get length     
  nBondRings = len(OrderedDict.fromkeys(Bonds).keys())   
  nBridgeEdges = len(OrderedDict.fromkeys(Bridges).keys())   
     
  # get nAtomRings   
  Atoms=[]   
  for ring in ri.AtomRings():   
    for id in ring:   
      Atoms.append(id)       
  nAtomRings=len(OrderedDict.fromkeys(Atoms).keys())   
     
  # descriptors   
  ringFusionDensity = 2 * float(nBridgeEdges) / float(nAtomRings)   
  ringComplexityIndex = float(totalRing) / float(nAtomRings)   
  molecularCyclizedDegree = float(nAtomRings) / float(nAtoms)   
  nRingSystems = (nBonds - nBondRings) - (nAtoms - nAtomRings) + 1   
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  if(nRingSystems < 1):    
    ringFusionDegree = 0   
  else:   
    ringFusionDegree = float(cyclomatic) / float(nRingSystems)   
     
  # set props   
  m.SetProp('TotalRing',str(totalRing))   
  m.SetProp('NumBridges',str(nBridgeEdges))   
  m.SetProp('nBondRings',str(nBondRings))   
  m.SetProp('nAtomRings',str(nAtomRings))   
  m.SetProp('ringFusionDensity',str(ringFusionDensity))   
  m.SetProp('ringFusionDegree',str(ringFusionDegree))   
  m.SetProp('ringComplexityIndex',str(ringComplexityIndex))   
  m.SetProp('molecularCyclizedDegree',str(molecularCyclizedDegree))   
  m.SetProp('NumRingSystems',str(nRingSystems))   
     
  return    
   
if __name__=='__main__':   
    file_in  = sys.argv[1]   
    file_out = file_in+".descr.sdf"   
    ms = [x for x in Chem.SDMolSupplier(file_in) if x is not None]   
    ms_wr = Chem.SDWriter(file_out)   
   
    nms= ('BalabanJ','BertzCT','FractionCSP3','MolWt','RingCount')   
    calc = MoleculeDescriptors.MolecularDescriptorCalculator(nms)   
   
    for i in range(len(ms)):   
      descrs = calc.CalcDescriptors(ms[i])   
      calcRingDescriptors(ms[i])   
      for x in range(len(descrs)):   
        ms[i].SetProp(str(nms[x]),str(descrs[x]))   
      ms_wr.write(ms[i])   
 
Three-dimensional histograms plotting Fsp3 and the number of stereogenic centers were 
prepared in OriginPro 2015 (OriginLab, Northampton, MA) using the 2D Frequency 
Count/Binning feature. The number of stereogenic centers was set to X and bin range was set to 
“Bin Centers”. The minimum bin center was set to 0, the max bin center was set to 8, and the bin 
size was set to 1. Outliers greater than or equal to the maximum were included and the output 
binning order was set to descending. Fsp3 was set to Y and the bin range was set to “Bin Centers”. 
The minimum bin center was set to 0, the max bin center was set to 1, and the bin size was set to 
0.1. Outliers greater than or equal to the maximum were included and the output binning order was 
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set to ascending. The quantity to compute was set to “Count”. The resulting data set was then 
exported to Excel (Microsoft, Redmond WA) and plotted in a 3D column plot (number stereogenic 
centers = series, Fsp3 = category).      
Tanimoto Similarity Analysis 
 
Extended connectivity fingerprints (32-bit) were calculated with Canvas 2.2 (Schrodinger, 
New York) using hashed radial (ECFP) fingerprints with 3 radial iterations, daylight invariant 
atom types, and bonds distinguished by bond order. Similarity matrices were created in Canvas 
using the Similarity/Distance From Fingerprints task. Heatmaps were generated in Excel 
(Microsoft, Redmond WA) using a three-color scale set to 0.04 (R=104, G=148, B=190), 0.38 
(R=216, G=227, B=125), and 1.0 (R=248, G=105, B=107).  
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    Chapter 4: Ring Distortion of Pleuromutilin 
Portions are reprinted with permission from Hicklin, R. W.; López Silva, T. L.; Hergenrother, P. 
J., Synthesis of Bridged Oxafenestranes from Pleuromutilin. Angew. Chem. Int. Ed. 2014, 53, 
9880-9883. 
4.1 Introduction 
Pleuromutilin is a terpene natural product composed of 8-, 6-, and 5-membered rings that 
contains 8 stereogenic centers (Figure 4.1).1 The highly complex core scaffold of pleuromutilin 
possesses four oxygen-containing functional groups (secondary alcohol, primary alcohol, ketone, 
and ester) and a terminal olefin. Pleuromutilin is found in several species of fungus and was 
identified in 1951 from a culture of Pleurotus mutilus due to its potent inhibitory activity towards 
the Gram positive bacteria Staphylococcus aureus.2, 3 The structure of pleuromutilin was 
established by chemical degradation and later confirmed by X-ray crystallography.4, 5 The Sandoz 
group (now Novartis) performed extensive structure-activity relationships on the pleuromutilin 
scaffold and were the first to advance semisynthetic derivatives of pleuromutilin into the clinic.6-8 
Two semisynthetic pleuromutilin derivatives, tiamulin and valnemulin (Novartis, Figure 4.1), are 
now used to treat swine dysentery and enzootic pneumonia in veterinary medicine.9 Additionally, 
 
Figure 4.1: Structure and key functional groups of pleuromutilin and structures of semisynthetic 
pleuromutilin derivatives used to treat Gram positive bacterial infections. 
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the semisynthetic pleuromutilin derivative retapamulin (GlaxoSmithKline, Figure 4.1) was 
approved by the FDA in 2007 for the topical treatment of impetigo in humans.10 The pleuromutilin 
class of antibiotics elicit their antibacterial effects by binding to the peptidyl transferase center of 
the bacterial 50S ribosome and inhibiting protein synthesis.9, 11, 12  
The widespread use of pleuromutilin-derived antibiotics in veterinary medicine and in 
humans requires significant quantities of pleuromutilin. Approximately 50 mg/L of pleuromutilin 
was obtained in the original isolation and numerous studies have been performed to improve the 
production of pleuromutilin in culture.2, 3, 13-16 Thus, significant quantities of pleuromutilin are 
commercially available at low cost (<$10/g). 
Due to the impressive antibacterial activity of pleuromutilin, substantial efforts have been 
made to understand the chemical reactivity of pleuromutilin in the context of structure elucidation, 
investigation of structure activity relationships, and total synthesis (Scheme 4.1).1 During structure 
elucidation studies, the Birch and Arigoni groups discovered several reactions that modified the 
pleuromutilin core scaffold.4, 5 For example, the Birch group identified a phosphorus 
pentachloride-mediated ring contraction of the 8-membered ring of pleuromutilin (Scheme 4.1A) 
and an alkaline autoxidation of a bis-acetate derivative of pleuromutilin that led to cleavage of the 
5-membered ring (Scheme 4.1B).4 Arigoni found that treatment of a triol derivative of 
pleuromutilin with lead tetraacetate results in intramolecular cyclization of the C3 alcohol onto C6 
(Scheme 4.1C).5  
Efforts to modify pleuromutilin to incorporate new functionality and improve its 
antibacterial activity have resulted in a variety of structural rearrangements.17-23 For example, 
pleuromutilin derivatives containing an internal cyclopropane have been synthesized and used as 
a substrate for the incorporation of amines onto the pleuromutilin scaffold (Scheme 4.1D).17, 19 
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Researchers at Bristol-Meyers Squibb discovered a ring expansion of the 8-membered ring of 
pleuromutilin as a by-product of a reaction to install a methoxymethyl protecting group on the C11 
secondary alcohol (Scheme 4.1E).20 Several total syntheses of pleuromutilin24-26 and the 
pleuromutilin scaffold27-29 have been reported and have provided further insight into the reactivity 
of the pleuromutilin scaffold. As part of a relay-synthesis of pleuromutilin, the Paquette group 
discovered a retro-Michael ring cleavage of the 8-memered ring of a diketone derivative of 
pleuromutilin (Scheme 4.1F).27   
 
Scheme 4.1: Examples of known ring distortion reactions of the pleuromutilin scaffold. 
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4.2 Synthesis of Complex and Diverse Molecules from Pleuromutilin 
 The highly congested ring system of pleuromutilin and the presence of an 8-membered ring 
facilitate a number of different structural rearrangements including carbocation rearrangements, 
intramolecular hydride migrations, and intramolecular cyclization reactions. Our approach to the 
ring distortion of pleuromutilin focused on iterative modification of the oxygen-containing 
functional groups on the pleuromutilin core (alcohol, ester, ketone) in order to achieve ring 
distortion of the 5-, 6-, and 8-membered rings that compose the pleuromutilin scaffold (Scheme 
4.2, P1-P6). These synthetic efforts were greatly aided by previous synthetic studies on 
pleuromutilin (Scheme 4.1), as these reports provided insight into the chemical reactivity of the 
pleuromutilin ring system and presented several good starting points for chemical diversification. 
In the course of our synthetic studies on pleuromutilin, 6 new complex and diverse molecular 
 
Scheme 4.2: Ring distortion of pleuromutilin. 
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scaffolds were synthesized in short synthetic sequences of 4-5 steps (Scheme 4.2, P1-P24). An 
additional 18 complex and diverse intermediate and related compounds were prepared en route to 
these target scaffolds. The compounds created via ring distortion of pleuromutilin are shown in 
Figure 4.2.    
Figure 4.2: Compounds produced by ring distortion of pleuromutilin (P1-P24). 
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4.2.1 Ring Contraction of Pleuromutilin by Carbocation Rearrangement 
 In 1966, Birch and coworkers found that treatment of pleuromutilin with phosphorus 
pentachloride resulted in activation of the C11 alcohol, carbocation rearrangement, and ring 
contraction to form diene P7.4 In our hands, this reaction proceeded smoothly to provide P7 as a 
single diastereomer whose configuration was confirmed by X-ray crystallography (Scheme 4.3). 
Further ring distortion of the P7 scaffold was enabled by silyl enol ether formation and 
Rubotom oxidation (Scheme 4.4). Treatment of P7 with an excess of fresh tert-butyldimethylsilyl 
trifluoromethanesulfonate resulted in quantitative formation of the kinetic silyl enol ether P8. 
Rubottom oxidation of P8 with excess m-chloroperbenzoic acid under acidic conditions led to 
oxidation of both C2 and C4 to provide epoxide P9 as a single disastereomer. Similar double-
oxidation products have been reported for Rubottom oxidations on the pleuromutilin scaffold and 
are attributed to the acid lability of the tertiary C4 proton.30  
Scheme 4.3: Ring contraction of pleuromutilin to diene P7. 
 
Scheme 4.4: Silyl enol ether formation and Rubottom oxidation of P7. 
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The mechanism for the formation of epoxide P9 is proposed to involve epoxidation from 
the less hindered face of the five membered ring, acid-catalyzed elimination to open the epoxide, 
and directed epoxidation of the resulting silyl enol ether to form the product (Scheme 4.5). The 
configuration of epoxide P9 was inferred based on the configuration of the desilylated scaffold 
P11 (vide infra). 
 Desilylation of epoxide P9 was accomplished by treatment with triethylamine 
trihydrofluoride to provide diol P10 as a single diastereomer (Scheme 4.6). Methylation of the C2 
secondary alcohol of P10 provided ether P11 and enabled assignment of the configuration at C2 
and C4 by 1D NOESY NMR spectroscopy (Figure 4.3).  
The chemical shift of the red proton on the C4 tertiary alcohol of P11 was confirmed by its 
NOE exchange with the residual water peak, highlighted in pink (Figure 4.3, spectra were obtained 
in d7-DMF at 80 ºC). The configuration of the green C2 proton geminal to the methyl ether was 
identified by its NOE correlation to a proton on the 6-membered ring (blue). The green C2 proton 
also exhibits an NOE signal for one of the vicinal C1 protons (light blue). Irradiation of the orange 
C11 proton on the 7-membered ring shows an NOE signal for the brown C1 proton, indicating that 
Scheme 4.5: Proposed mechanism for the formation of P9. 
 
Scheme 4.6: Desilylation of P9 and methylation to form P11. 
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brown C1 proton is in close proximity to the orange C11 proton and on the opposite face of the 5-
membered ring as the green C2 proton. The orange C11 proton also shows an NOE correlation to 
the red proton on the C4 tertiary alcohol. Similar results were observed upon irradiation of the 
purple C13 proton on the 7-membered ring. These data are consistent with the structure shown in 
Figure 4.3.  
Compound P10 contains multiple sites for further ring distortion and two ring distortion 
strategies were executed (Scheme 4.7). Treatment of P10 with lead tetraacetate results in oxidative 
cleavage and ring fusion to provide the formal ring expansion product P1 as a single diastereomer. 
The mechanism for the formation of lactone P1 is proposed to involve cleavage of the C2-C3 bond 
to form an aldehyde and an ester, hemiacetal formation between the C4 tertiary alcohol and the 
aldehyde, and lactonization between the hemiacetal and the lactone to provide the product. The 
 
Figure 4.3: Assignment of the configuration of P11 by 1D NOESY in d7-DMF at 80 ºC. 
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configuration of the hemiacetal was assigned based on the configuration of the C4 tertiary alcohol 
in P11 and the geometric constraints of cyclization that allow only one of the possible hemiacetal 
configurations to form a lactone (Scheme 4.7). Compound P10 also contains a diene that is readily 
amenable to cyclization upon treatment with a dienophile. Reaction of P10 with 4-phenyl-1,2,4-
triazoline-3,5-dione results in Diels-Alder cyclization to form P2.  
4.2.2 Ring Expansion of Epi-Mutilin P12 by Carbocation Rearrangement 
 Berner and coworkers at Sandoz reported an acid catalyzed C4 isomerization and 1,5-
hydride shift between C3 and C11 of pleuromutilin that forms alcohol P12 after saponification 
(Scheme 4.8).17, 19, 31-33 The C14 alcohol P12 is a good substrate for carbocation rearrangement as 
the other oxygen-containing functional groups at C3 and C11 are masked from reactivity with 
 
Scheme 4.7: Ring distortion of P10 by oxidative cleavage and Diels-Alder ring fusion. 
 
Scheme 4.8: Isomerization of pleuromutilin and saponification to epi-mutilin P12. 
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phosphorus pentachloride. Additionally, C14 is adjacent to a quaternary carbon (C5) that is poised 
to undergo a Wagner-Meerwein rearrangement to form a more stable tertiary carbocation at C5 
upon alcohol activation. Treatment of P12 with phosphorus pentachloride resulted in alcohol 
activation, ring expansion by C6 migration, and elimination to form P13 as a single isomer 
(Scheme 4.9). As Wagner-Meerwein 1,2-migrations occur in a suprafacial manner, the 
configuration at C14 must be the one depicted in Scheme 4.9. The connectivity of carbon and 
hydrogen atoms for P13 was confirmed by multidimensional NMR spectroscopy (See materials 
and methods).    
 Treatment of P13 with m-chloroperbenzoic acid resulted in regio- and diastereoselective 
epoxidation of the disubstituted olefin to provide epoxide P14 (Figure 4.4A). The configuration of 
the epoxide was assigned using 1D NOESY NMR spectroscopy (Figure 4.4B). Irradiation of the 
red C15 proton showed a strong NOE signal to the purple proton at C3. Irradiation of the green 
C15 proton showed a strong NOE signal for the C18 methyl protons. These data are consistent 
with the two C15 protons being on the same face of the 7-membered ring as the purple C3 proton 
and the blue C18 methyl protons as depicted in Figure 4.4.  
 
Scheme 4.9: Ring expansion of epi-mutilin P12. 
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 Nucleophilic addition into the C11 ketone and intramolecular epoxide opening was 
investigated as a ring distortion strategy for epoxide P14. However, treatment of epoxide P14 with 
methyl magnesium bromide resulted in elimination and epoxide opening to form allylic alcohol 
P3 (Scheme 4.10). Efforts to react the highly sterically-hindered C11 ketone with less basic 
nucleophiles were unsuccessful.  
 
 
Figure 4.4: A) Epoxidation of P13; B) Assignment of the configuration of P14 by 1D NOESY. 
B)
 
Scheme 4.10: Elimination and epoxide opening of P14. 
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4.2.3 Carbocation Rearrangement of a Pleuromutilin-Derived Cyclopropane 
 The cyclopropane derivative of pleuromutilin shown in Scheme 4.1D was identified as 
another potential scaffold for carbocation rearrangement.18, 19 This compound was prepared by 
ester saponification of pleuromutilin (P15), bis-acetylation (P16), and intramolecular 
cyclopropane formation by treatment with base to form P17 (Scheme 4.11).  
Saponification of the C11 acetate of P17 provided the desired carbocation rearrangement 
precursor, alcohol P18 (Scheme 4.12). Exposure of alcohol P18 to phosphorus pentachloride 
resulted in the formation of hemiketal P4 as a single diastereomer. The absolute configuration of 
P4 was assigned by X-ray crystallography (Scheme 4.12). The crystal structure of P4 provides 
insight into the possible mechanism of this reaction, as an inversion of configuration occurs at 
carbon atoms C5, C11, and C14 during the course of the reaction (Scheme 4.13). The inversion at 
C11 is indicative of a cyclopropyl bond migration to displace the activated alcohol. Due to the 
proximity of the C4-C14 bond to C11 and the inversion of configuration at C14, it is likely that 
migration of the C4-C14 bond occurs first to form a carbocation at C14. The newly-formed 6-
 
Scheme 4.11: Intramolecular cyclopropane formation from pleuromutilin. 
 
 Scheme 4.12: Carbocation rearrangement of P18 to form hemiketal P4. 
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membered ring then undergoes a ring flip to orient the empty C14 p-orbital so that the Si face 
overlaps with the C4-C5 bond, leading to the observed configuration at C14 upon migration of the 
C4-C5 bond to form a tertiary carbocation at C5. The C5 carbocation is geometrically constrained 
to only react with the ketone from the Si face to form an oxocarbenium that reacts with water when 
the reaction is quenched to form the product hemiketal P4. 
4.2.4 Ring Cleavage and Ring Expansion of Pleuromutilin 
 Oxidation of the C11 secondary alcohol of pleuromutilin provides a 1,5-diketone, which is 
known to undergo a retro-Michael reaction upon treatment with aqueous base to form a lactol that 
can be oxidized to lactone P20 upon treatment with pyridinium chlorochromate (Scheme 4.1F).27 
The mechanism for the ring cleavage reaction was proposed by Paquette and coworkers to involve 
ester hydrolysis, retro-Michael ring cleavage of the 8-membered ring, and lactol formation 
(Scheme 4.14).27 The pyridinium chlorochromate oxidation of the lactol was proposed to occur via 
C-O migration of the ethyl group to expel HCrO3 and form an oxonium intermediate, which 
hydrolyzes to lactone P20 upon aqueous workup.27  
Scheme 4.13: Proposed mechanism of carbocation rearrangement to form hemiketal P4. 
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We envisioned using the cleavage product P20 as a substrate for a ring expansion of the 5-
membered ring by a Beckmann rearrangement. Lactone P20 was prepared by oxidation of 
pleuromutilin with pyridinium chlorochromate to diketone P19, followed by retro-Michael ring 
cleavage and oxidation of the crude lactol to lactone P20 (Scheme 4.15). Reaction of lactone P20 
with hydroxylamine provided oxime P21, which was isolated as a single isomer. The Beckmann 
rearrangement was initiated with cyanuric chloride and N,N-dimethylformamide to afford a single 
isomer of the desired ring expansion product, lactam P5.  
 
Scheme 4.14: Proposed mechanism for retro-Michael ring cleavage and oxidative 
rearrangement to form P20. 
 
Scheme 4.15: Synthesis of lactone P20 and Beckmann ring expansion to form lactam P5. 
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The location of the nitrogen atom in P5 (α,β-unsaturated lactam or enamine) was assigned 
based on 3-bond 1H-13C correlations identified in a 1H-13C HMBC NMR experiment (Figure 4.5). 
A 3-bond correlation was found between the light blue methylene protons and the green carbonyl 
carbon, providing evidence for an α,β-unsaturated lactam instead of an enamine. Further evidence 
for the α,β-unsaturated lactam structure was provided by assigning the red and blue carbons in the 
α,β-unsaturated carbonyl system. If P5 contains a lactam, the β-carbon would be significantly 
deshielded, due to the electron withdrawing lactam, and have a higher 13C chemical shift than the 
α-carbon. The opposite trend would be anticipated for the enamine; the electron donating enamine 
would induce an increase in electron density for the β-carbon and a decrease in electron density at 
the α-carbon, resulting in the α-carbon possessing the greater 13C chemical shift. The red carbon 
was assigned as the α-carbon based on its 3-bond coupling to the purple methyl protons.  
Figure 4.5: Assignment of lactam P5 by 1H-13C HMBC NMR spectroscopy.  
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Assignment of the blue carbon as the β-carbon was based on its 3-bond coupling to an 
orange methylene proton, which was assigned based on the 3-bond coupling of the pink methyl 
protons to the orange carbon and the 1-bond 1H-13C HSQC coupling between the orange carbon 
and the orange proton (see Supporting Information for HSQC). This result is consistent with the 
proposed α,β-unsaturated lactam structure P5, since the blue β-carbon exhibits a significantly 
higher 13C chemical shift than the red α-carbon. 
4.2.5 Ring Fusion and Ring Cleavage of Pleuromutilin  
 The oxidation of C-H bonds has been used to modify the pleuromutilin scaffold at sites 
that are challenging to modify by traditional functional group manipulations (Scheme 4.16).18, 22, 
34, 35 Microbial fermentation of the pleuromutilin scaffold results in organism-dependent 
hydroxylation at C2, C7, or C8 (Scheme 4.16A).34 The White group has identified conditions for 
iron-catalyzed C-H oxidation of C7 on the pleuromutilin scaffold (Scheme 4.16B).35 Researchers 
at Pfizer reported a silver-catalyzed C-H amidation of C14 of the epi-mutilin scaffold (Scheme 
4.16C).22  
  
Scheme 4.16: C-H oxidation on the pleuromutilin scaffold. 
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We envisioned performing a C-H amidation on the pleuromutilin scaffold in order to 
achieve a ring fusion on the 8-membered ring without modifying the C3 ketone (Scheme 4.16D). 
The ring fusion precursor P23 was prepared from mutilin P15 by sequential acylation (P22) and 
primary carbamate formation (Scheme 4.17). Silver-catalyzed C-H amidation of P23 was 
accomplished using modified literature procedures22 to provide cyclic carbamate P24. The 
configuration of the cyclic carbonate was assigned based on the configuration of P6 (vide infra).  
Alkaline autoxidation has been reported for the pleuromutilin scaffold,4 and was used to 
alter the 5-membered ring of cyclic carbamate P24. Exposure of P24 to base in the presence of 
oxygen results in ring expansion to afford lactone P6 (Scheme 4.18). The mechanism for the 
formation of P6 is proposed to involve oxidative cleavage of the C3-C4 bond to form a keto acid, 
which undergoes a C11-C4 hydride migration and lactonization to form P6. The configurations of 
the protons at C4 (red) and C13 (light blue) were assigned using 1D NOESY NMR spectroscopy 
(Figure 4.6). Irradiation of the red C4 proton shows NOE signals for the green and blue methyl 
protons, which is consistent with a trans-configuration of the cyclic carbamate. Irradiation of the 
Scheme 4.17: Ring fusion of pleuromutilin by C-H amidation. 
 
Scheme 4.18: Alkaline autoxidation, hydride migration, and lactonization of P24. 
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equatorial green C15 methyl protons shows NOE signals for the red C14 proton and the light blue 
proton at C4, which indicates that the light blue C4 proton is also equatorial. Irradiation of the blue 
C18 methyl protons shows NOE signals for both the red C4 proton and the orange N1 proton. 
However, the C18 methyl group likely adopts a pseudo-equatorial configuration in the 8-
membered ring and would be anticipated to exhibit NOE signals for the equatorial N1 proton on 
the opposite face of the 8-membered ring, as well as the axial red C4 proton on the same face of 
the 8-membered ring as the C18 methyl group. Collectively, these data support the configuration 
shown in Figure 4.6.   
 
 
 
 
Figure 4.6: Assignment of the configuration of P6 by 1D NOESY NMR. 
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4.3 Structural Evaluation of P4: A Complex Oxafenestrane 
The tetrahedral 4-coordinate carbon is one of the fundamental structural features of organic 
molecules,36, 37 thus compounds possessing such carbon atoms but with altered geometries have 
long been of interest.38  Fenestranes are a class of compounds designed to deviate from the 
tetrahedral geometry by planarization of a 4-coordinate carbon.39-42 The fenestrane scaffold 
consists of four rings fused about a central quaternary carbon, whose planarization can be 
measured by two opposing bond angles, α and β (Figure 4.7). The magnitudes of α and β are 
dependent on the size of the rings and the relative configuration and substitution pattern of the 
bridgehead atoms.42 The potential for creating molecules with highly planarized tetracoordinate 
carbon atoms has made fenestranes attractive synthetic targets, however, the synthesis of chiral 
nonracemic fenestranes remains challenging.39  
 Compound P4 belongs to a novel class of oxygen-containing fenestranes (oxafenestranes) 
and is one of the few examples of a chiral non-racemic oxafenestrane that has been synthesized 
(Figure 4.7). Additionally, the ability to obtain single crystals of P4 enabled direct measurement 
of the degree of planarization about the central 4-coordinate carbon (C4). Oxafenestrane P4 was 
crystallized as a hydrogen-bonded dimer, thus, the bond angles α and β were measured for each 
molecule in the dimer (Figure 4.7). The observed bond angles (α=124.1º, β=119.1º and α=123.6º, 
 
Figure 4.7: All cis-[5,5,5,5]Fenestrane and Oxafenestrane P4.  
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β=118.4º) show significant planarization of the central carbon atoms and the values for α are larger 
than any previously reported for an all-cis[4.5.5.5]fenestrane.39 The large value for α is likely due 
to the presence of the bridging 7-membered ring, as bridged [4.6.4.6]- and [5.5.5.5]fenestranes 
exhibit similar increases in planarization for one bond angle.43, 44 However, the degree of 
planarization found in oxafenestrane P4 is less than the planarization possible in fenestranes with 
trans-bridgehead substituents,45 fenestranes with bridgehead olefins,46 or fenestranes with smaller 
ring sizes.47  
 Several derivatives of P4 were synthesized in order to investigate the influence of 
bridgehead substituents and ring size on the degree planarization of the central carbon. Several 
methods were developed to alter the substituents at the C3 bridgehead position. Quenching the 
reaction of P18 and phosphorus pentachloride with different alcohols and amines enabled the 
synthesis of simple ketal and aminal derivatives (Scheme 4.19, P25, P26, and P27). Unfortunately, 
single crystals of these ketal and aminal oxafenestranes were unable to be isolated.  
Direct derivatization of P4 with tribromoethanol and p-toluenesulfonic acid provided the 
crystalline tribromoethylketal derivative P28 (Scheme 4.20). X-ray crystallographic analysis of 
P28 reveals central bond angles of α=125.4º and β=119.2º, which demonstrates that ketal 
substituents have a substantial impact on the bond angle α and increase the planarization of the 
central carbon. 
 
Scheme 4.19: Synthesis of simple ketal and aminal derivatives of P4. 
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 Attempts to introduce bridgehead olefins through hemiketal dehydration were hindered by 
the tendency of P4 to undergo SN1 reactions. For example, tertiary alcohols and hemiketals 
typically undergo E1 elimination upon exposure to Martin’s sulfurane.48 Treatment of P4 with 
Martin’s sulfurane results in the formation of ketal P29, in spite of the poor nucleophilicity of 
1,1,1,3,3,3-hexafluoro-2-phenyl-2-propanol (Scheme 4.21). Ketal P29 is highly crystalline and its 
crystal structure provides insight into the effects of bulky ketal substituents on planarization of the 
central carbon. The crystal structure of P29 shows that significant steric bulk on one face of the 
molecule forces the fenestrane skeleton toward the opposite face, leading to a large increase in α 
and a modest decrease in β (Scheme 4.21). 
 
Scheme 4.20: Synthesis of tribromoethyl ketal P28.  
 
Scheme 4.21: Synthesis of ketal P29 with Martin’s sulfurane.  
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 Further ring distortion of P4 was performed to assess the influence of the number of rings 
and ring size on planarization. Reduction of P4 with sodium borohydride provides the broken 
fenestrane P30 which only contains 3-fused rings about the central carbon atom (Scheme 4.22). 
The configuration of the P30 was confirmed by X-ray crystallography and the effects of ring 
cleavage on the planarization of the central carbon were assessed. Cleavage of the 5-membered 
ring opposite the highly strained 4-membered ring results in a significant loss of planarization 
(α=111.3º and β=116.1º) and an increase in scissor distortion,49 a type of distortion commonly 
found in molecules containing small rings characterized by one angle contracting from the 
tetrahedral geometry and the opposite angle enlarging to compensate (demonstrated by the large 
difference between angles γ and δ).  
  Exposure of P30 to triphosgene results in cyclic carbonate formation to provide bridged 
all-cis[4.5.7.5]dioxafenestrane P31 (Scheme 4.22). To our knowledge, this is the first report of a 
[4.5.7.5]fenestrane. The X-ray crystal structure of P31 demonstrates the effects of increasing ring 
 
Scheme 4.22: Ring cleavage and ring expansion of P4. 
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size on the geometry of the central carbon atom (Scheme 4.22). While [4.5.5.5]oxafenestranes, 
such as P4, exhibit a high degree of planarization and large values of α and β, 
[4.5.7.5]dioxafenestrane P31 shows only modest planarization of the central carbon (α=113.4º and 
β=116.8º). The greater flexibility of the 7-membered ring enables P31 to exhibit significant scissor 
distortion (γ=121.7º and δ=90.3º), similar to that observed for the broken fenestrane P30.  
4.4 Anticancer Activity of the Compounds Derived from Pleuromutilin  
 A cell-based phenotypic screen with cytotoxicity read out was performed by Evijola 
Llabani using the compounds created from pleuromutilin in ES-2 human ovarian cancer and HCT 
116 human colon cancer cells (assessed by Alamar Blue assay).  Compounds P10, P1, P11, and 
P2 were identified as active and demonstrated dose-dependent cell death in both cell lines (Figure 
4.8). The structures of the active compounds P10, P1, P11, and P2 share several similarities (e.g. 
7-membered ring, 6-membered ring, and α-chloroester) but their differences provided some 
preliminary information regarding the structure-activity relationship for these molecules. 
Compound P10 showed a lower minimum inhibitory concentration (IC50) than P1, indicating that 
the substituents on the 5-membered ring are important for biological activity. However, the similar 
potency of methyl ether P11 to P10 shows that substitution of the secondary alcohol is tolerated. 
The greater potency of P2 compared to P10 demonstrates that modification of the diene of P10 
 
Figure 4.8: Pleuromutilin-derived compounds with anticancer activity. 
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improves potency. Since P2 was the most potent of the active compounds, further structure-activity 
relationship studies were performed using this scaffold. 
4.4.1 Synthesis and Activity of P2 Derivatives at C2, C18 and C20 
 Several series of P2 derivatives were synthesized in order to probe structure-activity 
relationships and provide tool compounds to study the biological activity of this class of 
compounds. The ability of P2 to tolerate substituents on the secondary alcohol was probed by 
methylation and acylation to provide methyl ether P32 and acetyl ester P33, respectively (Scheme 
4.23). The nearly equivalent IC50 values of P2, P32 and P33 indicate that modifications of the C2 
alcohol have little effect on the anticancer activity of these compounds.  
 Modifications of the 1,2,4-triazolidine-3,5-dione ring of P2 were prepared via Diels-Alder 
cycloaddition of P10 with different dienes (Scheme 4.24). Reaction of P10 with N-
phenylmaleimide provided P34 and reaction of P10 with N-alkynylmaleimide gave P35. Both 
compounds were obtained as a mixture of diastereomers, but showed only slightly-diminished 
activity compared to P2. Alkyne P35 was reacted with an azide-containing fluorophore via copper-
catalyzed 1,3-dipolar cycloaddition to create P36, a fluorescent analogue of the P2 scaffold with 
moderate anticancer activity.    
 
Scheme 4.23: Synthesis of methyl ether and acetyl ester derivatives of P2. 
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4.4.2 Synthesis of P2 Derivatives at C14 
Compound P2 and its bioactive derivatives contain an α-chloroester at C14 that could 
potentially react with cellular nucleophiles. A series of C14 ester derivatives were synthesized to 
determine if an electrophilic ester side-chain was required for anticancer activity. Three strategies 
were employed to access C14 ester modifications on the P2 scaffold. Direct nucleophilic 
displacement of the alkyl chloride was used to create α-azidoester P37 and α-iodoester P38 
(Scheme 4.25). α-Iodoester P38 was significantly more electrophilic than P2 and was used to 
create acetoxyester P39 by displacement of the iodide with acetate (Scheme 4.25).    
 
Scheme 4.24: Synthesis of 1,2,4-triazolidine-3,5-dione derivatives of P2. 
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Other C14 ester derivatives required α-chloroester saponification and esterification with 
suitable carboxylic acid derivatives. It was found that compounds containing the 1,2,4-triazolidine-
3,5-dione were unstable under saponification conditions and the C2 alcohol was more reactive to 
esterification than the highly hindered C14 alcohol. Thus, α-chloroester saponification was 
performed on compounds containing a C11 diene and lacking a free C2 alcohol. Saponification of 
P7 with potassium hydroxide provided alcohol P40 (Scheme 4.26). Esterification of the C14 
alcohol with sodium fluoroacetate provided α-fluoroester P41. Silyl enol ether formation (P42), 
Rubottom oxidation (P43), and desilylation of P41 gave diol P44. Diels-Alder cycloaddition of 
P44 with 4-phenyl-1,2,4-triazoline-3,5-dione yielded the α-fluoroester derivative P45.  
 
Scheme 4.25: Synthesis of C14 ester derivatives of P2 by α-chloroester displacement. 
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The synthesis of C14 ester derivatives from P40 requires an additional 4 synthetic steps 
after esterification to get to the P2 scaffold. In order to improve the synthetic efficiency of 
derivative synthesis, alcohol P47 was synthesized and used to install different ester substituents, 
since methyl ether P32 showed similar cytotoxicity to P2 and lacks a C2 alcohol (Scheme 4.27). 
Compound P47 was prepared by saponification of P11 to form P46 followed by Diels-Alder ring 
fusion. Ester couplings between P47 and appropriate carboxylic acid derivatives enabled the 
synthesis of C14 acetate P48, α,α-dichloroester P49, furoic ester P50, and acrylate ester P51 
(Scheme 4.27). 
 
 
 
 
 
 
Scheme 4.26: Synthesis of α-fluoroester P45. 
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4.4.3 Electrophilicity of P2 Derivatives 
 The trends in cytotoxicity of the C14 ester derivatives are consistent with an electrophilic 
mechanism of action for P2 (Figure 4.9). Acetate P48 lacks a potentially electrophilic α-substituent 
and exhibited no cytotoxicity in ES-2 or HCT 116 cells. α,α-Dichloroester P49 also showed no 
cytotoxic effects in these cell lines. Geminal dichlorides are known to have greatly reduced SN2 
reactivity, which has been proposed to arise from a four-electron repulsion in the transition state 
between a p-lone pair on a chlorine substituent and the π-type orbital associated with the reaction 
coordinate.50 The lack of activity for P48 and P49 indicates that an electrophilic α-substituent on 
 
Scheme 4.27: Synthesis of C14 ester derivatives of P2 by esterification of P47. 
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the C14 ester is required for activity. The degree of electrophilicity required for activity was 
evaluated based on the cytotoxicity of P2 derivatives containing α-substituents with different 
levels of electrophilicity. Weak electrophiles such as furoic ester P50, acetoxy ester P39, α-
azidoester P37, and α-fluoroester P45 showed little to no cytotoxicity. Acrylic ester P51 contains 
an electrophilic Michael acceptor and showed modest cytotoxicity in both cancer cell lines. The 
highly electrophilic α-iodoester P38 showed the highest cytotoxicity of any of the P2 derivatives. 
These results indicate that a moderate to strong electrophile at C14 is required for biological 
activity and that P2 and its cytotoxic derivatives likely act via a covalent mechanism of action. 
  
Figure 4.9: Anticancer activity of P2 ester derivatives. 
205 
 
4.4.4 Reactivity of P2 and Derivatives towards Glutathione 
α-Halocarbonyl compounds have been shown to selectively modify cysteine residues of 
proteins and other cellular nucleophiles.51, 52 The ability of ligands containing chloroacetamide, 
chloromethyl ketone, and chloroamidine electrophiles to selectively react with a single protein or 
family of proteins has been shown by numerous researchers and the activity of these molecules is 
highly dependent on the structure of the ligand.53-58 However, it is important to confirm that P2 
and its derivatives are not promiscuous electrophiles under physiological conditions. Glutathione 
(GSH) is an abundant cellular thiol (1-5 mM) that is known to react rapidly with many promiscuous 
electrophiles.59 The reactivity of α-chloroester P2, α-iodoester P38, and α,α-dichloroester P49 at 
100 µM (10% DMSO in PBS) towards an excess of GSH (5 mM) was measured in vitro by LCMS 
and used to approximate the electrophilicity of these compounds. Compound P38 was found to be 
highly reactive towards GSH and reached full conversion to the GSH-P38 adduct immediately 
after addition of GSH, as monitored by UV absorbance at 220 nm and mass spectrometry (Figure 
4.10). Compound P2 showed significantly reduced reactivity towards GSH and did not reach full 
 
Figure 4.10: Monitoring P38 reactivity towards GSH by LCMS. 
P38 UV: 220 nm
P38 + GSH no incubation UV: 220 nm
P38 + GSH 1 hr incubation UV: 220 nm
P38 + GSH 2 hr incubation UV: 220 nm
[M+Na]+
[M+GSH+H]+
[M+GSH+H]+
[M+GSH+H]+
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conversion after a 2 hour incubation period (Figure 4.11). The inactive derivative P49 showed no 
reactivity towards GSH (Figure 4.12). The results of this in vitro assay indicate that P38 is more 
electrophilic than P2 towards biologically-relevant nucleophiles and support an electrophilic mode 
of action for P2 and its bioactive derivatives. Investigation of the ability of P2 and its derivatives 
to selectivity modify proteins in whole cells and cell lysates was performed by Evijola Llabani.  
 
Figure 4.11: Monitoring P2 reactivity towards GSH by LCMS. 
P2 UV: 220 nm
P2 + GSH no incubation UV: 220 nm
P2 + GSH 1 hr incubation UV: 220 nm
P2 + GSH 2 hr incubation UV: 220 nm
[M+Na]+
[M+GSH+H]+
[M+Na]+
[M+Na]+
[M+Na]+[M+GSH+H]+
 
Figure 4.12: Monitoring P49 reactivity towards GSH by LCMS. 
P49 UV: 220 nm
P49 + GSH no incubation UV: 220 nm
P49 + GSH 1 hr incubation UV: 220 nm
P49 + GSH 2 hr incubation UV: 220 nm
[M+Na]+
[M+Na]+
[M+Na]+
[M+Na]+
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4.5 Cheminformatic Analysis of the Compounds Derived from Pleuromutilin 
 The compounds created through the ring distortion of pleuromutilin contain a variety of 
stereochemically complex multi-ring scaffolds. The visually-apparent molecular complexity of 
these compounds was approximated by calculating Fsp3 and the number of stereogenic centers 
(see Chapter 2). The structural diversity of this collection was quantified by calculating Tanimoto 
similarity coefficients for pairwise combinations of ECFP_6 molecular fingerprints (see Chapter 
2). 
4.5.1 Quantifying the Molecular Complexity of the Pleuromutilin Collection 
 Plotting the Fsp3 and number of stereogenic centers for the compounds in Figure 4.2 (P1-
P24) in 3D histograms shows that these compounds are highly complex, possessing a high Fsp3 
(range: 0.60-0.90, average: 0.77, median: 0.77) and numerous stereogenic centers (range: 4-9, 
average: 7.4, median: 8) (Figure 4.13). Analysis of all of the compounds created from pleuromutilin, 
including oxafenestranes P25-P31 and the P2 derivatives P32-P51, shows a similarly high level 
of complexity (Fsp3: range: 0.53-0.92, average: 0.74, median: 0.75; number stereogenic centers: 
range: 4-10, average: 7.9, median: 8) and both compound sets occupy the front right quadrant of the 
graph. 
 
Figure 4.13: Three-dimensional histogram graphs plotting Fsp3 and the number of stereogenic 
centers for P1-P24 and the full pleuromutilin set.  
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The molecular complexity of the pleuromutilin compounds is dramatically different from 
that of the Chembridge Microformat library (Figure 4.14, Fsp3: range: 0.0-1.0, average: 0.23, 
median: 0.20 and number of stereogenic centers: range: 0-11, average: 0.27, median: 0.0) and the 
two compound collections occupy different quadrants of the plot. Comparison of the molecular 
complexity of the pleuromutilin collection, the NCI Oncology library, and FDA antibacterial drugs 
(anticancer: Fsp3: range: 0.0-1.0, average: 0.44, median: 0.44 and number of stereogenic centers: 
range: 0-25, average: 2.64, median: 0.5; antibacterials: Fsp3: range: 0.0-1.0, average: 0.41, median: 
41 and number of stereogenic centers: range: 0-20, average: 3.49, median: 2.0) shows that the 
pleuromutilin compounds possess a similar molecular complexity profile to the most complex 
drugs, as all three sets populate the front right quadrant of the histogram plot (Figure 4.14). 
4.5.2 Quantifying the Structural Diversity of the Pleuromutilin Collection  
The structural diversity of the compounds created from pleuromutilin was assessed by 
creating a matrix of Tanimoto similarity coefficients (see Chapter 2) generated from ECFP_6 
three-bond radial fingerprints with Daylight invariant atom types and distinguishing bonds by bond 
order. The Tanimoto similarity matrix for the compounds created by ring distortion of 
pleuromutilin (P1-P24) is shown in Table 4.1. The target scaffolds P1-P6 exhibit considerable 
structural diversity between each other and pleuromutilin (P) and show low Tanimoto similarity 
 
Figure 4.14: Three-dimensional histogram graphs plotting Fsp3 and the number of stereogenic 
centers for the Chembridge Microformat library, FDA approved anticancer drugs, and FDA 
approved antibacterial drugs.  
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scores (blue to green in color, range: 0.05-0.20, average: 0.09, median: 0.08). Inclusion of the 
intermediate compounds (P7-P24) in the diversity analysis results in a few pairwise combinations 
with high similarity scores (yellow to orange in color), but the overall structural diversity of the 
collection remains high (range: 0.05-0.69, average: 0.13, median: 0.10). The Tanimoto similarity 
matrix for all of the compounds created from pleuromutilin, including oxafenestranes P25-P31 
and the P2 derivatives P32-P51, is shown in Table 4.2. As was the case for functional group 
derivatives of quinine (Chapter 2) and abietic acid (Chapter 3), functional group derivatives based 
on a single scaffold (e.g. P2) tend to have much higher structural similarity than compounds 
created by ring distortion and have many more pairwise combinations with high similarity (yellow 
to orange in color). 
 
 
 
Table 4.1: Tanimoto similarity of the compounds created by ring distortion of pleuromutilin. 
1.00
0.00
0.50
P P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 P21 P22 P23 P24
P 1.00 0.07 0.12 0.11 0.07 0.09 0.20 0.21 0.08 0.07 0.15 0.15 0.13 0.11 0.09 0.46 0.26 0.21 0.27 0.32 0.09 0.08 0.23 0.25 0.23
P1 0.07 1.00 0.08 0.11 0.07 0.10 0.07 0.11 0.20 0.21 0.11 0.11 0.06 0.07 0.12 0.06 0.08 0.08 0.06 0.08 0.10 0.09 0.08 0.08 0.07
P2 0.12 0.08 1.00 0.07 0.05 0.05 0.11 0.17 0.07 0.06 0.39 0.31 0.09 0.07 0.06 0.09 0.12 0.11 0.09 0.11 0.05 0.05 0.11 0.12 0.10
P3 0.11 0.11 0.07 1.00 0.11 0.13 0.09 0.09 0.12 0.08 0.09 0.10 0.09 0.09 0.27 0.08 0.11 0.11 0.07 0.12 0.14 0.12 0.11 0.11 0.10
P4 0.07 0.07 0.05 0.11 1.00 0.08 0.06 0.06 0.07 0.08 0.06 0.07 0.08 0.07 0.11 0.09 0.08 0.09 0.08 0.07 0.08 0.08 0.09 0.08 0.08
P5 0.09 0.10 0.05 0.13 0.08 1.00 0.08 0.07 0.09 0.10 0.07 0.08 0.07 0.07 0.12 0.08 0.08 0.09 0.08 0.09 0.48 0.31 0.08 0.08 0.08
P6 0.20 0.07 0.11 0.09 0.06 0.08 1.00 0.18 0.08 0.06 0.14 0.14 0.14 0.11 0.08 0.17 0.20 0.19 0.16 0.23 0.09 0.07 0.19 0.20 0.23
P7 0.21 0.11 0.17 0.09 0.06 0.07 0.18 1.00 0.10 0.08 0.27 0.26 0.10 0.09 0.08 0.18 0.27 0.18 0.15 0.22 0.07 0.06 0.26 0.26 0.22
P8 0.08 0.20 0.07 0.12 0.07 0.09 0.08 0.10 1.00 0.20 0.10 0.12 0.08 0.08 0.11 0.07 0.08 0.08 0.06 0.09 0.09 0.08 0.09 0.08 0.07
P9 0.07 0.21 0.06 0.08 0.08 0.10 0.06 0.08 0.20 1.00 0.09 0.10 0.07 0.07 0.09 0.07 0.07 0.08 0.06 0.07 0.11 0.10 0.08 0.07 0.07
P10 0.15 0.11 0.39 0.09 0.06 0.07 0.14 0.27 0.10 0.09 1.00 0.55 0.12 0.09 0.09 0.12 0.15 0.14 0.12 0.15 0.08 0.07 0.15 0.15 0.13
P11 0.15 0.11 0.31 0.10 0.07 0.08 0.14 0.26 0.12 0.10 0.55 1.00 0.13 0.09 0.09 0.12 0.16 0.15 0.11 0.14 0.08 0.07 0.15 0.15 0.14
P12 0.13 0.06 0.09 0.09 0.08 0.07 0.14 0.10 0.08 0.07 0.12 0.13 1.00 0.18 0.09 0.15 0.14 0.14 0.13 0.21 0.08 0.07 0.16 0.14 0.13
P13 0.11 0.07 0.07 0.09 0.07 0.07 0.11 0.09 0.08 0.07 0.09 0.09 0.18 1.00 0.10 0.12 0.13 0.14 0.12 0.15 0.08 0.07 0.13 0.12 0.13
P14 0.09 0.12 0.06 0.27 0.11 0.12 0.08 0.08 0.11 0.09 0.09 0.09 0.09 0.10 1.00 0.07 0.11 0.10 0.06 0.10 0.13 0.11 0.11 0.10 0.09
P15 0.46 0.06 0.09 0.08 0.09 0.08 0.17 0.18 0.07 0.07 0.12 0.12 0.15 0.12 0.07 1.00 0.22 0.19 0.30 0.22 0.08 0.08 0.27 0.21 0.22
P16 0.26 0.08 0.12 0.11 0.08 0.08 0.20 0.27 0.08 0.07 0.15 0.16 0.14 0.13 0.11 0.22 1.00 0.33 0.18 0.26 0.09 0.08 0.52 0.69 0.31
P17 0.21 0.08 0.11 0.11 0.09 0.09 0.19 0.18 0.08 0.08 0.14 0.15 0.14 0.14 0.10 0.19 0.33 1.00 0.25 0.20 0.10 0.09 0.33 0.32 0.26
P18 0.27 0.06 0.09 0.07 0.08 0.08 0.16 0.15 0.06 0.06 0.12 0.11 0.13 0.12 0.06 0.30 0.18 0.25 1.00 0.18 0.09 0.08 0.19 0.18 0.19
P19 0.32 0.08 0.11 0.12 0.07 0.09 0.23 0.22 0.09 0.07 0.15 0.14 0.21 0.15 0.10 0.22 0.26 0.20 0.18 1.00 0.10 0.08 0.24 0.26 0.20
P20 0.09 0.10 0.05 0.14 0.08 0.48 0.09 0.07 0.09 0.11 0.08 0.08 0.08 0.08 0.13 0.08 0.09 0.10 0.09 0.10 1.00 0.33 0.09 0.09 0.08
P21 0.08 0.09 0.05 0.12 0.08 0.31 0.07 0.06 0.08 0.10 0.07 0.07 0.07 0.07 0.11 0.08 0.08 0.09 0.08 0.08 0.33 1.00 0.08 0.07 0.07
P22 0.23 0.08 0.11 0.11 0.09 0.08 0.19 0.26 0.09 0.08 0.15 0.15 0.16 0.13 0.11 0.27 0.52 0.33 0.19 0.24 0.09 0.08 1.00 0.50 0.32
P23 0.25 0.08 0.12 0.11 0.08 0.08 0.20 0.26 0.08 0.07 0.15 0.15 0.14 0.12 0.10 0.21 0.69 0.32 0.18 0.26 0.09 0.07 0.50 1.00 0.30
P24 0.23 0.07 0.10 0.10 0.08 0.08 0.23 0.22 0.07 0.07 0.13 0.14 0.13 0.13 0.09 0.22 0.31 0.26 0.19 0.20 0.08 0.07 0.32 0.30 1.00
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Table 4.2: Tanimoto similarity of all compounds synthesized from pleuromutilin. 
P
P
1
P
2
P
3
P
4
P
5
P
6
P
7
P
8
P
9
P
1
0
P
1
1
P
1
2
P
1
3
P
1
4
P
1
5
P
1
6
P
1
7
P
1
8
P
1
9
P
2
0
P
2
1
P
2
2
P
2
3
P
2
4
P
2
5
P
2
6
P
2
7
P
2
8
P
2
9
P
3
0
P
3
1
P
3
2
P
3
3
P
3
4
P
3
5
P
3
6
P
3
7
P
3
8
P
3
9
P
4
0
P
4
1
P
4
2
P
4
3
P
4
4
P
4
5
P
4
6
P
4
7
P
4
8
P
4
9
P
5
0
P
5
1
P
1
.0
0
0
.0
7
0
.1
2
0
.1
1
0
.0
7
0
.0
9
0
.2
0
0
.2
1
0
.0
8
0
.0
7
0
.1
5
0
.1
5
0
.1
3
0
.1
1
0
.0
9
0
.4
6
0
.2
6
0
.2
1
0
.2
7
0
.3
2
0
.0
9
0
.0
8
0
.2
3
0
.2
5
0
.2
3
0
.0
8
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.0
8
0
.0
8
0
.1
1
0
.1
1
0
.1
2
0
.1
2
0
.0
8
0
.0
8
0
.1
2
0
.0
8
0
.1
8
0
.2
1
0
.0
8
0
.0
7
0
.1
5
0
.1
2
0
.1
2
0
.0
9
0
.1
1
0
.1
1
0
.0
8
0
.1
1
P
1
0
.0
7
1
.0
0
0
.0
8
0
.1
1
0
.0
7
0
.1
0
0
.0
7
0
.1
1
0
.2
0
0
.2
1
0
.1
1
0
.1
1
0
.0
6
0
.0
7
0
.1
2
0
.0
6
0
.0
8
0
.0
8
0
.0
6
0
.0
8
0
.1
0
0
.0
9
0
.0
8
0
.0
8
0
.0
7
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
9
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
6
0
.1
1
0
.0
6
0
.1
1
0
.0
7
0
.0
8
0
.1
6
0
.1
8
0
.0
9
0
.0
6
0
.0
8
0
.0
5
0
.0
7
0
.0
7
0
.1
0
0
.0
8
P
2
0
.1
2
0
.0
8
1
.0
0
0
.0
7
0
.0
5
0
.0
5
0
.1
1
0
.1
7
0
.0
7
0
.0
6
0
.3
9
0
.3
1
0
.0
9
0
.0
7
0
.0
6
0
.0
9
0
.1
2
0
.1
1
0
.0
9
0
.1
1
0
.0
5
0
.0
5
0
.1
1
0
.1
2
0
.1
0
0
.0
5
0
.0
4
0
.0
4
0
.0
4
0
.0
6
0
.0
6
0
.0
6
0
.6
5
0
.6
4
0
.4
4
0
.4
0
0
.2
9
0
.2
3
0
.7
8
0
.2
3
0
.1
1
0
.1
4
0
.0
6
0
.0
5
0
.3
3
0
.7
8
0
.2
1
0
.4
6
0
.5
7
0
.5
6
0
.2
3
0
.5
5
P
3
0
.1
1
0
.1
1
0
.0
7
1
.0
0
0
.1
1
0
.1
3
0
.0
9
0
.0
9
0
.1
2
0
.0
8
0
.0
9
0
.1
0
0
.0
9
0
.0
9
0
.2
7
0
.0
8
0
.1
1
0
.1
1
0
.0
7
0
.1
2
0
.1
4
0
.1
2
0
.1
1
0
.1
1
0
.1
0
0
.1
2
0
.0
8
0
.0
8
0
.0
9
0
.0
8
0
.1
1
0
.1
1
0
.0
7
0
.0
7
0
.0
7
0
.0
7
0
.0
5
0
.0
7
0
.0
7
0
.0
8
0
.0
7
0
.0
9
0
.1
2
0
.0
8
0
.0
9
0
.0
7
0
.0
8
0
.0
6
0
.0
7
0
.0
7
0
.0
9
0
.0
8
P
4
0
.0
7
0
.0
7
0
.0
5
0
.1
1
1
.0
0
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
8
0
.0
6
0
.0
7
0
.0
8
0
.0
7
0
.1
1
0
.0
9
0
.0
8
0
.0
9
0
.0
8
0
.0
7
0
.0
8
0
.0
8
0
.0
9
0
.0
8
0
.0
8
0
.4
4
0
.2
2
0
.2
2
0
.2
2
0
.2
0
0
.1
1
0
.2
0
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
4
0
.0
6
0
.0
5
0
.0
7
0
.0
7
0
.0
6
0
.0
7
0
.0
8
0
.0
6
0
.0
5
0
.0
8
0
.0
6
0
.0
5
0
.0
5
0
.0
7
0
.0
6
P
5
0
.0
9
0
.1
0
0
.0
5
0
.1
3
0
.0
8
1
.0
0
0
.0
8
0
.0
7
0
.0
9
0
.1
0
0
.0
7
0
.0
8
0
.0
7
0
.0
7
0
.1
2
0
.0
8
0
.0
8
0
.0
9
0
.0
8
0
.0
9
0
.4
8
0
.3
1
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
8
0
.0
6
0
.0
6
0
.0
5
0
.0
6
0
.0
6
0
.0
8
0
.0
5
0
.0
8
0
.0
6
0
.0
7
0
.0
9
0
.1
0
0
.0
7
0
.0
5
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
8
0
.0
6
P
6
0
.2
0
0
.0
7
0
.1
1
0
.0
9
0
.0
6
0
.0
8
1
.0
0
0
.1
8
0
.0
8
0
.0
6
0
.1
4
0
.1
4
0
.1
4
0
.1
1
0
.0
8
0
.1
7
0
.2
0
0
.1
9
0
.1
6
0
.2
3
0
.0
9
0
.0
7
0
.1
9
0
.2
0
0
.2
3
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
4
0
.0
7
0
.0
8
0
.1
1
0
.1
1
0
.1
1
0
.1
1
0
.0
8
0
.0
6
0
.1
1
0
.0
6
0
.1
4
0
.1
8
0
.0
8
0
.0
6
0
.1
4
0
.1
1
0
.1
1
0
.0
8
0
.1
0
0
.1
0
0
.0
6
0
.1
1
P
7
0
.2
1
0
.1
1
0
.1
7
0
.0
9
0
.0
6
0
.0
7
0
.1
8
1
.0
0
0
.1
0
0
.0
8
0
.2
7
0
.2
6
0
.1
0
0
.0
9
0
.0
8
0
.1
8
0
.2
7
0
.1
8
0
.1
5
0
.2
2
0
.0
7
0
.0
6
0
.2
6
0
.2
6
0
.2
2
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
4
0
.0
7
0
.0
8
0
.1
6
0
.1
6
0
.1
7
0
.1
8
0
.1
2
0
.0
6
0
.1
4
0
.0
6
0
.4
3
0
.6
9
0
.0
8
0
.0
6
0
.2
3
0
.1
4
0
.1
9
0
.1
1
0
.1
3
0
.1
4
0
.0
7
0
.1
4
P
8
0
.0
8
0
.2
0
0
.0
7
0
.1
2
0
.0
7
0
.0
9
0
.0
8
0
.1
0
1
.0
0
0
.2
0
0
.1
0
0
.1
2
0
.0
8
0
.0
8
0
.1
1
0
.0
7
0
.0
8
0
.0
8
0
.0
6
0
.0
9
0
.0
9
0
.0
8
0
.0
9
0
.0
8
0
.0
7
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
5
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
7
0
.0
8
0
.0
6
0
.0
9
0
.0
6
0
.1
0
0
.0
7
0
.0
8
0
.7
3
0
.1
7
0
.0
8
0
.0
6
0
.0
9
0
.0
6
0
.0
7
0
.0
7
0
.0
8
0
.0
8
P
9
0
.0
7
0
.2
1
0
.0
6
0
.0
8
0
.0
8
0
.1
0
0
.0
6
0
.0
8
0
.2
0
1
.0
0
0
.0
9
0
.1
0
0
.0
7
0
.0
7
0
.0
9
0
.0
7
0
.0
7
0
.0
8
0
.0
6
0
.0
7
0
.1
1
0
.1
0
0
.0
8
0
.0
7
0
.0
7
0
.0
7
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
8
0
.0
7
0
.0
7
0
.0
6
0
.0
6
0
.0
5
0
.1
0
0
.0
5
0
.1
1
0
.0
6
0
.0
6
0
.1
7
0
.7
4
0
.0
7
0
.0
5
0
.0
8
0
.0
5
0
.0
6
0
.0
6
0
.1
0
0
.0
7
P
1
0
0
.1
5
0
.1
1
0
.3
9
0
.0
9
0
.0
6
0
.0
7
0
.1
4
0
.2
7
0
.1
0
0
.0
9
1
.0
0
0
.5
5
0
.1
2
0
.0
9
0
.0
9
0
.1
2
0
.1
5
0
.1
4
0
.1
2
0
.1
5
0
.0
8
0
.0
7
0
.1
5
0
.1
5
0
.1
3
0
.0
7
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
8
0
.0
8
0
.3
1
0
.3
1
0
.3
9
0
.4
1
0
.2
6
0
.0
8
0
.3
3
0
.0
8
0
.2
0
0
.2
3
0
.0
8
0
.0
7
0
.7
0
0
.3
3
0
.3
5
0
.2
1
0
.2
5
0
.2
5
0
.0
7
0
.2
6
P
1
1
0
.1
5
0
.1
1
0
.3
1
0
.1
0
0
.0
7
0
.0
8
0
.1
4
0
.2
6
0
.1
2
0
.1
0
0
.5
5
1
.0
0
0
.1
3
0
.0
9
0
.0
9
0
.1
2
0
.1
6
0
.1
5
0
.1
1
0
.1
4
0
.0
8
0
.0
7
0
.1
5
0
.1
5
0
.1
4
0
.0
8
0
.0
6
0
.0
6
0
.0
6
0
.0
5
0
.0
8
0
.1
0
0
.4
1
0
.3
4
0
.3
2
0
.3
3
0
.2
2
0
.0
8
0
.2
6
0
.0
8
0
.1
9
0
.2
2
0
.0
9
0
.0
8
0
.4
5
0
.2
6
0
.4
7
0
.2
8
0
.3
4
0
.3
4
0
.0
8
0
.3
5
P
1
2
0
.1
3
0
.0
6
0
.0
9
0
.0
9
0
.0
8
0
.0
7
0
.1
4
0
.1
0
0
.0
8
0
.0
7
0
.1
2
0
.1
3
1
.0
0
0
.1
8
0
.0
9
0
.1
5
0
.1
4
0
.1
4
0
.1
3
0
.2
1
0
.0
8
0
.0
7
0
.1
6
0
.1
4
0
.1
3
0
.0
8
0
.0
5
0
.0
5
0
.0
6
0
.0
5
0
.0
8
0
.0
7
0
.0
9
0
.0
9
0
.0
9
0
.0
9
0
.0
7
0
.0
5
0
.0
9
0
.0
6
0
.1
2
0
.1
0
0
.0
8
0
.0
7
0
.1
2
0
.0
9
0
.1
5
0
.1
1
0
.1
0
0
.0
9
0
.0
7
0
.1
0
P
1
3
0
.1
1
0
.0
7
0
.0
7
0
.0
9
0
.0
7
0
.0
7
0
.1
1
0
.0
9
0
.0
8
0
.0
7
0
.0
9
0
.0
9
0
.1
8
1
.0
0
0
.1
0
0
.1
2
0
.1
3
0
.1
4
0
.1
2
0
.1
5
0
.0
8
0
.0
7
0
.1
3
0
.1
2
0
.1
3
0
.0
9
0
.0
5
0
.0
5
0
.0
6
0
.0
5
0
.0
7
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.0
7
0
.0
5
0
.0
5
0
.0
7
0
.0
6
0
.0
9
0
.0
9
0
.0
8
0
.0
7
0
.0
9
0
.0
7
0
.0
9
0
.0
7
0
.0
7
0
.0
7
0
.0
7
0
.0
8
P
1
4
0
.0
9
0
.1
2
0
.0
6
0
.2
7
0
.1
1
0
.1
2
0
.0
8
0
.0
8
0
.1
1
0
.0
9
0
.0
9
0
.0
9
0
.0
9
0
.1
0
1
.0
0
0
.0
7
0
.1
1
0
.1
0
0
.0
6
0
.1
0
0
.1
3
0
.1
1
0
.1
1
0
.1
0
0
.0
9
0
.1
3
0
.0
9
0
.0
9
0
.1
0
0
.0
9
0
.1
2
0
.1
1
0
.0
7
0
.0
7
0
.0
6
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
8
0
.1
1
0
.0
9
0
.0
9
0
.0
6
0
.0
8
0
.0
5
0
.0
7
0
.0
7
0
.0
9
0
.0
7
P
1
5
0
.4
6
0
.0
6
0
.0
9
0
.0
8
0
.0
9
0
.0
8
0
.1
7
0
.1
8
0
.0
7
0
.0
7
0
.1
2
0
.1
2
0
.1
5
0
.1
2
0
.0
7
1
.0
0
0
.2
2
0
.1
9
0
.3
0
0
.2
2
0
.0
8
0
.0
8
0
.2
7
0
.2
1
0
.2
2
0
.0
8
0
.0
7
0
.0
6
0
.0
7
0
.0
6
0
.0
9
0
.0
7
0
.0
9
0
.0
9
0
.0
9
0
.0
9
0
.0
6
0
.0
8
0
.0
9
0
.0
8
0
.2
2
0
.1
8
0
.0
7
0
.0
7
0
.1
2
0
.0
9
0
.1
5
0
.1
1
0
.0
9
0
.0
9
0
.0
7
0
.0
9
P
1
6
0
.2
6
0
.0
8
0
.1
2
0
.1
1
0
.0
8
0
.0
8
0
.2
0
0
.2
7
0
.0
8
0
.0
7
0
.1
5
0
.1
6
0
.1
4
0
.1
3
0
.1
1
0
.2
2
1
.0
0
0
.3
3
0
.1
8
0
.2
6
0
.0
9
0
.0
8
0
.5
2
0
.6
9
0
.3
1
0
.0
9
0
.0
7
0
.0
7
0
.0
7
0
.0
6
0
.0
8
0
.1
0
0
.1
2
0
.1
3
0
.1
2
0
.1
2
0
.0
9
0
.0
7
0
.1
2
0
.0
8
0
.2
5
0
.2
7
0
.0
8
0
.0
7
0
.1
5
0
.1
2
0
.1
4
0
.1
0
0
.1
4
0
.1
2
0
.0
8
0
.1
3
P
1
7
0
.2
1
0
.0
8
0
.1
1
0
.1
1
0
.0
9
0
.0
9
0
.1
9
0
.1
8
0
.0
8
0
.0
8
0
.1
4
0
.1
5
0
.1
4
0
.1
4
0
.1
0
0
.1
9
0
.3
3
1
.0
0
0
.2
5
0
.2
0
0
.1
0
0
.0
9
0
.3
3
0
.3
2
0
.2
6
0
.1
0
0
.0
8
0
.0
8
0
.0
8
0
.0
7
0
.0
8
0
.1
0
0
.1
1
0
.1
2
0
.1
1
0
.1
1
0
.0
8
0
.0
8
0
.1
1
0
.0
9
0
.1
7
0
.1
8
0
.0
8
0
.0
8
0
.1
4
0
.1
1
0
.1
3
0
.1
0
0
.1
3
0
.1
1
0
.0
9
0
.1
2
P
1
8
0
.2
7
0
.0
6
0
.0
9
0
.0
7
0
.0
8
0
.0
8
0
.1
6
0
.1
5
0
.0
6
0
.0
6
0
.1
2
0
.1
1
0
.1
3
0
.1
2
0
.0
6
0
.3
0
0
.1
8
0
.2
5
1
.0
0
0
.1
8
0
.0
9
0
.0
8
0
.1
9
0
.1
8
0
.1
9
0
.0
8
0
.0
7
0
.0
7
0
.0
7
0
.0
6
0
.0
8
0
.0
7
0
.0
8
0
.0
8
0
.0
9
0
.0
9
0
.0
6
0
.0
7
0
.0
9
0
.0
7
0
.1
6
0
.1
5
0
.0
6
0
.0
6
0
.1
2
0
.0
9
0
.1
2
0
.0
9
0
.0
9
0
.0
8
0
.0
7
0
.0
9
P
1
9
0
.3
2
0
.0
8
0
.1
1
0
.1
2
0
.0
7
0
.0
9
0
.2
3
0
.2
2
0
.0
9
0
.0
7
0
.1
5
0
.1
4
0
.2
1
0
.1
5
0
.1
0
0
.2
2
0
.2
6
0
.2
0
0
.1
8
1
.0
0
0
.1
0
0
.0
8
0
.2
4
0
.2
6
0
.2
0
0
.0
8
0
.0
6
0
.0
5
0
.0
6
0
.0
6
0
.0
9
0
.0
9
0
.1
1
0
.1
1
0
.1
1
0
.1
2
0
.0
8
0
.0
6
0
.1
1
0
.0
6
0
.1
8
0
.2
2
0
.0
9
0
.0
7
0
.1
5
0
.1
1
0
.1
1
0
.0
8
0
.1
0
0
.1
0
0
.0
7
0
.1
1
P
2
0
0
.0
9
0
.1
0
0
.0
5
0
.1
4
0
.0
8
0
.4
8
0
.0
9
0
.0
7
0
.0
9
0
.1
1
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.1
3
0
.0
8
0
.0
9
0
.1
0
0
.0
9
0
.1
0
1
.0
0
0
.3
3
0
.0
9
0
.0
9
0
.0
8
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
8
0
.0
9
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.0
4
0
.0
8
0
.0
5
0
.0
8
0
.0
6
0
.0
7
0
.0
9
0
.1
1
0
.0
8
0
.0
5
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
8
0
.0
7
P
2
1
0
.0
8
0
.0
9
0
.0
5
0
.1
2
0
.0
8
0
.3
1
0
.0
7
0
.0
6
0
.0
8
0
.1
0
0
.0
7
0
.0
7
0
.0
7
0
.0
7
0
.1
1
0
.0
8
0
.0
8
0
.0
9
0
.0
8
0
.0
8
0
.3
3
1
.0
0
0
.0
8
0
.0
7
0
.0
7
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
8
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
4
0
.0
8
0
.0
5
0
.0
7
0
.0
6
0
.0
6
0
.0
8
0
.1
0
0
.0
7
0
.0
5
0
.0
7
0
.0
5
0
.0
5
0
.0
5
0
.0
7
0
.0
6
P
2
2
0
.2
3
0
.0
8
0
.1
1
0
.1
1
0
.0
9
0
.0
8
0
.1
9
0
.2
6
0
.0
9
0
.0
8
0
.1
5
0
.1
5
0
.1
6
0
.1
3
0
.1
1
0
.2
7
0
.5
2
0
.3
3
0
.1
9
0
.2
4
0
.0
9
0
.0
8
1
.0
0
0
.5
0
0
.3
2
0
.0
9
0
.0
7
0
.0
7
0
.0
7
0
.0
6
0
.0
9
0
.1
0
0
.1
2
0
.1
2
0
.1
1
0
.1
2
0
.0
9
0
.0
8
0
.1
1
0
.0
9
0
.2
8
0
.2
6
0
.0
9
0
.0
8
0
.1
5
0
.1
1
0
.1
6
0
.1
2
0
.1
3
0
.1
2
0
.0
9
0
.1
2
P
2
3
0
.2
5
0
.0
8
0
.1
2
0
.1
1
0
.0
8
0
.0
8
0
.2
0
0
.2
6
0
.0
8
0
.0
7
0
.1
5
0
.1
5
0
.1
4
0
.1
2
0
.1
0
0
.2
1
0
.6
9
0
.3
2
0
.1
8
0
.2
6
0
.0
9
0
.0
7
0
.5
0
1
.0
0
0
.3
0
0
.0
9
0
.0
7
0
.0
7
0
.0
7
0
.0
6
0
.0
8
0
.1
0
0
.1
2
0
.1
2
0
.1
2
0
.1
2
0
.0
9
0
.0
7
0
.1
2
0
.0
8
0
.2
4
0
.2
6
0
.0
8
0
.0
7
0
.1
5
0
.1
2
0
.1
3
0
.1
0
0
.1
4
0
.1
2
0
.0
8
0
.1
3
P
2
4
0
.2
3
0
.0
7
0
.1
0
0
.1
0
0
.0
8
0
.0
8
0
.2
3
0
.2
2
0
.0
7
0
.0
7
0
.1
3
0
.1
4
0
.1
3
0
.1
3
0
.0
9
0
.2
2
0
.3
1
0
.2
6
0
.1
9
0
.2
0
0
.0
8
0
.0
7
0
.3
2
0
.3
0
1
.0
0
0
.0
8
0
.0
7
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
9
0
.1
0
0
.1
1
0
.1
0
0
.1
1
0
.0
8
0
.0
7
0
.1
0
0
.0
8
0
.2
0
0
.2
2
0
.0
7
0
.0
7
0
.1
3
0
.1
0
0
.1
2
0
.0
9
0
.1
2
0
.1
0
0
.0
8
0
.1
1
P
2
5
0
.0
8
0
.0
8
0
.0
5
0
.1
2
0
.4
4
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.0
8
0
.0
8
0
.0
9
0
.1
3
0
.0
8
0
.0
9
0
.1
0
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
9
0
.0
9
0
.0
8
1
.0
0
0
.2
2
0
.2
1
0
.2
2
0
.2
0
0
.1
1
0
.2
1
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
4
0
.0
5
0
.0
5
0
.0
7
0
.0
6
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.0
5
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
7
0
.0
6
P
2
6
0
.0
6
0
.0
6
0
.0
4
0
.0
8
0
.2
2
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
6
0
.0
6
0
.0
6
0
.0
5
0
.0
5
0
.0
9
0
.0
7
0
.0
7
0
.0
8
0
.0
7
0
.0
6
0
.0
6
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.2
2
1
.0
0
0
.3
8
0
.5
4
0
.4
1
0
.1
0
0
.2
0
0
.0
4
0
.0
4
0
.0
4
0
.0
4
0
.0
3
0
.0
5
0
.0
4
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
6
0
.0
6
0
.0
4
0
.0
7
0
.0
5
0
.0
4
0
.0
4
0
.0
5
0
.0
5
P
2
7
0
.0
6
0
.0
6
0
.0
4
0
.0
8
0
.2
2
0
.0
6
0
.0
5
0
.0
5
0
.0
6
0
.0
6
0
.0
5
0
.0
6
0
.0
5
0
.0
5
0
.0
9
0
.0
6
0
.0
7
0
.0
8
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
7
0
.0
7
0
.0
6
0
.2
1
0
.3
8
1
.0
0
0
.3
6
0
.3
2
0
.0
9
0
.1
9
0
.0
4
0
.0
4
0
.0
4
0
.0
4
0
.0
3
0
.0
5
0
.0
4
0
.0
6
0
.0
5
0
.0
5
0
.0
6
0
.0
6
0
.0
5
0
.0
4
0
.0
6
0
.0
4
0
.0
4
0
.0
4
0
.0
5
0
.0
5
P
2
8
0
.0
6
0
.0
7
0
.0
4
0
.0
9
0
.2
2
0
.0
7
0
.0
5
0
.0
5
0
.0
6
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
6
0
.1
0
0
.0
7
0
.0
7
0
.0
8
0
.0
7
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.0
7
0
.0
7
0
.2
2
0
.5
4
0
.3
6
1
.0
0
0
.4
1
0
.1
0
0
.1
9
0
.0
4
0
.0
4
0
.0
4
0
.0
4
0
.0
3
0
.0
5
0
.0
4
0
.0
5
0
.0
5
0
.0
5
0
.0
6
0
.0
7
0
.0
5
0
.0
4
0
.0
6
0
.0
5
0
.0
4
0
.0
4
0
.0
5
0
.0
5
P
2
9
0
.0
6
0
.0
6
0
.0
6
0
.0
8
0
.2
0
0
.0
6
0
.0
4
0
.0
4
0
.0
5
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
9
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.2
0
0
.4
1
0
.3
2
0
.4
1
1
.0
0
0
.0
9
0
.1
8
0
.0
7
0
.0
7
0
.0
6
0
.0
4
0
.0
5
0
.0
7
0
.0
6
0
.0
8
0
.0
5
0
.0
5
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.0
8
0
.0
7
P
3
0
0
.0
8
0
.0
7
0
.0
6
0
.1
1
0
.1
1
0
.0
7
0
.0
7
0
.0
7
0
.0
8
0
.0
7
0
.0
8
0
.0
8
0
.0
8
0
.0
7
0
.1
2
0
.0
9
0
.0
8
0
.0
8
0
.0
8
0
.0
9
0
.0
8
0
.0
7
0
.0
9
0
.0
8
0
.0
7
0
.1
1
0
.1
0
0
.0
9
0
.1
0
0
.0
9
1
.0
0
0
.0
9
0
.0
6
0
.0
6
0
.0
6
0
.0
6
0
.0
4
0
.0
6
0
.0
6
0
.0
6
0
.0
8
0
.0
7
0
.0
8
0
.0
7
0
.0
8
0
.0
6
0
.0
9
0
.0
6
0
.0
6
0
.0
6
0
.0
5
0
.0
6
P
3
1
0
.0
8
0
.0
9
0
.0
6
0
.1
1
0
.2
0
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.1
0
0
.0
7
0
.0
6
0
.1
1
0
.0
7
0
.1
0
0
.1
0
0
.0
7
0
.0
9
0
.0
9
0
.0
8
0
.1
0
0
.1
0
0
.0
9
0
.2
1
0
.2
0
0
.1
9
0
.1
9
0
.1
8
0
.0
9
1
.0
0
0
.0
7
0
.0
7
0
.0
6
0
.0
6
0
.0
5
0
.0
6
0
.0
6
0
.0
7
0
.0
6
0
.0
8
0
.0
8
0
.0
8
0
.0
8
0
.0
6
0
.0
8
0
.0
6
0
.0
7
0
.0
7
0
.0
8
0
.0
8
P
3
2
0
.1
1
0
.0
8
0
.6
5
0
.0
7
0
.0
5
0
.0
6
0
.1
1
0
.1
6
0
.0
8
0
.0
7
0
.3
1
0
.4
1
0
.0
9
0
.0
7
0
.0
7
0
.0
9
0
.1
2
0
.1
1
0
.0
8
0
.1
1
0
.0
6
0
.0
5
0
.1
2
0
.1
2
0
.1
0
0
.0
6
0
.0
4
0
.0
4
0
.0
4
0
.0
7
0
.0
6
0
.0
7
1
.0
0
0
.7
2
0
.3
3
0
.3
0
0
.2
3
0
.2
2
0
.5
8
0
.2
3
0
.1
1
0
.1
4
0
.0
7
0
.0
6
0
.2
6
0
.5
8
0
.2
8
0
.5
5
0
.7
2
0
.7
1
0
.2
3
0
.7
0
P
3
3
0
.1
1
0
.0
8
0
.6
4
0
.0
7
0
.0
5
0
.0
6
0
.1
1
0
.1
6
0
.0
8
0
.0
7
0
.3
1
0
.3
4
0
.0
9
0
.0
7
0
.0
7
0
.0
9
0
.1
3
0
.1
2
0
.0
8
0
.1
1
0
.0
6
0
.0
5
0
.1
2
0
.1
2
0
.1
1
0
.0
5
0
.0
4
0
.0
4
0
.0
4
0
.0
7
0
.0
6
0
.0
7
0
.7
2
1
.0
0
0
.3
3
0
.3
0
0
.2
4
0
.2
2
0
.5
6
0
.2
3
0
.1
1
0
.1
3
0
.0
7
0
.0
5
0
.2
6
0
.5
6
0
.2
3
0
.4
8
0
.6
1
0
.5
9
0
.2
3
0
.5
8
P
3
4
0
.1
2
0
.0
8
0
.4
4
0
.0
7
0
.0
5
0
.0
5
0
.1
1
0
.1
7
0
.0
7
0
.0
6
0
.3
9
0
.3
2
0
.0
9
0
.0
7
0
.0
6
0
.0
9
0
.1
2
0
.1
1
0
.0
9
0
.1
1
0
.0
6
0
.0
5
0
.1
1
0
.1
2
0
.1
0
0
.0
5
0
.0
4
0
.0
4
0
.0
4
0
.0
6
0
.0
6
0
.0
6
0
.3
3
0
.3
3
1
.0
0
0
.6
1
0
.4
1
0
.1
0
0
.3
7
0
.1
0
0
.1
1
0
.1
4
0
.0
6
0
.0
5
0
.3
4
0
.3
7
0
.2
1
0
.2
3
0
.2
7
0
.2
7
0
.1
0
0
.2
7
P
3
5
0
.1
2
0
.0
8
0
.4
0
0
.0
7
0
.0
5
0
.0
6
0
.1
1
0
.1
8
0
.0
8
0
.0
6
0
.4
1
0
.3
3
0
.0
9
0
.0
7
0
.0
7
0
.0
9
0
.1
2
0
.1
1
0
.0
9
0
.1
2
0
.0
6
0
.0
5
0
.1
2
0
.1
2
0
.1
1
0
.0
5
0
.0
4
0
.0
4
0
.0
4
0
.0
4
0
.0
6
0
.0
6
0
.3
0
0
.3
0
0
.6
1
1
.0
0
0
.4
2
0
.0
8
0
.3
4
0
.0
8
0
.1
2
0
.1
5
0
.0
6
0
.0
5
0
.3
5
0
.3
4
0
.2
2
0
.2
0
0
.2
4
0
.2
5
0
.0
8
0
.2
4
P
3
6
0
.0
8
0
.0
6
0
.2
9
0
.0
5
0
.0
4
0
.0
6
0
.0
8
0
.1
2
0
.0
6
0
.0
5
0
.2
6
0
.2
2
0
.0
7
0
.0
5
0
.0
5
0
.0
6
0
.0
9
0
.0
8
0
.0
6
0
.0
8
0
.0
4
0
.0
4
0
.0
9
0
.0
9
0
.0
8
0
.0
4
0
.0
3
0
.0
3
0
.0
3
0
.0
5
0
.0
4
0
.0
5
0
.2
3
0
.2
4
0
.4
1
0
.4
2
1
.0
0
0
.0
7
0
.2
5
0
.0
8
0
.0
8
0
.1
0
0
.0
5
0
.0
4
0
.2
3
0
.2
5
0
.1
5
0
.1
6
0
.2
0
0
.2
0
0
.0
7
0
.1
9
P
3
7
0
.0
8
0
.1
1
0
.2
3
0
.0
7
0
.0
6
0
.0
8
0
.0
6
0
.0
6
0
.0
9
0
.1
0
0
.0
8
0
.0
8
0
.0
5
0
.0
5
0
.0
6
0
.0
8
0
.0
7
0
.0
8
0
.0
7
0
.0
6
0
.0
8
0
.0
8
0
.0
8
0
.0
7
0
.0
7
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
7
0
.0
6
0
.0
6
0
.2
2
0
.2
2
0
.1
0
0
.0
8
0
.0
7
1
.0
0
0
.2
3
0
.7
0
0
.0
6
0
.0
6
0
.0
9
0
.1
0
0
.0
8
0
.2
3
0
.0
8
0
.2
3
0
.2
3
0
.2
2
0
.3
8
0
.2
2
P
3
8
0
.1
2
0
.0
6
0
.7
8
0
.0
7
0
.0
5
0
.0
5
0
.1
1
0
.1
4
0
.0
6
0
.0
5
0
.3
3
0
.2
6
0
.0
9
0
.0
7
0
.0
6
0
.0
9
0
.1
2
0
.1
1
0
.0
9
0
.1
1
0
.0
5
0
.0
5
0
.1
1
0
.1
2
0
.1
0
0
.0
5
0
.0
4
0
.0
4
0
.0
4
0
.0
6
0
.0
6
0
.0
6
0
.5
8
0
.5
6
0
.3
7
0
.3
4
0
.2
5
0
.2
3
1
.0
0
0
.2
3
0
.1
1
0
.1
4
0
.0
6
0
.0
5
0
.3
3
0
.7
8
0
.2
1
0
.4
6
0
.5
7
0
.5
5
0
.2
3
0
.5
5
P
3
9
0
.0
8
0
.1
1
0
.2
3
0
.0
8
0
.0
7
0
.0
8
0
.0
6
0
.0
6
0
.1
0
0
.1
1
0
.0
8
0
.0
8
0
.0
6
0
.0
6
0
.0
7
0
.0
8
0
.0
8
0
.0
9
0
.0
7
0
.0
6
0
.0
8
0
.0
7
0
.0
9
0
.0
8
0
.0
8
0
.0
7
0
.0
5
0
.0
6
0
.0
5
0
.0
8
0
.0
6
0
.0
7
0
.2
3
0
.2
3
0
.1
0
0
.0
8
0
.0
8
0
.7
0
0
.2
3
1
.0
0
0
.0
6
0
.0
6
0
.1
0
0
.1
1
0
.0
8
0
.2
3
0
.0
8
0
.2
4
0
.2
4
0
.2
3
0
.3
9
0
.2
3
P
4
0
0
.1
8
0
.0
7
0
.1
1
0
.0
7
0
.0
7
0
.0
6
0
.1
4
0
.4
3
0
.0
7
0
.0
6
0
.2
0
0
.1
9
0
.1
2
0
.0
9
0
.0
6
0
.2
2
0
.2
5
0
.1
7
0
.1
6
0
.1
8
0
.0
6
0
.0
6
0
.2
8
0
.2
4
0
.2
0
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
8
0
.0
6
0
.1
1
0
.1
1
0
.1
1
0
.1
2
0
.0
8
0
.0
6
0
.1
1
0
.0
6
1
.0
0
0
.4
3
0
.0
7
0
.0
6
0
.2
0
0
.1
1
0
.2
3
0
.1
3
0
.1
1
0
.1
1
0
.0
6
0
.1
2
P
4
1
0
.2
1
0
.0
8
0
.1
4
0
.0
9
0
.0
6
0
.0
7
0
.1
8
0
.6
9
0
.0
8
0
.0
6
0
.2
3
0
.2
2
0
.1
0
0
.0
9
0
.0
8
0
.1
8
0
.2
7
0
.1
8
0
.1
5
0
.2
2
0
.0
7
0
.0
6
0
.2
6
0
.2
6
0
.2
2
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
5
0
.0
7
0
.0
8
0
.1
4
0
.1
3
0
.1
4
0
.1
5
0
.1
0
0
.0
6
0
.1
4
0
.0
6
0
.4
3
1
.0
0
0
.1
0
0
.0
8
0
.2
7
0
.1
7
0
.1
9
0
.1
1
0
.1
3
0
.1
3
0
.0
7
0
.1
4
P
4
2
0
.0
8
0
.1
6
0
.0
6
0
.1
2
0
.0
7
0
.0
9
0
.0
8
0
.0
8
0
.7
3
0
.1
7
0
.0
8
0
.0
9
0
.0
8
0
.0
8
0
.1
1
0
.0
7
0
.0
8
0
.0
8
0
.0
6
0
.0
9
0
.0
9
0
.0
8
0
.0
9
0
.0
8
0
.0
7
0
.0
7
0
.0
5
0
.0
6
0
.0
6
0
.0
6
0
.0
8
0
.0
8
0
.0
7
0
.0
7
0
.0
6
0
.0
6
0
.0
5
0
.0
9
0
.0
6
0
.1
0
0
.0
7
0
.1
0
1
.0
0
0
.2
0
0
.1
0
0
.0
7
0
.0
9
0
.0
6
0
.0
7
0
.0
7
0
.0
8
0
.0
8
P
4
3
0
.0
7
0
.1
8
0
.0
5
0
.0
8
0
.0
8
0
.1
0
0
.0
6
0
.0
6
0
.1
7
0
.7
4
0
.0
7
0
.0
8
0
.0
7
0
.0
7
0
.0
9
0
.0
7
0
.0
7
0
.0
8
0
.0
6
0
.0
7
0
.1
1
0
.1
0
0
.0
8
0
.0
7
0
.0
7
0
.0
7
0
.0
6
0
.0
6
0
.0
7
0
.0
7
0
.0
7
0
.0
8
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
4
0
.1
0
0
.0
5
0
.1
1
0
.0
6
0
.0
8
0
.2
0
1
.0
0
0
.0
9
0
.0
6
0
.0
8
0
.0
5
0
.0
6
0
.0
6
0
.1
0
0
.0
7
P
4
4
0
.1
5
0
.0
9
0
.3
3
0
.0
9
0
.0
6
0
.0
7
0
.1
4
0
.2
3
0
.0
8
0
.0
7
0
.7
0
0
.4
5
0
.1
2
0
.0
9
0
.0
9
0
.1
2
0
.1
5
0
.1
4
0
.1
2
0
.1
5
0
.0
8
0
.0
7
0
.1
5
0
.1
5
0
.1
3
0
.0
7
0
.0
6
0
.0
5
0
.0
5
0
.0
6
0
.0
8
0
.0
8
0
.2
6
0
.2
6
0
.3
4
0
.3
5
0
.2
3
0
.0
8
0
.3
3
0
.0
8
0
.2
0
0
.2
7
0
.1
0
0
.0
9
1
.0
0
0
.3
9
0
.3
5
0
.2
1
0
.2
5
0
.2
5
0
.0
7
0
.2
6
P
4
5
0
.1
2
0
.0
6
0
.7
8
0
.0
7
0
.0
5
0
.0
5
0
.1
1
0
.1
4
0
.0
6
0
.0
5
0
.3
3
0
.2
6
0
.0
9
0
.0
7
0
.0
6
0
.0
9
0
.1
2
0
.1
1
0
.0
9
0
.1
1
0
.0
5
0
.0
5
0
.1
1
0
.1
2
0
.1
0
0
.0
5
0
.0
4
0
.0
4
0
.0
4
0
.0
7
0
.0
6
0
.0
6
0
.5
8
0
.5
6
0
.3
7
0
.3
4
0
.2
5
0
.2
3
0
.7
8
0
.2
3
0
.1
1
0
.1
7
0
.0
7
0
.0
6
0
.3
9
1
.0
0
0
.2
1
0
.4
6
0
.5
7
0
.5
5
0
.2
3
0
.5
5
P
4
6
0
.1
2
0
.0
8
0
.2
1
0
.0
8
0
.0
8
0
.0
7
0
.1
1
0
.1
9
0
.0
9
0
.0
8
0
.3
5
0
.4
7
0
.1
5
0
.0
9
0
.0
8
0
.1
5
0
.1
4
0
.1
3
0
.1
2
0
.1
1
0
.0
7
0
.0
7
0
.1
6
0
.1
3
0
.1
2
0
.0
7
0
.0
7
0
.0
6
0
.0
6
0
.0
6
0
.0
9
0
.0
8
0
.2
8
0
.2
3
0
.2
1
0
.2
2
0
.1
5
0
.0
8
0
.2
1
0
.0
8
0
.2
3
0
.1
9
0
.0
9
0
.0
8
0
.3
5
0
.2
1
1
.0
0
0
.3
8
0
.2
9
0
.2
8
0
.0
8
0
.3
0
P
4
7
0
.0
9
0
.0
5
0
.4
6
0
.0
6
0
.0
6
0
.0
5
0
.0
8
0
.1
1
0
.0
6
0
.0
5
0
.2
1
0
.2
8
0
.1
1
0
.0
7
0
.0
5
0
.1
1
0
.1
0
0
.1
0
0
.0
9
0
.0
8
0
.0
5
0
.0
5
0
.1
2
0
.1
0
0
.0
9
0
.0
5
0
.0
5
0
.0
4
0
.0
5
0
.0
7
0
.0
6
0
.0
6
0
.5
5
0
.4
8
0
.2
3
0
.2
0
0
.1
6
0
.2
3
0
.4
6
0
.2
4
0
.1
3
0
.1
1
0
.0
6
0
.0
5
0
.2
1
0
.4
6
0
.3
8
1
.0
0
0
.5
6
0
.5
5
0
.2
3
0
.5
5
P
4
8
0
.1
1
0
.0
7
0
.5
7
0
.0
7
0
.0
5
0
.0
6
0
.1
0
0
.1
3
0
.0
7
0
.0
6
0
.2
5
0
.3
4
0
.1
0
0
.0
7
0
.0
7
0
.0
9
0
.1
4
0
.1
3
0
.0
9
0
.1
0
0
.0
6
0
.0
5
0
.1
3
0
.1
4
0
.1
2
0
.0
6
0
.0
4
0
.0
4
0
.0
4
0
.0
7
0
.0
6
0
.0
7
0
.7
2
0
.6
1
0
.2
7
0
.2
4
0
.2
0
0
.2
3
0
.5
7
0
.2
4
0
.1
1
0
.1
3
0
.0
7
0
.0
6
0
.2
5
0
.5
7
0
.2
9
0
.5
6
1
.0
0
0
.7
2
0
.2
4
0
.7
2
P
4
9
0
.1
1
0
.0
7
0
.5
6
0
.0
7
0
.0
5
0
.0
6
0
.1
0
0
.1
4
0
.0
7
0
.0
6
0
.2
5
0
.3
4
0
.0
9
0
.0
7
0
.0
7
0
.0
9
0
.1
2
0
.1
1
0
.0
8
0
.1
0
0
.0
6
0
.0
5
0
.1
2
0
.1
2
0
.1
0
0
.0
6
0
.0
4
0
.0
4
0
.0
4
0
.0
7
0
.0
6
0
.0
7
0
.7
1
0
.5
9
0
.2
7
0
.2
5
0
.2
0
0
.2
2
0
.5
5
0
.2
3
0
.1
1
0
.1
3
0
.0
7
0
.0
6
0
.2
5
0
.5
5
0
.2
8
0
.5
5
0
.7
2
1
.0
0
0
.2
3
0
.7
0
P
5
0
0
.0
8
0
.1
0
0
.2
3
0
.0
9
0
.0
7
0
.0
8
0
.0
6
0
.0
7
0
.0
8
0
.1
0
0
.0
7
0
.0
8
0
.0
7
0
.0
7
0
.0
9
0
.0
7
0
.0
8
0
.0
9
0
.0
7
0
.0
7
0
.0
8
0
.0
7
0
.0
9
0
.0
8
0
.0
8
0
.0
7
0
.0
5
0
.0
5
0
.0
5
0
.0
8
0
.0
5
0
.0
8
0
.2
3
0
.2
3
0
.1
0
0
.0
8
0
.0
7
0
.3
8
0
.2
3
0
.3
9
0
.0
6
0
.0
7
0
.0
8
0
.1
0
0
.0
7
0
.2
3
0
.0
8
0
.2
3
0
.2
4
0
.2
3
1
.0
0
0
.2
3
P
5
1
0
.1
1
0
.0
8
0
.5
5
0
.0
8
0
.0
6
0
.0
6
0
.1
1
0
.1
4
0
.0
8
0
.0
7
0
.2
6
0
.3
5
0
.1
0
0
.0
8
0
.0
7
0
.0
9
0
.1
3
0
.1
2
0
.0
9
0
.1
1
0
.0
7
0
.0
6
0
.1
2
0
.1
3
0
.1
1
0
.0
6
0
.0
5
0
.0
5
0
.0
5
0
.0
7
0
.0
6
0
.0
8
0
.7
0
0
.5
8
0
.2
7
0
.2
4
0
.1
9
0
.2
2
0
.5
5
0
.2
3
0
.1
2
0
.1
4
0
.0
8
0
.0
7
0
.2
6
0
.5
5
0
.3
0
0
.5
5
0
.7
2
0
.7
0
0
.2
3
1
.0
0
211 
 
4.6 Conclusion  
Ring distortion was an efficient and effective method for the creation of structurally diverse 
molecules from pleuromutilin. Carbocation rearrangements of pleuromutilin and related 
compounds enabled dramatic structural changes to be made to the core scaffold. Base-catalyzed 
cleavage of the 8-membered ring of pleuromutilin and ring fusion by C-H amidation were also 
successfully employed to alter the pleuromutilin ring system and facilitate further ring distortion 
reactions. Through this complexity-to-diversity strategy, 6 target scaffolds were prepared in short 
synthetic sequences of 4-5 steps. In the course of the synthesis and characterization of these 
scaffolds, an additional 18 structurally complex compounds were obtained and added to the 
collection. From this collection a novel oxafenestrane containing a highly planarized carbon atom 
was identified and characterized. Several derivatives of this scaffold were prepared to probe the 
structural effects of bulky substituents and ring size on the degree of planarization. Additionally, 
a class of cytotoxic pleuromutilin derivatives were identified in a screen for cancer cell 
cytotoxicity. Analysis of structure-activity relationships indicated that these compounds likely 
induce cytotoxicity via covalent modification of a cysteine-containing target(s). Cheminformatic 
evaluation of the 51 compounds created from pleuromutilin shows that they exhibit exceptional 
molecular complexity and are quite structurally diverse.         
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4.7 Methods and Characterization 
All chemical reagents were purchased from commercial sources and used without further 
purification. Pleuromutilin was purchased from Waterstone Technology (95% purity) and Bosche 
Scientific LLC (90% purity) and was used as received. Anhydrous dichloromethane, 
tetrahydrofuran, methanol, N,N-dimethylformamide, and acetonitrile used in this study were dried 
by percolation through columns packed with activated alumina under positive pressure of nitrogen. 
Reactions were monitored by thin layer chromatography using phosphomolybdic acid with cerium 
sulfate and heat or KMnO4 and heat as developing agents. Flash chromatography was performed 
using silica gel (230-400 mesh).  
NMR spectra were recorded on Varian Unity spectrometers at 500 MHz for 1H NMR and 
125 MHz for 13C NMR. Spectra were obtained in the following solvents (reference peaks included 
for 1H & 13C NMR):  CDCl3 (
1H NMR: 7.26 ppm; 13C NMR: 77.23 ppm), C6D6 (
1H NMR: 7.16 
ppm; 13C NMR: 128.06 ppm) and DMF-d7 (
1H NMR: 8.03 ppm; 13C NMR: 163.15 ppm).  NMR 
experiments were performed at room temperature unless otherwise indicated.  Chemical shift 
values for all 1H NMR and 13C NMR spectra are reported in parts per million (ppm).  1H NMR 
multiplicities are reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = 
sextet, m = multiplet, br = broad. 
 High resolution mass spectra (HRMS) were acquired using Waters Q-TOF Ultima ESI 
and Agilent 6230 ESI TOF LC/MS spectrometers. LCMS spectra were collected using an Agilent 
6230 ESI TOF LC/MS spectrometers (10 µL injection) with Agilent eclipse plus C18 columns 
(1.8 µm, 2.1 x 50 mm) with a gradient of 2.5-80% acetonitrile in water with 0.1% formic acid (0 
min 2.5%, 1 min 2.5%, 7 min 80%, 8 min 80%, 9 min 2.5%, 10 min 2.5%). 
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ES-2 human cancer cells were obtained from ATCC. ES-2 and HC T116 cells were grown 
in RPMI 1640 supplemented with 10% (v/v) fetal bovine serum, 100 µg/ml penicillin, and 100 
µg/mL streptomycin.  Cells were maintained in a humidified atmosphere with 95% air and 5% 
CO2. Cell lines were detached using 0.05% trypsin/EDTA. Fluorescence measurements were made 
on an Analyst HT (LJL Biosciences) or a Spectramax M3 (Molecular Devices, Sunnyvale, CA. 
4.7.1 Synthesis of Target Scaffolds from Pleuromutilin 
 
 
Procedure: To a stirred suspension of pleuromutilin (6.0 g, 16 mmol) in benzene (150 mL) and 
pentane (150 mL) at 0 C was added phosphorous pentachloride (10.0 g, 48 mmol). The reaction 
mixture was stirred at 0 C for 1 hour then poured onto ice. The crude mixture was extracted with 
ethyl acetate, washed with sodium bicarbonate and brine, dried with magnesium sulfate, passed 
through a plug of silica (1:1 ethyl aceteate:hexanes elution), and evaporated. The partially purified 
product was suspended in ethanol and sonicated. Filtration provided pure diene P7 (3.5 g, 58% 
yield). Crystals suitable for X-ray crystallography were grown by slow evaporation in ethyl acetate 
or by vapor diffusion (inner vial: 1:1 dichloromethane:ethyl acetate, outer vial: hexanes). 
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1H-NMR (CDCl3, 500 MHz): δ 6.39 (dd, J = 17.7, 11.1 Hz, 1H), 5.54 (dd, J = 12.5, 3.1 Hz, 1H), 
5.44 (dd, J = 33.1, 13.1 Hz, 1H), 5.16 (d, J = 11.0 Hz, 1H), 5.06 (s, 1H), 4.97 – 4.74 (m, 1H), 3.98 
(s, 2H), 2.41 (s, 1H), 2.35 – 2.23 (m, 2H), 2.23 – 2.01 (m, 3H), 1.79 – 1.68 (m, 1H), 1.68 – 1.55 
(m, 3H), 1.55 – 1.45 (m, 2H), 1.43 – 1.36 (m, 1H), 1.40 (s, 3H), 1.20 – 1.10 (m, 1H), 0.74 (d, J = 
2.5 Hz, 3H), 0.72 (d, J = 2.8 Hz, 3H). 
1H NMR (d7-DMF, 500 MHz, 80 °C): δ 6.47 (dd, J = 17.6, 11.0 Hz, 1H), 5.64 – 5.54 (m, 2H), 
5.19 – 5.11 (m, 2H), 5.09 – 5.03 (m, 1H), 4.38 – 4.25 (m, 2H), 2.70 (ddd, J = 11.6, 3.8 Hz, 1H), 
2.41 (s, 1H), 2.35 – 2.20 (m, 3H), 2.20 – 2.09 (m, 1H), 1.81 (ddd, J = 12.7, 9.7 Hz, 1H), 1.76 – 
1.66 (m, 1H), 1.66 – 1.47 (m, 4H), 1.43 (s, 3H), 1.43 – 1.35 (m, 1H), 1.21 (ddd, J = 17.5, 12.8, 4.5 
Hz, 1H), 0.81 – 0.73 (m, 6H). 
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13C NMR (d7-DMF, 125 MHz, 80 °C): δ 216.60, 167.75, 153.42, 138.23, 115.62, 115.02, 73.03, 
60.40, 46.41, 46.26, 42.52, 42.04, 41.70, 36.67, 36.18, 35.64, 30.79, 28.69, 26.50, 16.53, 15.91, 
14.82. 
HRMS(ESI): m/z calc. for C22H31ClO3Na [M+Na]
+: 401.1859, found: 401.1850. 
X-ray Crystallographic Data for P7: 
 
 
Table 4.3: Crystal data and structure refinement for bm61uas.  
 
Identification code  bm61uas 
Empirical formula    C22 H31 Cl O3  
Formula weight    378.92 
Temperature     183(2)K  
Wavelength     0.71073 Å  
Crystal system    Trigonal  
Space group    P3(2) 
Unit cell dimensions    a = 13.1784(16)Å α= 90°  
     b = 13.1784(16)Å β= 90(2) 
     c = 9.8668(12)Å  γ= 120°  
Volume      1484.0(5) Å3   
Z     3  
Density (calculated)  1.272 g/cm3  
Absorption coefficient 0.212 mm-1  
F(000)  612 
Crystal size 0.487 x 0.262 x 0.25 mm3  
Theta range for data collection  1.78 to 26.44°  
Index ranges -16<=h<=16, -16<=k<=16, -12<=l<=12  
Reflections collected   17657  
Independent reflections   4075 [R(int) = 0.0332]  
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(Cont. Table 4.3:) 
Completeness to theta = 26.44°  99.9 %  
Absorption correction  Integration 
Max. and min. transmission  0.9358 and 0.9701 
Refinement method  Full-matrix least-squares on F2  
Data / restraints / parameters  4075 / 3 / 244 
Goodness-of-fit on F2  1.031  
Final R indices [I>2sigma(I)] R1 = 0.0273, wR2 = 0.0675  
R indices (all data) R1 = 0.0292, wR2 = 0.06889 
Absolute structure (Flack) parameter 0.01(4)   
Largest diff. peak and hole 0.153 and -0.136 e Å-3  
 
 
 
Procedure: To a solution of diene P7 (800 mg, 2.11 mmol) and triethylamine (1.77 mL, 12.7 
mmol) in dichloromethane (35 mL) at 0 C was added tert-butyldimethylsilyl 
trifluoromethanesulfonate (1.46 mL, 6.33 mmol). The reaction was stirred for 2 hours while 
warming to room temperature before being quenched by addition of water. The biphasic mixture 
was extracted with dichloromethane, washed with brine, dried with magnesium sulfate, and 
evaporated. Purification by flash chromatography (1:9 ethyl acetate:hexanes) provided silyl enol 
ether P8 (1.04g, 99%) as a colorless oil. 
Note: The reaction to form P8 exclusively provides the tri-substituted silyl enol ether when fresh 
tert-butyldimethylsilyl trifluoromethanesulfonate is used. It was found that aged bottles of tert-
butyldimethylsilyl trifluoromethanesulfonate may produce a mixture of the tri- and tetra-
substituted silyl enol ether isomers. Additionally, isomerization of the tri-substituted enol ether 
will occur upon prolonged exposure to silica gel. However, it was found that the tetra-substituted 
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silyl enol ether isomerizes cleanly to the tri-substituted silyl enol ether after stirring for 1 hour at -
78 C under the Rubottom oxidation conditions employed in the synthesis of P9; thus, both isomers 
provide epoxide P9 after warming the reaction to room temperature.   
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.38 (dd, J = 17.7, 10.9 Hz, 1H), 5.66 (dd, J = 12.2, 3.0 Hz, 1H), 
5.57 – 5.43 (m, 1H), 5.13 (d, J = 11.3 Hz, 1H), 5.03 (s, 1H), 4.99 – 4.81 (m, 1H), 4.43 (s, 1H), 
3.97 (s, 2H), 2.66 (s, 1H), 2.52 (s, 1H), 2.22 – 1.99 (m, 3H), 1.78 (td, J = 12.7, 5.5 Hz, 1H), 1.66 
– 1.57 (m, 3H), 1.48 – 1.37 (m, 2H), 1.33 (d, J = 1.1 Hz, 3H), 1.32 – 1.27 (m, 1H), 0.95 (s, 9H), 
0.73 (d, J = 6.3 Hz, 3H), 0.67 (d, J = 6.5 Hz, 3H), 0.21 (s, 6H). 
1H-NMR (C6D6, 500 MHz, 60 C): δ 6.46 (dd, J = 17.6, 11.1 Hz, 1H), 5.79 (dd, J = 12.3, 2.9 Hz, 
1H), 5.53 (d, J = 17.9 Hz, 1H), 5.10 (d, J = 11.0 Hz, 1H), 5.05 – 5.01 (m, 1H), 4.90 (s, 1H), 4.48 
– 4.44 (m, 1H), 3.45 (s, 2H), 2.63 (t, J = 2.9 Hz, 1H), 2.39 (td, J = 11.7, 4.4 Hz, 1H), 2.14 (tt, J = 
13.3, 6.7 Hz, 1H), 2.09 – 2.01 (m, 2H), 1.83 (td, J = 13.5, 5.7 Hz, 1H), 1.76 – 1.54 (m, 3H), 1.49 
(s, 3H), 1.41 (dd, J = 14.1, 3.3 Hz, 1H), 1.33 (dd, J = 14.0, 4.4 Hz, 1H), 1.24 (dd, J = 13.7, 4.7 Hz, 
1H), 1.00 (s, 9H), 0.81 (d, J = 6.9 Hz, 3H), 0.73 (d, J = 6.7 Hz, 3H), 0.21 (s, 3H), 0.20 (s, 3H). 
13C-NMR (C6D6, 125 MHz, 60 C): δ 165.90, 157.55, 152.18, 136.80, 114.91, 113.69, 99.53, 
72.66, 70.16, 53.61, 48.48, 40.91, 40.77, 36.54, 36.11, 35.31, 34.88, 31.84, 28.08, 25.80, 18.18,  
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17.10, 16.24, 15.15, -4.56, -4.93. 
 HRMS(ESI): m/z calc. for C28H46O3SiCl [M+H]
+: 493.2905, found: 493.2904. 
 
 
Procedure: To a solution of m-chloroperoxybenzoic acid (1.4 g, 6 mmol), pyridine (886 μL, 11 
mmol), and glacial acetic acid (2.6 mL, 46 mmol) in dichloromethane (18 mL) at -78 C was added 
a solution of silyl enol ether P8 (1.0 g, 2 mmol) in dichloromethane (2 mL). The reaction was 
stirred at -78 C for one hour then warmed to 0 C and stirred an additional 3 hours while allowing 
the reaction to warm to room temperature. The reaction was quenched by addition saturated 
sodium sulfite and saturated sodium bicarbonate. The biphasic mixture was then extracted with 
dichloromethane and the combined organic layers were washed with brine, dried with magnesium 
sulfate, and evaporated. Purification by flash chromatography (1:5 ethyl aceteate:hexanes) 
provided a single isomer of epoxide P9 (420 mg, 40%) as a white foam. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.40 (dd, J = 17.4, 11.0 Hz, 1H), 5.70 (d, J = 12.1 Hz, 1H), 5.58 
– 5.44 (m, 1H), 5.20 – 5.08 (m, 1H), 5.07 – 4.99 (m, 1H), 4.96 – 4.77 (m, 1H), 4.15 (dt, J = 10.2, 
7.5 Hz, 1H), 3.99 (s, 2H), 2.81 – 2.71 (m, 1H), 2.66 (dt, J = 16.8, 9.5 Hz, 1H), 2.22 (dd, J = 12.0, 
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6.5 Hz, 1H), 1.69 (q, J = 12.8, 11.3 Hz, 3H), 1.54 – 1.45 (m, 3H), 1.40 (d, J = 10.7 Hz, 1H), 1.28 
– 1.17 (m, 1H), 1.21 (s, 3H), 1.09 (dd, J = 12.8, 8.0 Hz, 1H), 0.94 (d, J = 2.4 Hz, 9H), 0.80 (d, J = 
6.4 Hz, 3H), 0.58 (d, J = 6.5 Hz, 3H), 0.29 (s, 3H), 0.27 (s, 3H). 
1H-NMR (C6D6, 500 MHz, 60 C): δ 6.52 (dd, J = 17.6, 11.0 Hz, 1H), 5.83 (dd, J = 11.9, 2.7 Hz, 
1H), 5.56 (d, J = 17.5 Hz, 1H), 5.12 (d, J = 11.0 Hz, 1H), 5.06 (s, 1H), 5.03 – 4.95 (m, 1H), 3.99 
(dt, J = 10.0, 7.6 Hz, 1H), 3.42 (s, 2H), 3.01 – 2.81 (m, 2H), 2.23 (dq, J = 11.5, 6.8 Hz, 1H), 1.74 
– 1.46 (m, 3H), 1.41 (s, 3H), 1.33 (ddd, J = 13.7, 4.4, 2.2 Hz, 1H), 1.24 – 1.11 (m, 2H), 1.03 (s, 
9H), 1.01 (d, J = 17.2 Hz, 1H), 0.98 – 0.87 (m, 2H), 0.79 (d, J = 6.8 Hz, 3H), 0.58 (d, J = 6.7 Hz, 
3H), 0.38 (s, 3H), 0.36 (s, 3H).  
13C-NMR (C6D6, 125 MHz, 60 C): δ 166.11, 152.57, 137.47, 115.06, 113.72, 89.93, 76.48, 73.27, 
72.17, 46.12, 44.71, 42.57, 41.09, 40.23, 38.21, 35.55, 34.92, 34.85, 27.61, 26.39, 18.70, 16.39, 
14.39, 14.06, -2.75, -2.98. 
HRMS(ESI): m/z calc. for C28H45O5SiClNa [M+Na]
+: 547.2622, found: 547.2621. 
 
Procedure: A solution of epoxide P9 (878 mg, 1.67 mmol) and triethylamine trihydrofluoride 
(2.72 mL, 16.7 mmol) in tetrahydrofuran (14 mL) was heated at 60 C for 3 hours. The reaction 
was then cooled to room temperature and quenched by addition of a solution of saturated sodium 
bicarbonate. The biphasic mixture was then extracted with ethyl acetate and the combined organic 
layers were washed with brine, dried with magnesium sulfate, and evaporated. The crude material 
was purified by flash chromatography (2:3 ethyl acetate:hexanes) to provide diol P10 (520 mg,  
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76%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.35 (dd, J = 17.5, 11.0 Hz, 1H), 5.40 (dd, J = 21.6, 12.6 Hz, 2H), 
5.09 (d, J = 11.0 Hz, 1H), 5.04 (s, 1H), 4.92 (s, 1H), 4.03 (s, 2H), 4.00 (d, J = 8.6 Hz, 1H), 3.29 (s, 
1H), 3.06 (s, 1H), 2.51 (s, 1H), 2.26 (s, 1H), 2.22 – 2.11 (m, 1H), 2.03 (ddd, J = 12.6, 8.3, 4.8 Hz, 
2H), 1.90 (d, J = 16.1 Hz, 1H), 1.79 – 1.64 (m, 2H), 1.63 – 1.52 (m, 1H), 1.48 – 1.36 (m, 1H), 1.43 
(s, 3H), 1.14 – 0.99 (m, 1H), 0.92 (d, J = 6.5 Hz, 3H), 0.89 (d, J = 8.0 Hz, 3H). 
1H-NMR (C6D6, 500 MHz, 60 C): δ 6.41 (dd, J = 17.4, 10.9 Hz, 1H), 5.57 – 5.39 (m, 2H), 5.06 
(d, J = 11.0 Hz, 1H), 5.01 (s, 1H), 4.91 (s, 1H), 3.81 (q, J = 6.7, 6.2 Hz, 1H), 3.47 (d, J = 3.2 Hz, 
2H), 3.37 – 3.27 (m, 1H), 3.14 (d, J = 32.6 Hz, 1H), 2.94 (d, J = 50.8 Hz, 1H), 2.53 – 2.39 (m, 
1H), 2.14 (ddd, J = 12.6, 7.3, 2.2 Hz, 1H), 1.96 (td, J = 7.0, 3.1 Hz, 1H), 1.81 (ddd, J = 14.8, 7.0, 
3.1 Hz, 1H), 1.72 – 1.58 (m, 2H), 1.49 (d, J = 2.8 Hz, 3H), 1.38 (qd, J = 13.6, 4.4 Hz, 1H), 1.15 – 
1.08 (m, 1H), 1.02 – 0.90 (m, 1H), 0.81 (d, J = 6.9 Hz, 3H), 0.73 (d, J = 6.9 Hz, 3H), 0.69 – 0.56 
(m, 1H). 
13C-NMR (C6D6, 125 MHz, 60 C): δ 211.48, 165.98, 153.37, 137.86, 114.72, 113.67, 84.72, 
75.50, 71.90, 45.68, 44.42, 41.03, 40.12, 39.88, 38.84, 37.82, 36.90, 35.68, 27.44, 16.69, 16.00,  
15.42. 
HRMS(ESI): m/z calc. for C22H31O5ClNa [M+Na]
+: 433.1758, found: 433.1756. 
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Procedure: To a solution of diol P10 (470 mg, 1.14 mmol) and proton sponge (366 mg, 1.70 
mmol) in dichloromethane (22.8 mL) containing molecular sieves was added trimethyl 
tetrafluoroborate (180 mg, 1.26 mmol). The reaction was stirred for 3 hours at room temperature 
and then quenched by addition of water. The crude mixture was extracted with dichloromethane, 
washed with brine, dried with magnesium sulfate, and evaporated. Purification by flash 
chromatography (1:3 ethyl acetate:hexanes) provided methyl ether P11 (393 mg, 81%) as a white 
solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.35 (dd, J = 17.5, 11.0 Hz, 1H), 5.51 – 5.34 (m, 2H), 5.13 – 4.98 
(m, 2H), 4.97 – 4.84 (m, 1H), 4.00 (s, 2H), 3.60 (ddd, J = 9.2, 7.1, 1.8 Hz, 1H), 3.57 – 3.49 (m, 
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3H), 3.37 – 3.16 (m, 1H), 2.88 (s, 1H), 2.46 – 2.23 (m, 1H), 2.23 – 2.10 (m, 1H), 2.10 – 1.99 (m, 
1H), 1.94 (dd, J = 12.4, 8.1 Hz, 1H), 1.89 – 1.74 (m, 2H), 1.67 (qd, J = 13.4, 4.4 Hz, 1H), 1.62 – 
1.47 (m, 1H), 1.42 (s, 3H), 1.46 – 1.39 (m, 1H), 0.99 (td, J = 13.3, 3.6 Hz, 1H), 0.91 – 0.84 (m, 
6H). 
1H-NMR (d7-DMF, 500 MHz, 80 °C): δ 6.47 (dd, J = 17.5, 11.0 Hz, 1H), 5.58 – 5.45 (m, 2H), 
5.21 (s, 1H), 5.12 (d, J = 11.0 Hz, 1H), 5.08 (s, 1H), 4.98 (s, 1H), 4.36 (d, J = 14.4 Hz, 1H), 4.31 
(d, J = 14.6 Hz, 1H), 3.69 (t, J = 7.9 Hz, 1H), 3.48 (s, 3H), 3.34 (ddd, J = 12.9, 8.3, 5.8 Hz, 1H), 
2.63 (ddd, J = 14.5, 10.7, 8.3 Hz, 1H), 2.23 – 2.15 (m, 1H), 2.12 (dd, J = 12.2, 7.5 Hz, 1H), 1.85 
(dd, J = 12.1, 8.3 Hz, 1H), 1.77 (dtd, J = 13.4, 6.6, 4.0 Hz, 1H), 1.73 – 1.66 (m, 2H), 1.66 – 1.56 
(m, 1H), 1.48 (d, J = 2.1 Hz, 3H), 1.48 – 1.38 (m, 1H), 1.09 (ddd, J = 15.0, 12.5, 5.0 Hz, 1H), 0.85 
(d, J = 7.1 Hz, 3H), 0.84 (d, J = 7.2 Hz, 3H). 
13C-NMR (d7-DMF, 500 MHz, 80 °C):  δ 209.37, 167.73, 154.70, 138.74, 115.18, 113.97, 84.10, 
80.55, 75.16, 58.65, 46.27, 45.22, 42.51, 40.86, 39.34, 39.24, 37.85, 35.72, 34.64, 28.19, 16.76, 
16.64, 14.74. 
HRMS(ESI): m/z calc. for C23H33O5ClNa [M+Na]
+: 447.1914, found: 447.1904 
 
Procedure: To a flask containing diol P10 (l00 mg, 0.24 mmol) in benzene (10 mL) and methanol 
(5 mL) at 0 C was added lead tetraacetate (129 mg, 0.29 mmol). The reaction was stirred at 0 C 
for 90 minutes then quenched by addition of a saturated solution of sodium bicarbonate and 
extracted with ethyl acetate. The combined organic layers were washed with brine, dried with 
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magnesium sulfate, and evaporated. Purification by flash chromatography (1:4 ethyl 
acetate:hexanes) afforded a single isomer of lactone P1 (42 mg, 43%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.27 (dd, J = 17.5, 11.0 Hz, 1H), 5.85 (d, J = 3.0 Hz, 1H), 5.44 (s, 
1H), 5.41 (d, J = 3.7 Hz, 1H), 5.07 (d, J = 11.0 Hz, 1H), 5.01 (s, 1H), 4.90 (s, 1H), 4.11 (d, J = 
14.9 Hz, 1H), 4.06 (d, J = 14.9 Hz, 1H), 2.99 (s, 1H), 2.39 (d, J = 13.3 Hz, 1H), 2.23 (s, 1H), 2.16 
(ddd, J = 15.9, 9.8, 3.6 Hz, 1H), 2.03 – 1.94 (m, 2H), 1.91 – 1.76 (m, 3H), 1.71 (dd, J = 11.8, 2.9 
Hz, 1H), 1.59 – 1.50 (m, 1H), 1.15 (s, 3H), 1.00 (d, J = 7.1 Hz, 3H), 0.85 (d, J = 7.2 Hz, 3H). 
1H-NMR (C6D6, 500 MHz, 60 C): δ 6.23 (dd, J = 17.5, 11.0 Hz, 1H), 5.55 (d, J = 17.5 Hz, 1H), 
5.50 (dd, J = 6.9, 3.8 Hz, 1H), 5.19 (d, J = 3.0 Hz, 1H), 5.01 (d, J = 11.1 Hz, 1H), 4.91 (s, 1H), 
4.77 (s, 1H), 3.67 (d, J = 1.8 Hz, 2H), 3.08 (td, J = 12.7, 4.3 Hz, 1H), 2.51 (ddd, J = 15.7, 6.7, 4.4 
Hz, 1H), 2.04 (ddd, J = 15.9, 9.5, 3.8 Hz, 1H), 1.95 (d, J = 13.2 Hz, 1H), 1.88 – 1.76 (m, 2H), 1.55 
– 1.37 (m, 2H), 1.24 (s, 3H), 1.22 – 1.11 (m, 3H), 0.78 (d, J = 7.0 Hz, 3H), 0.72 (d, J = 7.1 Hz, 
3H). 
13C-NMR (C6D6, 125 MHz, 60 C): δ 171.04, 166.58, 152.95, 138.05, 114.65, 114.04, 100.00, 
91.55, 72.65, 45.84, 45.55, 42.16, 41.08, 40.89, 40.08, 39.47, 38.73, 37.29, 28.47, 19.56, 19.53, 
15.99. 
HRMS(ESI): m/z calc. for C22H29 O5ClNa [M+Na]
+: 431.1601, found: 431.1597. 
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Procedure: To a solution of diene P10 (100 mg, 0.24 mmol) in dichloromethane (2.4 mL) was 
added 4-Phenyl-1,2,4-triazole-3,5-dione (63 mg, 0.36 mmol) and the reaction was stirred for 3 
hours at room temperature. Evaporated and purification by flash chromatography (2:1 ethyl 
acetate:hexanes) gave P2 (101 mg, 71%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 7.53 (d, J = 6.9 Hz, 2H), 7.47 (t, J = 6.7 Hz, 2H), 7.37 (t, J = 7.5 
Hz, 1H), 5.68 (s, 1H), 5.32 (d, J = 8.3 Hz, 1H), 4.30 – 4.07 (m, 4H), 4.04 (s, 2H), 4.03 – 3.97 (m, 
1H), 3.18 (s, 2H), 3.05 – 2.75 (m, 1H), 2.55 – 2.34 (m, 1H), 2.13 (dd, J = 13.2, 7.8 Hz, 1H), 2.10 
– 1.92 (m, 2H), 1.91 – 1.67 (m, 2H), 1.66 – 1.61 (m, 1H), 1.58 (d, J = 15.9 Hz, 1H), 1.49 – 1.39 
(m, 1H), 1.42 (s, 3H), 1.13 – 0.99 (m, 1H), 0.91 (t, J = 7.8 Hz, 6H). 
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1H-NMR (d7-DMF, 500 MHz, 80 °C): δ 7.66 – 7.58 (m, 2H), 7.53 (t, J = 7.9 Hz, 2H), 7.46 – 7.39 
(m, 1H), 5.82 (td, J = 3.2, 1.6 Hz, 1H), 5.47 (dd, J = 10.5, 3.1 Hz, 1H), 5.16 (s, 1H), 5.07 (s, 1H), 
4.41 – 4.34 (m, 1H), 4.36 (d, J = 2.1 Hz, 2H), 4.23 – 4.17 (m, 1H), 4.16 (h, J = 2.2 Hz, 2H), 3.99 
(t, J = 7.8 Hz, 1H), 3.30 – 3.21 (m, 1H), 2.76 – 2.69 (m, 1H), 2.17 (ddd, J = 16.9, 12.2, 7.0 Hz, 
2H), 1.88 (dd, J = 12.1, 8.4 Hz, 1H), 1.80 – 1.62 (m, 4H), 1.50 (s, 3H), 1.46 – 1.38 (m, 1H), 1.11 
(ddd, J = 14.8, 12.2, 5.5 Hz, 1H), 0.93 (d, J = 6.9 Hz, 3H), 0.87 (d, J = 6.1 Hz, 3H). 
13C-NMR (d7-DMF, 125 MHz, 80 °C): δ 211.35, 167.98, 153.62, 153.61, 139.86, 133.61, 129.91, 
128.82, 126.85, 116.89, 84.20, 74.90, 72.07, 46.37, 45.21, 44.35, 44.27, 43.35, 42.51, 38.39, 38.27, 
37.31, 36.59, 28.10, 17.15, 16.74, 14.68. 
HRMS(ESI): m/z calc. for C30H37N3O7Cl [M+H]
+: 586.2320, found: 586.2313. 
 
 
Procedure: Pleuromutilin (1.00 g, 2.6 mmol) was dissolved in trimethyl orthoformate (1.28 mL, 
11.7 mmol) and methanol (3.7 ml) and cooled to 0 C. Concentrated sulfuric acid (0.283 mL, 5.2 
mmol) was then added dropwise with stirring. The reaction was then heated to 30 C, stirred for 8 
hours, then cooled to room temperature. A solution of sodium hydroxide (832 mg, 20.8 mmol) in 
water (0.87 mL) was then added and the reaction was heated at 60 C for 2 hours. The crude 
reaction mixture was then cooled, diluted with water, and extracted with ethyl acetate. The 
combined organic layers were washed with brine, dried with magnesium sulfate, and evaporated. 
Purification by flash chromatography (1:5 ethyl acetate:hexanes) to provide alcohol P12 (637 mg, 
73%) as white solid.  
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1H-NMR (CDCl3, 500 MHz): δ 6.00 (dd, J = 17.6, 10.8 Hz, 1H), 5.27 (d, J = 10.5 Hz, 1H), 5.24 
(d, J = 17.6 Hz, 2H), 4.63 (dd, J = 9.2, 5.9 Hz, 1H), 3.47 (ddd, J = 11.3, 8.1, 5.5 Hz, 1H), 3.21 (s, 
3H), 2.91 (q, J = 6.5 Hz, 1H), 2.42 (dd, J = 15.3, 9.3 Hz, 1H), 2.19 (ddd, J = 13.6, 10.2, 3.5 Hz, 
1H), 2.04 – 1.91 (m, 2H), 1.82 (d, J = 15.3 Hz, 1H), 1.71 (d, J = 11.3 Hz, 1H), 1.55 – 1.49 (m, 2H), 
1.46 (dtd, J = 14.7, 4.1, 2.7 Hz, 1H), 1.34 (dtd, J = 18.6, 6.9, 3.9 Hz, 1H), 1.23 (tdd, J = 12.3, 5.4, 
3.4 Hz, 1H), 1.16 (s, 3H), 1.15 (s, 3H), 1.14 – 1.09 (m, 1H), 1.07 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 
6.5 Hz, 3H).  
13C-NMR (CDCl3, 125 MHz): δ 217.02, 140.77, 117.23, 83.44, 69.32, 64.41, 57.02, 54.66, 47.86, 
45.64, 44.97, 44.38, 44.34, 40.75, 30.82, 29.65, 29.05, 26.01, 19.08, 18.13, 15.41.  
HRMS(ESI): m/z calc. for C21H34O3Na [M+Na]
+: 357.2406, found: 357.2393. 
 
 
Procedure: To a solution of alcohol P12 (50 mg, 0.15 mmol) in benzene (2.5 mL) and pentane 
(2.5 mL) at room temperature was added phosphorus pentachloride (34 mg, 0.16 mmol). The 
reaction was stirred 15 minutes and quenched by addition of water. The biphasic mixture was 
extracted with ethyl acetate and the combined organic layers were washed with brine, dried with 
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magnesium sulfate, and evaporated. The crude product was purified by flash chromatography (3% 
ethyl acetate in hexanes) to provide a single isomer of P13 (11 mg, 23%) as a white solid.  
 
 
1H-NMR (CDCl3, 500 MHz): δ 5.67 (dd, J = 17.4, 10.6 Hz, 1H), 5.12 (d, J = 17.5 Hz, 1H), 5.09 
(d, J = 10.7 Hz, 1H), 5.00 – 4.96 (m, 2H), 3.65 (t, J = 6.7 Hz, 1H), 3.30 (s, 3H), 3.20 (q, J = 7.1 
Hz, 1H), 2.96 (dd, J = 11.9, 5.3 Hz, 1H), 2.46 (dd, J = 15.4, 5.7 Hz, 1H), 2.40 (dt, J = 6.0, 3.2 Hz, 
1H), 2.09 – 1.88 (m, 4H), 1.84 (dd, J = 13.0, 6.7 Hz, 1H), 1.74 – 1.63 (m, 2H), 1.51 (ddd, J = 14.2, 
5.5, 2.4 Hz, 1H), 1.35 – 1.23 (m, 2H), 1.27 (s, 3H), 0.96 (d, J = 7.0 Hz, 3H), 0.94 (d, J = 7.3 Hz, 
3H).  
13C-NMR (CDCl3, 125 MHz): δ 216.72, 148.92, 143.49, 116.83, 114.88, 89.13, 61.12, 56.45, 
56.05, 49.99, 47.69, 44.33, 39.63, 37.40, 36.72, 32.35, 29.15, 28.84, 23.62, 22.78, 16.60.  
HRMS(ESI): m/z calc. for C21H33O2 [M+H]
+: 317.2481, found: 317.2473. 
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Procedure: Olefin P13 (50 mg, 0.16 mmol) was dissolved in dichloromethane (1.6 m) then 
sodium bicarbonate (27 mg, 0.32 mmol) and m-chloroperoxy benzoic acid (44 mg, 0.19 mmol) 
were added. The reaction was stirred at room temperature for 5 hours then quenched by addition 
of a saturated solution of sodium sulfite and extracted with dichloromethane. The combined 
organic layers were washed with brine, dried with magnesium sulfate, and evaporated. Purification 
by flash chromatography (1:4 ethyl acetate:hexanes) provided a single isomer of epoxide P14 (36 
mg, 67%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 5.72 (dd, J = 17.4, 10.6 Hz, 1H), 5.15 (d, J = 17.6 Hz, 1H), 5.14 
(d, J = 10.4 Hz, 1H), 3.49 (t, J = 7.6 Hz, 1H), 3.29 (q, J = 7.1 Hz, 1H), 3.20 (s, 3H), 3.12 (d, J = 
4.6 Hz, 1H), 2.73 (dd, J = 4.7, 1.1 Hz, 1H), 2.43 (dd, J = 15.7, 5.1 Hz, 1H), 2.38 – 2.28 (m, 1H), 
2.21 (d, J = 7.1 Hz, 1H), 2.04 – 1.87 (m, 3H), 1.84 (dd, J = 13.1, 6.9 Hz, 1H), 1.73 (dd, J = 15.7, 
12.4 Hz, 1H), 1.62 – 1.50 (m, 3H), 1.41 – 1.33 (m, 1H), 1.31 (s, 3H), 1.27 (dd, J = 11.9, 6.7 Hz, 
1H), 0.98 (d, J = 7.0 Hz, 3H), 0.96 (dd, J = 7.0, 1.0 Hz, 3H).  
13C-NMR (CDCl3, 125 MHz): δ 215.86, 143.48, 115.09, 85.89, 61.27, 59.65, 56.67, 56.66, 55.71, 
49.95, 49.03, 44.17, 39.38, 37.60, 35.43, 31.47, 28.49, 28.43, 23.71, 23.51, 16.38.  
HRMS(ESI): m/z calc. for C21H32O3Na [M+Na]
+: 355.2249, found: 359.2243. 
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Procedure: Epoxide P14 (12 mg, 0.036 mmol) was dissolved in tetrahydrofuran (0.36 mL) and 
cooled to 0 C. A 3.0 M solution of methyl magnesium bromide in diethyl ether (36 μL, 0.108 
mmol) was then added and the reaction was stirred from 0 C to room temperature over 4 hours. 
The reaction was quenched by addition of a saturated solution of ammonium chloride and extracted 
with ethyl acetate. The combined organic layers were washed with brine, dried with magnesium 
sulfate and evaporated. Purification by flash chromatography (1:3 ethyl acetate:hexanes) afforded 
allylic alcohol P3 (7 mg, 60 %) as a white solid.  
 
 
1H-NMR (CDCl3, 500 MHz): δ 5.59 (dd, J = 17.5, 10.6 Hz, 1H), 5.07 (d, J = 17.3 Hz, 1H), 5.06 
(d, J = 10.7 Hz, 1H), 4.28 (d, J = 10.9 Hz, 1H), 4.14 (dd, J = 5.8, 3.2 Hz, 1H), 3.78 (q, J = 7.0 Hz, 
1H), 3.60 (t, J = 10.9 Hz, 1H), 3.30 (s, 3H), 2.70 (d, J = 11.7 Hz, 1H), 2.63 – 2.56 (m, 1H), 2.49 
(dd, J = 15.4, 5.9 Hz, 1H), 2.20 – 2.06 (m, 1H), 2.04 – 1.93 (m, 2H), 1.80 (ddt, J = 12.4, 10.7, 6.1 
Hz, 1H), 1.76 – 1.57 (m, 4H), 1.53 (td, J = 13.4, 4.1 Hz, 1H), 1.39 (ddd, J = 13.1, 10.8, 6.5 Hz, 
1H), 1.00 (s, 3H), 0.98 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 6.9 Hz, 3H). 
230 
 
13C-NMR (CDCl3, 125 MHz): δ 214.42, 151.22, 142.79, 142.40, 114.55, 84.33, 69.69, 55.73, 
55.37, 47.12, 44.03, 41.24, 38.15, 36.55, 35.32, 33.72, 29.24, 27.50, 22.64, 21.88, 14.44. 
HRMS(ESI): m/z calc. for C21H32O3Na [M+Na]
+: 355.2249, found: 355.2248. 
 
 
Procedure: A solution of pleuromutilin (2.4 g, 6.34 mmol, 1 equiv.), 1.26 mL 50% NaOH(aq.), 
water (9 mL), and ethanol (14.4 mL) was heated at 50 C for 3 h under air. Upon cooling, the 
reaction mixture was diluted with water and concentrated to precipitate the crude product. The 
solid was filtered, washed with water and hexanes, and then dried under vacuum to provide 1.875 
g (92%) of mutilin P15 as an off white solid.33    
1H-NMR (CDCl3, 500 MHz): δ 6.15 (dd, J = 17.8, 11.1 Hz, 1H), 5.37 (dd, J = 17.8, 1.4 Hz, 1H), 
5.29 (dd, J = 11.1, 1.4 Hz, 1H), 4.35 (dd, J = 7.7, 5.6 Hz, 1H), 3.41 (t, J = 6.6 Hz, 1H), 2.33 – 2.11 
(m, 3H), 2.05 (s, 1H), 1.91 (dd, J = 15.8, 7.7 Hz, 1H), 1.74 (dq, J = 14.5, 3.2 Hz, 1H), 1.68 (ddd, 
J = 11.6, 7.0, 3.9 Hz, 1H), 1.64 – 1.53 (m, 2H), 1.52 – 1.42 (m, 3H), 1.42 – 1.36 (m, 1H), 1.36 (s, 
3H), 1.24 (d, J = 5.6 Hz, 1H), 1.16 (s, 3H), 1.16 – 1.08 (m, 1H), 0.96 (d, J = 7.1 Hz, 3H), 0.92 (d, 
J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 217.9, 139.6, 116.1, 75.3, 67.0, 59.3, 45.6, 45.4, 45.3, 42.5, 37.0, 
36.7, 34.6, 30.6, 28.8, 27.3, 25.3, 18.4, 13.6, 11.5. 
HRMS(ESI): m/z calc. for C20H32O3Na [M+Na]+:343.2249, found: 343.2254 
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Procedure: A solution of P15 (5.518 g, 17.2 mmol, 1 equiv.), N,N-dimethylaminopyridine (1.05 
g, 8.6 mmol, 0.5 equiv.), acetic anhydride (45 mL, 482 mmol, 28 equiv.), and pyridine (91 mL, 
1.135 mol, 66 equiv.) was heated at 100 C for 6 h. Upon cooling the black reaction mixture was 
passed through a plug of silica and eluted with ethyl acetate. The resulting solution was washed 
with 2 M HCl (3x). The aqueous layer was extracted once with ethyl acetate and the combined 
organic layers were washed with brine, dried with magnesium sulfate, and adsorbed onto silica gel 
by evaporation. Purification by silica gel chromatography using a gradient of 1:5-1:4 ethyl 
acetate:hexanes provided 4.230g (61%) of bisacetate P16 as a white solid.4 
1H-NMR (CDCl3, 500 MHz): δ 6.35 (dd, J = 17.6, 11.1 Hz, 1H), 5.64 (d, J = 8.1 Hz, 1H), 5.25 
(dd, J = 11.1, 1.3 Hz, 1H), 5.16 (dd, J = 17.5, 1.3 Hz, 1H), 4.87 (d, J = 6.7 Hz, 1H), 2.50 (p, J = 
7.0 Hz, 1H), 2.30 (ddt, J = 19.5, 11.0, 1.7 Hz, 1H), 2.20 (d, J = 2.0 Hz, 1H), 2.19 – 2.13 (m, 1H), 
2.13 – 2.02 (m, 1H), 2.07 (s, 3H), 1.96 (s, 3H), 1.89 (ddd, J = 13.2, 11.0, 9.3 Hz, 1H), 1.72 (dq, J 
= 14.4, 3.0 Hz, 1H), 1.68 – 1.51 (m, 2H), 1.45 (s, 3H), 1.39 – 1.30 (m, 3H), 1.12 (td, J = 14.2, 4.5 
Hz, 1H), 0.99 (s, 3H), 0.79 (d, J = 7.0 Hz, 3H), 0.71 (d, J = 6.8 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 217.6, 170.8, 169.8, 139.8, 116.3, 76.8, 68.3, 58.8, 45.5, 45.4, 
43.1, 42.1, 36.9, 36.3, 34.8, 30.5, 27.5, 27.1, 25.2, 22.2, 21.0, 16.4, 15.1, 12.0. 
HRMS(ESI): m/z calc. for C24H37O5 [M+H]
+: 405.2641, found: 405.2658. 
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Procedure: To a flame dried flask containing P16 (438 mg, 1.08 mmol, 1 equiv.) in dry N,N-
dimethylformamide (4.4 mL) at 0 C under argon was added potassium tert-butoxide (203 mg, 
1.81 mmol, 1.67 equiv.). The reaction was allowed to warm to room temperature and stirred 16 h. 
Upon completion, the reaction was diluted with ethyl acetate and quenched with water and 2 M 
HCl. The crude mixture was then extracted with ethyl acetate, washed with brine, dried with 
magnesium sulfate, and evaporated. Purification by flash chromatography provided 271 mg (73%) 
of cyclopropane P17 as a white solid.19 
1H-NMR (CDCl3, 500 MHz): δ 6.11 – 5.96 (m, 1H), 5.20 – 5.12 (m, 2H), 4.53 (d, J = 8.8 Hz, 1H), 
2.72 – 2.61 (m, 1H), 2.38 – 2.24 (m, 2H), 2.14 – 2.06 (m, 2H), 2.06 (s, 3H), 1.89 (d, J = 13.4 Hz, 
1H), 1.72 – 1.62 (m, 2H), 1.44 (ddd, J = 13.7, 12.0, 8.0 Hz, 1H), 1.39 – 1.31 (m, 1H), 1.27 (s, 3H), 
1.15 (d, J = 12.2 Hz, 1H), 1.09 (td, J = 13.7, 3.5 Hz, 1H), 1.00 – 0.93 (m, 1H), 0.92 (d, J = 6.5 Hz, 
3H), 0.89 (s, 3H), 0.76 (d, J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 215.9, 170.9, 141.9, 113.6, 79.5, 49.6, 46.1, 44.9, 43.8, 42.3, 39.2, 
36.9, 33.7, 33.6, 29.1, 27.9, 27.2, 27.1, 20.9, 19.4, 12.9, 12.1. 
HRMS(ESI): m/z calc. for C22H33O3 [M+H]
+: 345.2424, found: 345.2413. 
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Procedure: A solution of acetate P17 (226 mg, 0.659 mmol) was refluxed 12 h in a solution of 
5% potassium hydroxide in ethanol (7 mL). Upon cooling, the reaction was diluted with ethyl 
acetate and washed with water. The organic layer was then washed with brine, dried with 
magnesium sulfate, and adsorbed on to silica gel by evaporation. Purification by flash 
chromatography using 1:4 ethyl acetate:hexanes provided alcohol P18 (142 mg, 71%) as a white 
solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.11 (dd, J = 17.7, 11.1 Hz, 1H), 5.20 (dd, J = 11.1, 1.4 Hz, 1H), 
5.13 (dd, J = 17.7, 1.5 Hz, 1H), 3.08 (d, J = 8.7 Hz, 1H), 2.40 – 2.24 (m, 2H), 2.26 – 2.14 (m, 2H), 
2.10 – 2.00 (m, 1H), 1.78 (dd, J = 13.4, 1.7 Hz, 1H), 1.73 (ddd, J = 13.7, 4.3, 2.7 Hz, 1H), 1.66 
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(ddd, J = 11.2, 9.0, 5.7 Hz, 1H), 1.46 (ddd, J = 13.7, 11.4, 6.4 Hz, 1H), 1.37 (dq, J = 14.4, 4.3 Hz, 
1H), 1.26 – 1.18 (m, 1H), 1.23 (s, 3H), 1.14 – 1.04 (m, 1H), 1.08 (s, 3H), 1.04 – 0.94 (m, 1H), 0.93 
(d, J = 2.3 Hz, 3H), 0.92 (d, J = 1.8 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 215.4, 141.5, 114.1, 78.1, 50.3, 45.9, 45.4, 43.5, 42.3, 39.4, 36.8, 
33.3, 33.1, 29.4, 28.2, 27.0, 26.9, 19.4, 12.9, 12.5. 
HRMS(ESI): m/z calc. for C20H30O2Na [M+Na]
+: 325.2138, found: 325.2157. 
 
 
Procedure: To a flame dried round bottom flask containing P18 (490 mg, 1.62 mmol, 1 equiv.) 
in dry dichloromethane (16.2 mL) under argon at 0 C was added phosphorous pentachloride (371 
mg, 1.78 mmol, 1.1 equiv.). The reaction was allowed to warm to room temperature and stirred 
for 1 h. The reaction was quenched by pouring onto ice. The crude reaction mixture was then 
transferred to a separatory funnel and extracted with dichloromethane. The combined organic 
layers were washed with brine, dried with magnesium sulfate, and evaporated. Purification by flash 
chromatography provided fenestrane P4 (250 mg, 51 %) as a white solid. Crystals suitable for X-
ray crystallography were grown by slowly cooling a solution of compound in dichloromethane.  
Note: Compound P4 equilibrates between the hemiketal form and the open ketone S1 in solution, 
thus, both isomers are observed in 1H and 13C NMR spectra. In DMF-d7, the hemiketal form is the 
major isomer (4:1 P4:S1 by 1H NMR) since the intensities of the three characteristic oxa-
fenestrane peaks (116.6, 90.2, 71.8 ppm) are much greater than that of the carbonyl at 224.5 ppm. 
In CDCl3, ketone S1 is the dominant isomer (2.5:1 S1:P4 by 
1H NMR ) as can be observed by the 
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greater intensity of the carbonyl carbon (224.6 ppm) in the 13C NMR spectra compared to the three 
characteristic peaks of hemiketal P4 (116.6, 91.3, 71.1 ppm) (See NMR Spectra). As the presence 
of interconverting isomers makes structure analysis by NMR quite challenging, complete NMR 
assessment of the oxa-fenestrane scaffold was performed on ketal P26. For further confirmation 
of the structure of P4, see the X-ray crystal structure below. 
Major Isomer – P4 
1H-NMR (DMF-d7, 500 MHz): 5.94 (dd, J = 17.7, 10.7 Hz, 1H), 5.56 (s, 1H), 5.07 – 4.97 (m, 
2H), 2.52 (dd, J = 13.5, 6.2 Hz, 1H), 2.30 (dt, J = 13.3, 9.6 Hz, 1H), 2.24 – 2.13 (m, 1H), 2.09 – 
1.97 (m, 2H), 1.92 – 1.80 (m, 2H), 1.75 – 1.68 (m, 3H), 1.50 – 1.41 (m, 2H), 1.40 – 1.32 (m, 1H), 
1.28 – 1.20 (m, 1H), 1.23 (s, 3H), 1.17 (s, 3H), 0.94 (t, J = 6.9 Hz, 6H). 
Major Isomer – P4 
13C-NMR (DMF-d7, 125 MHz): δ 146.89, 116.58, 110.15, 90.22, 71.76, 53.59, 51.35, 48.13, 
46.60, 44.19, 43.44, 41.53, 41.19, 34.43, 32.00, 29.77, 29.15, 24.24, 17.32, 16.81. 
HRMS(ESI): m/z calc. for C20H29O [M-OH]
+: 285.2213, found: 285.2219. 
 
X-ray Crystallographic Data for P4: Crystallographic data for the structure have been deposited 
with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-
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998209. Copies of the data can be obtained, free of charge, on application to CHGC, 12 Union 
Road, Cambridge CB2 1EZ, UK (fax: +44 1223 336033 or email: deposit@ccdc.cam.ac.uk). 
Table 4.4: Crystal data and structure refinement for cc33bas. 
 
Identification code  cc33bas 
Empirical formula  2(C20 H30 O2),C1 H2 Cl2 
Formula weight  689.81 
Temperature  183(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions  a = 9.4263(4) Å α= 90° 
 b = 10.9498(4) Å β= 90 
 c = 37.6993(15) Å γ= 90° 
Volume 3891.2(3) 
Z  4 
Density (calculated)  1.177 g/cm3 
Absorption coefficient  1.791 mm-1 
F(000)  1496 
Crystal size  0.40 x 0.357 x 0.188 mm3 
Theta range for data collection  68.09 to 2.34° 
Index ranges  -10<=h<=11, -13<=k<=12,  
 -44<=l<=45 
Reflections collected  6785 
Independent reflections  6487 [R(int) = 0.0455] 
Completeness to theta = 68.09°  97.3 % 
Absorption correction  Integration 
Max. and min. transmission  0.7899 and 0.6054 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  6785 / 0 / 438 
Goodness-of-fit on F2  1.058 
Final R indices [I>2sigma(I)] R1 = 0.0349, wR2 = 0.0869 
R indices (all data) R1 = 0.0366, wR2 = 0.0879 
Absolute structure (Flack) parameter 0.022(11) 
Largest diff. peak and hole 0.268 and -0.238 e. Å-3 
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Procedure: Pyridinium chlorochromate (1.71 g, 7.92 mmol) was added to a stirred solution of 
pleuromutilin (2.00 g, 5.28 mmol) in dichloromethane (80 mL) at room temperature. The reaction 
was stirred 15 hours, diluted with ether, and passed through a short column of silica (ethyl acetate 
elution). The crude reaction mixture was evaporated, taken up in a minimal amount of 
dichloromethane, and hexanes were added to precipitate reaction impurities. Filtration and 
evaporation provided pleuromutilone P19 (1.67 g, 84%) as a white solid.  
1H-NMR (CDCl3, 500 MHz): δ 6.63 (dd, J = 17.6, 10.7 Hz, 1H), 5.99 (d, J = 8.9 Hz, 1H), 5.31 (d, 
J = 10.7 Hz, 1H), 5.03 (d, J = 17.6 Hz, 1H), 4.09 (q, J = 17.1 Hz, 2H), 3.25 (q, J = 6.6 Hz, 1H), 
2.61 (s, 1H), 2.29 – 2.19 (m, 1H), 2.18 – 2.09 (m, 2H), 2.03 (dd, J = 15.6, 8.9 Hz, 1H), 1.68 – 1.52 
(m, 4H), 1.48 (d, J = 15.6 Hz, 1H), 1.43 (s, 3H), 1.46 – 1.33 (m, 2H), 1.14 (d, J = 13.4 Hz, 1H), 
1.11 (s, 3H), 1.05 (d, J = 6.5 Hz, 3H), 0.72 (d, J = 5.9 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 216.68, 214.43, 172.57, 140.21, 118.63, 70.76, 61.53, 59.12, 
53.62, 45.74, 45.45, 43.82, 42.20, 37.23, 34.82, 29.98, 26.96, 24.96, 24.86, 17.04, 15.09, 14.04. 
HRMS(ESI): m/z calc. for C20H29O2 [M-C2H3O3]
+: 301.2168, found: 301.2171. (loss of ester) 
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Procedure: Pleuromutilone P19 (613 mg, 1.63 mmol) was added to a solution of 10% potassium 
hydroxide in ethanol (61 mL) and stirred at reflux for 14 hours. The reaction mixture was then 
cooled, poured onto ice, acidified with concentrated hydrochloric acid, and extracted with 
dichloromethane. The combined organic layers were neutralized with saturated sodium 
bicarbonate, washed with brine, and dried with magnesium sulfate. The crude mixture was then 
evaporated and taken up in 30 mL of dichloromethane and pyridinium chlorochromate (2.00 g, 
9.28 mmol) was added. The reaction was stirred at room temperature 32 hours and passed through 
a plug of silica (ethyl acetate elution). The crude solution was then adsorbed onto silica by 
evaporation and purified by flash chromatography using 3:2 ethyl acetate:hexanes to provide 
lactone P20 (217 mg, 46%). 
 
1H-NMR (CDCl3, 500 MHz): δ 6.01 (dd, J = 17.4, 10.7 Hz, 1H), 5.17 (d, J = 17.7 Hz, 2H), 5.16 
(d, J = 10.3 Hz, 1H), 5.02 (dd, J = 11.2, 5.9 Hz, 1H), 2.59 (dd, J = 13.1, 11.1 Hz, 1H), 2.42 (dt, J 
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= 6.5, 3.9 Hz, 2H), 2.39 – 2.23 (m, fH), 1.79 (m, 2H), 1.73 – 1.62 (m, 2H), 1.31 (s, 3H), 1.23 (s, 
3H), 0.97 (d, J = 6.5 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 208.49, 179.80, 176.09, 140.11, 139.93, 114.90, 79.04, 46.48, 
40.47, 38.08, 36.30, 35.29, 29.51, 27.44, 26.89, 22.94, 19.06, 16.88. 
HRMS(ESI): m/z calc. for C18H25O3 [M+H]
+: 289.1804, found: 289.1813. 
 
 
Procedure: Lactone P20 (125 mg, 0.443 mmol) was taken up in ethanol (4.43 mL) then sodium 
acetate (291 mg, 3.54 mmol) and hydroxylamine hydrochloride (246 mg, 3.54) mmol were added. 
The reaction was stirred at reflux for 22 hours then cooled and poured into water. The crude 
mixture was extracted with dichloromethane, washed with brine, dried with magnesium sulfate, 
and evaporated. Purification by flash chromatography (2:3 ethyl acetate:hexanes) provided a single 
diastereomer of oxime P21 (79 mg, 59%) as a white foam. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 7.63 (s, 1H), 6.04 (dd, J = 17.4, 10.6 Hz, 1H), 5.18 (d, J = 17.2 
Hz, 1H), 5.17 (d, J = 11.0 Hz, 1H), 5.12 (dd, J = 11.2, 6.1 Hz, 1H), 2.72 (ddd, J = 18.5, 7.7, 3.5 
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Hz, 1H), 2.67 – 2.60 (m, 1H), 2.60 – 2.54 (m, 1H), 2.43 – 2.32 (m, 2H), 2.31 – 2.22 (m, 1H), 2.18 
– 2.08 (m, 1H), 1.88 (dd, J = 12.9, 6.0 Hz, 1H), 1.77 (td, J = 7.8, 7.1, 3.7 Hz, 2H), 1.70 – 1.60 (m, 
1H), 1.35 (s, 3H), 1.27 (s, 3H), 0.99 (d, J = 6.8 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 180.07, 168.40, 157.49, 140.25, 135.01, 114.87, 80.01, 46.76, 
41.09, 38.22, 36.77, 32.38, 27.29, 25.97, 25.02, 23.10, 20.79, 17.28. 
HRMS(ESI): m/z calc. for C18H26NO3 [M+H]
+: 304.1913, found: 304.1905. 
 
 
Procedure: Cyanuric chloride (44 mg, 0.24 mmol) was added to 0.3 mL of N,N-
dimethylformamide and stirred for 30 minutes until the solution turned yellow. A solution of oxime 
P21 (36 mg, 0.12 mmol) in N,N-dimethylformamide (3 mL) was then added and the reaction was 
stirred for 24 hours. The reaction was quenched with water and extracted with dichloromethane. 
The combined organic layers were then washed with brine, dried with magnesium sulfate, and 
evaporated. The crude mixture was then taken up in toluene and adsorbed onto silica by 
evaporation. Purification by flash chromatography (1:4 ethyl acetate:hexanes) afforded a single 
isomer of pure lactam P5 (19 mg, 52%) as  a white solid. 
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1H-NMR (CDCl3, 500 MHz): δ 8.62 (s, 1H), 6.04 (dd, J = 17.4, 10.7 Hz, 1H), 5.27 – 5.20 (m, 
1H), 5.19 (d, J = 6.3 Hz, 1H), 5.16 (d, J = 13.0 Hz, 1H), 2.82 (ddd, J = 19.0, 7.2, 3.3 Hz, 1H), 2.73 
(ddd, J = 19.0, 7.2, 3.6 Hz, 1H), 2.58 – 2.50 (m, 1H), 2.47 – 2.40 (m, 2H), 2.37 – 2.28 (m, 1H), 
2.18 (dt, J = 19.5, 6.0 Hz, 1H), 1.93 (dd, J = 12.8, 6.1 Hz, 1H), 1.82 (dtd, J = 14.1, 6.8, 3.4 Hz, 
2H), 1.64 (ddt, J = 13.6, 7.6, 5.3 Hz, 1H), 1.35 (s, 3H), 1.28 (s, 3H), 0.98 (d, J = 6.9 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 13C NMR (126 MHz, CDCl3) δ 179.74, 174.39, 163.26, 140.00, 
134.46, 114.92, 79.78, 46.77, 41.15, 37.45, 36.33, 32.60, 27.00, 26.96, 25.87, 23.41, 21.19, 17.05. 
HRMS(ESI): m/z calc. for C18H26NO3 [M+H]
+: 304.1913, found: 304.1907. 
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Procedure: To a solution of mutilin P15 (600 mg, 1.6 mmol) and N,N-dimethylamino pyridine 
(232 mg, 1.9 mmol) in dichloromethane (19 mL) was added acetic anhydride (265 μL, 2.8 mmol). 
The reaction was stirred 4 hours and then quenched by addition of water and extracted with 
dichloromethane. The combined organic layers were washed with brine, dried with magnesium 
sulfate, and evaporated. The crude mixture was purified by flash chromatography (1:4 ethyl 
acetate:hexanes) to provide acetate P22 (467mg, 68%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 6.07 (dd, J = 17.9, 11.2 Hz, 1H), 5.39 (d, J = 17.9 Hz, 1H), 5.23 
(d, J = 11.2 Hz, 1H), 4.82 (d, J = 6.7 Hz, 1H), 4.25 (t, J = 6.6 Hz, 1H), 2.31 – 2.17 (m, 2H), 2.17 
– 2.02 (m, 2H), 2.07 (s, 3H), 1.96 – 1.80 (m, 2H), 1.70 – 1.57 (m, 3H), 1.48 – 1.37 (m, 2H), 1.34 
(d, J = 1.2 Hz, 3H), 1.34 – 1.28 (m, 2H), 1.09 (td, J = 14.0, 4.3 Hz, 1H), 0.94 (d, J = 1.2 Hz, 3H), 
0.92 (d, J = 7.1 Hz, 3H), 0.75 (d, J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 217.90, 170.58, 140.09, 115.71, 76.89, 67.05, 59.33, 45.28, 44.62, 
44.27, 42.42, 36.92 (2C), 34.63, 30.46, 29.07, 27.38, 25.21, 20.91, 18.37, 13.60, 11.97. 
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HRMS(ESI): m/z calc. for C22H35O4 [M+H]
+: 363.2535, found: 363.2529. 
 
 
Procedure: To a solution of chlorosulfonyl isocyanate (192 μL, 2.2 mmol) in dichloromethane (8 
mL) at 0 C was added a solution of acetate P22 (400 mg, 1.1 mmol) in dichloromethane (3 mL). 
The reaction was stirred for 4 hours while warming to room temperature. Upon completion, the 
reaction mixture was cooled to 0 C and tetrahydrofuran (3 mL) and water (1.5 mL) were added. 
The mixture was then heated at 40 C for 24 hours. The crude reaction was then cooled to room 
temperature, diluted with water, and extracted with dichloromethane. The combined organic layers 
were washed with brine, dried with magnesium sulfate, and evaporated. The crude product was 
purified by flash chromatography (1:2 ethyl acetate:hexanes) to provide carbamate P23 (339 mg, 
76%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): 6.42 (dd, J = 17.5, 11.2 Hz, 1H), 5.56 (d, J = 8.2 Hz, 1H), 5.29 (dd, 
J = 11.2, 1.3 Hz, 1H), 5.23 (dd, J = 17.5, 1.4 Hz, 1H), 4.90 (d, J = 6.7 Hz, 1H), 4.62 (s, 2H), 2.53 
(p, J = 7.0 Hz, 1H), 2.38 – 2.29 (m, 1H), 2.25 – 2.14 (m, 2H), 2.11 (s, 3H), 2.13 – 2.04 (m, 1H), 
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1.96 – 1.86 (m, 1H), 1.76 (dd, J = 14.3, 2.9 Hz, 1H), 1.71 – 1.63 (m, 2H), 1.49 (d, J = 16.1 Hz, 
1H), 1.44 (s, 3H), 1.42 – 1.34 (m, 2H), 1.17 (dt, J = 13.9, 6.6 Hz, 1H), 1.03 (s, 3H), 0.82 (d, J = 
3.8 Hz, 3H), 0.80 (d, J = 3.1 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 217.74, 170.76, 155.57, 139.84, 116.30, 76.89, 69.63, 58.86, 
45.54, 45.11, 43.07, 42.24, 36.94, 36.37, 34.81, 30.59, 27.62, 27.05, 25.30, 20.94, 16.42, 15.05, 
12.01. 
HRMS(ESI): m/z calc. for C23H35NO5Na [M+Na]
+: 428.2413, found: 428.2408. 
 
 
Procedure: Carbamate P23 (250 mg, 0.62 mmol) and (diacetoxyiodo)benzene (1.198 g, 3.7 mmol) 
were dissolved in acetonitrile and stirred for 20 min. In a separate flask, silver nitrate (11 mg, 0.062 
mmol) and 4,4′,4″-tri-tert-butyl-2,2′:6′,2″-terpyridine (25 mg, 0.062 mmol) were suspended in 
acetonitrile (2 mL), stirred for 20 min, and then added to the flask containing carbamate XX. The 
combined reaction mixture was heated to reflux and stirred for 24 hours. The crude reaction was 
then cooled to room temperature, concentrated, and purified by flash chromatography (1:1 ethyl 
acetate:hexanes) to afford cyclic carbamate P24 (189 mg, 76%) as a white solid. 
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1H-NMR (CDCl3, 500 MHz): δ 7.22 (s, 1H), 6.11 – 5.92 (m, 1H), 5.45 – 5.28 (m, 2H), 4.96 (d, J 
= 7.0 Hz, 1H), 4.87 (d, J = 6.6 Hz, 1H), 3.63 (d, J = 6.9 Hz, 1H), 2.40 (p, J = 7.0 Hz, 1H), 2.36 – 
2.25 (m, 1H), 2.23 – 2.12 (m, 1H), 2.10 (s, 3H), 1.87 (ddd, J = 13.4, 10.8, 9.0 Hz, 1H), 1.72 (dddd, 
J = 24.4, 17.8, 6.6, 3.9 Hz, 3H), 1.51 – 1.38 (m, 3H), 1.36 (s, 3H), 1.15 (ddd, J = 14.9, 11.7, 6.5 
Hz, 1H), 1.10 (s, 3H), 0.93 (d, J = 7.0 Hz, 3H), 0.80 (d, J = 6.9 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 216.21, 170.57, 159.69, 134.59, 120.24, 77.60, 75.13, 60.43, 
57.62, 46.84, 45.46, 41.61, 36.77, 36.33, 34.47, 30.35, 27.36, 25.48, 23.98, 20.90, 17.52, 14.00, 
12.49. 
HRMS(ESI): m/z calc. for C23H34NO5 [M+H]
+: 404.2437, found: 404.2432. 
 
 
Procedure: Carbamate P24 (60 mg, 0.15 mmol) and potassium t-butoxide (168 mg, 1.5 mmol) 
were dissolved in t-butanol (3 mL) and stirred while bubbling oxygen through the reaction mixture 
for 5 minutes. The reaction was then stirred for 1 hour under ambient atmosphere then quenched 
by addition of 2 M hydrochloric acid. The crude mixture was then extracted with diethyl ether and 
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washed with 0.1 M sodium hydtoxide. The combined organic layers were washed with brine, dried 
with magnesium sulfate, and evaporated to provide lactone P6 (31 mg, 55%) as a white solid. 
 
 
1H-NMR (CDCl3, 500 MHz): δ 7.30 (s, 1H), 6.34 (dd, J = 17.6, 11.0 Hz, 1H), 5.49 (d, J = 10.9 
Hz, 1H), 5.34 (d, J = 8.6 Hz, 1H), 5.18 (d, J = 17.6 Hz, 1H), 3.64 – 3.56 (m, 2H), 3.04 (q, J = 6.4 
Hz, 1H), 2.68 (ddd, J = 13.6, 8.6, 4.6 Hz, 1H), 2.45 – 2.28 (m, 2H), 1.99 (dq, J = 12.8, 8.4, 6.5 Hz, 
1H), 1.49 (h, J = 5.1, 4.2 Hz, 4H), 1.27 (s, 3H), 1.25 – 1.22 (m, 1H), 1.17 (s, 3H), 1.08 (d, J = 6.3 
Hz, 3H), 1.00 (d, J = 7.1 Hz, 3H). 
1H-NMR (C6D6, 500 MHz): δ 7.76 (s, 1H), 5.93 (dd, J = 17.5, 10.9 Hz, 1H), 5.05 (d, J = 8.6 Hz, 
1H), 5.01 (d, J = 10.9 Hz, 1H), 4.84 (d, J = 17.5 Hz, 1H), 3.37 (d, J = 8.5 Hz, 1H), 3.23 (s, 1H), 
2.60 (q, J = 6.5 Hz, 1H), 2.32 (ddd, J = 13.7, 8.6, 4.9 Hz, 1H), 2.10 (ddd, J = 16.5, 6.9, 4.8 Hz, 
1H), 2.00 (dt, J = 16.6, 9.2 Hz, 1H), 1.74 (p, J = 7.5 Hz, 1H), 1.37 (s, 3H), 1.10 (s, 3H), 1.09 – 1.00 
(m, 1H), 0.99 – 0.91 (m, 5H), 0.87 (dd, J = 10.1, 7.2 Hz, 1H), 0.73 – 0.70 (m, 1H), 0.68 (d, J = 6.3 
Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 213.04, 172.44, 159.08, 133.92, 121.65, 82.67, 77.23, 59.22, 
57.38, 44.29, 43.63, 40.94, 34.84, 30.03, 27.12, 26.72, 26.34, 22.26, 17.27, 16.14, 15.65. 
HRMS(ESI): m/z calc. for C21H30NO5 [M+H]
+: 376.2124, found: 376.2118. 
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4.7.2 Synthesis of Oxafenestrane P4 Derivatives 
 
 
Procedure: To a flame dried round bottom flask containing P18 (331 mg, 1.09 mmol, 1 equiv.) 
in dry dichloromethane (11 mL) under argon at 0 C was added phosphorous pentachloride (371 
mg, 1.78 mmol, 1.1 equiv.). The reaction was allowed to warm to room temperature, stirred for 1 
h, and then 0.5 mL aliquots were removed and syringed into the appropriate quench solvent (0.5 
mL) at 0 C. The crude mixtures were then diluted with water and extracted with dichloromethane. 
The combined organic layers were washed with brine, dried with magnesium sulfate and 
evaporated. Purification by flash chromatography (1:4 ethyl acetate:hexanes) provided pure 
products (vide infra). The portion of the reaction mixture not used in quenching studies was 
quenched by pouring onto ice and worked up as described previously to provide 6 (102 mg, 36% 
based on 9.5 mL reaction mixture). 
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P25: Quench: 0.5 mL Methanol 
 
Yield: 5 mg (31% based on 0.5 mL reaction mixture) 
 
State: White solid 
 
1H-NMR (CDCl3, 500 MHz): δ 5.82 (dd, J = 17.8, 10.5 Hz, 1H), 5.03 – 4.88 (m, 2H), 3.32 (s, 3H), 
2.48 (dd, J = 13.4, 6.2 Hz, 1H), 2.26 – 2.05 (m, 3H), 1.94 – 1.77 (m, 4H), 1.74 – 1.64 (m, 2H), 
1.61 – 1.53 (m, 1H), 1.48 – 1.33 (m, 2H), 1.30 – 1.23 (m, 1H), 1.26 (s, 3H), 1.15 (s, 3H), 0.95 (d, 
J = 6.5 Hz, 3H), 0.92 (d, J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 145.8, 118.5, 109.5, 91.2, 71.5, 52.2, 50.7, 50.5, 47.1, 45.1, 43.1, 
40.8, 40.4, 36.9, 33.7, 31.4, 28.8, 28.8, 23.2, 16.9, 16.5. 
HRMS(ESI): m/z calc. for C20H29O [M-CH3O]
+: 285.2213, found: 285.2202. 
 
P26: Quench: 0.5 mL Ethanol 
 
Yield: 7 mg (44% based on 0.5 mL reaction mixture) 
 
State: White solid 
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1H-NMR (CDCl3, 500 MHz): δ 5.83 (dd, J = 17.2, 11.1 Hz, 1H), 5.07 – 4.84 (m, 2H), 3.76 (dq, J 
= 9.2, 7.1 Hz, 1H), 3.40 (dq, J = 9.1, 7.0 Hz, 1H), 2.48 (dd, J = 13.3, 6.2 Hz, 1H), 2.24 – 2.07 (m, 
3H), 1.96 (dd, J = 13.4, 11.8 Hz, 1H), 1.92 – 1.79 (m, 3H), 1.70 (d, J = 7.4 Hz, 1H), 1.68 – 1.65 
(m, 1H), 1.56 (t, J = 3.6 Hz, 1H), 1.45 – 1.33 (m, 2H), 1.29 – 1.21 (m, 1H), 1.25 (s, 3H), 1.18 (t, J 
= 7.0 Hz, 3H), 1.16 (s, 3H), 0.94 (d, J = 7.2 Hz, 3H), 0.92 (d, J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 145.9, 118.1, 109.4, 91.1, 71.6, 58.1, 52.2, 50.7, 47.1, 44.8, 43.1, 
40.8, 40.5, 37.3, 33.6, 31.5, 28.7, 28.7, 23.3, 16.9, 16.5, 16.4. 
HRMS(ESI): m/z calc. for C20H29O [M-CH3CH2O]
+: 285.2213, found: 285.2218. 
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P27: Quench: 0.5 mL Morpholine 
 
Yield: 4 mg (20% based on 0.5 mL reaction mixture) 
 
State: White solid 
 
1H-NMR (CDCl3, 500 MHz): δ 5.80 (dd, J = 17.2, 11.1 Hz, 1H), 5.13 – 4.85 (m, 2H), 3.72 (dddd, 
J = 29.4, 10.9, 6.2, 2.6 Hz, 4H), 2.91 (s, 2H), 2.62 (s, 2H), 2.55 (dd, J = 13.8, 5.6 Hz, 1H), 2.38 
(ddd, J = 14.5, 11.0, 2.3 Hz, 1H), 2.26 (dd, J = 13.8, 11.5 Hz, 1H), 2.06 – 1.88 (m, 3H), 1.88 – 
1.79 (m, 2H), 1.71 (ddd, J = 11.8, 7.8, 5.3 Hz, 2H), 1.62 (ddd, J = 13.8, 9.5, 2.3 Hz, 1H), 1.47 – 
1.38 (m, 2H), 1.25 (s, 3H), 1.24 – 1.19 (m, 1H), 1.18 (s, 3H), 0.93 (d, J = 7.3 Hz, 3H), 0.91 (d, J 
= 7.2 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 145.6, 109.6, 106.6, 89.6, 72.5, 68.0, 54.6, 50.5, 48.8, 48.7, 45.0, 
42.7, 41.0, 40.6, 34.5, 32.5, 29.9, 29.2, 29.1, 23.2, 16.8, 16.7. 
HRMS(ESI): m/z calc. for C24H38NO2 [M+H]
+: 372.2897, found: 372.2893. 
 
 
 
Procedure: To a solution of P4 (84 mg, 0.276 mmol, 1 equiv.) and 2,2,2-tribromoethanol (820 
mg, 2.9 mmol, 10.5 equiv.) in N,N-dimethylformamide (2.9 mL) at 0 C was added p-toluene 
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sulfonic acid monohydrate (266 mg, 1.45 mmol, 5.25 equiv.). The reaction was allowed to warm 
to room temperature and stirred for 17 h. The reaction mixture was then diluted with ethyl acetate 
and washed with water. The organic layer was washed with brine, dried using magnesium sulfate, 
and evaporated. Purification by flash chromatography using a gradient of 1:9 to 1:4 ethyl 
acetate:hexanes provided 58 mg (37%) of ketal P28 as a white solid. Single crystals suitable for 
X-ray crystallography were grown by slow evaporation from hexanes.  
1H-NMR (CDCl3, 500 MHz): δ 5.91 – 5.76 (m, 1H), 5.05 – 4.93 (m, 2H), 4.51 (d, J = 10.9 Hz, 
1H), 4.16 (d, J = 10.9 Hz, 1H), 2.53 (dd, J = 13.5, 6.2 Hz, 1H), 2.34 – 2.16 (m, 4H), 1.94 (p, J = 
7.1 Hz, 1H), 1.89 – 1.76 (m, 3H), 1.73 (dd, J = 11.9, 6.2 Hz, 1H), 1.65 – 1.58 (m, 1H), 1.47 – 1.36 
(m, 2H), 1.32 (s, 3H), 1.32 – 1.25 (m, 1H), 1.25 (s, 3H), 0.97 (d, J = 3.6 Hz, 3H), 0.96 (d, J = 3.7 
Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 145.9, 118.8, 109.5, 92.9, 79.6, 71.8, 51.9, 51.0, 46.8, 45.1, 43.0, 
40.8, 40.7, 40.1, 37.2, 33.6, 31.4, 28.7, 28.6, 23.1, 16.9, 16.6. 
HRMS(ESI): m/z calc. for C20H29O [M-CBr3CH2O]
+: 285.2213, found: 285.2212. 
 
 
X-ray Crystallographic Data for P28: Crystallographic data for the structure have been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. 
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CCDC-998210. Copies of the data can be obtained, free of charge, on application to CHGC, 12 
Union Road, Cambridge CB2 1EZ, UK (fax: +44 1223 336033 or email: 
deposit@ccdc.cam.ac.uk). 
Table 4.5: Crystal data and structure refinement for cc36asa. 
 
Identification code  cc36asa 
Empirical formula  C22 H31 Br3 O2 
Formula weight  567.20 
Temperature  183(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions  a = 10.6731(4) Å α= 90° 
 b = 11.3013(4) Å β= 90 
 c = 18.9451(7)Å γ= 90° 
Volume 2285.16(14) Å3 
Z  4 
Density (calculated)  1.649 g/cm3 
Absorption coefficient  6.653 mm-1 
F(000)  1136 
Crystal size  0.606 x 0.334 x 0.292 mm3 
Theta range for data collection  4.56 to 67.63° 
Index ranges  -12<=h<=12, -13<=k<=12,  
 -22<=l<=20 
Reflections collected  4037 
Independent reflections  4015 [R(int) = 0.0527] 
Completeness to theta = 67.63°  98.3 % 
Absorption correction  Integration 
Max. and min. transmission  0.4231 and 0.0857 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  4037 / 0 / 249 
Goodness-of-fit on F2  1.119 
Final R indices [I>2sigma(I)] R1 = 0.0218, wR2 = 0.0540 
R indices (all data) R1 = 0.0219, wR2 = 0.0541 
Absolute structure (Flack) parameter -0.022(15) 
Largest diff. peak and hole 0.402 and -0.696 e. Å-3 
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Procedure: To a flame dried round bottom flask under argon containing a solution of P4 (50 mg, 
0.165 mmol, 1 equiv.) in dry dichloromethane (4.13 mL) at 0 C was added Martin sulfurane (334 
mg, 0.496 mmol, 3 equiv.). The reaction was allowed to warm to room temperature and stirred for 
1 h and then adsorbed onto silica gel and purified by flash chromatography (1:5 ethyl 
acetate:hexanes) to provide 61 mg (70%) of ketal P29 as a colorless crystalline solid. Crystals 
suitable for X-ray crystallography were grown by vapor diffusion of ispropanol into a solution of 
compound in dichloromethane. 
1H-NMR (CDCl3, 500 MHz): δ 7.98 – 7.76 (m, 2H), 7.49 – 7.40 (m, 3H), 5.85 (dd, J = 17.5, 10.8 
Hz, 1H), 5.09 – 4.96f (m, 2H), 2.53 (dd, J = 13.6, 6.1 Hz, 1H), 2.08 (dd, J = 13.7, 12.0 Hz, 1H), 
1.90 (dtt, J = 13.9, 9.3, 4.6 Hz, 3H), 1.79 (dd, J = 12.0, 6.0 Hz, 1H), 1.75 – 1.58 (m, 3H), 1.36 (s, 
3H), 1.45 – 1.28 (m, 4H), 1.27 (s, 3H), 1.20 (dd, J = 14.8, 6.3 Hz, 1H), 0.95 (d, J = 3.7 Hz, 3H), 
0.94 (d, J = 2.9 Hz, 3H). 
13C-NMR (CDCl3, 125 MHz): δ 145.9, 131.2, 130.1, 129.3, 128.4, 123.0 (qd, JC-F = 288.8, 10.3 
Hz), 122.3, 109.5, 92.9, 82.2 (sept, JC-F = 28.5 Hz), 74.7, 53.2, 50.7, 46.7, 44.1, 42.7, 40.4, 39.8, 
37.6, 33.5, 32.0, 28.8, 28.2, 22.5, 16.8, 16.6. 
HRMS(ESI): m/z calc. for C29H35O2F6 [M+H]
+: 529.2541, found: 529.2545. 
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X-ray Crystallographic Data for P29: Crystallographic data for the structure have been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. 
CCDC-998212. Copies of the data can be obtained, free of charge, on application to CHGC, 12 
Union Road, Cambridge CB2 1EZ, UK (fax: +44 1223 336033 or email: 
deposit@ccdc.cam.ac.uk). 
Table 4.6: Crystal data and structure refinement for cd69isa. 
 
Identification code  cd69isa 
Empirical formula  C29 H34 F6 O2 
Formula weight  528.56 
Temperature  100(2)K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions  a = 9.3110(3) Å α= 90° 
 b = 13.9282(4) Å β= 90 
 c = 19.8162(6) Å γ= 90° 
Volume 2569.87(14) Å3 
Z  4 
Density (calculated)  1.366 g/cm3 
Absorption coefficient  0.969 mm-1 
F(000)  1112 
Crystal size  0.473 x 0.192 x 0.102 mm3 
Theta range for data collection  3.879 to 72.128° 
Index ranges  -11<=h<=11, -17<=k<=16,  
 -22<=l<=24 
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(Cont. Table 4.6:) 
Reflections collected  37473 
Independent reflections  5033 [R(int) = 0.0310] 
Completeness to theta = 72.128°  99.6 % 
Absorption correction  Integration 
Max. and min. transmission  0.91657 and 0.69286 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  5033 / 0 / 338 
Goodness-of-fit on F2  1.054 
Final R indices [I>2sigma(I)] R1 = 0.0257, wR2 = 0.0649 
R indices (all data) R1 = 0.0261, wR2 = 0.0652 
Absolute structure (Flack) parameter 0.038(18) 
Largest diff. peak and hole 0.174 and -0.237 e. Å-3 
 
 
 
Procedure: To a flame dried round bottom flask containing a solution of P4 (95 mg, 0.31 mmol, 
1 equiv.) in methanol (3.1 mL) and tetrahydrofuran (3.1 mL) under argon at 0 C was added sodium 
borohydride (23 mg, 0.62 mmol, 2 equiv.). The reaction was allowed to warm to room temperature 
and stirred 6h. Upon completion, the reaction was quenched with saturated aqueous ammonium 
chloride and extracted with ethyl acetate. The combined organic layers were washed with bride, 
dried with magnesium sulfate and evaporated. Purification by flash chromatography (1:4 ethyl 
acetate:hexanes) provided 82 mg (87%) of diol P30 as a white solid.  
1H-NMR (CDCl3, 500 MHz): δ 5.76 (dd, J = 17.4, 11.0 Hz, 1H), 5.04 – 4.90 (m, 2H), 4.06 (d, J 
= 4.3 Hz, 1H), 2.40 (dd, J = 14.3, 4.2 Hz, 1H), 2.05 – 1.95 (m, 5H), 1.87 (ddd, J = 13.6, 8.2, 1.8 
Hz, 1H), 1.76 – 1.62 (m, 2H), 1.62 – 1.52 (m, 2H), 1.48 – 1.39 (m, 2H), 1.19 (s, 3H), 1.13 (d, J = 
8.3 Hz, 1H), 1.08 (s, 3H), 0.94 (d, J = 7.2 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H).  
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13C-NMR (CDCl3, 125 MHz): δ 145.6, 109.7, 76.2, 74.6, 63.2, 59.0, 48.3, 45.9, 44.3, 44.2, 39.8, 
39.6, 36.5, 35.4, 31.8, 31.0, 28.9, 25.6, 17.5, 16.2. 
HRMS(ESI): C20H32O2Na [M+Na]
+: 327.2300,  found: 327.2296. 
 
 
 
Table 4.7: Crystal data and structure refinement for cd33hsa. 
 
Identification code  cd68hsa 
Empirical formula  C20 H32 O2 
Formula weight  304.45 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions  a = 9.6940(10) Å α= 90° 
 b = 11.0738(10) Å β= 90 
 c = 163606(16) Å γ= 90° 
Volume 1756.3(3) Å3 
Z  4 
Density (calculated)  1.151 g/cm3 
Absorption coefficient  0.553 mm-1 
F(000)  672 
Crystal size  0.467 x 0.233 x 0.17 mm3 
Theta range for data collection  4.822 to 69.628° 
Index ranges  -11<=h<=11, -13<=k<=13,  
 -19<=l<=19 
Reflections collected  31926 
Independent reflections  3293 [R(int) = 0.0281] 
Completeness to theta = 72.089°  99.8 % 
Absorption correction  Integration 
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(Cont. Table 4.7:) 
Max. and min. transmission  0.8193 and 0.9384 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  3293 / 0 / 220 
Goodness-of-fit on F2  1.066 
Final R indices [I>2sigma(I)] R1 = 0.0283, wR2 = 0.0725 
R indices (all data) R1 = 0.0291, wR2 = 0.0732 
Absolute structure (Flack) parameter 0.04(3) 
Largest diff. peak and hole 0.208 and -0.166 e. Å-3 
 
 
 
Procedure: To a flame dried round bottom flask containing P30 (30 mg, 0.099 mmol, 1 equiv.) 
in pyridine (72 μL, 0.891 mmol, 9 equiv.) and dichloromethane (1.98 mL) under argon at 0 C was 
added triphosgene (37 mg, 0.126 mmol, 1.27 equiv.). The reaction was warmed to room 
temperature and stirred for 1h. The reaction was then quenched with saturated aqueous ammonium 
chloride, extracted with dichloromethane, washed with brine, and dried with magnesium sulfate. 
Evaporation of the organic layer provide pure P31 (31 mg, 96%) as a white solid. Single crystals 
suitable for X-ray crystallography were grown by vapor diffusion of isopropanol into a solution of 
compound in tetrahydrofuran. 
1H-NMR (CDCl3, 500 MHz): δ 5.76 (dd, J = 17.5, 10.8 Hz, 1H), 5.05 (dd, J = 10.8, 1.1 Hz, 1H), 
5.00 (dd, J = 17.6, 1.1 Hz, 1H), 4.55 (d, J = 3.1 Hz, 1H), 2.53 (dd, J = 14.0, 4.7 Hz, 1H), 2.39 (qt, 
J = 7.2, 3.4 Hz, 1H), 2.12 (p, J = 7.2 Hz, 1H), 2.08 – 1.91 (m, 4H), 1.90 – 1.83 (m, 1H), 1.75 – 
1.67 (m, 1H), 1.67 – 1.60 (m, 1H), 1.51 – 1.36 (m, 3H), 1.33 (s, 3H), 1.25 (d, J = 8.2 Hz, 1H), 1.11 
(s, 3H), 1.05 (d, J = 7.2 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H). 
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13C-NMR (CDCl3, 125 MHz): δ 154.6, 144.5, 110.5, 92.0, 82.4, 59.6, 58.2, 45.5, 45.2, 44.8, 41.1, 
40.9, 40.4, 33.0, 32.1, 31.0, 29.9, 28.2, 28.0, 19.6, 16.7. 
HRMS(ESI): m/z calc. for C21H31O3 [M+H]
+: 331.2273, found: 331.2271. 
 
X-ray Crystallographic Data for P31: Crystallographic data for the structure have been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. 
CCDC-998211. Copies of the data can be obtained, free of charge, on application to CHGC, 12 
Union Road, Cambridge CB2 1EZ, UK (fax: +44 1223 336033 or email: 
deposit@ccdc.cam.ac.uk). 
Table 4.8: Crystal data and structure refinement for cd68isa. 
 
Identification code  cd68isa 
Empirical formula  C21 H30 O3 
Formula weight  330.45 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions  a = 9.5603(6) Å α= 90° 
 b = 12.7626(8) Å β= 90 
 c = 15.0057(9) Å γ= 90° 
Volume 1830.9(2) Å3 
Z  4 
Density (calculated)  1.199 g/cm3 
Absorption coefficient  0.616 mm-1 
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(Cont. Table 4.8:) 
F(000)  720 
Crystal size  0.654 x 0.406 x 0.194 mm3 
Theta range for data collection  4.548 to 72.089° 
Index ranges  -11<=h<=11, -15<=k<=15,  
 -18<=l<=18 
Reflections collected  23346 
Independent reflections  3575 [R(int) = 0.0355] 
Completeness to theta = 72.089°  99.8 % 
Absorption correction  Integration 
Max. and min. transmission  0.92469 and 0.80142 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters  3575 / 0 / 221 
Goodness-of-fit on F2  1.123 
Final R indices [I>2sigma(I)] R1 = 0.0331, wR2 = 0.0833 
R indices (all data) R1 = 0.0332, wR2 = 0.0834 
Absolute structure (Flack) parameter 0.15(4) 
Largest diff. peak and hole 0.200 and -0.206 e. Å-3 
 
4.7.3 Synthesis of Derivatives for Structure-Activity Relationship Studies 
 
 
Procedure: To a solution of diol P2 (200 mg, 0.34 mmol) and proton sponge (219 mg, 1.02 mmol) 
in dichloromethane (7.2 mL) containing molecular sieves was added trimethyl tetrafluoroborate 
(75 mg, 0.51 mmol). The reaction was stirred for 5 hours at room temperature and then quenched 
by addition of water. The crude mixture was extracted with dichloromethane, washed with brine, 
dried with magnesium sulfate, and evaporated. Purification by flash chromatography (1:1 ethyl 
acetate:hexanes) provided methyl ether P32 (131 mg, 64%) as a white solid. 
260 
 
1H-NMR (CDCl3, 500 MHz): δ 7.53 (d, J = 7.9 Hz, 2H), 7.47 (t, J = 7.6 Hz, 2H), 7.37 (t, J = 6.8 
Hz, 1H), 5.66 (s, 1H), 5.33 (d, J = 7.4 Hz, 1H), 4.31 – 4.08 (m, 4H), 4.03 (s, 2H), 3.61 (t, J = 7.6 
Hz, 1H), 3.54 (d, J = 1.0 Hz, 3H), 3.20 (s, 1H), 2.84 (s, 1H), 2.47 (s, 1H), 2.13 (dd, J = 12.7, 6.8 
Hz, 1H), 2.04 (dd, J = 7.1, 1.0 Hz, 1H), 1.95 (dd, J = 12.7, 8.4 Hz, 1H), 1.87 – 1.70 (m, 2H), 1.69 
– 1.52 (m, 2H), 1.47 (d, J = 5.5 Hz, 1H), 1.44 (s, 3H), 1.01 (td, J = 11.7, 9.6, 6.2 Hz, 1H), 0.93 – 
0.86 (m, 6H). 
HRMS(ESI): m/z calc. for C31H37N3O7Cl [M-H]
-: 598.2320, found: 598.2318. 
 
 
 
Procedure: To a solution of diol P2 (11 mg, 0.019 mmol), triethylamine (8 μL, 0.057 mmol), and 
NN-dimethylaminopyridine (1 mg, 0.0095 mmol) in dichloromethane (1 mL) was added acetic 
anhydride (6 μL, 0.057 mmol). The reaction was stirred at room temperature for 2 hours and then 
quenched by addition of water. The crude reaction mixture was extracted with dichloromethane, 
dried with magnesium sulfate, and evaporated. Purification by flash chromatography (1:1 ethyl 
acetate:hexanes) gave ester P33 (9 mg, 77%) as a white solid.   
1H-NMR (CDCl3, 500 MHz): δ 7.55 – 7.51 (m, 2H), 7.50 – 7.45 (m, 2H), 7.40 – 7.35 (m, 1H), 
5.68 (s, 1H), 5.32 (d, J = 7.6 Hz, 1H), 5.12 (t, J = 8.2 Hz, 1H), 4.23 – 4.06 (m, 4H), 4.05 (s, 2H), 
3.27 – 3.09 (m, 1H), 3.00 – 2.82 (m, 1H), 2.43 – 2.29 (m, 1H), 2.18 (dd, J = 12.5, 7.8 Hz, 1H), 
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2.13 (s, 3H), 2.13 – 2.07 (m, 1H), 2.04 – 1.93 (m, 1H), 1.91 – 1.81 (m, 1H), 1.78 – 1.68 (m, 1H), 
1.68 – 1.59 (m, 2H), 1.54 – 1.46 (m, 1H), 1.44 (s, 3H), 1.22 – 1.12 (m, 1H), 0.96 – 0.89 (m, 6H). 
HRMS(ESI): m/z calc. for C32H39N3O8Cl [M+H]
+: 628.2426, found: 628.2410. 
 
 
 
Procedure: A solution of diene P10 (20 mg, 0.05 mmol) and N-phenylmaleimide (26 mg, 0.15 
mmol) in toluene (1 mL) was heated at 60 C in a sealed vial for 20 hours. The reaction was then 
cooled and directly purified by flash chromatography (3:2 ethyl acetate:hexanes) to afford 
succinimide P34 (19 mg, 68%, white solid) as a mixture of diastereomers. 
1H-NMR (CDCl3, 500 MHz): δ 7.49 – 7.41 (m, 4H), 7.41 – 7.34 (m, 2H), 7.20 (d, J = 7.5 Hz, 2H), 
7.16 (d, J = 7.4 Hz, 2H), 5.80 – 5.51 (m, 2H), 5.51 – 5.33 (m, 1H), 5.31 – 5.16 (m, 1H), 4.08 – 
3.85 (m, 6H), 3.35 – 3.14 (m, 4H), 3.05 – 2.86 (m, 2H), 2.78 – 2.46 (m, 6H), 2.42 (dd, J = 15.9, 
7.5 Hz, 1H), 2.37 – 2.29 (m, 1H), 2.26 (ddt, J = 15.5, 7.5, 2.7 Hz, 1H), 2.23 – 2.02 (m, 5H), 2.04 
– 1.76 (m, 6H), 1.75 – 1.45 (m, 10H), 1.45 – 1.25 (m, 8H), 1.10 – 0.95 (m, 2H), 0.96 – 0.82 (m, 
6H), 0.85 – 0.66 (m, 6H).  
HRMS(ESI): m/z calc. for C32H39NO7Cl [M+H]
+: 584.2415, found: 584.2410. 
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Procedure: Diene P10 (30 mg, 0.073 mmol) and N-propargyl maleimide were dissolved in toluene 
(0.73 mL) heated to 80 C in a sealed vial for 19 hours. The reaction was the cooled to room 
temperature and purified by flash chromatography (3:2 ethyl acetate:hexanes) to provide alkyne 
P35 (35.7 mg, 90%, white solid) as a mixture of diastereomers (dr=1:1). 
1H-NMR (CDCl3, 500 MHz): δ 5.58 – 5.47 (m, 2H), 5.49 – 5.34 (m, 1H), 5.29 – 5.11 (m, 1H), 
4.30 – 4.04 (m, 8H), 4.04 – 3.90 (m, 2H), 3.23 – 3.04 (m, 5H), 3.04 – 2.81 (m, 3H), 2.69 – 2.61 
(m, 3H), 2.62 – 2.43 (m, 2H), 2.43 – 2.31 (m, 1H), 2.28 – 2.03 (m, 8H), 1.95 (ddq, J = 26.6, 12.4, 
7.5, 6.6 Hz, 3H), 1.88 – 1.77 (m, 1H), 1.75 – 1.63 (m, 7H), 1.58 (dt, J = 24.0, 8.0 Hz, 3H), 1.50 – 
1.32 (m, 8H), 1.03 (dtd, J = 32.8, 19.0, 16.4, 8.9 Hz, 2H), 0.91 (dd, J = 9.3, 5.8 Hz, 6H), 0.77 (d, 
J = 7.0 Hz, 6H).  
HRMS(ESI): m/z calc. for C29H36NO7ClNa [M+H]
+: 568.2078, found: 568.2084.  
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Procedure: To a solution of alkyne P35 (3 mg, 0.005 mmol) and BDP FL azide (2 mg, 0.005 
mmol) in N,N-dimethylformamide (0.3 mL) were added sodium ascorbate (1 mg, 0.005 mmol) 
and copper sulfate pentahydrate (1 mg, 0.003 mmol). The reaction was stirred in darkness for 24 
hours then quenched by addition of water. The crude mixture was extracted with ethyl acetate, 
washed with water, dried with magnesium sulfate, and dry loaded onto silica by evaporation. 
Purification by flash chromatography (1% methanol in ethyl acetate) provided fluorescent probe 
P36 (2.4 mg, 49%) as a mixture of diastereomers. 
Note: Compound P36 exists as a mixture of diastereomers and >100 protons are present in the 1H 
NMR spectrum. The 1H NMR spectra for P36 is provided in the NMR spectra section, however, 
the data were not tabulated.  
HRMS(ESI): m/z calc. for C46H58N7O8ClBF2 [M+H]
+: 920.4097, found: 920.4105. 
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Procedure: To a solution of α-chloroester P2 (20 mg, 0.034 mmol) in N,N-dimethylformamide 
(0.68 mL) was added sodium azide (9 mg, 0.14 mmol). The reaction was stirred 75 minutes and 
then poured into water and extracted with ethyl acetate. The combined organic layers were washed 
with water and brine, dried with magnesium sulfate, and evaporated. Purification by flash 
chromatography (3:2 ethyl acetate:hexanes) provided azide P37 (14 mg, 72 %) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.53 (d, J = 7.8 Hz, 2H), 7.47 (t, J = 7.8 Hz, 2H), 7.41 – 7.33 (m, 
1H), 5.77 – 5.64 (m, 1H), 5.41 (d, J = 8.3 Hz, 1H), 4.29 – 4.07 (m, 4H), 4.02 (q, J = 7.4, 6.9 Hz, 
1H), 3.95 – 3.80 (m, 2H), 3.16 (s, 1H), 2.94 (s, 1H), 2.75 (s, 1H), 2.52 – 2.38 (m, 1H), 2.11 (dd, J 
= 12.7, 7.2 Hz, 1H), 2.02 (dq, J = 12.7, 8.3, 6.7 Hz, 2H), 1.84 – 1.57 (m, 4H), 1.51 – 1.43 (m, 1H), 
1.42 (s, 3H), 1.04 (td, J = 14.9, 4.6 Hz, 1H), 0.96 – 0.84 (m, 6H). 
HRMS(ESI): m/z calc. for C30H37N6O7 [M+H]
+: 593.2724, found: 593.2719. 
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Procedure: A solution of α-chloroester P2 (106 mg, 0.18 mmol) and sodium iodide (54 mg, 3.6 
mmol) in acetone was heated at 50 C for 16 hours. The reaction was then cooled, evaporated and 
purified by flash chromatography (3:1 ethyl acetate:hexanes) to provide α-iodoester P38 (106 mg, 
87%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.52 (d, J = 7.5 Hz, 2H), 7.47 (t, J = 7.8 Hz, 2H), 7.40 – 7.34 (m, 
1H), 5.71 (s, 1H), 5.26 (dd, J = 8.1, 2.8 Hz, 1H), 4.24 – 4.08 (m, 4H), 4.02 (td, J = 8.5, 8.0, 4.3 Hz, 
1H), 3.69 (d, J = 10.3 Hz, 1H), 3.66 (d, J = 10.3 Hz, 1H), 3.19 (s, 1H), 3.07 (s, 1H), 2.84 – 2.70 
(m, 1H), 2.40 – 2.31 (m, 2H), 2.15 (dd, J = 12.6, 7.3 Hz, 1H), 2.03 – 1.93 (m, 2H), 1.79 (d, J = 
15.7 Hz, 1H), 1.75 – 1.53 (m, 4H), 1.51 – 1.39 (m, 1H), 1.43 (s, 3H), 1.05 (dq, J = 17.6, 5.3 Hz, 
1H), 0.94 (s, 3H), 0.93 (s, 3H).  
HRMS(ESI): m/z calc. for C30H37N3O7I [M+H]
+: 678.1676, found: 678.1669. 
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Procedure: To a solution of acetic acid (3 μL, 0.045 mmol) and potassium carbonate (19 mg, 0.14 
mmol) in N,N-dimethylformamide was added α-iodoester P38 (20 mg, 0.030 mmol). The reaction 
was stirred at room temperature for 4 hours then quenched by addition of water. The crude mixture 
was extracted with ethyl acetate, washed with water and brine, dried with magnesium, and 
evaporated. Purification by flash chromatography (3:1 ethyl acetate:hexanes) provided ester P39 
(13 mg, 69%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.56 – 7.51 (m, 2H), 7.48 (td, J = 8.2, 7.8, 1.9 Hz, 2H), 7.41 – 7.34 
(m, 1H), 5.70 (s, 1H), 5.35 (d, J = 8.2 Hz, 1H), 4.61 (d, J = 15.9 Hz, 1H), 4.53 (d, J = 15.9 Hz, 
1H), 4.23 – 4.08 (m, 4H), 4.07 – 3.98 (m, 1H), 3.19 – 3.03 (m, 1H), 2.86 (s, 1H), 2.62 (s, 1H), 2.44 
– 2.31 (m, 1H), 2.16 (d, J = 1.8 Hz, 3H), 2.15 – 2.09 (m, 1H), 2.09 – 1.94 (m, 2H), 1.89 – 1.77 (m, 
1H), 1.77 – 1.54 (m, 3H), 1.54 – 1.42 (m, 1H), 1.39 (d, J = 1.7 Hz, 3H), 1.13 – 0.99 (m, 1H), 0.98 
– 0.85 (m, 6H). 
HRMS(ESI): m/z calc. for C32H40N3O9 [M+H]
+: 610.2765, found: 610.2758.  
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Procedure: To a solution of ester P7 (615 mg, 1.62 mmol) in ethanol (16 mL) was added 
potassium hydroxide (909 mg, 16.2 mmol) and the reaction was stirred at room temperature for 15 
hours then quenched by addition of water. The crude mixture was extracted with ethyl acetate, 
washed with brine, dried with magnesium sulfate, and evaporated. Purification by flash 
chromatography (1:4 ethyl acetate:hexanes) afforded diol P40 (356 mg, 73%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 6.30 (dd, J = 17.7, 11.1 Hz, 1H), 5.44 (d, J = 17.8 Hz, 1H), 5.13 
(d, J = 11.1 Hz, 1H), 5.05 (s, 1H), 4.89 (s, 1H), 4.28 (dd, J = 12.1, 3.0 Hz, 1H), 2.39 (q, J = 10.4 
Hz, 1H), 2.34 – 2.10 (m, 3H), 2.09 – 1.93 (m, 2H), 1.82 – 1.52 (m, 5H), 1.53 – 1.43 (m, 2H), 1.40 
(ddd, J = 14.3, 9.8, 2.5 Hz, 1H), 1.30 (s, 3H), 1.15 (td, J = 13.8, 5.2 Hz, 1H), 0.94 (d, J = 6.8 Hz, 
3H), 0.71 (d, J = 6.8 Hz, 3H). 
HRMS(ESI): m/z calc. for C20H29O [M-H2O]
+: 285.2218, found: 285.2218. 
 
 
 
Procedure: To a solution of alcohol P40 (460 mg, 1.5 mmol), 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (863 mg, 4.5 mmol), and dimethyl amino 
pyridine (550 mg, 4.5 mmol) in N,N-dimethylformamide (30 mL) was added sodium fluoroacetate 
(450 mg, 4.5 mmol). The reaction was stirred for 15 hours then quenched by addition of water. 
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The crude reaction mixture was extracted with ethyl acetate, washed with water and brine, dried 
with magnesium sulfate, and evaporated. Purification by flash chromatography (1:4 ethyl 
acetate:hexanes) afforded α-fluoroester P41 (201 mg, 36%) as a white solid.  
1H-NMR (CDCl3, 500 MHz): δ 1H NMR (500 MHz, Chloroform-d) δ 6.40 (dd, J = 17.6, 11.0 Hz, 
1H), 5.66 – 5.52 (m, 1H), 5.59 – 5.48 (m, 1H), 5.25 – 5.12 (m, 1H), 5.07 (s, 1H), 4.95 – 4.81 (m, 
1H), 4.88 – 4.78 (m, 1H), 4.71 (d, J = 1.0 Hz, 1H), 2.49 – 2.35 (m, 1H), 2.35 – 2.24 (m, 2H), 2.24 
– 2.05 (m, 2H), 1.80 – 1.70 (m, 1H), 1.70 – 1.58 (m, 3H), 1.54 – 1.39 (m, 4H), 1.38 (d, J = 1.0 Hz, 
3H), 1.16 (td, J = 13.7, 5.3 Hz, 1H), 0.73 (t, J = 6.8 Hz, 6H). 
HRMS(ESI): m/z calc. for C22H31O3FNa [M+Na]
+: 385.2143, found: 385.2155. 
 
 
 
Procedure: To a solution of diene P41 (200 mg, 0.55 mmol) and triethylamine (460μL, 3.3 mmol) 
in dichloromethane (9 mL) at 0 C was added tert-butyldimethylsilyl trifluoromethanesulfonate 
(380μL, 1.65 mmol). The reaction was stirred for 3 hours while warming to room temperature then 
quenched by addition of water. The crude mixture was extracted with dichloromethane, washed 
with brine, dried with magnesium sulfate, and evaporated. Purification by flash chromatography 
(1:8 ethyl acetate: hexanes) provided silyl enol ether P42 (234 mg, 89%) as a colorless oil. 
1H-NMR (CDCl3, 500 MHz): δ 6.38 (dd, J = 17.6, 11.1 Hz, 1H), 5.74 (dd, J = 12.4, 3.0 Hz, 1H), 
5.58 – 5.42 (m, 1H), 5.13 (d, J = 11.0 Hz, 1H), 5.03 (s, 1H), 4.98 – 4.80 (m, 1H), 4.79 (s, 1H), 4.69 
(s, 1H), 4.43 (s, 1H), 2.66 (s, 1H), 2.57 – 2.45 (m, 1H), 2.25 – 2.08 (m, 2H), 2.05 (d, J = 14.4 Hz, 
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1H), 1.84 – 1.70 (m, 1H), 1.67 – 1.55 (m, 3H), 1.48 – 1.38 (m, 2H), 1.36 – 1.23 (m, 1H), 1.30 (s, 
3H), 0.95 (s, 9H), 0.73 (d, J = 6.0 Hz, 3H), 0.67 (d, J = 6.7 Hz, 3H), 0.21 (s, 6H). 
HRMS(ESI): m/z calc. for C28H46O3FSi [M+H]
+: 477.3200, found: 477.3191. 
 
 
Procedure: To a solution of m-chloroperoxybenzoic acid (339 mg, 1.47 mmol), pyridine (218 μL, 
2.70 mmol), and glacial acetic acid (647 μL, 11.3 mmol) in dichloromethane (4 mL) at -78 C was 
added a solution of silyl enol ether P42 (234 mg, 0.49 mmol) in dichloromethane (0.9 mL). The 
reaction was stirred at -78 C for one hour then warmed to 0 C and stirred an additional 3 hours 
while allowing the reaction to warm to room temperature. The reaction was quenched by addition 
of a saturated sodium sulfite solution and by addition of a solution of saturated sodium bicarbonate. 
The reaction mixture was then extracted with dichloromethane, washed with brine, and dried with 
magnesium sulfate. Purification of crude mixture was accomplished by adsorption onto silica by 
evaporation and flash chromatography (1:7 ethyl aceteate:hexanes) to provide a single isomer of 
epoxide P43 (110 mg, 44%) as a white foam. 
1H-NMR (CDCl3, 500 MHz): δ 6.40 (dd, J = 17.4, 10.9 Hz, 1H), 5.84 – 5.72 (m, 1H), 5.62 – 5.37 
(m, 1H), 5.13 (s, 1H), 5.03 (s, 1H), 4.99 – 4.85 (m, 1H), 4.81 (d, J = 2.3 Hz, 1H), 4.72 (d, J = 2.5 
Hz, 1H), 4.15 (dt, J = 10.4, 6.6 Hz, 1H), 2.85 – 2.72 (m, 1H), 2.73 – 2.58 (m, 1H), 2.25 (dt, J = 
12.3, 6.4 Hz, 1H), 1.83 – 1.61 (m, 4H), 1.54 – 1.45 (m, 2H), 1.40 (d, J = 10.6 Hz, 1H), 1.25 (dd, J 
= 17.5, 5.4 Hz, 1H), 1.19 (d, J = 1.7 Hz, 3H), 1.15 – 1.01 (m, 1H), 0.93 (d, J = 2.1 Hz, 9H), 0.80 
(d, J = 6.6 Hz, 3H), 0.59 (d, J = 6.8 Hz, 3H), 0.27 (d, J = 12.4 Hz, 6H). 
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HRMS(ESI): m/z calc. for C28H46O5FSi [M+H]
+: 509.3099, found: 509.3085. 
 
 
Procedure: A solution of epoxide P43 (107 mg, 0.21 mmol) and tetrabutylammonium fluoride 
(0.42 mL, 0.42 mmol, 1.0 M in THF) in tetrahydrofuran (4.2 mL) stirred at room temperature for 
3 hours and then quenched by addition of a solution of sodium iodide in acetone and water. The 
crude mixture was extracted with ethyl acetate and the combined organic layers were washed with 
brine, dried with magnesium sulfate, and evaporated. Purification by flash chromatography (3:2 
ethyl acetate:hexanes) gave diol P44 (39 mg, 48%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 6.36 (dd, J = 17.4, 10.9 Hz, 1H), 5.46 (dd, J = 37.2, 11.6 Hz, 2H), 
5.09 (d, J = 11.0 Hz, 1H), 5.03 (s, 1H), 4.90 (s, 1H), 4.83 (s, 1H), 4.74 (s, 1H), 4.00 (t, J = 7.8 Hz, 
1H), 3.36 – 3.06 (m, 3H), 2.37 (s, 1H), 2.17 – 2.01 (m, 2H), 1.98 (dd, J = 12.8, 8.6 Hz, 1H), 1.91 
– 1.77 (m, 1H), 1.77 – 1.62 (m, 2H), 1.63 – 1.54 (m, 1H), 1.45 – 1.40 (m, 1H), 1.40 (s, 3H), 1.06 
– 0.94 (m, 1H), 0.88 (d, J = 4.6 Hz, 3H), 0.85 (d, J = 5.7 Hz, 3H). 
HRMS(ESI): m/z calc. for C22H30O5F [M-H]
-: 393.2077, found: 393.2072. 
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Procedure: To a solution of diene P44 (8 mg, 0.02 mmol) in dichloromethane (0.4 mL) was added 
4-Phenyl-1,2,4-triazole-3,5-dione (4 mg, 0.24 mmol). The reaction was stirred 3 hours at room 
temperature then quenched by addition of water. The crude mixture was extracted with 
dichloromethane, dried with magnesium sulfate, and evaporated. Purification by flash 
chromatography (3:2-3:1 ethyl acetate:hexanes) provided urazole P45 (6 mg, 49%) as a white 
solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.53 (dd, J = 8.4, 1.5 Hz, 2H), 7.48 (dd, J = 8.7, 7.0 Hz, 2H), 7.41 
– 7.34 (m, 1H), 5.68 (s, 1H), 5.41 (d, J = 9.3 Hz, 1H), 4.87 (s, 1H), 4.78 (s, 1H), 4.30 – 4.07 (m, 
4H), 4.02 (t, J = 7.9 Hz, 1H), 3.25 – 3.09 (m, 1H), 2.93 – 2.79 (m, 1H), 2.63 – 2.51 (m, 1H), 2.51 
– 2.36 (m, 1H), 2.13 (dd, J = 12.8, 6.9 Hz, 1H), 2.07 – 1.97 (m, 2H), 1.87 – 1.70 (m, 2H), 1.72 – 
1.55 (m, 2H), 1.51 – 1.43 (m, 1H), 1.42 (s, 3H), 1.03 (t, J = 14.3 Hz, 1H), 0.92 (d, J = 7.0 Hz, 3H), 
0.90 (d, J = 6.6 Hz, 3H). 
HRMS(ESI): m/z calc. for C30H37N3O7F [M+H]
+: 570.2616, found: 570.2610. 
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Procedure: To a solution of ester P11 (356 mg, 0.84 mmol) in ethanol (8.4 mL) was added 
potassium hydroxide (235 mg, 4.1 mmol) and the reaction was stirred at room temperature for 12 
hours then quenched by addition of saturated aqueous ammonium chloride. The crude mixture was 
extracted with ethyl acetate, washed with brine, dried with magnesium sulfate, and evaporated. 
Purification by flash chromatography (1:3 ethyl acetate:hexanes) gave diol P46 (107 mg, 36%) as 
a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 1H NMR (500 MHz, Chloroform-d) δ 6.32 (dd, J = 17.2, 10.5 Hz, 
1H), 5.43 (d, J = 17.4 Hz, 1H), 5.11 – 5.04 (m, 2H), 4.93 (s, 1H), 4.06 (dd, J = 10.4, 2.1 Hz, 1H), 
3.95 (s, 1H), 3.55 (d, J = 2.6 Hz, 2H), 3.32 (s, 1H), 2.83 (t, J = 12.1 Hz, 1H), 2.29 – 2.11 (m, 1H), 
2.10 – 1.87 (m, 4H), 1.61 (d, J = 18.9 Hz, 2H), 1.55 (s, 3H), 1.47 – 1.24 (m, 4H), 1.03 – 0.83 (m, 
6H). 
HRMS(ESI): m/z calc. for C21H32O4Na [M+Na]
+: 371.2198, found: 371.2190. 
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Procedure: Diene P46 (85 mg, 0.24 mmol) and 4-phenyl-1,2,4-triazole-3,5-dione (51 mg, 0.29 
mmol) were dissolved in dichloromethane (2.4 mL) and stirred for 7 hours. The reaction was 
quenched by addition of water and extracted with dichloromethane. The combined organic layers 
were washed with brine, dried with magnesium sulfate, and evaporated. Purification by flash 
chromatography (2:1 ethyl acetate:hexaes) afforded urazole P47 (111 mg, 88%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.54 – 7.51 (m, 2H), 7.48 (dd, J = 8.6, 7.0 Hz, 2H), 7.41 – 7.35 
(m, 1H), 5.72 (s, 1H), 5.54 – 5.21 (m, 1H), 4.27 – 4.02 (m, 4H), 3.96 (s, 1H), 3.55 (d, J = 0.8 Hz, 
2H), 3.33 – 3.10 (m, 1H), 2.S90 – 2.73 (m, 1H), 2.22 (s, 1H), 2.10 (s, 2H), 1.99 (dt, J = 12.9, 6.5 
Hz, 1H), 1.90 (dd, J = 11.9, 6.8 Hz, 1H), 1.55 (d, J = 1.6 Hz, 3H), 1.52 – 1.49 (m, 1H), 1.49 – 1.39 
(m, 1H), 1.33 (td, J = 13.0, 12.1, 2.9 Hz, 3H), 0.94 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 7.1 Hz, 3H). 
HRMS(ESI): m/z calc. for C29H38N3O6 [M+H]
+: 524.2761, found: 524.2755. 
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Procedure: A solution of diol P47 (20 mg, 0.04 mmol), acetic acid (7 μL, 0.12 mmol), 1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride (23 mg, 0.12 mmol), and dimethyl amino 
pyridine (15 mg, 0.12 mmol) in dichloromethane (0.4 mL) was stirred for 26 hours then quenched 
by addition of water. The crude reaction mixture was extracted with dichloromethane, dried with 
magnesium sulfate, and evaporated. Purification by flash chromatography (3:2 ethyl 
acetate:hexanes) provided ester P48 (9 mg, 42%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.53 (dd, J = 8.5, 1.5 Hz, 2H), 7.47 (dd, J = 8.7, 7.0 Hz, 2H), 7.41 
– 7.33 (m, 1H), 5.65 (s, 1H), 5.26 (d, J = 6.9 Hz, 1H), 4.33 – 4.19 (m, 1H), 4.20 – 4.00 (m, 4H), 
3.54 (s, 3H), 3.06 (s, 1H), 2.89 (s, 1H), 2.70 – 2.56 (m, 1H), 2.42 – 2.23 (m, 1H), 2.10 – 1.96 (m, 
1H), 2.04 (d, J = 3.5 Hz, 3H), 1.80 – 1.66 (m, 1H), 1.66 – 1.52 (m, 1H), 1.47 (dd, J = 14.5, 4.2 Hz, 
2H), 1.42 – 1.36 (m, 1H), 1.34 (d, J = 4.2 Hz, 3H), 1.33 – 1.22 (m, 2H), 0.90 – 0.80 (m, 6H). 
HRMS(ESI): m/z calc. for C31H40N3O7 [M+H]
+: 566.2866, found: 566.2859.  
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Procedure: To a solution of diol P47 (20 mg, 0.04 mmol) and dimethyl amino pyridine (15 mg, 
0.12 mmol) in dichloromethane (0.4 mL) was added dichloroacetyl chloride (12 μL, 0.12 mmol). 
The reaction was stirred for 19 hours then quenched by addition of water. The crude reaction 
mixture was extracted with dichloromethane, dried with magnesium sulfate, and evaporated. 
Purification by flash chromatography (2:1 ethyl acetate:hexanes) afforded dichloro ester P49 (11 
mg, 43%) as a white solid. 
1H-NMR (CDCl3, 500 MHz): δ 7.55 – 7.50 (m, 2H), 7.51 – 7.45 (m, 2H), 7.41 – 7.35 (m, 1H), 
5.94 (s, 1H), 5.68 (s, 1H), 5.37 – 5.25 (m, 1H), 4.21 – 4.05 (m, 5H), 3.55 (s, 3H), 3.36 – 3.14 (m, 
1H), 2.88 – 2.79 (m, 1H), 2.77 – 2.64 (m, 2H), 2.51 – 2.28 (m, 1H), 2.15 – 1.97 (m, 2H), 1.97 – 
1.72 (m, 1H), 1.57 – 1.48 (m, 1H), 1.48 – 1.45 (m, 1H), 1.44 (s, 3H), 1.41 (s, 1H), 1.37 – 1.30 (m, 
1H), 0.95 (d, J = 7.0 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H).  
HRMS(ESI): m/z calc. for C31H36N3O7Cl2 [M-H]
-:632.1930, found: 632.1924. 
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Procedure: A solution of diol P47 (20 mg, 0.04 mmol), furoic acid (14 mg, 0.12 mmol), 1-Ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride (23 mg, 0.12 mmol), and dimethyl amino 
pyridine (15 mg, 0.12 mmol) in dichloromethane (0.4 mL) was stirred for 24 hours then quenched 
by addition of water. The crude reaction mixture was extracted with dichloromethane, dried with 
magnesium sulfate, and evaporated. Purification by flash chromatography (2:3 ethyl 
acetate:hexanes) afforded furoic ester P50 (8 mg, 34%) as a white solid.  
1H-NMR (CDCl3, 500 MHz): δ 7.60 – 7.56 (m, 1H), 7.55 – 7.49 (m, 2H), 7.51 – 7.43 (m, 2H), 
7.40 – 7.34 (m, 1H), 7.19 (d, J = 3.6 Hz, 1H), 6.53 (dd, J = 3.6, 1.8 Hz, 1H), 5.74 – 5.53 (m, 1H), 
5.49 – 5.32 (m, 1H), 4.31 – 3.98 (m, 5H), 3.55 (s, 3H), 3.31 – 3.08 (m, 1H), 2.79 – 2.64 (m, 1H), 
2.46 – 2.28 (m, 1H), 2.14 – 2.00 (m, 2H), 1.98 – 1.82 (m, 1H), 1.69 – 1.54 (m, 3H), 1.55 – 1.45 
(m, 2H), 1.44 (s, 3H), 1.36 – 1.29 (m, 1H), 0.98 – 0.75 (m, 6H). 
HRMS(ESI): m/z calc. for C34H40N3O8 [M+H]
+: 618.2815, found: 618.2813. 
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Procedure: A solution of diol P47 (20 mg, 0.04 mmol), acrylic acid (8 μL, 0.12 mmol), 1-Ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride (23 mg, 0.12 mmol), and dimethyl amino 
pyridine (15 mg, 0.12 mmol) in dichloromethane (0.4 mL) was stirred for 24 hours then quenched 
by addition of water. The crude reaction mixture was extracted with dichloromethane, dried with 
magnesium sulfate, and evaporated. Purification by flash chromatography (2:1 ethyl 
acetate:hexanes) afforded furoic ester P51 (3 mg, 15%) as a white solid.  
1H-NMR (CDCl3, 500 MHz): δ 7.53 – 7.44 (m, 4H), 7.42 – 7.34 (m, 1H), 5.70 (s, 1H), 5.67 – 5.30 
(m, 1H), 4.24 – 4.00 (m, 6H), 3.91 (s, 1H), 3.53 (s, 3H), 3.36 – 3.12 (m, 1H), 2.86 – 2.73 (m, 1H), 
2.71 – 2.53 (m, 1H), 2.14 – 2.02 (m, 3H), 1.97 (dq, J = 12.9, 6.6 Hz, 1H), 1.88 (q, J = 8.6 Hz, 1H), 
1.52 (s, 3H), 1.43 (ddt, J = 16.6, 11.1, 5.0 Hz, 1H), 1.36 – 1.22 (m, 4H), 0.99 – 0.91 (m, 3H), 0.90 
(d, J = 7.1 Hz, 3H). 
HRMS(ESI): m/z calc. for C32H40N3O7 [M+H]
+: 578.2866, found: 578.2869. 
4.7.4 Cell Culture Studies 
Anticancer Screen: 40 µL of media was added to all wells of a 384-well tissue culture-treated 
plate using an electronic multichannel pipette. 3x 100 nL of compound in DMSO was then pin-
transferred from compound storage plates (2 mM stocks) into media-containing wells using the 
Platemate Plus at the UIUC HTSF. A 100,000 cells/mL suspension of HCT 116, ES-2, and Mia 
278 
 
Paca-2 cells was prepared, and 10 µL was added to each well using an electronic multichannel 
pipette for a final concentration of 1000 cells/well. Doxorubicin (100 µM final) was used as a 
positive control. Plates were sealed with gas-permeable seals and incubated at 37 °C for 72 h. After 
incubation, 5 µL of Alamar blue (440 µM resazurin in sterile PBS) was added and allowed to 
incubate for 3-4 h, until visible color change occurred. 
Dose Response (IC50) Curves: To a 384-well plate, 40 µL of 1.25X compound dilution or 1.25% 
DMSO-containing media was added (final volume of 1% DMSO in all wells). Concentrations of 
compounds tested were 100µM to 100 nM. On each plate at least 3 technical replicates were 
performed. Next, 10 µL of a 100,000 cells/mL suspension (HCT 116 or ES-2 cells) was added to 
each well, yielding a final concentration of 1,000 cells/well. To three wells in column 2 was added 
1 µL of 10 mM doxorubicin (final concentration of 200 µM) as positive control that should result 
in cell death. Plates were sealed with gas-permeable seals and incubated at 37 ˚C for 72 h. At that 
time, 5 µL of Alamar blue (440 µM resazurin in sterile PBS) was added, the plates were incubated 
for 3-4 hours. Fluorescence was read on an Analyst HT or a Molecular Devices SpectraMax 3 
(excitation = 555 nm, emission = 585 nm, emission cutoff = 570 nm). Wells were normalized to 
the average of untreated wells (0% cell death). The data were plotted as compound concentration 
versus percent dead cells, and fitted to a logistic-dose response curve using OriginPro 2015 
(OriginLab, Northampton, MA). Hill Slope and Emax values were obtained from curves fitted by 
OriginPro. The data were generated in triplicate, and IC50 values are reported as the average of 
three separate experiments along with standard error of the mean. 
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4.7.5 Glutathione Conjugation Assay 
 To a 2 mL glass scintillation vial was added 225 µL of 1X PBS, 5 µL of 10 mM DMSO 
stock of compound (P2, P38, or P49), 20 µL of DMSO, and 250 µL of 10 mM reduced glutathione 
in 1X PBS. Immediately after addition of glutathione, a 50 µL aliquot was removed. The remaining 
solution was then incubated at 37 ºC and 50 µL aliquots were removed after 1 hour and 2 hours. 
Aliquots were diluted with 150 µL of methanol, centrifuged, and analyzed by LCMS. The reactions 
between glutathione and P2, P38, and P49were monitored by UV-vis spectroscopy (220 nM) and 
mass spectrometry. Molecular ions for compounds and glutathione adducts were identified by 
extracted ion chromatograms (EIC) of mass spectra (GSH [M+H]+ = 308.09, P2 [M+Na]+ = 
608.21, P2+GSH [M+H]+ = 857.34, P38 [M+Na]+ = 700.15, P38+GSH [M+H]+ = 8557.34, P49 
[M+Na]+ = 642.17, P49+GSH [M+H]+ = 891.30). 
P2 + GSH no incubation UV: 220 nm
P2 + GSH no incubation EIC (308.0-308.2)
[M+H]+
[M+GSH+H]+
P2 + GSH no incubation
EIC (608.1-608.3)
P2 + GSH no incubation
EIC (857.2-857.4)
[GSH+H]+
[M+H]+
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P2 + GSH 1 hr incubation UV: 220 nm
P2 + GSH 1 hr incubation EIC (308.0-308.2)
[M+H]+
[M+GSH+H]+
P2 + GSH 1 hr incubation
EIC (608.1-608.3)
P2 + GSH 1 hr incubation
EIC (857.2-857.4)
[GSH+H]+
[M+H]+
[M+GSH+H]+
P2 + GSH 2 hr incubation UV: 220 nm
P2 + GSH 2 hr incubation EIC (308.0-308.2)
[M+H]+
[M+GSH+H]+
P2 + GSH 2 hr incubation
EIC (608.1-608.3)
P2 + GSH 2 hr incubation
EIC (857.2-857.4)
[GSH+H]+
[M+H]+
[M+GSH+H]+
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P38 + GSH no incubation UV: 220 nm
P38 + GSH no incubation EIC (308.0-308.2)
[M+GSH+H]+
[M+GSH+H]+
P38 + GSH no incubation
EIC (700.1-700.3)
P38 + GSH no incubation
EIC (857.2-857.4)
[GSH+H]+
[M+H]+
[M+H]+
P38 + GSH 1 hr incubation UV: 220 nm
P38 + GSH 1 hr incubation EIC (308.0-308.2)
[M+GSH+H]+
[M+GSH+H]+
P38 + GSH 1 hr incubation
EIC (700.1-700.3)
P38 + GSH 1 hr incubation
EIC (857.2-857.4)
[M+H]+
[GSH+H]+
P38 + GSH 2 hr incubation UV: 220 nm
P38 + GSH 2 hr incubation EIC (308.0-308.2)
[M+GSH+H]+
[M+GSH+H]+
P38 + GSH 2 hr incubation
EIC (700.1-700.3)
P38 + GSH 2 hr incubation
EIC (857.2-857.4)
[GSH+H]+
[M+H]+
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P49 + GSH no incubation UV: 220 nm
P49 + GSH no incubation EIC (308.0-308.2)
[M+H]+
P49 + GSH no incubation
EIC (656.1-656.3)
P49 + GSH no incubation
EIC (905.2-905.4)
[GSH+H]+
[M+H]+
P49 + GSH 1 hr incubation UV: 220 nm
P49 + GSH 1 hr incubation EIC (308.0-308.2)
[M+H]+
P49 + GSH 1 hr incubation
EIC (656.1-656.3)
P49 + GSH 1 hr incubation
EIC (905.2-905.4)
[GSH+H]+
[M+H]+
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4.7.6 Computational Analysis 
Molecular Property Distribution Histograms 
 
Library data for the MicroFormat Library was obtained via the ChemBridge website. 
Library data for approved cancer drugs was obtained from NCI as the Approve Oncology Drugs 
Set VI (https://wiki.nci.nih.gov/display/NCIDTPdata/Compound+Sets). Library data for approved 
antibacterials was obtained from O’Shea and Moser.60  
The number of stereogenic centers were calculated in Canvas 2.2 (Schrodinger, New York) 
using the Ligfilter Descriptor “Num_chiral_centers” in the Molecular Properties application. The 
following Python program (ctd_score.py) calculates several relevant molecular descriptors given 
a properly formatted sdf file. The ctd_score.py requires RDKit, an open-source collection of 
cheminformatics software. 
The program is run from the command line with the following syntax: 
 
  > python ctd_score.py FILENAME.sdf 
where FILENAME.sdf is a collection of molecules to be calculated. A new file is written with 
“descr.sdf” appended to the end of the filename. 
 
 
 
 
P49 + GSH 2 hr incubation UV: 220 nm
P49 + GSH 3 hr incubation EIC (308.0-308.2)
[M+H]+
P49 + GSH 2 hr incubation
EIC (656.1-656.3)
P49 + GSH 2 hr incubation
EIC (905.2-905.4)
[GSH+H]+
[M+H]+
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#   
# calculation of molecular descriptors and complexity index   
#   
# Implements RDKit   
#   
# Bryon Drown, May 2015   
# Updated Oct. 9, 2015   
# University of Illinois, Urbana-Champaign   
#   
#   
   
import sys   
from rdkit import Chem   
from rdkit.Chem import Descriptors   
from rdkit.ML.Descriptors import MoleculeDescriptors   
from collections import defaultdict   
from collections import OrderedDict   
   
def calcRingDescriptors(m):   
  nBonds = m.GetNumBonds()   
  nAtoms = m.GetNumAtoms()   
  cyclomatic = nBonds - nAtoms + 1   
  if(cyclomatic < 1): return   
     
  ri = m.GetRingInfo()   
  if(ri.NumRings() < 1): return   
  # get total ring path and nBondRings   
  totalRing = 0   
  Bonds = []   
  Bridges = []   
  for ring in ri.BondRings():   
    for id in ring:   
      if (ri.NumBondRings(id) > 1):   
        Bridges.append(id)   
      totalRing+=1   
      Bonds.append(id)   
         
  # remove duplicates, then get length     
  nBondRings = len(OrderedDict.fromkeys(Bonds).keys())   
  nBridgeEdges = len(OrderedDict.fromkeys(Bridges).keys())   
     
  # get nAtomRings   
  Atoms=[]   
  for ring in ri.AtomRings():   
    for id in ring:   
      Atoms.append(id)       
  nAtomRings=len(OrderedDict.fromkeys(Atoms).keys())   
     
  # descriptors   
  ringFusionDensity = 2 * float(nBridgeEdges) / float(nAtomRings)   
  ringComplexityIndex = float(totalRing) / float(nAtomRings)   
  molecularCyclizedDegree = float(nAtomRings) / float(nAtoms)   
  nRingSystems = (nBonds - nBondRings) - (nAtoms - nAtomRings) + 1   
  if(nRingSystems < 1):    
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    ringFusionDegree = 0   
  else:   
    ringFusionDegree = float(cyclomatic) / float(nRingSystems)   
     
  # set props   
  m.SetProp('TotalRing',str(totalRing))   
  m.SetProp('NumBridges',str(nBridgeEdges))   
  m.SetProp('nBondRings',str(nBondRings))   
  m.SetProp('nAtomRings',str(nAtomRings))   
  m.SetProp('ringFusionDensity',str(ringFusionDensity))   
  m.SetProp('ringFusionDegree',str(ringFusionDegree))   
  m.SetProp('ringComplexityIndex',str(ringComplexityIndex))   
  m.SetProp('molecularCyclizedDegree',str(molecularCyclizedDegree))   
  m.SetProp('NumRingSystems',str(nRingSystems))   
     
  return    
   
if __name__=='__main__':   
    file_in  = sys.argv[1]   
    file_out = file_in+".descr.sdf"   
    ms = [x for x in Chem.SDMolSupplier(file_in) if x is not None]   
    ms_wr = Chem.SDWriter(file_out)   
   
    nms= ('BalabanJ','BertzCT','FractionCSP3','MolWt','RingCount')   
    calc = MoleculeDescriptors.MolecularDescriptorCalculator(nms)   
   
    for i in range(len(ms)):   
      descrs = calc.CalcDescriptors(ms[i])   
      calcRingDescriptors(ms[i])   
      for x in range(len(descrs)):   
        ms[i].SetProp(str(nms[x]),str(descrs[x]))   
      ms_wr.write(ms[i])   
 
Three-dimensional histograms plotting Fsp3 and the number of stereogenic centers were 
prepared in OriginPro 2015 (OriginLab, Northampton, MA) using the 2D Frequency 
Count/Binning feature. The number of stereogenic centers was set to X and bin range was set to 
“Bin Centers”. The minimum bin center was set to 0, the max bin center was set to 8, and the bin 
size was set to 1. Outliers greater than or equal to the maximum were included and the output 
binning order was set to descending. Fsp3 was set to Y and the bin range was set to “Bin Centers”. 
The minimum bin center was set to 0, the max bin center was set to 1, and the bin size was set to 
0.1. Outliers greater than or equal to the maximum were included and the output binning order was 
set to ascending. The quantity to compute was set to “Count”. The resulting data set was then 
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exported to Excel (Microsoft, Redmond WA) and plotted in a 3D column plot (number stereogenic 
centers = series, Fsp3 = category).      
Tanimoto Similarity Analysis 
 
Extended connectivity fingerprints (32-bit) were calculated with Canvas 2.2 (Schrodinger, 
New York) using hashed radial (ECFP) fingerprints with 3 radial iterations, daylight invariant 
atom types, and bonds distinguished by bond order. Similarity matrices were created in Canvas 
using the “Similarity/Distance From Fingerprints” task. Heatmaps were generated in Excel 
(Microsoft, Redmond WA) using a three-color scale set to 0.04 (R=104, G=148, B=190), 0.38 
(R=216, G=227, B=125), and 1.0 (R=248, G=105, B=107).  
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